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Molecular model for the enzyme barnase interacting with a penta-nucleotide ligand. 
The enzyme molecular surface is shown in blue and the penta-nucleotide ligand is represen-
ted using a stick model with oxygen atoms in red, nitrogen atoms in blue, carbon atoms in 
yellow and the phosphorous atom in white. 
The enzyme atomic coordinate are from the 2A resolution crystal structure; the ligand coor-
dinates were generated using molecular modelling techniques. 
Image generated using BRUGEL, a computer program developed jointly by UCMB-ULB and Plant Genetic System 
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The European Commission's BIOTECHNOLOGY programme constitutes the natural 
continuation of the three previous Community programmes (BEP, BAP and BRIDGE) 
that, from 1982 to 1993, provided the framework for the establishment of a European 
network for training and research in the field of Biotechnology [1 ]. These programmes 
contributed to the development of supportive infrastructures for biotechnology research 
in Europe and to the elimination of barriers to knowledge and know-how which could 
have prevented exploitations of the results originating from modem biology [2]. 
The aim of research activities under the BIOTECHNOLOGY programme is to reinforce 
the access to, and use of biological knowledge as the rate-limiting step for 
biotechnological applications in agriculture, industry, health care and the environment. 
There is a major need to strengthen the scientific research base to improve Europe's 
competitiveness --public and industry expectations are best served by maintaining a 
sound basic research structure upon which either normative activities or commercial 
technologies can be developed by the actors themselves in their regulatory and 
economic environments. 
The current programme BIOTECHNOLOGY covers the period 1992-1994 with a 
budget of ECU 189 million. Research activities in this programme are implemented via 
four different modalities: 
- Basic research projects, integrating research efforts in adapted Community structures 
(European Laboratories Without Walls - EL WW [3], initially implemented in the BAP 
programme) for tasks where the main bottlenecks result from gaps in basic knowledge. 
- Generic Research Projects, deliberately combining the contributions of different 
disciplines and techniques through efforts intended to remove important bottlenecks 
resulting from structural and scale constraints. They will lead to the constitution of 
clusters of laboratories addressing in an integrated manner, throughout the Community, 
highly specific research issues where an impact is to be expected. 
- Projects of Technological Priority, aiming to achieve a higher degree of coherence 
and ultimate impact in certain areas of the programme. The areas are defined as those 
where a significant change of the state of the art now requires exceptional cross-linking 
efforts involving a wide range of potential contributors. 
- Concerted Actions, creating Community networks of competencies and skills where 
national funding is widely available or where coordination of existing work and projects 
is a prerequisite to the launching, in a future Community programme, of new specific 
Basic and Generic research projects. 
Following the first call for proposals in 1992, 99 projects have been launched during 
1993. These encompass 856 participants from the 12 Member States and EFTA 
countries. These projects were selected from originally 529 proposals involving a total 
2 Catalogue of contracts 
of 2,856 organisations. Table 1 gives an overview of the results of the selection. 
The present Catalogue groups the projects under areas, topics and sub-topics 
corresponding to the organisation of the Biotechnology work programme. Within each 
sub-topic, projects are grouped according to the implementation modalities described 
above. For each of these projects, the catalogue provides a title, some contract details, 
a summary of the objectives as well as a brief work description and a number of 
keywords. This outline is followed by a list of names of each of the participants in the 
projects. Indexes of participants, contract numbers and keywords are given at the end 
of the catalogue. 
TABLE 1 
BIOTECHNOLOGY 
1st CALL FOR PROPOSALS 
Projects Partners Cost proposed Contribution 
proposed involved (million ECU) requested 
(million 
ECU) 
Entire Call 529 2,856 888 679 
Selected 131 872 258 196 
Contracted 99 856 149 111 
Detailed information on these projects can be found in brochures describing each of the 
G-projects and the ELWW's constructed around the B-projects. These brochures are 
available from the Biotechnology unit of the European Commission upon request. 
Annual reports giving full details of the results are foreseen to appear during 1994 and 







Directorate Life Sciences and Technologies. 
Directorate-General for Science, Research and Development - Joint Research Center 
[1] Magnien, E., de Nettancourt, D. (1993). What drives EC Biotechnology research. 
IJTM, Special publication on the Management of Biotechnology, 47-58. 
[2] Vassarotti, A. and Magnien, E. (1991) Biotechnology R&D in the European 
Communities, vol I, Catalogue of BAP Achievements, Elsevier, Paris 
(3] Magnien, E., Aguilar, A., Wragg, P. and de Nettancourt, D. (1989) Biofutur, 
November, 17-30. 
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1.1 Protein structure and function 

1.1.1 Understanding of the catalytic mechanism of enzymes associated with 
biological membranes. Priority will be given to multidisciplinary studies of 
structure-function relationships of cytochromes and transport ATPases, using 
a variety of comple-mentary techniques (spectroscopic, crystallographic, 
molecular genetic, etc.). 
1.1.2 Understanding of the interaction of antibodies with antigens: design of 
antigen binding sites leading to antibodies having predictable new properties, 
such as increased affinity or enzymatic properties. 
1.1.3 Multidisciplinary studies of the structure-function relationships of receptors. 
Priority will be given to proposals that focus on ligand-receptor interactions 
and their consequent signal transduction events. 
1.1.4 Production of novel biocatalysts, as a follow-up of tasks 1, 2 & 3 above. 

Protein structure and function 
Structure/function studies of the cytochrome bf complex by biochemical, 
biophysical, and molecular genetic techniques 
Contract number: CT930076 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 738,000 ECU 
Objectives: 
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1. Structural details on the molecular level of the cytochrome bf complex. 2. Internal 
functions of the subunits and the redox centers. 3. Interaction of the complex within the 
framework of energy converting electron transfer chains. 
Brief description: 
The project will provide detailed information on the structure-function relationship of 
the membrane bound cytochrome bf complex at a molecular level. This complex plays 
a central role in electron transfer and energy conservation in photo-synthetic electron 
transport. The knowledge of the cytochrome bf complex is far less advanced than that 
of the photo-synthetic reaction centers and requires a combined effort in order to make 
a substantial progress. The project represents a multi-disciplinary effort by a group of 
European laboratories each of which is involved in the forefront of research related to 
this enzyme since many years. The cooperation will concentrate the resources of the 
laboratories in advanced biochemical, biophysical, and molecular genetic methods 
which will add a new dimension to the efficiency of research in this field. The 
combined spectroscopic facilities of the laboratories will create an extraordinary 
combination. The alga Chlamydomonas reinhardtii which is well established in one of 
our groups is the only organism available today for protein design by site-directed 
mutagenesis of the cytochrome bf complex in order to study specific structural and 
functional questions. Our investigation of this complexes will also include other 
organisms covering a broad range from anaerobic photosynthetic bacteria and 
thermophilic cyanobacteria to higher plants. The supply of manpower is expected to 
provide the impact for solving the mechanism of this poorly understood complex, for 
performing the structural studies by molecular genetics and mass spectrometry in 
combination with measurements of the function, and for solving the three-dimensional 
structure from X-ray diffraction in the long term. 
Keywords: 
Cytochrome bf complex, Protein, Photosynthesis, Protein interaction, Structure function 
relationship, Mutagenesis, Electron transport, Reaction kinetics, Chlamodymonas 
reinhardtii 
12 Molecular Approaches 
Coordinator 
PROF.DR HAEHNEL WOLFGANG 
ALBERT LUDWIGS UNIVERSITAT FREIBURG 
INSTITUT FUR BIOLOGIE II 
LEHRSTUHL FUR BIOCHEMIE DER PFLANZEN 
SCHANZLESTR. 1 
D - 79104 FREIBURG 
Participants 
JOLIOT PIERRE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
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Structure and function of photosynthetic membrane- H+·ATPases 
Contract number: CT930078 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 1,095,000 ECU 
Objectives: 
Optimization of H+-A TPase and subunit preparations for crystallization studies. Partial 
resolution of three-dimensional protein complex and subunit structures. Elucidation of 
specific subunit functions and enzyme modulation mechanisms. Analysis of 
protein-lipid interaction and of factors determining protein thermostability. 
Brief description: 
This project aims at the elucidation of the structure and function of the H+-ATPases of 
photosynthetic organisms. These key enzymes for energy conservation transform a 
trans-membrane proton gradient into ATP, and vice versa. They are regulated by 
ingeneous mechanisms, tuned to the specific requirements of different organisms. They 
are experimentally advantageous objects by enabling activation by light and fast kinetic 
analysis. The high-resolution three-dimensional structures of the H+-ATPases are not 
known, and the regulatory mechanisms that modulate ATP synthesis or hydrolysis and 
coupled proton transport are not fully understood. A collaborative network was 
established for multi-disciplinary research of these aspects. The ATPases will be 
isolated and purified from chloroplasts, photosynthetic bacteria and cyanobacteria. 
These include thermostable species which are of particular advantage for crystallization 
and application-motivated studies. Enzyme structure will be investigated in 
two-dimensional crystal lattices by high-resolution electron microscopy and image 
analysis, and by atomic force microscopy. In addition, fluorescence, Ff-IR and NMR 
spectroscopy, as well as DSC will be employed, also in soluble and pre-crystalline 
states. The function and regulation of the A TPases will be studied in reconstituted 
proteoliposomes and in native membranes. This will involve kinetic measurements of 
the catalytic reactions and coupled proton flux, analysis of coupling efficiency and of 
enzyme modulation, and effects of lipids and membrane surface charge on protein 
insertion and enzymatic activities. Moreover, the functions of the small ATPase 
subunits will be studied by heterologous subunit exchange and by site-directed amino 
acid substitutions. New results obtained with the native thermostable and with modified 
forms of these enzymes are of great interest to protein engineering, i.e. technological 
applications. 
Keywords: 
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Drug, antibiotic and toxin excretion mechanisms in pro- and eukaryotic cells 
Contract number: CT930145 (Basic Research Project) 
Start date: 01/08/93 Duration: 36 months 
EC contribution: 1,186,000 ECU 
Objectives: 
To converse the knowledge from eukaryotic and bacterial drug, antibiotic and toxin 
excretion systems, to understand the molecular mechanisms of these excretion systems 
and to manipulate these systems in order to control the effect of the toxic compounds 
on cells. 
Brief description: 
The aim of this project is to analyze the functional and structural properties of transport 
systems involved in the secretion of drugs, antibiotic and toxins in pro- and eukaryotes. 
Some of these systems belong to the ABC superfamily of ATP-dependent transporters, 
whereas others belong to the class of ion-linked secondary transporters. The substrate 
recognition determinants will be defined that effect the high specificity of some and the 
low specificity of other systems. The transport processes will be analyzed energetically 
and kinetically upon functional reconstitution of the individual systems into artificial 
membranes. These studies will reveal common features for the excretion of (mostly) 
hydrophobic compounds, and may suggest ways to manipulate individual efflux 
processes in vivo. The knowledge that will be generated about drug, antibiotic and 
toxin transport may have medical and industrial impact for the near future. 
Keywords: 
Drug resistance, ATPase, Transport, Membrane, Bacteria, Eukaryotes, Toxins, 
Antibiotics, Drugs, Excretion, Energetics 
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Coordinator 
PROF. KONINGS WIL 
UNIVERSITY OF GRONINGEN 
DEPARTMENT OF MICROBIOLOGY 
BIOLOGICAL CENTER 
KERKLAAN 30 
NL- 9751 NN HAREN 
Participants 
Molecular Approaches 
COVE JONATHAN ........................................ GB 
HIGGINS CHRISTOPHER ................................... GB 
HOLLAND IAN BARRY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
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Protein structure and function 
Membrane bound ATPases involved in the translocation of hydrophobic 
molecules 
Contract number: CT930348 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 1,171,000 ECU 
Objectives: 
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To understand at the molecular level the family of ATPases involved in the 
translocation of phospholipids and/or drugs from one side of a membrane to the other. 
To purify, clone and characterize proteins from this "flippase" family. To evaluate the 
physiological consequences of any impairement of flippase activity. 
Brief description: 
Several membrane bound ATPases are involved in the translocation of hydrophobic 
molecules through the membranes of eukaryotes. The aminophospholipid translocase, 
also called "flippase", transports aminophospholipids from the outer monolayer to the 
inner monolayer of plasma membranes. Such transport requires hydrolysable Mg-ATP. 
Recently it has been suggested that one should include in the same category of 
proteins the 170 kDa P-glycoprotein (P-gP) which is responsible for the multidrug 
resistance in cancer cells. The latter carrier transports hydrophobic molecules from the 
inner to the outer monolayer of plasma membranes. The P-gP appears to be also a 
chloride channel. The aminophospholipid translocase which is partially purified from 
red cells will be cloned and antibodies generated. The activity of the protein will be 
studied in reconstituted systems; its role on lipid asymmetry and membrane shape 
change will be investigated in giant liposomes. Attempts will be made to find such 
selective translocation of phospholipids in the membrane of organelles (Golgi system, 
endosomes). The physiological consequences of the flippase activity will be 
considered in particular during red cell clearance, myoblast fusion and possibly blood 
doting. In parallel experiments the flippase hypothesis for the P-gP will be verified 
by measuring the orientation of hydrophobic molecules transported by this ATPase. 
A putative role of the P-gP in lipid (cholesterol ?) asymmetry will be investigated. Site 
directed mutagenesis of P-gP will be used to study its flippase and chloride channel 
activities in cells or in reconstituted systems. 
Keywords: 
Mg-atpases, Flippase, Multidrug-resistance, Aminophospholipid translocase, 
P-glycoprotein, Ion channel, Lipid asymmetry, Spin-labels 
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Structure and function of NADH : ubiquinone oxidoreductase ( complex 1 ) 
Contract number: CT930364 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 836,000 ECU 
Objectives: 
To study crystallisation of bovine complex I and fragments of it. 
To characterise its redox centres. 
To characterise complex I from Rhodobacter capsulatus and plant chloroplasts, and 
hydrogenase from Chromatium. 
Brief description: 
NADH:ubiquinone oxidoreductase (complex I) provides the entry point for electrons 
from NADH into the respiratory chain in mitochondrial membranes. Defects in the 
enzyme are associated with major human diseases (Parkinson's and Alzheimer's 
disease), rare neuromuscular disorders and ageing. The main aim of this proposal is 
to study structure and organisation of subunits of complex I, and to determine the 
locations of redox centres. This proposal builds on existing collaborations between 
Cambridge and Amsterdam [studies of Fe-S clusters by Electron Paramagnetic 
Resonance (EPR) spectroscopy] and Cambridge and Grenoble (studies of bacterial 
complex I). Drs Walker, Dupuis (Grenoble) and Arizmendi (Bilbao) have also 
collaborated on studies of bovine complex I conducted in Cambridge. It is proposed to 
use a variety of techniques to study the topography of complex I, to attempt to 
crystallise it and active subcomplexes, to locate NADH, FMN and Fe-S cluster binding 
sites, to characterise a bacterial enzyme from Rhodobacter capsulatus and a related 
enzyme for which at least 14 subunits are encoded in chloroplast DNA in higher plants. 
Keywords: 
Complex i, Mitochondrial, Rhodobacter capsulatus, Chloroplasts, Flavin 
mononucleotide, Iron-sulphur clusters, Hydrogenase, Chromatium, Sequences, Structure, 
Electron paramagnetic resonance spectra, Antibody 
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Protein structure and function 
Combined structural mechanistic and functional analysis of two similar 
eucaryotic transport ATPases : the H+ and Ca2+ pumps 
Contract number: CT930422 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 760,000 ECU 
Objectives: 
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The main objective of this project will be the understanding of the molecular 
mechanism of the P-type ion pumps, more specifically the coupling mechanism 
between the phosphate transfer reaction and the ion translocation through the 
membrane, with a special emphasis on yeast plasma membrane H+-ATPase and 
sarcoplasmic reticulum Ca2+-A TPase. 
Brief description: 
The main objective of this project is the understanding of the molecular mechanism of 
the P-type ion pumps. More specifically the coupling mechanism between the 
phosphate transfer reaction and the ion translocation through the membrane, with a 
special emphasis on yeast plasma membrane H+-ATPase and sarcoplasmic reticulum 
Ca2+-ATPase. These two enzymes are among the simplest eukaryotic P-type ion pumps 
(nob-subunit) whose biochemical and biophysical properties of the purified enzymes 
have been well studied by the participating scientists. Genetic engineering is well 
developed and a major expertise in molecular biologyis available for the yeast 
H+-ATPase. Biophysical knowledge of the Ca2+-ATPase is by far the most advanced 
among the P-type pumps, especially attributable to the development of highly 
sophisticated instruments by members of the group. The elucidation of the molecular 
mechanism of these P-type ATPases involve the following intermediate targets: 1) 
Functional and structural analysis of the small and large hydrophilic loops (nucleotide 
binding, phosphorylation, phosphatase activity) 2) Functional analysis of the 
hydrophobic transmembrane region (ion binding and translocation), 3) Functional and 
structural analysis of selected peptides(phosphorylation and nucleotide binding site), 
4) Investigation of the interactions between the cytoplasmic region and the 
transmembrane domain. The manufacturing of ATPase protein( wild type and chimeric), 
of large fragments and of peptides constitute the most innovative approach that may 
lead to the understanding of the molecular mechanism of energy transduction in p-type 
A TPases. Investigations include genetic engineering,expression of protein fragments 
synthetic peptides,studies on active site reactivity and substrate binding transient state 
kinetic studies, role of the H+ -ATPase proteolipid search for specific inhibitors and 
substrate analogues, electrophysiological and biophysical (fluorescence, circular 
dichroism, FR-IR, FT-Raman, NMR and X-ray crystallography) studies and molecular 
modeling. 
Keywords: 
ATPase, H+ pump, Ca2+ pump, Structure, Membrane 
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Plantibodies : A flexible approach to endow plants with new properties 
Contract number: CT920239 (Basic Research Project) 
Start date: 01/01/92 Duration: 36 months 
EC contribution: 1,199,972 ECU 
Objectives: 
The objective is to improve the basic technology to express and target "single chain" 
variable fragments (scFv) of antibody molecules in plants. This technology offers the 
possibility to design and alter metabolic routes (catalytic antibodies) to engineer disease 
resistance and to study plant growth and development by antisense-like approaches. 
Brief description: 
Antibodies have an enormous potential to enrich plants with new properties. Exploiting 
the vast immune repertoire of animals will lead to new strategies in plant breeding. 
Antibody molecules offer, for example, perspectives to engineer disease resistance, to 
alter or design metabolic routes ('catalytic antibodies') and to modify plant growth and 
development by antisense-like approaches. This joint effort is aimed at improving the 
basic technology to express and target antibody molecules in plants. Antibodies have 
several desirable features with regard to protein engineering. The variable domains 
carrying the antigen-binding loops (VH and VI domains) can be used separately from 
the constant domains without loss of affinity. This project is focused on the expression 
and targeting of functional 'single chain' variable antibody fragments (scFv) in plants. 
In an scFv the variable parts of the heavy (VH) and light (VL) chain of the 
immunoglobulin molecule are linked by a peptide. Expression of scFv overcomes 
several problems inherent to the expression and assembly of heteromultimeric 
immunoglobulins in plants. In addition it is possible to incorporate two or more single 
chain antibodies having distinct specificities without having the problem of at random 
combination of VH and VL regions, which drastically reduces the affinity and 
specificity. To optimize the expression and targeting, the effect of different promoters, 
signal peptides, fusion to large parts of existing genes and the KDEL sequence will be 
studied. In addition we will investigate the role of the Bip-protein, which is found in 
the ER of animal systems. The Bip-proteins is a chaperone and may improve the 
assembly and folding of monoclonal antibodies in plants. Immunoglobulins inhibiting 
the development of three distinct plant pathogens (a bacterium, a virus and a plant 
parasitic nematode) will serve as model antibodies. These pathogens invade and 
colonize their hosts along different routes and are suitable models to study the 
versatility of monoclonal antibodies in targeting functional scFv's to different cellular 
compartments. 
Keywords: 
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Protein structure and function 
Generation of functionally optimized antibody fragments for industrial 
(non-pharmaceutical) use 
Contract number: CT920367 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 840,000 ECU 
Objectives: 
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To define general rules by which to improve stability of antibody derived fragments. 
The aim is to provide fragments by large scale fermentation, that will withstand 
industrial scale downstream processes. Concurrently, the relation between protein 
stability, flexibility and binding characteristics will be investigated, and exploited to 
endow fragments with optimized functionality. 
Brief description: 
In the present project draft, we propose to modify antibody fragment (ABF) structures 
with the aim to control flexibility in essential regions (core, secondary structural 
elements, and surface loops and cavities ) of the protein. There is sufficient scientific 
evidence to justify that such control, depending on its precise localization (core or 
surface), will enable us to improve overall stability of the protein, and in addition, to 
manipulate interaction dynamics with ligands. Precisely these two characteristics of 
protein function, need optimization in order to generate ABFs suited for industrial 
purposes. At present ABFs lack sufficient stability to allow industrial scale production 
and manufacturing processes. Furthermore, a number of envisaged applications, demand 
initial binding of ABF to target molecules with subsequent release of the target upon 
change of conditions, i.e. control over binding dynamics. We propose to use 2 existing 
ABFs. One of known 3D structure, acting as the model in which engineering concepts 
and randomly found mutations can be tested and rationalized. The other of commercial 
importance, allowing final testing under application conditions. All aspects of protein 
engineering technology will be covered: precise and random mutagenesis followed by 
screening, multiple peptide synthesis, structure determination (X-ray), biophysical 
protein studies, and computer modelling. The proposed research presents a unique 
combination of scientific expertises, and can provide a breakthrough in the application 
of ABFs in industrial (non-pharmaceutical) products. 
Keywords: 
Antibody fragments, Protein flexibility, Protein engineering, Ligand binding, Kinetics 
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Protein structure and function 
Protein engineering of therapeutic antibodies and peptide antagonists of 
scatter factor, a novel protein involved in cancer growth and spreading 
Contract number: CT920484 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 754,000 ECU 
Objectives: 
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To engineer molecules which will block the interaction of scatter factor with its 
receptor and the response of target cells to the factor. 
Brief description: 
There is currently no specific treatment for arresting the invasion and metastasis of 
epithelial tumours. During the last few years, however, a process has been uncovered 
which may represent the first step towards cancer invasiveness. The process is the 
conversion of epithelial cells from a stationary phenotype to the highly motile and 
invasive phenotype typical of malignant cells. The conversion is induced by a specific 
cytokine (called scatter factor) through binding to its membrane receptor (the product 
of the c-met protooncogene ). Scatter factor and the c-met receptor have therefore 
become specific molecular targets for the control of cancer invasion. We propose to 
produce therapeutic antibodies and peptides which will block the interaction between 
scatter factor and the c-met receptor using a combination of structural, protein 
engineering and genetic techniques. The antibodies and peptides with therapeutic 
potential will be first selected for activity in vitro and subsequently assessed for 
activity in vivo in mice carrying a human scatter factor and/or c-met receptor 
transgene(s). This work will establish the ability of antibodies and antagonists of 
scatter factor and the c-met receptor to prevent cancer invasion and will lay the 
foundation for the rational design of specific non-peptide drugs for the therapy of 
invasive and metastatic cancers. 
Keywords: 
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Structural and Functional analysis of the interactions of tyrosine kinase 
receptors with the conserved guanine nucleotide releasing proteins activating 
P21ras 
Contract number: CT930005 (Basic Research Project) 
Start date: 01/10/93 Duration: 36 months 
EC contribution: 795,000 ECU 
Objectives: 
Study structure-function relationships in GRFs using mutagenesis, biochemical and 
structural techniques. Search of GRF-interacting proteins from mammalian cells and 
tissues Reconstruction of ras/GAP/GRF cycle in vivo and in vitro. 
Brief description: 
Ligand binding at the extracellular domain of tyrosine kinase receptors (TKR) allows 
adjacent cytosolic domains within a receptor dimer to cross-phosphorylate each other 
on tyrosine residues, causing a conformational change that enhances kinase activity 
towards other substrates and creates binding sites for recruitment of other enzymes, 
resulting in the formation of signalling complexes. Ras proteins are activated in at least 
one third of human tumors and play an essential role in mammalian cell proliferation 
by growth factors. Rapid conversion of p21ras-GDP to the active, GTP-bound form 
follows insulin, EGF, NGF and PDGF binding to their cognate receptors. We propose 
to perform the following experiments. Biochemical and mutational analysis of the 
interaction between TKRs and Guanine Nucleotide Releasing Factors (GRFs) after 
stimulation with the cognate growth factors, agonists and antagonists. Reconstruction 
of a TKR-dependent signal transduction system both in vitro and in vivo (in yeast). The 
latter system will allow functional identification of missing elements and screening of 
engineered receptors and/or ligands. GRF(s)-interacting proteins (and their cDNAs) in 
different cell lines, tissues or developmental stages will be searched. GRF residues 
involved ras binding will be identified by random and/or site-directed mutagenesis. Ras 
mutagenesis will take advantage of the knowledge of its 3D structure. Structural 
analysis of Dpd- and Sos-GRFs, adaptor molecules, such as GRB2, or receptor domains 
directly interacting with GRFs. 
Keywords: 
Oncogenes, Guanine nucleotide releasing factors, GRF, Sos-GRF, GRB2, Receptor, 
Mutagenesis, Protein structural analysis, Cloning, Yeast, Nervous system, Oncogenesis 
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Protein structure and function 
Molecular mechanisms of Beta-adrenergic receptor function and regulation 
(Euroceptor) 
Contract number: CT930083 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 700,000 ECU 
Objectives: 
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The project is aimed at a molecular analysis of the signal transduction and the 
regulation mechanisms of adrenergic receptors. It is intended to identify key steps in 
these processes and to develop inhibitors which may become lead compounds for drug 
development. 
Brief description: 
This project represents a multidisciplinary collaboration studying the ligand-receptor 
interaction, signal transduction and regulation of human adrenergic receptors. These 
receptors are prototypes for the large superfamily of G-protein coupled receptors and 
are the targets of many drugs used to treat, for example, bronchial asthma and high 
blood pressure. We will use techniques of molecular biology, biochemistry, biophysics 
and computer modelling to achieve two primary objectives: (1) a three-dimensional 
model of the ligand-binding pocket and of the agonist-induced conformational change, 
and (2) the identification of rate-limiting steps in the signal transduction and regulation 
cascade. Both objectives will allow the rational design of lead compounds for novel 
drugs that act on this receptor system. This proposal will result in the identification and 
the contracting of pharmaceutical companies for the development of such lead 
compounds. Informal collaborations exist already with several pharmaceutical 
companies, but it is hoped that, in addition, collaborations with new specialized SMEs 
will develop. These efforts should help to reestablish a European stronghold in an area 
that is of importance both for basic science and for drug development. 
Keywords: 
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Interactions of activins with type II activin receptors in differentiation systems : 
structure-function analysis and synthesis of dominant negative ligands and 
receptors 
Contract number: CT930102 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 812,000 ECU 
Objectives: 
To synthesize recombinant antagonistic activin A. To carry out a structure function 
study on the ligand and the type II receptor 
Brief description: 
Some members of the Transforming Growth Factor (TGF)-beta superfamily of growth-
and differentiation-regulatory polypeptides have been implicated as regulators of 
mesoderm formation in early embryonic development of vertebrates. These include 
TGF-beta2, BMP-4, and activin A and B. Several studies point to a role of activin as 
a strictly concentration-dependent morphogen in Xenopus. Activins (A, B and AB) are 
multifunctional proteins, at least in vitro. Activin A is identical to an erythroid 
differentiation factor (EDF) for erythroleukemia (EL) cells. Many of its activities in 
vitro and in vivo, and the mechanisms through which activins act, remain to be 
elucidated. The recent cloning of type II and type 11-B receptors for activin will 
contribute to the understanding of the function of the ligands in significant detail. We 
want to manipulate the signalling process experimentally at the level of the interaction 
of activins with their type II receptors. We want to understand through detailed 
analysis of the molecular interaction between the ligands and the receptors the function 
of the activin type II receptors in the generation of bio-activities of activins with sharp 
tresholds. We will carry out part of our studies in Xenopus oocytes and embryos, in 
embryonic stem and embryonal carcinoma cells, and in EL cells. This project will help 
to explain at the molecular level how different isoforms of the type II activin receptors 
generate different affinities for activins, and to identify which protein domains or amino 
acid residues in the receptors and in the ligands are essential for this. This should 
contribute to the design of synthetic peptides, derived from either the ligand of the 
receptor sequences, that are able to interfere with the bio-activity of activins. 
Keywords: 
Activins, TgfB-superfamily, Receptor, Differentiation, Embryo 
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Structure and function of glutamate receptors 
Contract number: CT930243 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 1,500,000 ECU 
Objectives: 
The main objective is to be able to predict the structure of glutamate receptors. The 
methodology is multidisciplinary with the use of molecular biology, molecular 
electrophysiology, chemistry and protein chemistry. The final goal is to obtain the 
three-dimensional structure of the glutamate receptor. This research aims to produce 
a high resolution map of one of the receptors. 
Brief description: 
The amino acid glutamate is the neurotransmitter responsible for most of the excitatory 
synaptic transmission in the central nervous system. It plays a central role in many 
important physiological processes including learning and memory. The diverse effects 
of glutamate are mediated by a number of membrane bound receptors. In the recent 
years, two main classes of receptors have been characterized: 1) the ionotropic 
glutamate receptors are ligand gated channels permeable to cations whose properties 
and structural features resemble the nicotinic ionotropic receptor; 2) the metabotropic 
glutamate receptors are GTP-binding protein (G protein)-coupled receptors with seven 
membrane spanning domains. In the last two years more than twenty subunits of the 
glutamate ionotropic receptors and several metabotropic receptors have been cloned. 
The fine characteristics of both native and transfected ionotropic receptors can now be 
studied both at the whole cell level and at the single channel level. The two main goals 
of this project are 1) the study of functional domains of glutamate receptors (binding 
sites, channels of ionotropic receptors, region of coupling to G proteins for 
metabotropic receptors) combining available molecular biology techniques, biochemistry 
and electrophysiology; 2) the determination of the subunit composition of the various 
ionotropic receptors. In the three years duration of the project we also hope to develop 
1) methods for the obtention of materials suitable for tridimensional structural analysis 
and 2) better predictive methods for the identification of specific ligands of the various 
receptor subtypes. This basic research could lead to the discovery of glutamate 
antagonists for use in the treatment or prevention of a number of CNS diseases linked 
to excitotoxicity. The concept of excitotoxicity, assumes that an excess of glutamate 
may be at the origin of a neurodegenerative process, in chronic diseases such as 
Alzheimer's, Parkinson's and Huntington's diseases and in stroke. 
Keywords: 
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Structures of a membrane bound receptorits ligand interaction activation and 
signal transduction cascades : studies aimed at atomic resolution using a 
multidisciplinary approach of chemistry, spectroscopy and molecular biology 
Contract number: CT930467 (Basic Research Project) 
Start date: 01/08/93 Duration: 36 months 
EC contribution: 840,000 ECU 
Objectives: 
To define models for phototransduction in rhodopsins; to develop further solid state 
NMR for study of biomolecules; to express membrane proteins in a large scale 
production; to incorporate genetically stable NMR isotopes into membrane receptors 
Brief description: 
The specific goal of this project is to initiate a multidisciplinary study of the structure, 
the genuine ligand-receptor interactions and the natural signal transduction events for 
the visual transmembrane photoreceptor rhodopsin. This aims at developing a novel and 
general approach for refining membrane protein structure including, for example, 
cytochromes and transport A TPases. New basic knowledge about receptor function and 
consequent signal transduction processes at the molecular and atomic level will be 
generated, adding to the core knowledge and methods used world-wide in 
pharmaceutical and health industries. The receptors chosen for this highly 
multidisciplinary proposal are visual receptors of higher organisms, rhodopsins, which 
are archetypes of a super family of higher organism receptors involved in signal 
transduction following activation. Initial studies will be on wild type rhodopsins but 
then expression systems currently in use for bovine and squid proteins with two of the 
proposers, will be optimized to provide sufficient recombinant protein for spectroscopic 
studies. The specific objectives of the proposal are to refine the structural descriptions 
of two membrane bound proteins, which are activated by photons and convert the 
received energy into a biochemical response. The structural information, in the form 
of descriptions of the amino acids and their positions within the protein, will be used 
to describe the functional activity of the proteins. 
Keywords: 
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Functional architecture of the acetylcholine nicotinic receptor as a model of 
ligandgated ion channel : investigations at the amino acid level 
Contract number: CT930518 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 420,000 ECU 
Objectives: 
The aim of this proposal is to investigate by joint protein engineering, pharmacological 
and microphysiological techniques the functional architecture of the nicotinic receptor 
for the neurotransmitter acetylcholine as a model for the superfamily of 
ligand-gated-ion channels which, in brain, muscle or electric organ synapses, mediate 
the conversion of neurotransmitter signals into cation channel openings. 
Brief description: 
Our main objectives will be to exploit, altogether, chemical labelling, sitedirected 
mutagenesis and chimeric genes construction between various receptor species to 
identify : 1) the amino acids which determine the interaction with agonists and 
antagonits ; 2) the chemical mechanism of ion translocation through the channel ; 3) 
the signal transduction process which mediates the interaction between receptor sites 
and ion channel ; 4) the regulation of the signal transduction process by high order 
molecular transitions (desensitization, potentiation) via allosteric sites for "modulatory" 
ligands. To achieve these objectives we regroup the potentials of three European 
laboratories that possess complementary expertises in : 1) at the Institut Pasteur in 
Paris: protein chemistry with membrane-bound and purified receptor from Torpedo 
electric organ ; recombinant DNA technology including site-directed mutagenesis, 
mosaic genes construction, and rapid kinetic methods among other biophysical 
techniques ; 2) at the Geneva University: gene expression into Xenopus oocyte, 
electrophysiological recordings including voltage-clamp and pharmacology of chicken 
brain homooligomeric alpha7 receptor ; 3) at Bath University: pharmacology and 
medicinal chemistry of brain nicotinic receptors from insects (ARL2) in relation with 
insecticidal potenty in locusts, and from vertebrates in relation with nicotine addiction 
; culture of neurons or transfected cell lines ; recombinant DNA technology and 
molecular modeling. 
Keywords: 
Receptor, Neurotransmitter, Ion channel structure 
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1.2 Gene structure 

1.2.1 Microorganisms : S. cerevisiae and B. subtilis 
• Sequencing networks 
Participants invited to apply for : 
- small scale sequencing 
Sequencing of contiguous fragments of at least 25 thousand base pairs 
per year from either Saccharomyces cerevisiae (strain S288C), or 
Bacillus subtilis at a funding of 2 ECU per base pair. 
- medium scale sequencing 
Sequencing of contiguous fragments of at least 100 thousand base pairs 
per year from Saccharomyces cerevisiae (strain S288C), or Bacillus 
subtilis at a funding of 1.6 ECU per base pair. 
• DNA coordinator: S. cerevisiae 
Construction of organised chromosome libraries, distribution of 
appropriate overlapping clones to be sequenced, at a funding of 0.1 ECU 
per base pair. 
1.2.2 Higher organisms : A. thaliana 
Sequencing networks 
Participants invited to apply for : 
small scale sequencing 
Sequencing of contiguous fragments of at least 25 thousand base pairs 
per year fromArabidopsis thaliana (including the sequences of cognate 
cDNAs) at a funding of 2 ECU per base pair. 
medium scale sequencing 
Sequencing of contiguous fragments of at least 100 thousand base pairs 
per year from Arabidopsis thaliana (including the sequences of cognate 
cDNAs) at a funding of 1.6 ECU per base pair. 
• eDNA sequencing 
Coordination and preliminary funding of large-scale eDNA sequencing 
activities from A. thaliana sorted libraries. On a pilot basis, eDNA 
clones from the characterized libraries will be assigned for sequence 
determination to laboratories, particularly those making already a 
contribution to genomic DNA sequencing activities, or exceptionally to 
other ones having appropriate network connections with the sequencing 
community and linked to the same database. 
• DNA coordinator 
Maintenance of organized Y AC and cosmid libraries, and of eDNA 
libraries of characterized origins; planned distribution of clones (with 
their restriction map) covering chromosomal regions defined 
beforehand; cognate eDNA screening and mapping as a means of 
characterizing coding sequences within genomic DNA; coordination and 
monitoring of progress of small and medium scale sequencing work in 
liaison with the informatics coordinator; organisation of links with the 
international programme. Parts of these tasks could be subcontracted 
under supervision of the DNA coordinator, at a funding of 0.1 ECU per 
base pair or fractions thereof, according to their state of advancement. 
1.2.3 Sequence data coordination 
For any of the genomes specified above, collection, organisation and 
analysis of sequence data at a funding of 0.05 ECU per base pair of the 
final sequence handled. Proposals for either one or the three species are 
welcome. 
1.2.4 Coordination of gene function search and preparation of future actions. 
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Systematic sequencing of the yeast genome 
Contract number: CT920063 (Project of Technological Priority) 
Start date: 01/01/93 Duration: 18 months 
EC contribution: 6,194,000 ECU 
Objectives: 
. Sequencing of 1,5 Mb from the yeast genome per year . 
. Sorting out and organisation of yeast chromosomal libraries for future BIOTECH II 
sequencing activities. 
Brief description: 
Administrative coordination of the systematic sequencing of the yeast genome including 
chromosomes X (750 kb ), XIV (800 kb ), XV (1150 kb) and VII (1150 kb ). -
Construction of the necessary organised cosmid libraries plus those of the two longest 
yeast chromosomes: IV (1600 kb) and XII (2200 kb). 
- Establishement, implementation and payment of the 54 subcontracts. 
- Organisation of annual spring meeting of subcontractors. 
- Implementation of a new blind control system by sequencing random non overlapping 
DNA fragments. 
Subdivision of responsibilities: 
* Sequencing chromosomal fragments as indicated by DNA coordinator 
* * Sequencing and organisation of chromosomal library 
* * * Sequencing and DNA coordination 
* * * * Sequencing, organisation of chromosomal library and DNA coordination 
Name of the contractor Fax Institution 
ALEXANDRAKI Despina * 30 81 230 469 GR IMBB Heraklion 
ANSORGE Wilhem * 49 6221 387 306 D EMBL Heidelberg 
ARINO Joaquin * 34 3 581 2006 E Univ. Autonoma Barcelona 
BOLOTIN Monique * 33 1 69 41 72 96 F Univ. Paris-Sud 
BOYD Alan* 44 31 650 3711 GB Univ. of Edinburgh 
BRUSCHI Carlo * 39 40 375 7343 I Int. Center Gen. Eng. Biot 
Trieste 
CROUZET Marc* 33 56 51 85 61 F Univ. de Bordeaux II 
DELIUS Hajo * 49 6261 424 667 D Deutsch Krebsforsch. 
Heidelberg 
DOMDEY Horst * 49 89 8578 3795 D Ludwig-Max.-Univ. 
Mi.inchen 
DUJON Bernard** 33 1 4061 3060 F lnst. Pasteur, Paris 
DUSTERHOFT Andreas * 49 2103 892 222 D Diagen GmbH Hilgen 
ENTIAN Karl-Dieter * 49 69 6301 7639 D Univ. Frankfurt 
FELDMANN Horst* 49 89 59 96 316 D Ludwig-Maxi.-Univ. 
Mi.inchen 
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FOURY Francoise ** 32 10 47 38 72 B Univ. Catholique Louvain 
GAILLARDIN Claude * 33 1 30 81 54 57 F Inst. Nat. Agronom. 
Paris-Grignon 
GALIBERT Francis*** 33 1 42 06 02 50 FLab. Hematologie Exper. 
Paris 
GANCEDO Carlos * 34 1 585 4587 E Inst. Investig. Biomed. 
Madrid 
GLANSDORFF Nicolas * B Inst. CERIA-COOVI 
Bruxelles 
GRIVELL Leslie Alan* 31 20 668 5086 NL Univ. Amsterdam 
HEGEMANN Johannes * 49 641 702 7390 D Justus-Liebig-Univ. Giessen 
HERBERT Christopher J * 33 1 69 07 55 39 F CNRS Gif-Sur-Yvette. 
HERRERO Enrique * 34 73 702 426 E Univ. Lleida 
HILGER Francois * 32 81 61 15 55 B Fac. Sc. Agronomiques 
Gembloux 
HOLLENBERG Comelis P. * 49 211 311 5370 D Heinrich-Heine Univ. 
Dusseldorf 
JACQ Claude * * * * 33 1 44 32 39 41 F CNRS Paris 
JACQUET Michel * 33 1 69 41 72 96 F Univ. Paris Sud 
JAUNIAUX Jean-Claude * 49 6221 42 4962 D Deutsch.Krebsforsch. 
Heidelberg 
JIMENEZ Antonio * 34 1 397 4799 E Univ. Autonoma Madrid 
KRAMER Wilfried * 49 551 393 805 D Univ. Gottingen 
LANDT Olfert * 49 30 712 7734 D TIB Molbiol GmbH Berlin 
LAUQUIN Guy * 33 56 99 90 59 F IBCN/CNRS Bordeaux 
MARTIN Robert P * 33 88 61 06 80 F CNRS Strasbourg 
NETTER Pierre * 33 1 69 07 53 22 F Centre Genet. Mol. 
Gif-Sur-Yvette 
NOMBELA Cesar * 34 1 394 17 45 E Univ. Complutense Madrid 
Prof. OLIVER Stephen * 44 61 236 0409 GB UMIST Univ. Manchester 
P ANZERI Lucia * 39 2 266 4551 I Univ. Milano 
PHILIPPS EN Peter * * * 41 61 267 21 18 CH Inst. Applied Microbiology 
Basel 
PLANT A Rudi J. * 31 20 548 5648 NL Vrije Universiteit 
Amsterdam 
POHL Thomas * 49 7531 57 313 D G. Anal.Techn.Consult. 
Konstanz 
POHL Fritz M. * 49 7531 882 966 D Univ. Konstanz 
RODRIGUES-POUSADA 
Claudina* 351 1 443 16 31 P Funda~ao Gulbenkian Oeiras 
SCARCEZ Thierry * 32 91 410 799 B Innogenetics Gent 
SCHWEIZER Michael * 44 603 58 414 GB IFRN Nmwich 
SOR Frederic* 33 1 69 86 94 29 F Inst. Curie, Section Biologie 
Orsay 
SOUCIET Jean-Luc * 33 88 61 06 80 F CNRS Strasbourg 
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Sequencing the yeast genome - Sequence data coordination 
Contract number: CT920172 (Project of Technological Priority) 
Start date: 01!05/93 Duration: 36 months 
EC contribution: 423,000 ECU 
Objectives: 
Sequence data administration and analysis for the European Yeast Sequencing Project 
Brief description: 
We have served as the informatics coordination center for the processing, analysis, and 
assembly of the sequence data for yeast chromosomes II and XI. We propose to 
continue this effort for other chromosomes to be sequenced under the BIOTECH 
programme. We will provide the following services: 1. collection and administration 
of submitted sequence data; 2. verification of the DNA coordinator's restriction map; 
3. quality control by clone overlaps and resequencing efforts; 4. DNA level sequence 
data analysis to identify promotors and upstream activating sequences (UAS), 
autonomously replicating sequences (ARS), introns, tRNA genes, and yeast specific 
regulatory sequence repeats; 5. protein level sequence data analysis of the open reading 
frames by similar searches against the most comprehensive sequence data sets 
(PASTA/BLAST); 6. sensitive comparison of candidate sequence homologs, pattern 
searches using the available pattern collections (e.g. PROSITE), and analysis of ORF'S 
for internal repeats; 7. linkage of sequence data to the corresponding genomic data 
collections; 8. submission of data to public sequence databases; 9. submission of 
bimonthly reports on new ORF's homologies to the Commission and the Yeast Industry 
Platform; 10. full annotation of protein sequence data emerging from the project; 11. 
provision of a supported online system for sequence data analysis; 12. establishment 
of a confidential sequence database to test novel sequences against protected data; 13. 
provision of training support for members of the participating laboratories. 
Keywords: 
Genome analysis, Yeast, Informatics, Sequence analysis 
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Experimental pilot study for a European cooperation on gene function search 
in the yeast Saccharomyces cerevisiae 
Contract number: CT930022 (Project of Technological Priority) 
Start date: 01/11/93 Duration: 36 months 
EC contribution: 800,000 ECU 
Objectives: 
To undertake a systematic gene function search of the novel, protein coding genes 
(ORFs) of chromosome III; (ii) to prepare a final action which can be applicable to the 
study of genes to be discovered by the future sequencing of other chromosomes. 
Brief description: 
Under the auspices of the EC programmes the complete sequence of chromosome III 
of S. cerevisiae has been established and the sequencing of several other chromosomes 
is underway. The most striking observation is that the majority of the new genes 
revealed by genomic sequencing are unrelated to the genes contained in data banks and 
their exact function is unknown. The objectives of this project are ambitious and we 
envisage to analyse of the order of one hundred genes in three years. Although each 
step of the analysis is rather classical, the extent of the undertaking is not. Therefore, 
novel strategies will be developped and our project will constitute a major 
methodological investement. It is apparent that the situation encountered with 
chromosome III is not unique, since a large fraction of ORFs discovered on other 
chromosomes are functionally not understood. In order to understand the function, the 
individual genes will be inactivated and amplified. In each case a battery of phenotypic 
tests will be applied, RNA transcripts analysed, protein-2D-maps investigated and 
protein spots partially sequenced. The information that has emerged from the EC 
sponsored collaborative sequencing of chromosome III has already received 
international recognition, and it has been stressed on many occasions that the major 
challenge is to relate the sequence to the function. The long term benefit of the research 
proposed herein is not a linear function of the novel cell activities that will be identified 
but rather a combinatorial function of this new information added to what we already 
know, providing an ensemble of facts that we can manipulate to design more incisive 
experiments and ask more intelligent questions. S. cerevisiae is an exceptional model 
of the eukaryotic cell in the sense that the amount of genetic, physiological and 
biochemical knowledge already accumulated and the facility of genetic engineering are 
not encompassed. The understanding of function of novel yeast genes will be precious 
for the study of other organism, including man, since several chromosome III ORF's 
display significant homology with human or other vertebrate genes of unknown 
function. 
Keywords: 
Yeast, Function search, 2D-gel electrophoresis maps, Transcripts analysis, Protein 
microsequencing, Orfs analysis 
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Gene structure 
Development and use of Arabidopsis thaliana as a tool for isolating genes of 
agronomic importance 
Contract number: CT920529 (Project of Technological Priority) 
Start date: 01!02/93 Duration: 18 months 
EC contribution: 1,653,860 ECU 
Objectives: 
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establish a physical map of the genome. develop methods for gene isolation 
and characterisation . isolation of genes involved in floral induction, and seed 
formation . establish stock centres 
Brief description: 
The small genome size, rapid life cycle and good genetic base in Arabidopsis makes 
it an ideal model plant. However, various molecular genetic methods used in other 
organisms need to be adapted for use in Arabidopsis. The programme is contributing 
to an international effort to establish a detailed physical map of the genome using 
cosmid and YAC libraries. Transposon tagging is being developed as an efficient way 
to generate mutations and to recover the mutated loci. Approaches include using 
modified versions of the maize elements Ac and En. Existing mutant and ecotype 
collections are being relocated and catalogued to provide a long-term resource for the 
Arabidopsis community in collaboration with the AFRC (UK). A DNA resource centre 
has been set up to provide a readily accessible store of recombinant libraries, RFLP 
probes, etc. Gene replacement is being studied with the aim of utilising this powerful 
technique for identifying gene function. Mutants affecting floral induction are being 
characterised physiologically, mapped, and walks to some of the loci have started. 
New combinations of mutants have been made to determine the pathways leading to 
floral induction. Seed development is also being studied, and mutants affecting seed 
maturation involving abscisic acid are being mapped and isolated. The effect of these 
mutations on seed protein deposition and the activity of other genes is being studied. 
A novel method called "enhancer trapping" to identify genes active in early states of 
embryogenesis is being used. 
Keywords: 
Genome analysis, Arabidopsis genetics, Gene isolation 
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European scientists sequencing Arabidopsis 11 ESSA 11 
Contract number: CT930075 (Project of Technological Priority) 
Start date: 01/09/93 Duration: 12 months 
EC contribution: 1,022,957 ECU 
Objectives: 
establish an Informatics centre for Arabidopsis sequence . determine sequence 
of areas of interest . establish physical maps of entire chromosomes . prepare 
basis for large-scale Arabidopsis sequencing 
Brief description: 
This proposal brings together a network of European scientists (ESSA) that will initiate 
the first large-scale attempt to sequence the nuclear genome of a higher plant. The 
planned work involves the close integration of the activities of 25 European laboratories 
in 8 nations, many of which are already active in Arabidopsis research. The long-term 
objective of this project is to sequence 2750kb of genomic DNA, and to obtain 
approximately 900kb of partial eDNA sequence. The information obtained from 
genomic sequencing carried out in ESSA may identify and fully characterise the 
chromosomal location, coding regions and controlling elements of between 300 and 800 
new genes, while the eDNA programme will identify between 2000 to 3000 new genes 
by partial sequencing. Sequencing a large contiguous region of a chromosome, together 
with partial sequencing of cognate cDNAs, will initially provide knowledge on gene 
density, and will relate sequence to recombination frequency, a particularly important 
process in breeding programmes for crop plants. Partial sequencing of a large number 
of cDNAs is the most rapid route to partial knowledge of gene identity, and will 
provide a large number of EST (Expressed Sequence Tag) markers, which will be used 
to help complete the physical map, and will also lead to the further complete 
characterisation of the genes themselves. Novel genes, and genes of known function 
previously only identified by map position, will be characterised further. The work 
planned here will provide a firm foundation of expertise, databases, and networks of 
laboratories which will be the means to achieve these aims, and provides a foundation 
for future work. Once completed, the availability of the sequence of Arabidopsis will 
revolutionise many aspects of plant research and create a particularly valuable resource 
for European agricultural industries in their search for new uses for crop plants, and for 
improved efficiencies of production. This application is the first step towards these 
goals. 
Keywords: 
Genome sequencing, Physical mapping, Informatics, Arabidopsis 
56 
Coordinator 
DR. BEVAN MICHAEL 
PLANT SCIENCE RESEARCH LIMITED 
COLNEY LANE 
GB - NR4 7UJ NORWICH 
Participants 
Molecular Approaches 
DEAN CAROLINE ........................................ GB 
DEBLAERE ROLF . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . B 
DEKKER BERNARDUS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . NL 
DELSENY MICHEL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
GIRAUDAT J ............................................. F 
HARBERD NICHOLAS .................................... GB 
JAMES RICHARD ........................................ GB 
KAVANAGH TONY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . IRL 
KREIS MARTIN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
LESCURE BERNARD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
MACHE REGIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
MEWES HANS-WERNER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D 
MURPHY GEORGE ....................................... GB 
PALME KLAUS ........................................... D 
PUIGDOMENECH PEDRO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . E 
SCHOFFL FRIEDRICH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D 
SMEEKENS JOSEPH ...................................... NL 
STIEKEMA WILLEM ...................................... NL 
VOS PIETER ............................................ NL 
Gene structure 57 
Sequencing of the Bacillus subtilis genome 
Contract number: CT930272 (Project of Technological Priority) 
Start date: 01/08/93 Duration: 24 months 
EC contribution: 1,169,000 ECU 
Objectives: 
The determination of 576Kb of the DNA sequence of the Bacillus Subtilis genome. 
Brief description: 
The following european groups participate to this project : 
(1) K. Devine (Trinity College, Dublin, Ireland) 
(2) J. Errington (University of Oxford, United Kingdom) 
(3) A. Galizzi (University of Pavia, Italy) 
(4) S.D. Ehrlich (INRA, Jouy-en-Josas, France) 
(5) A. Danchin and P. Glaser associated with G. Rapoport and F. Kunst (Institut 
Pasteur, Paris, France) 
(6) S. Bron and G. Venema (University of Groningen, The Netherlands) 
(7) C. Harwood and P.T. Emmerson (University of Newcastle United Kingdom) 
(8) R. Mellado (University of Madrid, Spain) 
(9) G. Grandi (Eniricerche, Italy) 
D. Karamata (Institut de Genetique, Lausanne, Switzerland) is also participating in this 
effort. 
The groups are estimated to produce a total of 576 kbp of new DNA sequences in two 
years. 
These sequences will be analyzed using modern computer sequence analysis programs 
(coordinator of data handling : A. Dan chin, Institut Pasteur Paris, France). 
These sequences together with useful comments will then be sent to the international 
databases (EMBL databank, Genbank). 
Keywords: 
Genome sequencing, Bacillus subtilis, Computer data handling 
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1.3 Expression of genes 

1.3.1 Processes through which the information stored as DNA in the genes is 
expressed in models of practical importance : DNA and DNA polymerases, 
factors affecting transcription, and self- splicing mechanisms. Typical 
multinational projects will include 3 to 5 laboratories using complementary 
approaches to study the same nucleic acid polymerase or the same transcription 
factor. 

Expression of genes 63 
Transcription by RNA-Polymerase III: a paradigm to study eukaryotic gene 
expression 
Contract number: CT920090 (Basic Research Project) 
Start date: 01!02/93 Duration: 36 months 
EC contribution: 603,000 ECU 
Objectives: 
The objective of this project is to analyze RNA polymerase III (pol III) and its cognate 
transcription factors in an attempt to understand how molecular mechanisms underlying 
the formation of specific transcription complexes on different genes expressed by this 
enzyme and to gain insight in how expression patterns of eukaryotic genes are 
expressed in response to external stimuli. 
Brief description: 
The pol III transcription system has been well characterized with respect to promoter 
structures and required transcription factors and was -hence chosen as a model system. 
Since pol III shares common factors with the pol I and pol II transcription systems, the 
conclusions drawn from this model system could also apply to transcription regulation 
in a more general sense. By using convergent techniques of biochemistry, genetics and 
genetic engineering in different experimental systems (yeast, plant (Arabidopsis) and 
vertebrate cells) with complementary advantages, we hope to uncover the structural 
basis of DNA-protein and protein-protein interactions among individual transcription 
factors and pol III within the transcription initiation complex. Detailed knowledge of 
these particular interactions could potentially be important for the development of new 
techniques to modify by genetic engineering individual transcription factors involved 
in the positive or negative regulation of eukarytic gene expression. The project focusses 
on: 1.) Analysis by mutagenesis of extragenic (U6;U3) and hybrid (trnasec) pol 
III -promoters. How does the spacing of individual promoter elements determine 
polymerase specificity? How does sequence information control species-specificity? 2.) 
Identification of individual transcription factors, cloning and expression of their genes. 
Analysis of protein-DNA and protein-protein interactions between individual factors and 
pol III subunits by biochemical and genetic methods. The use of heterologous 
transcription systems (yeast, plant, vertebrate) could uncover species-specific factors. 
3.) Functional and structural characterization of components in isolated transcription 
complexes formed on different pol III promoters. 4.) Assessment of the potential 
influence of transcription factor binding to promoter Sequences on nucleosome 
positioning and chromatin structure. 
Keywords: 
RNA polymerase, Protein DNA interactions, Transcription 
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Expression of genes 
Cytokine-mediated interaction of NF -KB-like proteins and cooperative 
regulatory factors with genomic DNA for induction of gene transcription 
Contract number: CT920130 (Basic Research Project) 
Start date: 01!01/93 Duration: 36 months 
EC contribution: 1,185,000 ECU 
Objectives: 
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The role and function of the transcription factor NF-KB (and associated and/or related 
factors) and its interaction with genomic DNA for the onset of gene expression will be 
studied in different cell systems and for different genes using multi-disciplinary 
approaches. The final goal is to arrive at a general and integrated understanding of how 
gene expression might be regulated in response to major inflammatory cytokines, such 
as TNF and ILl. 
Brief description: 
The structure and function of the transcription factor NF-KB and its interaction with 
genomic DNA and/or with other co-activated factors will be studied in a number of 
different cell systems in order to obtain a detailed and integrated understanding of how 
particular genes are induced (or not) in response to cytokines such as ILl and TNF. 1. 
Indeed a number of examples is already known where NF-KB is constitutively present 
or can be induced by cytokines without corresponding gene transcription; in other 
instances, genuine NF-KB has to compete with other inducible NF-KB-like protein 
complexes or with constitutively present KB sequence-binding factors for induction of 
appropriate genes. In these different systems, the subunit composition of the various KB 
sequence-binding complexes will be characterized. Moreover, their competition with 
NF-KB for DNA binding and the resulting effect on gene induction (or repression) will 
be analysed. 2. It is fairly certain that NF-KB alone, although in most cases a necessary 
factor for cytokine-mediated gene activation, is not sufficient for full induction and 
regulation of gene transcription. A multi-disciplinary approach will be set up as a direct 
tool to characterize the co-activated factors as well as their corresponding DNA 
sequences and/or NF-KB factor subunits, with which they interact for transactivation 
or transrepression. 3. Finally, it will also be studied how gene induction, that normally 
requires NFkB, is realized by alternative pathways. Furthermore, the superimposed 
effect of cytokines, which additionally do activate NF-KB, will also be investigated. 
Taken together, an overall approach to analyse the interaction of NF-KB, NF-KB-like 
proteins and coactivated factors with each other and with genomic DNA for induction 
of gene transcription in different cellular systems will be undertaken in order to fully 
understand NF-KB-regulated gene activation as well as disregulation in several diseases. 
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Analysis of the transcriptional regulation of vertebrate Hox-2.8/1.11 subgroup 
genes 
Contract number: CT930060 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 1,038,000 ECU 
Objectives: 
The major goal of this project is to identify and characterize the factors involved in the 
transcriptional regulation of the vertebrate HOX-2.8/1.11 group of Hox homeobox 
genes. 
Brief description: 
Hox genes are transcription factors which play important regulatory roles in pattern 
formation, but virtually nothing is known about the regulatory cascade which governs 
their activity. The experimental plan is designed to identify upstream factors which 
regulate one subfamily of Hox genes, as a model for understanding interactions and 
regulation of the Hox network in general. The project builds upon three aspects which 
emerged from collaborative pilot studies in the participating laboratories: 1) retinoic 
acid influences Hox expression in cell lines and embryos; 2) the Krox-20 zinc finger 
gene is involved in regulating the Hox-2.8 gene in rhombomeres r3 and r5 during 
mouse hindbrain segmentation; 3) the Xenopus Krox-20 gene influences the expression 
of members of the Hox complex. The nature of the retinoic acid response elements will 
be investigated and it will be determined whether they play a role in the regulation of 
Hox gene expression during embryogenesis. The involvement of Krox-20 in the 
activation of the Hox-2.8/1.11 genes in rhombomeres r3 and r5 will be further analysed 
and other cis-acting elements and cooperating factors required for the regulation will 
be identified and characterized in detail. The cis-acting sequences involved in Hox-2.8 
activation in rhombomere r4 and in the second branchial arch have been localized. 
They are distinct from those responsible for expression in rhombomeres r3 and r5 and 
will be analysed in detail. Possible cross-regulatory interactions between members of 
the Hox complex itself will also be evaluated. Finally a central theme which 
complements and expands all of these goals will be the analysis and comparison of the 
regulation and of cis-acting elements of Hox-2.8/1.11 genes from Xenopus, chicken, 
mouse and human. The objective is to identify transcription factors and components of 
the regulatory cascade which are highly conserved between species and presumably 
play a fundamental role in regulating pattern formation in all vertebrates. 
Keywords: 
Hox gene, Transcription factors, Pattern formation, Vertebrate, .Krox-20, Retinoic acid, 
Rhombomere, Embryogenesis 
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Transcriptional control of phenylpropanoid metabolism 
Contract number: CT930101 (Basic Research Project) 
Start date: 01!08/93 Duration: 36 months 
EC contribution: 1,230,000 ECU 
Objectives: 
determine role of myc and myb factors in gene expression . establish a 
mechanism for b-ZIP proteins in gene expression . isolation and characterise 
mutants affecting flavonoid biosynthesis . isolate transcription factors involved in 
pheny lpropanoid biosynthesis 
Brief description: 
The developmental and environmental controls exerted on the plant phenylpropanoid 
pathway at the transcriptional level make this an appealing system for the analysis of 
gene regulation. The phenylpropanoid pathway is among the best characterised 
biosynthetic pathway in either animals or plants since more than 20 structural and 
regulatory genes have already been identified and isolated by genetical and biochemical 
approaches. The levels of all the key regulatory enzymes of the pathway are 
determined primarily by transcriptional initiation rates, in response to both 
environmental and developmental stimuli. Genetical and biochemical evidence shows 
there are at least three classes of factors (myb, myc and b-ZIP proteins) involved in the 
regulation of genes encoding enzymes of the pathway. These will be the subject for 
investigation in this project. A detailed picture on how a set of transcription factors 
determines the tissue-specificity and environmental inducibility of particular plant genes 
will be built up, as well as how the activities of sets of genes, particularly those in 
biosynthetic pathways, are modulated, and how transcription factors determine this 
integration. Environmental stimuli such as light and abiotic stress (mechanical damage) 
cause the induction of phenylpropanoid biosynthesis via transcriptional activation. 
Responses to short-wavelength light is particularly important as it is part of a stress 
response to UV light. Phenylpropanoids and their derivatives are of major importance 
in crop plants and as industrial products derived from plants. Thus knowledge of 
co-ordination of gene expression that underlies the accumulation of particular 
end-products will be of substantial biotechnological importance. 
Keywords: 
Transcription, Phenylpropanoid biosynthesis, Gene expression 
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Expression of genes 
Liver transcription factors HNFl and HNF4- structure, function and 
interrelationship 
Contract number: CT930103 (Basic Research Project) 
Start date: 01!08/93 Duration: 36 months 
EC contribution: 840,000 ECU 
Objectives: 
71 
Our aim is to study the hepatic nuclear factors 1 and 4 and their regulation in liver, 
using our complementary expertise in structural, functional, genetic and clinical 
methods. The goal is to understand the molecular details of how these two 
transcription factors cooperate in liver-specific gene regulation. 
Brief description: 
The liver is the largest organ in the human body and indispensable for life. Medically, 
studies of liver are vital to increase our basic knowledge of the pathogenesis of 
circulatory disorders, as these are the single commonest cause of death. The liver, 
because it controls the secretion of clotting factors and apolipoproteins and the uptake 
of lipids and cholesterol, which are known risk factors for thrombosis, is an essential 
target for those interested in gene regulation. In the early 1980's the genes for many 
proteins expressed solely in the liver were cloned and intensively studied. Later, the 
regulating proteins or transcription factors responsible for the liver-specific expression 
of these genes were, themselves, also studied and cloned. A small family of 4 
transcription factors (and variants of these factors) which are enriched in liver are now 
known. The regulation of 2 of these factors, hepatic nuclear factors (HNF) 1 & 4 
appears to be interrelated such that HNF4 regulates HNFl. Our goal is to study these 
2 liver-specific factors in detail combining our complementary expertise in structural, 
functional, genetic and clinical investigation. The immediate objectives are to study 
(1) the structure and function of HNFl & 4 and the domains that control DNA binding 
and their ability to dimerize and to activate transcription alone or with cofactors. 
Detailed biophysical studies are proposed to solve 3-dimensional structure by NMR and 
X-ray crystallography, (2) the function of HNFl and its variant in vivo in mice by 
means of a classic 'knock-out' of the HNFl, and variant HNFl and HNF4, (3) the 
regulation of HNFl & 4 in somatic cell hybrids, and (4) the regulation of the promoter 
affinity of HNFl & 4 for liver-expressed genes including the factor IX gene, in which 
haemophilia B patients with promoter mutants defective in HNF4 binding are known. 
Our long term goals are to understand how the specific transcription factors HNFl & 
4 interact with the ubiquitous factors and the basic transcriptional machinery to control 
expression in the liver. Our detailed structural work on HNFl & 4 should also allow 
the design of new drugs able to interfere with transcription in the liver and thus control 
the expression of genes of medical interest. 
Keywords: 
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The regulation of the GATA proteins and their role in haematopoietic 
differentiation 
Contract number: CT930315 (Basic Research Project) 
Start date: 01/10/93 Duration: 36 months 
EC contribution: 1,050,000 ECU 
Objectives: 
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.Inactivation of the GATA genes by homologous recombination in embryonic stem (ES) 
cells 
.Conditional expression of GATA 1 and GATA 3 
.Expression analysis of GATA 2 
.Studies on the regulation of GATA factors and a number of their target genes 
.Structural (NMR, X-Rays) analysis of GATA 1 and its role in the developmental 
expression of the human globin genes. 
Brief description: 
We will study the role of the GATA family of transcription factors in haematopoiesis. 
This will involve the study of the regulation of these genes and the genes that are 
regulated by the GATA factors. This will be carried out by DNA mediated gene 
transfer in animal cells and transgenic mice. Emphasis will be given to the globin 
genes, in particular, the molecular mechanism of the adult repression of the gamma 
globin gene. Derepression of this gene greatly ameliorates the effects of sickle cell 
anaemia and thalassaemia. A mouse based assay to screen for compounds that may 
derepress the gamma globin gene in the adult will be developped. 
Keywords: 
Transcription, GATA factors, Haematopoiesis, Genes, NMR 
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Expression of genes 
The HNF3/fork head and HNFI transcription factor families : 
structural/functional analysis and developmental role 
Contract number: CT930319 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 1,050,000 ECU 
Objectives: 
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Characterization of new members of the HNF3 family Define the biological 
role of individual members of the HNF3 family and vHNF1/LFB3 by targeted 
mutation Regulation in organ and advanced cell culture systems Three 
dimensional structural analysis of the forkhead DNA binding domain by NMR 
Brief description: 
The present proposal concerns the study of two families of transcription factors: 
HNF3/forkhead and HNF1. HNF3 is a large family of transcription factors that share 
a novel DNA binding motif. The HNF1 family is composed of two members: 
HNF1/LFB1 and vHNF1/LFB3, both characterized by an atypical homeodomain. Our 
goal is to determine the precise role played by the individual members in differentiation 
of endoderm and mesoderm derived organs. Therefore, five European laboratories 
working in the field and using biological systems that provide complementary data, 
collaborate in this project. Focus on these factors is dictated by the fact that several 
members of the HNF3 family and vHNF1/LFB3 are expressed very early in 
development in a spatial and temporal profile that place them as good candidates to 
play key roles and cooperate in the establishment of the different patterns of endoderm 
differentiation.Immediate aims are: A) -Characterization of new members of the 
HNF3/forkhead family in mouse and their homologues in fish. B) -Developmental role 
of individual members of the HNF3 family and vHNF1/LFB3 gene by targeted 
mutation in mice. C) - Analysis of vHNF1/LFB3 and HNF1/LFB1 expression in organ 
and advanced cell culture systems: characterization of vHNF1/LFB3 and HNF1/LFB1 
promoters in these systems, in Xenopus and fish. D) - Three dimensional structural 
analysis of the forkhead DNA binding domain by Nuclear Magnetic Resonance (NMR) 
analysis. E) - Autoregulatory circuits and interrelationship between HNF3 and HNF1 
families. The elucidation of the molecular and genetic basis of endoderm 
differentiation and organogenesis is expected to lead to a better understanding of 
carcinogenesis and birth defects. 
Keywords: 
HNF, Gene targeting, Mutation, Transgenic vertebrates, Differentiation, NMR 
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In vitro selection of RNA structural motifs with self-splicing activity 
Contract number: CT930345 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 550,000 ECU 
Objectives: 
. Amplification and selection of new RNAs with designed chemical and physical 
properties Characterization by NMR techniques and molecular modelling of 
specifically selected RNAs. 
Brief description: 
Since RNA can function both as a genome and a gene product, it is suitable for 
manipulation and selection of molecules with new properties. A very elegant procedure 
for the selection and amplification of RNA molecules, developed and successfully used 
by G. JOYCE at the Scripps Clinic at San Diego, can be viewed as directed darwinian 
evolution in the test tube. The principle consists in synthesizing a large pool of 
partially or randomly mutagenized molecules using bacteriophage RNA polymerase. 
This pool is then subjected to selection by separating the molecule with the desired 
chemical or physical properties from the rest of the pool. Finally, using reverse 
transcription and PCR, a DNA pool can be synthesized from which in tum an enriched 
RNA pool can be generated. The project consists in using in vitro selection procedures 
to try and decipher some of the structural motifs that appear to be in recurrent use in 
self-splicing RNAs or ribozymes, whose activity rests upon their ability to fold by 
themselves into intricate three-dimensional structures. Towards this goal, the 
experience and skills of the participating scientists will be focused, respectively, on 
RNA-RNA interactions between ribozymes and substrates (F. MICHEL), on the 
interactions underlying inhibition of RNA self-splicing by antibiotics (R. 
SCHROEDER), on the development of ribozymes which catalyse their own cleavage 
by amino acids (M. FAMULOK), on the determination of the 3D structures of selected 
RNA molecules by NMR techniques (M. KOCHOY AN), and on molecular modelling 
of critical RNAs in order to build a data base of the functionally and structurally 
important 3D motifs (E. WESTHOF). 
Keywords: 
RNA, Ribozyme, Catalysis, Self-splicing, Selection, Evolution, NMR, 3D-modelling 
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Role of the PML, PML/RARa and RARa nuclear proteins during the myeloid 
differentiation process 
Contract number: CT930450 (Basic Research Project) 
Start date: 01/10/93 Duration: 36 months 
EC contribution: 684,000 ECU 
Objectives: 
To define the role PML, PML/RARa and RARa play during the normal and neoplastic 
myeloid differentation processes. 
TQ identify genes involved in the PML, PML/RARa and RARa endogenous activation 
pathways (PML and RARa target genes). 
Brief description: 
Both direct and indirect experimental evidence suggests that the RARa, PML/RARa 
and PML nuclear proteins are involved in the myeloid differentiation process: I) 
functional RARa protein is required for the retinoic acid-induced differentiation of 
myeloid precursors; II) the RARa and PML genes are the breakpoint sites of the acute 
promyelocytic leukemia-specific 15;17 translocation; III} a PML/RARa fusion protein 
is formed as a consequence of the translocation; IV) the PML/RARa protein plays a 
role in determining the differentiation block typical of leukemias; V) the PML/RARa 
protein interferes with both the PML and RARa endogenous activation pathways and 
its biological activity depends on the presence of both the PML putative DNA binding 
domain an the RARa DNA binding domain in the fusion protein. The following 
complementary approaches will be adopted 1) - Biochemical and biophysical 
characterization of the PML protein: I) isolation of PML-binding sites and binding 
proteins; II} characterization of the PML divalent metal binding properties. 2) -
Characterization of the effects PML, PML/RARa and RARa exert on the differentiation 
properties of hematopoietic precursors: phenotypic definition of myeloid precursor cells 
that overexpress PML, PML/RARa or RARa proteins. 3) - Identification of PML, 
PML/RARa or RARa target genes involved in myeloid differentiation: differential 
screenings between I) undifferentiated or differentiated cells of myeloid origin; II} cell 
that overexpress or do not express PML, PML/RARa or RARa. 4) - Studies on the 
capacity of PML/RARa to induce neoplasias in mice: I) generation of mice transgenic 
for PML!RARa eDNA; II) infection of mouse bone marrow with ecotropic retroviruses 
encoding the PML/RARa protein. 5- Characterization of the functional interactions 
between RARa or PML/RARa and proteins putatively involved in their functional 
pathways ( e.g.HOX genes): I) analysis of the expression of HOX genes in myeloid 
cells, and myeloid cells engineered to overexpress PML, PML/RARa and RARa; II) 
effects of HOX gene overexpression on growth and differentiation of cultured myeloid 
precursors. 
Keywords: 
Nuclear proteins, Differentiation, Leukemia, Haematopoietic precursors. 
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Mechanisms of transcriptional activation and developmental role of 
transcription factor TIF-1 
Contract number: CT930454 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 763,000 ECU 
Objectives: 
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To define the template requirements for ITF-1 activity To identify 
post-translational modifications of TTF-1 necessary for stimulation of transcription . 
To isolate co-factors that, in conjunction with TIF-1, determine its cell-type specific 
activity . To define the developmental role of ITF-1. 
Brief description: 
The thyroid follicular cells express a unique set of genes. Among these, for the 
Thyroglobulin (Tg) and Thyroperoxidase (TPO) genes has been shown that their 
exclusive expression in thyroid depends largely on transcriptional regulatory 
mechanisms. The transcription factor TTF-1 binds at several sites in both promoters. 
Mutations of the ITF-1 binding sites greatly reduce promoter activity in thyroid cells. 
In addition, expression of TTF -1 in some non-thyroid cells results in activation of both 
Tg and TPO promoters, indicating that ITF-1 plays an important role in controlling 
thyroid differentiation. Expression of TTF-1 during thyroid development supports its 
role. The TTF-1 protein is found first at the stage of determination of thyroid cells, 
preceding, as expected, expression of the differentiated phenotype. On the other hand, 
a five days lag is observed between the appearance of TTF-1 and the expression of Tg 
and TPO, suggesting that the activity of TTF-1 on these two promoters is regulated. 
This view is supported by the finding that TTF-1 is present in two other tissues 
different from thyroid, i.e. in the epithelial cells of the lung and in restricted regions 
of the fetal brain. The aim of this research project is to understand the cell-type specific 
mechanisms that restrict the activity of a transcription factor on a specific set of 
promoters. To this end, the precise template requirements for ITF-1 activity, the role 
of additional molecules for TTF -1 function and the developmental role of TTF -1 in the 
tissues where it is expressed will be defined. 
Keywords: 
Transcription, Phosphorylation, TIF-1, Development, Thyroid 
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Characterization of the a-amanitin resistant RNA polymerase associated with 
high level late transcription in baculovirus-infected insect cells 
Contract number: CT930457 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 540,000 ECU 
Objectives: 
. To purify the baculovirus-induced RNA polymerase from virus-infected cells 
. To micro-sequence components of the polymerase and map appropriate virus 
genes . To produce baculovirus mutants deficient in late gene transcription . To 
devise an in vitro transcription system to analyse the RNA polymerase components 
Brief description: 
In baculovirus-infected insect cells, early virus gene transcription is relatively weak, 
whereas late gene expression derives very high levels of virus-specific mRNA and 
proteins. Late virus gene promoters have been used in a very successful expression 
system. The efficacy of the late phase of virus transcription appears to be related to 
the induction of an a-amanitin resistant RNA polymerase. The primary goal of this 
project to investigate the nature of the baculovirus (Autographa californica nuclear 
polyhedrosis virus, (AcNPV) late RNA polymerase and associated co-factors 
responsible for hyper expression in the late phase of replication. This will be achieved 
by purifying the RNA polymerase complex from baculovirus-infected insect cells, 
determining the partial protein sequence of some or all of the constituent molecules and 
matching this information with the complete AcNPV nucleotide sequence. Should this 
approach prove unsuccessful, the protein sequence data will be used to design 
oligonucleotides for probing genomic libraries to identify putative host genes involved 
in late gene transcription. The direct approach to the analysis of the virus-induced 
RNA polymerase will be complemented with the derivation of AcNPV mutants 
defective in late gene expression. These mutants will be mapped by marker rescue 
techniques and compared with the complete AcNPV sequence to identify the gene. An 
in vitro transcription system will also be established to facilitate the analysis of the 
virus mutants and the role of the polymerase components purified from virus-infected 
cells. The project will provide information about baculovirus late gene transcription and 
assist the future development of baculovirus expression vectors. 
Keywords: 
Baculovirus, RNA polymerase, Transcription, Late gene mutants 
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Control of gene expression by nuclear receptors: interaction with ligands, DNA 
and other factors 
Contract number: CT930473 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 1,562,000 ECU 
Objectives: 
. To elucidate the molecular mechanism of action of nuclear receptors as transcription 
factors . To analyse function of normal/aberrant receptors in hormone responsive 
diseases and identify new targets for therapy . Model and natural promoters will be 
used to characterise the role of ligand and intermediary factors. 
Brief description: 
This project will provide detailed information on the molecular mechanism of action 
of nuclear receptors as ligand-inducible transcription factors. Model and natural 
promoter systems will be used in order to provide a molecular basis for potential 
therapeutic intervention in diverse diseases associated with the action of nuclear 
receptors. It is proposed to investigate the structure and function of domains 
responsible for ligand binding, DNA binding, and transcriptional activation, develop 
methods for the isolation of new target genes and characterise and attempt to clone 
transcription intermediary factors ( coactivators) that mediate the enhancer function of 
nuclear receptors. Established in vitro transcription systems for the analysis of steroid 
receptors, retinoid receptors and a number of orphan receptors will be modified and 
refined by substituting crude fractions with overexpressed recombinant factors. In 
parallel, the interaction of nuclear receptors and other trans- acting factors on the 
promoters of the growth hormone and apolipoprotein genes will be investigated to 
elucidate the regulation of complex natural promoters. The study of these promoters 
may lead to the identification of novel members of the nuclear receptor family. To 
unravel the mechanisms involved in steroid hormone-induced growth regulation the 
action of estrogen on the transcription of genes that are involved in cell cycle 
regulation will be investigated and immediate early response to mitogenic signals. The 
transcriptional control mechanisms governing the regulation of all the above genes 
will be studied in a completely defined in vitro transcription system. 
Keywords: 
Receptor, Steroids, Retinoids, Transcription 
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Area 2 
Cellular and Organism Approaches 

2.1 Cellular regeneration, reproduction 
and development of living organisms 

ANIMALS 
2.1.1 Control of development, cell commitment and cell totipotency in farm animals 
of major economic importance, starting at the earliest levels of organisation, 
namely gametes, eggs, proliferating lines and their reorganisation into organs and 
embryos. 
2.1.2 Genome mapping: contributions to the mapping of the bovine genome. The 
project will be implemented in close cooperation with the "Pigmap" project of 
BRIDGE and, with regard to infrastructure and retrieval of data concerning pig 
and bovine genome mapping, in accordance with specifications on "information 
infrastructure" on page 16. 

Cellular regeneration, reproduction and development 93 
Improvement of in vitro production of cattle embryos 
Contract number: CT920067 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,060,000 ECU 
Objectives: 
Mimic the in vivo environment of the embryo. Use serum free media conditionned by 
different kind of cells (granulosa, oviduct, others). Identify embryotrophic factors in 
these media and define optimal culture conditions. Study genome activation and gene 
expression in the various media and the freezability of embryos. 
Brief description: 
The in vitro production of embryos from slaughtered cattle represents an economical 
way to develop biotechnologies of reproduction in farm animal species. It is also a 
valuable tool for fundamental research. However the yield of this technology is low as 
only 15 to 30% of treated oocytes reach the required stage of development for transfer 
to recipient cows and, after transfer, only 40% of these cows give birth to a calf. These 
results reflect a lack of basic information at different levels of the process. The aim 
of our project is to reconsider the successive steps of the in vitro methodology with 
new and innovative approaches. The following points will be investigated : 1. Oocyte 
competence and maturation (F1) 2. In vitro fertilization (F1) 3. Regulation of early 
embryonic development and gene expression 3.1. Preparation of protein free 
conditioned media (B) 3.2. Evaluation of the quality of conditioned media (B,I) 3.3. 
Biochemical analysis of the media and determination of biological activity of isolated 
fractions (F2, I) 3.4. Ability of the embryos to develop and implant (GE, F2) 3.5. 
Cryopreservation of embryos (GE, B). The five groups will exchange their scientists, 
the results and material. A meeting will be held every six months (alternatively 
general meeting and committee meeting). The benefit should be a better understanding 
of the regulatory mechanisms involved in early bovine embryonic development and 
as a consequence the elaboration of a reproductible methodology for in vitro 
production of transferable embryos. F1 = France 1; B = Belgium; I = Italy; F2 = 
France 2; GE = Germany. 
Keywords: 
Cattle, Embryo, In vitro, Gene expression, Reproduction 
94 Cellular and Organism Approaches 
Coordinator 
PROF MASSIP ALBAN 
UNITE DES SCIENCES VETERINAIRES 
PLACE CROIX DU SUD 3 
B - 1348 LOUV AIN-LA-NEUVE 
Participants 
BREM GOTIFRIED ........................................ D 
CHARPIGNY GILLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
GANDOLFI FULVIO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . I 
MERMILLOD PASCAL ..................................... F 
Cellular regeneration, $$reproduction and development 
Investigation of signal transduction systems and their activation in the 
control of pre-implantation embryo development in cattle 
Contract number: CT920163 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,006,000 ECU 
Objectives: 
95 
To improve our understanding of the control of embryo growth, development and 
differentiation, including intra-embryonic and embryonic-maternal communication in 
cattle. 
Brief description: 
The pre-implantation mammalian embryo is of enormous biological importance because 
1) contains the entire genomic information for the development of the adult animal, 2) 
at the transition from morula to blastocyst it begins the differentiation process, 3) at the 
blastocyst stage it commences rapid growth, and 4) despite being foreign tissue it 
escapes rejection by the maternal immune system. An understanding of the cellular 
mechanisms controlling these processes is fundamental to the development of novel 
embryo-based biotechnology. An exciting possibility is the production of cloned 
embryos by a combination of trophoblastic vesicles with embryo stem cells containing 
foreign valuable genes specifically targeted to have the gene product secreted in the 
milk. Such a process would lead to production of safe, medically important human 
protein products, uncontaminated by bacterial products. This is not yet possible due to 
lack of even the most basic knowledge on control of cell proliferation and 
differentia Von in cattle embryos. Understanding these mechanisms could also lead to 
developments in the control of immune processes and in cell ageing not yet possible 
to envisage. The peptide growth factors that control cell proliferation and differentiation 
bind to specific cell membrane receptors. Such receptor-ligand binding leads to 
activation of signal transduction systems causing the cellular responses essential for 
division and differentiation. Little data exists on these signal transduction systems in 
farm animal embryos. This proposal investigates the presence, location and role of the 
major signal transduction systems viz., cyclic adenosine monophosphate (cAMP), cyclic 
guanine monophosphate (cGMPJ, phosphotidylinositol (Ptdlns), tyrosine kinase and 
calcium signalling systems in the control of growth and differentiation of cattle 
embryos. The disciplines of immunocytochemistry, cellular physiology, and embryo 
micromanipulation are brought together from 4 major research organisations and a 
biotechnology (SME) company in 4 countries of the EC. The proposal involves in vivo 
and in vitro fertilised (IVF) cattle embryos and synchronous oviduct and uterine tissues. 
Keywords: 
Cattle, Embryo, Transduction system, Reproduction, In vitro 
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Totipotency and commitment in farm animal embryos 
Contract number: CT920358 (Basic Research Project) 
Start date: 01/04/93 Duration: 36 months 
EC contribution: 1,310,000 ECU 
Objectives: 
The scientific objective of this project is to gain understanding of the 
mechanisms in the early embryo of farm animals which determine whether a cell 
will retain the ability to contribute to all of the tissues of the conceptus or 
become committed to differentiation along a specific pathway. 
Brief description: 
In seeking to build up an understanding of these mechanisms, several different 
approaches are being followed. These are to define the role of polypeptide growth 
factors, examine changes in transcription factors, seek promoters specific to totipotent 
cells, study epigenetic mechanisms involved in embryonic stem cell isolation and to 
identify intracellular and extracellular markers of totipotency and differentiation. The 
research will be carried out with embryos from cattle, sheep and pigs. Most of the 
studies will be concerned with cells of the early embryo, but a comparison will also be 
made between totipotent cells in the early embryo and primordial germ cells. Some 
comparisons will be made with cultured cells derived from the early embryo and from 
specific lineages in order to monitor changes during differentiation. In addition some 
comparisons will be made between cells of livestock species and embryonic stem cells 
of the mouse as they are the only cultured cells proven to be totipotent. The group of 
proposers bring several different disciplines to the project including molecular biology, 
cell biology, tissue culture and ultrastructural analysis. The collaboration will be 
achieved in several ways: by exchange of cells, probes or antibodies, by provision of 
advice and instruction and by discussion of new approaches in project meetings. The 
practical value of the project lies in the provision of knowledge which is necessary for 
the establishment of two novel methods for livestock breeding: embryonic stem cell 
isolation and nuclear transfer. The combined application of the two procedures would 
provide a unique opportunity to spread genetic improvement throughout Europe and to 
introduce specific, precise changes to the genome. Most of the laboratories, which are 
drawn from 5 countries, are already collaborating with commercial groups who will be 
able to exploit the results of the project. It is the objective of the project to provide new 
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Identification of genes involved in early fish development 
Contract number: CT930430 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 1,110,000 ECU 
Objectives: 
The goal of this project is to increase the knowledge of molecular basis of fish early 
devlopment. Novel key genes will be researched and studied independent upon their 
homology with other genes already identified in other animals. Laboratory fish will be 
used and the information gathered will be ultimately transferred to domestic fish. 
Brief description: 
Several fish developmental genes already isolated, including activin genes, TGF beta 
genes and proto-oncogenes will be studied, as well as other members of the family of 
growth factors and their receptors. Novel genes will be researched by large-scale 
introduction of enhancerless and promoterless reporter genes, radiation and chemical 
mutagenesis, and differential cloning of cDNAs between successive stages of 
embryogenesis. After their structural characterization, their function and regulation will 
be monitored at the RNA and protein levels in normal development, but also studied 
by altering the level, site and timing of expression with gene transfer methods. A 
number of methodological improvements and innovations will be required to conduct 
the project. Methods of uniparental reproduction will be used and improved in 
laboratory fish for rapid inbreeding. A strong effort will also be devoted in domestic 
and laboratory fish to innovate in gene transfer technologies, in order to increase the 
rates of stable transformation and to render the gene integration as early as possible. 
This should permit to modify the normal expression of foreign genes under study, as 
well as to abolish their expression in embryos. A major challenge of the project will 
be the research and development of ES cells in fish. Efforts in this area will include 
characterization of presumptive ES cells in embryos, definition of culture conditions, 
reintroduction of these cells and non-selected blastomeres into embryos after short or 
long term in vitro culture. The availability of ES cells should permit to knock out 
candidate developmental genes under study, and also to greatly facilitate their isolation 
by enhancer and gene trap technologies. 
Keywords: 
Fish, Development, Gene transfer, Mutagenesis, ES cells 
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Development of genetic and physical marker maps of the bovinegenome (Bovine 
Gene Mapping project- Bovmap) 
Contract number: CT920359 (Basic Research Project) 
Start date: 01!01/93 Duration: 36 months 
EC contribution: 1,200,000 ECU 
Objectives: 
This project describes the development of a pre-competitive public domain genetic and 
physical map of the bovine genome. The general objective of the programme is to map 
existing markers and to produce additional markers to construct a low resolution map. 
Brief description: 
The following tasks will be addressed : 1) To constitute a panel of reference families, 
allowing the construction of a genetic map 2) To generate a large number of highly 
polymorphic markers and analyze their segregation in the reference families 3) To 
establish the physical marker map, using a panel of somatic cell hybrids to assign 
markers to syntenic groups and in situ hybridization to determine precise chromosomal 
locations of "landmark" markers 4) To implement new technologies 5) To develop 
statistical and computational facilities. The construction of the bovine marker map is 
a too ambitious goal for individual laboratories or countries and requires collaboration 
between laboratoires and commercial partners internationally. The BovMap project, 
coordinated under the auspices of ISAG brings together most of the laboratories with 
bovine gene mapping expertise in EC and EFTA countries and will be a major 
contribution to the global effort. The cattle breeding industry will contribute in making 
available full-sib families to establish a reference family panel which is the first priority 
task in the project. A Management system will be set up to ensure efficient progress 
in allocating tasks to the laboratories according to experience and skills. The ultimate 
goal is to establish a marker map for mapping and then cloning of quantitative trait loci 
(QTL), comparative mapping and marker assisted selection. Three phases will be 
required to achieve these objectives, of which this proposal comprises only the first, 1) 
construction of a low resolution map 2) development of technologies and resource 
populations or families 3) practical implementation of results in breeding strategies. 
Keywords: 
Bovine, Genome, Microsatellites, Genetic mapping, Linkage, Physical mapping 
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Genome mapping informatics infrastructure (Gemini-project) 
Contract number: CT920451 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 300,000 ECU 
Objectives: 
This project brings together the two laboratories responsible for coordinating 
the pig gene mapping project (PiGMaP) which is funded under the EC BRIDGE 
programme and the proposed bovine gene mapping project (Bo VMaP) which has been 
submitted for funding under the EC BIOTECH programme. 
Brief description: 
This project brings together the two laboratories responsible for coordinating the pig 
gene mapping project (PiGMaP) which is funded under the EC BRIDGE programme 
and the proposed bovine gene mapping project (Bo VMaP) which has been submitted 
for funding under the EC BIOTECH programme. These European collaborative genome 
mapping projects are and will produce large volumes of complex data which must be 
stored, accessed, analyzed and interpreted. Our work will be directed at providing the 
informatics infrastructure and will include the development of the resource databases 
for storing the raw observational data together with the generated linkage maps. The 
collaborations need easy access to up-to-date information in order to carry out analyses 
and to assist with the management of their work. Networked access and communication 
support will be established for these databases. We will provide and develop a wide 
spectrum of software for the analysis, display and interpretation of the experimental 
data. Training, documentation and technical support will be available. The resource 
databases will use a common relational structure and have a graphical genome 
front-end. The pigmap database will be maintained at IAPGR, Edinburgh and the 
Bo VMaP database maintained at INRA, Jouy-en-Josas. These informatic systems will 
be developed in full consultation with those groups who provie the equivalent resources 
for the human, munine and other genome mapping endeavours. Wherever practical and 
appropriate the systems developed to support the porcine and bovine projects will build 
upon systems employed for these other species. 
Keywords: 
Genome mapping 
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2.1.3 Elucidation of the mechanism of action of plant growth factors : 
Many of the typical features of plant development are associated with the 
activities of five groups of more or less simple signal molecules (auxins, 
cytokinins, ethylene, abscisic acid, gibberelins). In addition it was recently found 
that some oligosaccharides, lipooligosaccharides and other signal molecules also 
play a role in the regulation of plant growth. 
Each of these factors controls a remarkable diversity of developmental and 
physiological processes. Their mechanisms of action should be understood and 
the genes involved in these mechanisms should be isolated and characterised. 
Molecular scenarios of their regulatory functions over plant developmental 
patterns should be proposed. Gamete encounters, egg formation, the acquisition 
of "competence", meristem differentiation and embryogenic pathways should be 
revisited with a primary interest in plant sensing mechanisms and how these 
interact with developmentally-regulated specific gene transcription. 
The following Project of Technological Priority also covers topics 2.2.2, 2.2.3 and 
2.2.4, which are listed further on. 
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Plant molecular genetics for an environmentally compatible agriculture 
Contract number: CT930400 (Project of Technological Priority) 
Start date: 01!11/93 Duration: 30 months 
EC contribution: 18,840,710 ECU 
Objectives: 
The PTP project "Plant Molecular Genetics for an Environmentally Compatible 
Agriculture" has been conceived to provide critical scientific knowledge relevant to an 
environmentally sustainable agriculture. In fact research will be undertaken in the broad 
area of plant and microbial biochemical genetics with a particular focus on the 
development in the future of new options for the improvement of plants for a more 
environmentally friendly agriculture and horticulture. The research has been organised 
in 4 different topics, each performed in a coordinated and interactive way by a number 
of networks built up from existing labs in different EC countries. 
Brief description: 
This EC scientific research project in plant biotechnology explores many of the 
fascinating aspects of how plants grow, how they store molecules in seeds, tubers and 
leaves that we rely on for food, how plants cope with adverse environments and how 
plants respond to and utilise nitrogen fertilisers. The work is organized in five networks 
of collaborating laboratories. 
Under Network A, studies are carried out on the transition from vegetative growth to 
reproductive growth, mechanisms that control the development of flowers and seeds, 
the molecular action of plant growth factors and novel classes of growth regulators. 
Network B is undertaking research on the isolation and characterisation of genes that 
contribute to tolerance to abiotic stresses, the effects of salinity and potassium 
deficiency on plant growth, and to drought tolerance in maize. 
Network C concentrates on storage organs in crops plants, studies on starch synthesis, 
redirecting carbohydrate flow, metabolic regulation in the developing seed, and new 
research on commercially important carotenoid biosynthesis. These topics are very 
relevant to the ongoing improvement of plants, by breeders, to provide better options 
for our agriculture to be more harmonious with our environment and more sustainable 
economically. 
Network D focuses on the biochemical mechanisms in plants that determine the 
efficiency of nitrate fertiliser utilisation. The efficiency will be altered by introducing 
new genes. Laboratories in Ireland, Greece and Portugal will benefit from specific 
measures to facilitate the transfer of technology via Network E, so as to bring advanced 
methods closer to the realities of agro-biotechnological research at the periphery of 
Europe. 
The engine of the project is built from small groups of researchers who have formed 
interactive multinational teams to tackle specific problems. Teams tackling similar 
problems are networked together and all the teams in the four major research areas will 
keep in touch with each other's progress and meet once a year to share their progress 
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and problems. On a daily basis all scientists can be in touch with each other by 
electronic mail, fax and telephone. This then is a truly European effort involving 117 
research groups who wish to participate in research to advance European plant science. 
Another major aim of the project will be to provide training for scientists, especially 
those in emerging laboratories where contact with established laboratories will 
strengthen the overall capabilities of European plant science. The overall coordination 
and management of the project will be the responsibility of a new European partnership 
between the Max Planck Institute for Plant Breeding- KOln, Germany- and the John 
Innes Centre - Norwich, UK-, two major institutes in the area of plant science. The 
scientific coordination will be carried out by the PTP science coordination board, with 
representation of all networks around their designated coordinators. 
Keywords: 
Embryo, Growth factors, Oligosaccharides, Hormone, Abiotic stress, Salinity, Potassium 
deficiency, Quantitative trait loci, Drought tolerance, Translocation, Partitioning, 
Storage products, Starch, Carbohydrate flow, Carotenoid, Seed, Nitrogen utilisation, 
Nitrate 
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NETWORK A • PLANT GROWTH FACTORS AND PLANT DEVELOPMENT 
The organisation and patterns of growth and development of each plant species are 
highly adapted to meet its needs in the range of environments it commonly encounters 
during evolution. Nevertheless there is significant variation within each species which 
has enabled plant breeders to select forms that are better adapted to the needs and 
conditions of agriculture. In spite of this progress there is no reason to presume that the 
growth habitats of the species currently used in agriculture and horticulture are ideal 
for efficient productivity in a safe and sustainable way, with minimum detrimental 
impact on the environment. To be able to manipulate growth and development further 
and to assess the value of novel forms in agriculture and horticulture, more information 
is required on the mechanisms of how growth and development are determined and of 
the genes that specify theses mechanisms. 
It is abundantly documented that a number of low-molecular weight signal molecules 
(phytohormones) such as auxins and the quantity and quality of light, temperature etc. 
play critical roles in plant growth, differentiation, flowering, embryogenesis, stress 
responses, etc. Therefore, an array of contributions covering the action of these and 
other potent molecules and light effectors, together with contributions to explore the 
molecular and genetic steps in signal recognition and transduction in the critical 
processes of flowering, embryo formation, leaf and rood development have been 
combined to create a major project of novel research. This project will shed much new 
light on the determination of plant shape and form by hormones and other chemical 
signals and, of special importance, on how to manipulate shape and form genetically 
in plant breeding. 
This topic is central to most other aspects of this PTP project and is organised in the 
form of a series of subnetworks dealing with 5 themes. 
Title : 
Theme A 1 - Coordinators : S. de Vries and J. Schell 
Pattern formation in plant embryos; study of the transition from 
vegetative to reproductive growth and of the control of development of 
flowers and seeds, as well as of the determination of leaf shape, size and 
number of axillary shoot meristem formation. 
Participants : 
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Theme A 2 - Coordinators : M. Hall and J. Schell 
Molecular mechanisms of action of plant growth factors. Particular 
attention will be paid here to the study of the mechanisms underlying 
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Theme A 3 - Coordinators : S.C. Fry and R.B. Flavell 
Biochemical and physiological mechanisms of action of xyloglucan 
oligosaccharides as novel plant growth factors. 
Participants : 
FRY Stephen C. 
PEREZ Lorences Ester 
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Theme A 4 - Coordinators: T. Wang and R.B. Flavell 
Hormone-mediated regulation of cellular development in the moss, 
Physcomitrella patens. 
Participants : 
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The aim is to analyse the mechanisms allowing some plants tolerate stresses such as 
desiccation, drought, salinity, cold, heat, phosphate starvation and active radicals as well 
as the role played by transporters located in plant cell membranes in establishing 
tolerance to abiotic stresses, including salinity and potassium deficiency. 
Theme B 1 - Coordinators : D. Bartels and F. Salamini 
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Theme B 2 - Coordinators : R. Leigh and F. Salamini 
Molecular and cellular studies of the role of membrane transport 
processes in plant resonses to environment and to abiotic stresses, 
including salinity and potassium deficiency. 
Participants : 
LEIGH Roger B2.1 GB PL 920126 
RODRIGUEZ-NAY ARRO Alonso B2.2 E PL 920126 
SANDERS Dale B2.3 GB PL 920126 
SERRANO Ramon B2.4 E PL 920126 
SENTENAC Herve B2.5 F PL 920126 
BOUTRY Marc B2.6 B PL 920433 
PALMGREN Michael B2.7 DK PL 920433 
OKKELS Finn B2.8 DK PL 920433 
Theme B 3 - Coordinators : D. de Vienne and F. Salamini 
A strategy to characterize the QTLs involved in drought 
tolerance in maize 
Participants : 
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NETWORK C • SYNTHESIS, MOBILISATION TRANSLOCATION AND 
PARTITIONING OF PlANT STORAGE PRODUCTS 
The aim of this topic is to contribute to an increase in the economic value of crops by 
improving yield and/or value of crops. The regulation of the formation of storage 
organs, e.g. tubers, fruits, seeds etc. and the mechanisms leading to partitioning of 
carbohydrates, pigments, proteins, lipids and cell wall precursors will be studied in this 
network. 
Theme C 1 - Coordinators: D. Vreugdenhil and D. von Wettstein 
Title : Development and differentiation of starch storing organs - the 
potato tuber as a model system 
Participants : 
VREUGDENHIL Dick C1.1 NL PL 920150 
DAVIES Howard C1.2 GB PL 920150 
VISSER Richard C1.3 NL PL 920150 
MINGO-CASTEL Angel C1.4 E PL 920150 
DU JARDIN Patrick C1.5 B PL 920150 
MARTIN Catherine C1.6 GB PL 920403.73 
KOSSMANN Jens C1.7 D PL 920403.68 
KRUGER Nicholas C1.9 GB PL 920403.70 
Theme C 2 - Coordinators : J. Smeekens and D. von Wettstein 
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Theme C 3 - Coordinators: P. Bramley and D. von Wettstein 
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Theme C 4 - Coordinators : R. Thompson and D. von Wettstein 
Metabolic regulation in the developing seed 
Participants : 
THOMPSON Richard 
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NETWORK D • NITROGEN UTILISATION EFFICIENCY 
N-fertilizers and their utilisation efficiency are key elements affecting yield but also 
environmental pollution. The genetically regulated physiological processes defining the 
efficiency of N-fertilizer use will be studied. 
Title : 
Theme D 1 - Coordinators : M. Caboche and B. Forde 
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Theme D 2 - Coordinators : B. Forde and M. Caboche 
The regulation of the nitrate assimilatory pathway in Lotus japonicus and 
the improvement of nitrogen utilisation efficiency in crop plants through 
genetic manipulation. 
Participants : 
FORDE Brian D2.1 GB PL 920410 
CLARKSON David D2.2 GB PL 920410 
HIREL Bertrand D2.3 F PL 920410 
MARQUEZ Antonio J. D2.4 E PL 920410 
STOUGAARD Jens D2.5 DK PL 920410 
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NETWORK E - LOCAL NETWORKS 
The local networks serve to bring biotechnological research and training in plant 
sciences to interact with pioneering work supported by the Project of Technological 
Priority. The networks also serve to get new knowledge and methods to bear on more 
applied aspects of plant breeding relevant to their local agricultures. Laboratories in 
Ireland, Greece and Portugal active in these areas of research are associated with the 
main project : 
a) to provide advanced graduate and postdoctoral training in plant sciences and in 
the basic research-plant biotechnology interphase; 
b) to strengthen already existing and support new research collaborations among 
the relatively few good laboratories engaged in plant molecular cellular genetics 
and in biochemical-physiological research in the three mentioned countries. 
These initiatives are expected to help remedy the problem of the lack of minimum 
critical mass currently existing in those parts of Europe. 
Theme E 1 - N. Panopoulos and J. Schell 








TSAFf ARIS Athanasios 
HASSIOTOU Efthimia 
GR PL 920406 
GR PL 920406 
GR PL 920406 
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GR PL 920406 
GR PL 920406 
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Theme E 2 - L. Margaritis and J. Schell 
The Greek "node" on plant molecular biology 
Participants : MARGARITIS L. and associated laboratories 
Theme E 3 - J.M. Novais and F. Garcia-Olmedo 
Portuguese network 
Participants : NOV AIS J.M. and associated laboratories 
I 
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Theme E 4 - Coordinators: J. Ryan and R.B. Flavell 
Molecular markers for juvenility in woody plant species 
Participants : RYAN J. and associated laboratories. 

IN VITRO DEVELOPMENTAL 
TOXICOLOGY 
2.1.4 Development of in vitro test systems for the study of the potentially toxic 
effects of novel and highly specific compounds, during cell differentiation and 
organogenesis, especially upon the immune, nervous and reproductive systems. 
Such tests will have to be compatible with the pre-normative requirements for 
sensitivity, specificity, quantitation and for transposability of results to man. 
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A new strategy for developmental toxicology in vitro using molecular and 
cellular markers in mammalian whole embryo culture to enhance sensitivity 
and selectivity 
Contract number: CT930107 (Generic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 631,000 ECU 
Objectives: 
To perfect an in vitro system that will detect, with sensitivity and specificity, subtle 
chemically-induced defects in the development of the nervous system. Reliable 
detection by a simple system requiring only small quantities will facilitate discovery 
of safe chemicals and evaluation of environmental and biological samples for toxicants. 
Brief description: 
The test we propose is the ability of a chemical to affect selected molecular and cellular 
markers in whole mammalian embryos developing in culture. We propose, for the first 
time, to marry recent advances in knowledge of developmental control genes and 
proteins with proven culture methods to produce a unique test system. Rodent embryos 
in culture are as close to human development as is possible in an in vitro test system. 
Culture methods were designed years ago, but for a decade there has been a bottleneck 
in devising approaches that could be exploited by industry for practical testing. We 
argue that our strategy will overcome problems in specificity and sensitivity that have 
prevented the wide-spread adoption of in vitro developmental toxicology. Our 
immediate objective is to identify those markers (of nervous system cell populations) 
that will respond to sub-dysmorphogenic exposure to developmental toxicants. We 
have selected a panel of prospective markers, mostly genes encoding transcription 
factors involved in cell fate. Rat and mouse embryos, in culture and in vivo, will be 
exposed to prototype nervous system teratogens (cocaine, ethanol, retinoic acid, 
valproate) and non-teratogens (diphenhydramine and 2-ene valproate). Using 
systematic treatments of graded effect we will identify those markers that respond 
informatively. We will monitor chemical exposure levels in vivo. This will generate 
a unique set of data enabling comparisons of: rat-mouse; in vitro-in vivo; 
morphology-markers; and developmentally toxic with non-toxic agents. Following 
selection of a few useful markers, we plan to simplify detection for routine use. A 
future goal is to generate transgenic lines with reporter constructs to enable 
visualisation of markers in test embryos by a one-step process. 
Keywords: 
Embryo culture, Nervous system, Developmental toxicity, Toxicology, In vitro test 
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Coordinator 
DR BROWN NIGEL 
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ST. GEORGE'S HOSPITAL MEDICAL SCHOOL 
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Participants 
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Neurotoxicological systems 
Contract number: CT930108 (Generic Research Project) 
Start date: 01/11/93 Duration: 36 months 
EC contribution: 663,000 ECU 
Objectives: 
To establish an organotypic long-term culture system of the developing mammalian 
brain. To preevaluate the culture system for neurotoxicological needs using various test 
toxins and endpoint assays. 
Brief description: 
Toxicological evaluation of novel long-term neuroembryological cultures. Neurotoxic 
effects of xenobiotics will be best elucidated in an in vitro system that preserves the 
native brain architecture with all its cell-cell interactions. Therefore the central objective 
of the proposed research is to use an organotypic roller culture of mammalian 
neuroembryonic tissue, which differentiates over several weeks in vitro as in vivo due 
to optimized nutrient and gas exchange. This is achieved by continuous motion of 
immobilised embryonic rat brain micro slices between the culture medium and gas 
phase. Characterization and validation of the system will be performed by using various 
test toxins and by endpoint determinations with the aid of novel and standard assays. 
These assays include metabolising enzymes, differentiation markers, toxicological 
relevant metabolites and histology. A computerised cell viability assay will be 
incorporated into the programme as well as specific test conditions such as hypoxia for 
oxygenation dependent toxicity of xenobiotics. For comparison a single cell culture will 
be used. 
Keywords: 
Development, Neuroembyotoxicology, Xenobiotic, Toxicology, In vitro test 
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DR SCHLOSSHAUER BURKHARD 
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UNIVERSITAT TUBINGEN 
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Cellular regeneration, $$reproduction and development 125 
Development of in-vitro neural and related immune systems for the study of 
potentially toxic effects of novel and highly specific compounds during cell 
differentiation 
Contract number: CT930224 (Generic Research Project) 
Start date: 01/10/93 Duration: 36 months 
EC contribution: 1,007,000 ECU 
Objectives: 
This proposal provides a multidisciplinary approach with input from biochemists, 
pharmacologists, molecular biologists, immunologists and toxicologists to develop and 
test in vitro neuronal and glial cell systems for use in the study of the potentially toxic 
effects of novel and highly specific compounds during central nervous system 
development. 
Brief description: 
Development of the central nervous system is primarily a matter of cell proliferation, 
movement, cell differentiation, cell-cell interaction and programmed cell death. The 
study of the mechanisms and regulation of signalling by cell-surface receptors for 
neurotransmitters and modulators, their effects on regulation of neuronal and glial cell 
gene expression, and the effects of drugs and toxins on these phenomena provides a 
molecular and mechanistic basis for increasing our basic biological knowledge as a 
foundation for the proposal of new in vitro toxicological and pharmacological tests. 
Emphasis will be placed on the well characterized glutamatergic and GABAergic 
neuronal cell signalling systems and their supporting glial cells and on those agents 
known to interact with these systems with which the proposers have much experience. 
Effects (potential end-points) such receptoreffector coupling, oncogene and transcription 
factor activation, cell morphology, receptor expression and cell death will be assessed. 
The cell systems will include rodent primary cultures of cerebral cortex neurons, 
cerebellar granule cells and astrocytes; cell lines such as C-6 glioma, neuroblastoma 
and rat PC12 cells; the multicellular brain slice system; and neuroendocrine related cell 
lines. The studies will cover the expression and functioning of genes and receptors 
under normal and pathological states, the influence of neurotransmitters and interacting 
drugs and toxins such as convulsants, anticonvulsants, sedatives, anxiolytics, 
anxiogenics, excitotoxins and polychlorinated hydrocarbons, and the influence on cell 
growth and differentiation of regulators such as cytokines and lipid-based compounds. 
Keywords: 
Neural cells, In vitro toxicology, Differentiation, Toxicology, Cytokine, In vitro test 
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Development of a new test of developmental toxicology 
Contract number: CT930394 (Generic Research Project) 
Start date: 01!11!93 Duration: 36 months 
EC contribution: 805,000 ECU 
Objectives: 
To develop a test for developmental toxicology without the use of warm blooded 
animals. Each partecipant will check on one embryonic or cellular system the effects 
of some pharmaceutical drugs. 
Brief description: 
Much money, evaluable in about 400 million ECU per year is spent by the 
pharmaceutical industries of the E. C. for testing the effect of new pharmaceutical drugs 
on human reproduction. The current tests imply the use of rats and rabbits. We aim to 
test such unwanted effects on simpler and less expensive systems which will provide 
informations on the following parameters: cell division,fertilization, differentiation, 
morphogenesis, metabolism. The results obtained with these systems will be compared 
with those obtained with the traditional methods, i.e. with rats and rabbits. If a good 
correlation is observed, and namely if the systems under examination show, as 
predictable,a sensitivity not lower than the traditional ones, the pharmaceutical industry 
may in the future make a prescreening of the drugs to be tested on the simpler and less 
expensive system developed by our studies and go to the more expensive and 
complicated traditional test on mammals only for those drugs which have passed the 
prescreening. The systems to be studied have been selected with a double criterion: the 
characteristics of the material, which permit easy and clear answers to the above listed 
questions, and the competence and long standing experience of the participants. The 
systems are 1) Yeast; 2) Dictyostelium amoebae; 3) Drosophila embryos; 4) Sea urchin 
eggs and embryos; 5) Cultures of human keratinocytes. 
Keywords: 
Toxicology, Embryo, Development, Yeast, In vitro test 
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The use of gene transfer technology inconjunction with primary and clonal 
culture for the establishment of predictive in vitro screening assays for 
teratogenic potential : development, validation and transfer to the industrial 
Contract number: CT930471 (Generic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 934,000 ECU 
Objectives: 
1) Pre-validate an antiproliferative assay for teratogens and compare it with the 
micromass system. 2) Engineer cell lines with human cell recognition systems for study 
of teratogen influence on cell migration and axon extension. 3) Develop teratogen 
structure-activity relationships. 
Brief description: 
The project proposes to develop in vitro bioassays which will identify putative 
teratogens by their ability to impair the major developmental events of cell proliferation 
rate, adhesion, migration and cell-cell recognition. Studies, initiated in BAP, on 
teratogen-compromised human and rodent cell proliferation rates will be expanded to 
define structure activity principles and mechanisms of G 1-phase blockade using 
valproate and thalidomide, and their metabolites, and the retinoids. The results of these 
studies will be validated by comparison with the limb bud micromass cell system and 
cell affinity for lectin coated surfaces. The technology associated with these in vitro 
systems will be transferred to the industrial sector as an adjunct to the preclinical 
screening of pharmaceuticals . Rodent cell lines, transfected with individual human 
recognition molecules (NCAM, L1 and N-Cadherin), will be developed and used to 
evaluate teratogen perturbations of cell migration and neurite outgrowth from human 
and rodent primary neurons. The influence of teratogens on the normal expression of 
cell recognition systems will be evaluated with 15 coded structures, selected for 
synthesis by computer modelling and quantitative structure-activity relationship 
calculations for the valproate teratogen. The in vitro systems, structure activity 
principles and collective expertise will be used to further establish the molecular modes 
of teratogen action. 
Keywords: 
Toxicology, Nervous system, Development, Adhesion molecules, In vitro test 
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2.2 Metabolism of animals, plants and 




2.2.1 Analysis of the contributions which transgenic animals could make to the study 
of human health (cancer, AIDS, Alzheimer, hypertension, etc.) and, at the same 
time, definition of rational criteria to assess consequences of transgenosis upon 
animal welfare in relation with each type of genetic transfer. Towards the end 
of the programme, research could be financed for the development of new 
animal models, more representative of human material, including the use, where 
necessary, of transgenic animals relevant to the study of human health and its 
protection. 
Further to the 1st call for proposals, this sub-topic was addressed via the funding of 2 
small studies on: 
i. Title: Development and use of transgenic mice for the study and 
detection of carcinogenic risk factors. 
Coordinator: C.F. van Kreyl 
ii. Title: Modelling tumor necrosis factor mediated pathology in 
transgenic mice. 
Coordinator: Geroge Kollias 
which are preparatory to research activities to be amplified under ulterior calls (see next 
edition). 
PLANTS 
2.2.2 Possibilities to modify the nitrogen utilisation efficiency of cultivated crops, 
particularly at limiting steps of the nitrate storage and assimilation pathway. 
Application of molecular biological techniques to the characterisation and 
modification of key enzymes and transporters. 
2.2.3 Characterisation of genes, enzymes and transfer molecules involved in the 
synthesis, mobilisation, translocation and partitioning of storage products within 
the plant at tissue, cellular and organellar levels. 
2.2.4 Molecular investigation of specific sensing mechanisms and plant pathways 
associated with abiotic environmental stresses (drought, salinity, ... ), with a view 
to identifying adaptive functions. 
Please refer back to 2.1.3 
MICROORGANISMS 
2.2.5 Mechanisms governing essential biological functions/metabolic activities 
important to man, such as secretion processes for heterologous proteins in 
filamentous fungi. This task shall lead to the development of an intimate 
knowledge of the molecular and physiological mechanisms that control key cell 
functions in filamentous fungi. The information to be obtained will enable the 
researchers to modify the cell, genetically and/or physiologically, in order to 
meet the requirements of industry. 
2.2.6 Mechanisms governing essential biological functions/metabolic activities in 
industrial microbial species important to man, other than filamentous fungi. 
Particular attention will be paid to microbial processes poorly understood, such 
as molecular mechanisms of spore formation and their relation to secondary 
metabolism; molecular and environmental factors that govern the switch from 
primary to secondary metabolism, etc. 
2.2.7 Mechanisms of gene regulation for the expression of economically important 
products such as secondary metabolites and heterologous proteins (ie : antibodies 
and hybrid antibodies). This task aims, first to understand and to manipulate 
genetic elements that control regulatory signals for the expression of genes 
involved on secondary metabolism, and second, to unravel and to circumvent the 
controls that prevent efficient expression of heterologous proteins in 
microorganisms. 
2.2.8 Biochemical, physiological and genetic studies of representative types of 
extremophile microorganisms ( acidophiles, thermophiles, etc.) aiming at 
understanding and exploiting better their biotechnological capabilities. 
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pH regulation, carbon catabolite repression, secreted enzymes and secondary 
metabolites in filamentous fungi 
Contract number: CT930174 (Basic Research Project) 
Start date: 01/09/93 Duration: 30 months 
EC contribution: 886,715 ECU 
Objectives: 
To identify the pH signal molecule. To characterise Pace transcription factor-receptor 
interactions. To characterise CREA-mediated transcriptional repression. To characterise 
and assess the penicillin production role of P. chrysogenum Pace. To identify structural 
genes for the xylanolytic complex, determining and exploiting their regulation. 
Brief description: 
This project concerns two wide domain gene regulatory systems in the filamentous 
fungus Aspergillus nidulans, pH regulation of synthesis of secreted enzymes, permeases 
and exported metabolites and carbon catabolite repression of synthesis of enzymes and 
permeases involved in carbon nutrition, and manipulates these regulatory systems to 
improve production of an important secondary metabolite, penicillin, in P.chrysogenum 
and an important group of secreted enzymes, the xylanolytic complex inA.nidulans and 
A.niger. A.nidulans is the appropriate model organism as it is the only organism in 
which pH regulation has been identified and characterised despite its widespread 
occurrence in microorganisms and the relevant wide domain and pathway-specific 
regulatory systems have been characterised. Objectives include identification of the 
signal molecule mediating recognition of external pH; characterisation of interactions 
between the PacC transcription factor mediating pH regulation and DNA target sites; 
comparison of A.nidulans and P.chrysogenum pace genes; characterisation of 
interactions between the CREA negative transcription factor mediating carbon catabolite 
repression and DNA binding sites; mutational dissection of the mechanism and 
specificity of CREA mediated repression; molecular analysis and assessment of the role 
in penicillin production of the P.chrysogenum pace gene; identification and definition 
of the regulatory characteristics of structural genes for xylanases and related activities, 
pathway-specific induction, carbon catabolite repression and pH regulation and use of 
knowledge of composition and regulation of the xylanolytic complex to improve 
production. 
Keywords: 
Aspergilli nidulans,Aspergilli niger, Catabolite repression, Penicillin, P. chrysogenum, 
pH, Transcription, Secreted enzymes, Metabolism, Xylanolytic system 
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Study of the mechanisms of secretion of heterologous proteins in filamentous 
fungi as a knowledge base for efficient protein production 
Contract number: CT930008 (Concerted Action) 
Start date: 01/11/93 Duration: 36 months 
EC contribution: 53,000 ECU 
Objectives: 
Characterisation of the secretion pathway and analysis of post-translational 
protein-modification processes; development of protein-fusion strategies to improve 
heterologous-protein secretion; physiological studies to elucidate optimal cultivation 
conditions for efficient secretion. 
Brief description: 
With a number of filamentous fungal strains efficient secretion of homologous proteins 
can be achieved. The secretion of heterologous proteins, however, is much less 
efficient. Due to the virtual lack of knowledge concerning the molecular and 
physiological mechanisms of protein secretion, it is very difficult to identify the factors 
which hamper efficient secretion of heterologous proteins. The research proposal 
describes a highly coordinated and inter-dependent research programme with the 
general objective of investigating the molecular and physiological mechanisms that 
control key cell functions involved in secretion of heterologous proteins in filamentous 
fungi. Research effort is concentrated on : 1) molecular characterisation of the secretion 
pathway and analysis of post-translational protein-modification processes with the goal 
to identify and manipulate the proteins which are of importance for efficient secretion 
of biologically -active, heterologous proteins; 2) development of protein-fusion strategies 
with the goal to improve heterologous-protein secretion; 3) physiological studies with 
the goal to elucidate optimal cultivation conditions for efficient secretion of 
heterologous proteins. Aspergillus niger is chosen as target organism because of its 
accessibility to genetic modification, biotechnological importance, GRAS-status and 
great capacity of protein secretion. The programme will be carried out by seven 
laboratories from four countries with complementary expertise in (molecular) genetics, 
cellular biology, subcellular analysis and physiology/fermentation. 
Keywords: 
Filamentous fungi, Aspergilli niger, Secretion, Protein secretion, Protein fusion, Protein 
modification, Subcellular analysis, Physiology, Fermentation 
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Protein secretion in filamentous fungi Trichoderma 
Contract number: CT930502 (Concerted Action) 
Start date: 01!10/93 Duration: 36 months 
EC contribution: 47,000 ECU 
Objectives: 
Our aim is to understand the complex process of protein secretion in Trichoderma and 
to develop strains that are improved in protein secretion. Understanding the key events 
in secretion in this fungus is highly relevant to its exploitation by companies in Europe 
involved in the production of recombinant proteins of therapeutic interest. 
Brief description: 
Trichoderma is a fungus used by many biotechnological companies in Europe for the 
production of enzymes. These are employed in a diversity of industries from food 
manufacture to paper making. The virtue of the fungus in this important area of 
economic exploitation is that of protein secretion, at which it is highly efficient. 
Because of this, Trichoderma has great potential as a host for the production of 
recombinant proteins for therapeutic use. Recombinant therapeutic proteins are highly 
value products and are undoubtedly of interest to the European pharmaceutical industry 
and to the economies of the countries involved. These products are of relevance to the 
development of established, and the inception of new, small to medium sized 
companies. However, to maximise the benefits of Trichoderma our knowledge of the 
secretion process must be developed and this is the broad goal of the proposed research. 
To achieve it, several key areas embracing the biochemistry, genetics, cell biology and 
physiology of the process will be addressed. At the molecular level important questions 
concern gene structure and its influence on protein yield, the N- terminal and 
proteolytic processing of proteins along the secretory pathway and the isolation and 
characterisation of genes and mutations which enhance secretion. At the biochemical 
level glycosylation is of key significance and an understanding of glycan structures, the 
biosynthesis of the glycans and the importance of the glycosylation pattern are relevant 
to the efficient secretion of proteins. At the cell level the role of the cytoplasmic 
cytoskeletal structures in the secretion pathway will be assessed as will the influence 
of the cultivation conditions on secretion. The knowledge gained from these lines of 
investigation will be adopted to develop strains which are improved in the secretion of 
heterologous proteins. 
Keywords: 
Trichoderma, Protein secretion, Protein modification, Secretion, N-terminal processing, 
Proteolytic processing, Glycosylation, Genes which enhance secretion, Cytoskeleton 
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Study of catabolite repression in gram-positive industrially important, 
food-grade bacteria, as a knowledge basis for strain improvement programmes 
Contract number: CT920137 (Basic Research Project) 
Start date: 01/02/93 Duration: 36 months 
EC contribution: 1,150,000 ECU 
Objectives: 
Identification and characterization of: 
1. cis- and trans-acting elements involved in catabolite repression in Gram-positive 
bacteria. 
2. signalling pathways from carbon sources to gene expression. Developement of strains 
resistant to catabolite repression and therefore better suited for use in production 
processes. 
Brief description: 
The presence in growth media of rapidly metabolizable carbon sources (catabolite 
repression, CR) affects the industrial production by bacteria of enzymes, extra-cellular 
polysaccharides and secondary metabolites, as well as bioconversion and degradation 
of extra-cellular polysaccharides. The aim of this study is to provide a knowledge basis 
for strain improvement of Bacillus, Lactobacillus, Lactococcus and Staphylococcus 
carnosus. The economic importance of these bacteria is beyond doubt. Strains of these 
genera are already used in industrial processes. Their properties may be considerably 
improved by elucidating the mechanisms controlling CR. Every strain used has the 
GRAS status facilitating application of genetically modified strains in production 
processes. All species are evolutionary closely related facilitating expression of 
mutually exchanged genes. The range of organisms studied in this highly coordinated, 
interdependent research programme allows recognition of potentially common 
regulatory pathways mediating CR. As results of this programme we expect to 
understand CR in detail. Since many applications of the use of these organisms are 
affected by CR, this knowledge should allow to develop new stratagies for strain 
improvement by either classical genetic or molecular genetic methods in a directed and 
predetermined way. The results should also allow the developement of improved 
physiological conditions for efficient production processes. Direct modification of the 
control of CR may result in strains that are no longer subject to CR under conditions 
where rapid metabolizable carbon ources are abundant (e.g. complex growth media). 
Keywords: 
Catabolite repression, Bacteria, Phospho transferase system, Phosphorylation, Cis acting 
elements, Protein 
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Regulation of cell division during growth and sporulation in bacteria of basic 
and applied interest : an integrated view 
Contract number: CT920483 (Basic Research Project) 
Start date: 01!01/93 Duration: 36 months 
EC contribution: 800,000 ECU 
Objectives: 
To study the molecules that build the septum, either during sporulation or in vegetative 
division, in Streptomyces, Bacillus, Brevibacterium, and Escherichia coli, including the 
description of the regulatory mechanisms that control the expression of the genes that 
code for septal components and of those that control the timing and placement of the 
septum. 
Brief description: 
Sporulation and secondary metabolism in Bacillus and Streptomyces are associated 
temporally, physiologically and genetically. The earliest morphological manifestation 
of sporulation in both genera is specialized septation. The proteins mediating this 
probably include some that are sporulation-specific and some that also take part in 
normal cell division. To investigate the role of these proteins, their regulation and 
interactions, and their relevance for morphological differentiation and secondary 
metabolism, an integrated study of septation will be done in Bacillus subtilis, 
Streptomyces coelicolor, and Brevibacterium lactofermentum, organisms that combine 
excellent genetics with industrial relevance. The investigation will depend heavily on 
advances in analyzing septation in the model organism Escherichia coli. E. coli studies 
will focus on the structure and regulation of gearbox promoters, regulation of ftsZ 
expression, and biochemical activity of FtsA. Genes homologous to the division genes 
of E. coli will be cloned and analyzed in Bacillus, in particular the homologues of the 
2.5 min cluster (PBP3 and fts genes). Their differential regulation during vegetative 
growth and sporulation will be investigated in relation to the underlying transcriptional 
differentiation mechanisms, mediated by sigma factors, that occur during sporulation. 
These basic mechanisms of division and sporulation will be correlated with those 
governing sporulation septation in Streptomyces. For this purpose whi gene-dependent 
genes, and division gene homologues will be cloned and characterized. Characterization 
of PBPs at the protein level will be done in Brevibacterium. Genes homologous to the 
E. coli ones will be isolated by using suitable molecular probes and their expression 
studied. The results will be integrated to provide a view of bacterial division and its 
modification during morphological and physiological differentiation. The conclusions 
will be of applied interest both because of their potential impact on fermentation 
microbiology and because cell division genes are attractive targets for antibiotic 
screening. 
Keywords: 
Septation, Cell division, Sporulation, Gene expression, Bacillus subtilis, Brevibacterium 
lactofermentum, Escherichia coli, Streptomyces coelicolor 
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Characterisation and optimisation of the Bacillus subtilis protein secretion 
apparatus 
Contract number: CT930254 (Basic Research Project) 
Start date: 01/09/93 Duration: 30 months 
EC contribution: 1,223,702 ECU 
Objectives: 
147 
This project will characterise the protein secretion apparatus of Bacillus subtilis in order 
to provide the knowledge base required to optimise the production of native and 
heterologous proteins from this and related industrial microorganisms. Thus, the project 
will produce information of immediate applicability to EC industries. 
Brief description: 
To characterise the protein secretion apparatus of Bacillus subtilis, the project identifies 
four major targets: (A), the identification and characterisation of the components of the 
secretion apparatus; (B), the development of in vitro systems to analyse the mode of 
action and the function of these components;(C), the identification of secretion 
bottlenecks; and (D), the development of strategies to optimise secretion. The proposed 
work is divided into six main tasks. Four of these are defined by the different stages 
in the secretion process: (!),chaperones; (2) translocase; (3), late stages; and (4), cell 
wall. Milestones for these tasks include: the cloning of genes for components of the 
secretion apparatus, the mutational analysis of these genes, the analysis of their 
expression, the overproduction of identified components, the purification of the 
identified components, the in vitro characterisation of purified components, the 
introduction of heterologous chaperones and the analysis of the relationships between 
cell wall composition and protein secretion. Task 5 aims at the identification of 
secretion bottlenecks. Its milestones include the identification of components limiting 
for secretion and the identification of components of extremophilic bacilli that may 
overcome secretion defects in B.subtilis. Task 6 aims at the establishment of in vitro 
protein translocation systems. Its milestones include the in vitro reconstitution of 
protein translocation and the analysis of the energy requirements of secretion. Nine 
research groups, including two from industry, which together are experienced in 
molecular genetics, biochemistry, biophysics, microbial physiology and molecular 
biology, will undertake these studies in an integrated way. 
Keywords: 
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Early steps in protein secretion 
Contract number: CT930470 (Basic Research Project) 
Start date: 01/10/93 Duration: 30 months 
EC contribution: 640,000 ECU 
Objectives: 
1. Characterization of new components affecting protein translocation by mutagenesis 
in yeasts. 2. Development of immunological probes to dissect the translocation process. 
3. Development of in vitro systems to reconstitute actively translocating 
proteoliposomes. 4. Characterization of the components of SRP. 5. Analysis of the 
critical regions of the components of the translocation apparatus by genetic techniques. 
6. Application of the reconstituted proteoliposomes to the determination of the role of 
the identified components of the translocon to the translocation process. 
Brief description: 
In all living organisms, the translocation of the polypeptides through a membrane is the 
basic process of the protein secretion pathway. A better understanding of the 
translocation machinery may lead to the improvement in the efficiency of secretion of 
foreign proteins. This work will combine results obtained on different organisms so that 
a link will be established between the in vitro tools developed in higher eukaryotes and 
the genetic tractability of yeast. The first task, recruitment and presentation of the 
polypeptides to the translocon, is performed by the Signal Recognition Particle or SRP. 
Progress in the understanding of the SRP function requires the use of molecular biology 
tools available in the yeasts. Work will be carried out concurrently in two different 
yeast species (Saccharomyces cerevisiae and Yarrowia lipolytica) in order to get an 
unified picture of SRP function and to take advantage of the techniques available in 
either of these yeasts. Two approaches will be followed : identification of components 
of the SRP targeting pathway bY mutagenesis and their molecular characterization. The 
second task, translocation through the ER membrane, is carried out by a complex of 
several proteins known as the translocon. Our project is focused on the study of 
SEC61p, a crucial component of the translocon, and of a multicopy suppressor of a 
sec61 mutation (SSSI) which is associated with the ER membrane. It will involve 
determination of topology of these proteins and structure-function relationships. In vitro 
heterologous complementation will be use to determine the degree of functional 
conservation between yeast and mammals. Reconstitution experiments with either 
mammalian purified components or with wild type/mutated components from yeast will 
permit the identification of those which mediate the observed differences between 
various secreted proteins. The ultimate goal will be to reconstitute translocation 
competent proteoliposomes from purified components. 
Keywords: 
Protein secretion, Yeast, Saccharomyces cerevisiae 
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Biotechnology of extremophiles 
Contract number: CT930274 (Generic Research Project) 
Start date: 01/09/93 Duration: 30 months 
EC contribution: 4,298,582 ECU 
Objectives: 
The main goal of the project is the development of physiological, biochemical and 
genetic studies of microorganisms living under extreme conditions (high temperature, 
high salt concentration, extremes of pH) aiming at understanding and exploiting their 
biological capabilities. 
Brief description: 
The commercial potential of microorganisms and their enzymes is widely recognized. 
However, the introduction of biotechnological processes is severely hampered by the 
lack of stability of biocatalysts currently available. The finding of unique 
microorganisms and stable enzymes that are active under extreme conditions (high 
temperature, high salt concentration, extremes of pH) will give a strong impetus to the 
development of new applications. Microorganisms which thrive under extreme 
conditions offer a rich and unexplored source of new biocatalysts. Due to the unique 
properties of extremophilic microorganisms and their enzymes, they are expected to fill 
the gap between biological and chemical industrial processes. The proposal includes a 
multidisciplinary research approach that is performed at three levels, namely 
isolation/taxonomy, physiology/biochemistry, and molecular biology/genetics. These 
studies will offer in depth information on the strategies developed by newly isolated 
and already known extremophiles to sustain life under extreme conditions. Detailed 
investigations will be conducted on the molecular properties of the enzymes and their 
genes that are present in extremophiles. The different expression systems of such 
microorganisms will be studied in detail. 
Keywords: 
Thermophiles, Alkaliphiles, Acidophiles, Halophiles, Physiology, Metabolism, Enzyme 
stability, Structure function relationship, Fermentation, Taxonomy, Bioenergetics 
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HUMAN AND VETERINARY 
VACCINES 
2.3.1 New immunological approaches to develop effective, safe and preferably 
economic vaccines particularly against/with those antigenic epitopes that are 
poorly immunogenic. Research should focus upon the identification of the main 
characteristics of T and B antigenic epitopes, the mechanisms of antigen 
presentation and processing, lymphocyte activation, cell-cell communication, 
carrier, adjuvants, vectors, delivery systems, ... Preference will be given to 
multidisciplinary proposals, including 4 to 6 laboratories using complementary 
methods and/or techniques, and having the potential to solve well- defined and 
specific problems linked to the development of human and/or veterinary 
vaccines. The proposals should address the immunological methodology of 
preparation for future vaccines against pathogens or antigens of special 
importance of man and/or animals, rather than against any specific disease. 
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New approach for oral vaccination against infectious diseases 
Contract number: CT920089 (Basic Research Project) 
Start date: 01!01!93 Duration: 36 months 
EC contribution: 850,000 ECU 
Objectives: 
Development of a new generation of recombinant oral vaccines by using non 
pathogenic Gram positive live vectors (e.g. Staphylococcus xylosus) expressing multiple 
recombinant antigens on its surface for the induction of multivalent protective immune 
responses against infectious diseases. 
Brief description: 
The purpose of the proposal is to develop a new generation of vaccines which 
utilizes the non-pathogenic bacterium of S.xylosus as a novel system for the 
expression of recombinant antigens. Because it can colonize the host in testing, this 
bacterium may be used to orally immunize hosts against recombinant proteins 
expressed on its surface. Sueh a system facilitates the design of safe, effective and 
cheap oral vaccines that may be administrated soon after birth. The proposal consists 
of a basic research programme on such vaccines which express viral antigens (subunit 
peptides or proteins of RSV and PIV-3), bacterial antigens and/or subunit B of cholera 
toxin. Five laboratories from three countries will collaborate over 3 years in the 
following manner: the S.xylosus model will be extended and optimized with new 
Gram positive expression systems; the genes of the chosen antigens, which are • 
already cloned, will be expressed in S.xylosus and the recombinant bacterial strains 
characterized; the immune response of the Mucosa Associated Lymphoid Tissue to 
S.xylosus will be studied in mice and humans; the ontogenesis of the immune 
response, as well as T and B cells responses will be examined in rats and baboons; 
finally pep tides with appropriate B-cell epitopes or enhanced T -cell stimulating 
properties will be designed. After the 3 years of this research programme candidate 
vaccines with thorough preclinical documentation will be available for efficacy testing 
in humans. This programme constitutes an important step towards the concept of early 
oral vaccination against multiple infectious diseases according to World Health 
Organization recommendations. 
Keywords: 
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New strategies for the development of oral vaccines : vectors based on 
non-pathogenic commensal bacteria, synthetic peptides and lipophilic 
adjuvants 
Contract number: CT920131 (Basic Research Project) 
Start date: 01!04/93 Duration: 36 months 
EC contribution: 635,000 ECU 
Objectives: 
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To test (a) recombinant gram-positive commensales of the oral cavity (f.i. S. gordonii) 
expressing measles virus (MV) proteins and (b) MV -peptides in conjunction with 
lipophilic adjuvants (Pam3Cys, ISCOMs) for their ability to serve as vectors for 
mucosal immunization. 
Brief description: 
One of the major challenges of new vaccines is to find a save and non-invasive route 
of immunization. Oral immunization is probably the simplest way for large scale 
immunization programs. The long-term objective of this project is to develop vectors 
and adjuvants for oral immunization against viral diseases based on: (a) non-pathogenic 
bacteria of the normal microflora of the oral cavity in humans and animals, (b) 
lipophilic adjuvans for peptides. The immediate objective of the project is (a) to 
develop a recombinant S. gordonii expressing heterologous proteins and to test wether 
such contructs are likely candidate vectors for mucosal immunization, (b) to synthesize 
the Pam3Cys-peptide conjugates, (c) to prepare lipophilic ISCOMS containing 
recombinant viral proteins and/or viral peptides and to test their ability to induce 
mucosal-immunity. The measles virus (MV) hemagglutinin (H) and fusion (F) protein 
serve as test model system. Both the local and systemic immune response will be 
studied after oral and/or nasal immunization in a mouse system. MV vaccines 
cross-protect against Rinderpest (RPV) and peste des petits ruminants (PPRV) two 
major veterinary pathogens. The aim is, that by the end of the project we have a 
vector/carrier/adjuvant in our hands suitable for being tested for protection in an animal 
disease model such as PPRV or RPV. The novel strategies for non-invasive 
immunization developed here, can potentially be applied to other viral or bacterial 
pathogens. 
Keywords: 
Mucosal immunisation, Vaccine, Vector 
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Communication systems within living matter 
Development of attenuated shigella flexneri vectors as vaccines to elicit 
protection against mucosally transmitted infectious diseases 
Contract number: CT920134 (Basic Research Project) 
Start date: 01/02/93 Duration: 36 months 
EC contribution: 215,000 ECU 
Objectives: 
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-Design a live attenuated vector stimulating colonic mucosal immunity. -Use Shigella 
invasion proteins for expression of foreign epitopes. - Identify promoters that are 
highly expressed in vivo. -Develop mucosal protection against HIV. 
Brief description: 
We want to develop an orally delivered vaccine vector based on rational genetic 
attenuation of virulence of the invasive enteric pathogen Shigella flexneri. Gene 
deletions will be introduced in order to attenuate virulence and reach a balance 
between reactogenicity and strong mucosal immunogenicity. This vaccine strain will 
be used as a vector for high-level expression and/or exportation of heterologous 
antigens in order to elicit protective immunity against mucosally-transmitted infectious 
diseases. Shigella promoters that are maximally transcribed when bacteria are 
intracellular will be identified. Such promoters will be introduced into expression 
cassettes that also contain the gene encoding a relevant heterologous antigen. These 
cassettes will be introduced in the S. flexneri genome. Exportation of antigens will be 
achieved by exploiting the unique exportation apparatus of S. flexneri for Invasion 
plasmid antigens. Gene fusions containing sequences encoding epitopes of the 
heterologous antigens will be constructed in these Ipa proteins which are strongly 
immunogenic. These strategies will be assessed in a macaque monkey model, the best 
available animal model for shigellosis and for AIDS. Homologous protection against 
shigellosis will be tested using the vaccine candidates constructed in this study. 
Heterologous protection will be first tested against endocervically transmitted SIV in 
animals orally immunized by Shigella vaccine strains expressing and/or exporting key 
antigenic motives of this simian retrovirus. 
Keywords: 
Shigella, Mucosal immunisation, AIDS, Vaccine 
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Vaccine development : principles that govern antigen processing and peptide 
presentation to CDB cytolytic T lymphocytes 
Contract number: CT920177 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,165,000 ECU 
Objectives: 
Sequence influence on antigen processing. Proteasomes and antigen processing. Role 
of transporters in antigen presentation vectors and delivery systems for peptides. 
Brief description: 
Immune control of chronic infections by viruses and other intracellular pathogens, and 
also immunotherapy of tumors demands the activation of antigensprecific major 
histocompatibility complex (MHC) class I restricted T Lymphocytes. These important 
effector cells recognize antigens only subsequent to protein degradation and peptide 
transport to the cell membrane where antigenic peptides are presented by MHC class 
I molecules. Today it is difficult to predict which part of an antigenic protein is 
presented, and the manipulation of antigenicity has been restricted to anecdotal cases. 
To understand the principles of antigen processing and presentation at the molecular 
level six laboratories employ complementary techniques. The project can be divided 
into three major aspects: A rational genetic engineering program to insert defined 
anligenic epitopes from viruses and tumors into model proteins that provide different 
efficacies of antigen presentation as determined by extraction of naturally presented 
antigenic peptides, by T -cell mediated destruction of target cells in vitro, and by 
protection against lethal virus disease or tumors in vivo. The biochemical analysis of 
the model proteins that differ in antigen presentation with regard to the steps reflecting 
protease degradation, intracellular peptide transport, and MHC class I mediated peptide 
delivery. C Testing the genetic constructs when expressed by other viral vectors or by 
delivery systems of synthetic protein fragments. Rather than studying by the research 
groups different antigens in parallel using different techniques, the same model antigens 
will be employed by all laboratories. It is the conviction of the participants that this 
type of organization, although demanding in discipline, will most quickly unravel the 
mechanism of antigen processing and presentation, and indicate the fields of biomedical 
application. 
Keywords: 
Mhc class i molecules, Vaccine, ISCOM, Immunology 
164 Cellular and Organism Approaches 
Coordinator 
PROF.DR KOSZINOWSKI ULRICH 
INSTITU FUR MEDIZINISCHE VIROLOGIE 
IM NEUENHEIMER FELD 324 
D - 69120 HEIDELBERG 
Participants 
ALMOND JEFFREY W. . ................................... GB 
DALSGAARD KRISTIAN ................................... DK 
DEL VAL MARGARITA ..................................... E 
EVANS DAVID .......................................... GB 
HOWARD JONATHAN .................................... GB 
MELIEF CORNELIS ....................................... NL 
Communication systems within living matter 165 
Recombinant bacillovirus expressed particulate vehicles as multiple epitopes 
presentation systems 
Contract number: CT920290 (Basic Research Project) 
Start date: 01!03/93 Duration: 36 months 
EC contribution: 946,000 ECU 
Objectives: 
The purpose of the project is to exploit recombinant baculovirus derived single 
or multiple capsid virus-like particles as vaccine delivery systems for animals 
and human pathogens. 
Brief description: 
The purpose of the project is to exploit recombinant baculovirus derived single or 
multiple capsid virus-like particles as vaccine delivery systems for animals and human 
pathogens. These particles mimic 1)bluetongue virus (BTV) single capsid core-like 
particles (CPLS consisting of VP3 and VP7, r 4 proteins VP2, VP3, VP5 and VP7, or 
proteins, VPI-7 and 2) porcine parvo-virus (PPV) single capsid (containing vp2 
protein). These capsid structures lack nucleic acids and are highly immunogenic. Recent 
virus challenge studies in animals immunized with 10 ug of BTV VLPS or 3ug of PPV 
particles confirmed the immunogeneity and protection capabilities of these structures. 
The high level production (20-30 mg per liter of insect cell culture), of these particles 
from baculovirus vectors suggested that this system may be adopted as a carrier system 
in which antigens can be presented in polyvalent forms to the immune system to induce 
both cellular and humoral immunities. We have synthesized chimeric particles by 
insertion of foreign epitopes that are relevant to protection against various animal and 
human disease ( eg, hepatitis surface antigen, rabies glycopro- tein, foot and mouth 
disease virus epitopes etc). The derived chimaeric particles are easily purified from 
other cellular proteins by surcrose density centrifugation of cell extracts. Currently, the 
immunogenicity of these chimaeras are under investigation. We propose to synthesize 
chimaeric particles containing various viral (human and animal) immunogenic regions 
(initially the known epitopes and then the epitopes which will be determined by 
computer analysis). The integrity of the derived particles will be examined by 3-D 
analysis through cryoelectron microscopy. The perfect assembled particles will be tested 
for their immune responses (t-helper, cell mediated, humoral responses), and protective 
efficacies using appropriate challenges in post-vaccinated animals (eg, first in mice and 
then in the relevant animal species). It can be anticipated that it should be possible to 
make vaccine chimaeras containing multiple immunogens representing selected viral 
pathogens which may lead to novel prospects for future vaccine technology. 
Keywords: 
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Strategies for the design of peptide vaccines for the control of m~or human 
infections 
Contract number: CT920321 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: S75,000 ECU 
Objectives: 
To identify proteins and peptide epitopes of 3 major human pathogens (Plasmodium 
falciparum, Borellia Burgdorferi, HIV) which elicit strong T cell mediated responses 
against these pathogens and which are therefore candidates for protective vaccines. 
Brief description: 
The general aim of the project is to evaluate strategies for designing peptide vaccines 
for major infectious diseases of viral (AIDS), bacterial (Lyme Disease) and parasitic 
(Malaria) origin. For non of these diseases is an effective vaccine available. 
Nevertheless, in each of these diseases there is considerable background information 
on the nature of the infectious agent and on the nature of the human immune response 
to it. The induction of immmunity generally follows similar intial mechanisms 
independent of the nature of the infectious agent and the effector functions necessary 
for its elimination. These include antigen uptake, processing and presentation of 
peptides with MHC molecules on antigen presenting cells. Recognition of MHC/peptide 
complexes by CDS and CD4 T lymphocytes and initiation either of a predominantly 
antibody mediated immune response. Therefore we plan to identify proteins of the three 
types of infectious agents that induce strong T cell mediated responses and to identify 
peptide epitopes of these proteins which are presented with MHC class I and class II 
molecules thus initiating CDS and CD4 T cell mediated responses. A significant part 
of the project will be devoted to the development of technologies for peptide vaccines 
and their application. 
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Construction of stable recombinant BCG and other live mycobacterial vaccines 
Contract number: CT920520 (Basic Research Project) 
Start date: 01!02/93 Duration: 36 months 
EC contribution: 1,060,000 ECU 
Objectives: 
-Utilisation of BCG as a vector- Insertion mutagenesis of mycobacteria- Expression 
of cytokins in BCG - Study of recombination in mycobacteria - Study of mycobacterial 
plasmid replication 
Brief description: 
Foreign antigens have been successfully cloned and expressed in the BCG vaccine. 
Cellular and humoral immune responses against these antigens have been observed 
upon immunization of animals with the recombinant BCG strains. In order to improve 
the immunogenicity of these BCG strains, potential protective antigens will be 
expressed as exported products together with IL2 and Y-IFN. Information provided by 
the study of plasmid replication (pAL500 which is generally used for gene cloning in 
BCG) and site specific integration (pSAM2 an integrative plasmid from Streptomycetes 
and the Ms6 temperate mycobacteria phage) will allow the construction of more stable 
vaccine strains. This will enable the development of BCG as a multivaccine vehicle 
which can be used to immunize against a wide variety of pathogens at the same time. 
In order to improve the BCG efficacy against tuberculosis and to construct new 
vaccine candidates against this disease mycobacterial virulence genes will be 
investigated by insertion mutagenesis using transposons already characterized by the 
collaborating teams. These transposable elements will also be improved by the addition 
of reporter genes and modified to enhance transposition efficiency. This project 
concerns teams that have already worked together on mycobacteria and posses 
complementary skills. 
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An investigation into the mechanism ofadjuventicity of immuno-stimulating 
complexes (ISCOMS) of defined chemical composition using a primate model of 
Epstein-Barr virus induced lymphoma. 
Contract number: CT930105 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 632,000 ECU 
Objectives: 
To investigate the mechanism of adjuventicity of chemically defined ISCOMS to 
provide a sound scientific basis for their possible future use in humans. 
Brief description: 
The only adjuvants currently licensed for human use are based on aluminium salts 
which, while effective in a limited number of conventional vaccines, are relatively weak 
when used with many of the new experimental recombinant viral subunit vaccines. 
Furthermore, aluminium salt adjuvants induce only weak cell-mediated immune 
responses and it is becoming increasingly clear that in the majority of cases cell-
mediated immune responses provide the basis for effective protective immunity. 
Immunostimulating complexes (ISCOMS) provide an extremely potent antigen 
presentation and adjuvant formulation. However, the lack of knowledge of the 
mechanism of action of ISCOMS and their induction of some side effects has provided 
the impetus for analysing their composition and mechanism of action. Initially cell-
mediated, antibody and cytokine responses will be investigated in banal laboratory 
animals following immunisation with chemically defined ISCOMS carrying the Epstein-
Barr virus (EBV) envelope glycoprotein gp340. The EBV glycoprotein gp340 has 
already been shown to be a protective immunogen in a primate model of lymphoma 
induced by EBV. In this model it is clear that immune protection is mainly provided 
by cell-mediated immune responses. Successful completion of these studies will have 
importance with respect to the use of ISCOM adjuvants in a range of vaccines in 
humans and animals. 
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Technologies for optimisation of mucosal immune responses 
Contract number: CT930111 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 980,000 ECU 
Objectives: 
To achieve a rational approach to induce a specific S-IgA response against infectious 
agents using two models antigens and addressing two most important mucosal surfaces, 
the gastro-intestinal tract and the respiratory tract. 
Brief description: 
It is recognized that the development of new vaccines through mucosal, mainly oral 
immunization would represent a major breakthrough in the control of many infectious 
and parasitic diseases. The purpose of the present proposal is to lay the technological 
and scientific groundwork for a rational approach to induce a specific S-IgA response 
against infectious agents using two model antigens and addressing two most important 
mucosal surfaces, the gastrointestinal tract and the respiratory tract. In order to achieve 
the three main goals of this strategy : a) optimal targeting of antigen presentation b) 
prolonged stimulation of the immune response c) amplification of local immune 
response, the objectives of the proposed projects will be : 1) to develop the 
technologies including the development of live vectors, the use of microcapsules and 
appropriate adjuvants in order to optimize the IgA and S-IgA response 2) to identify 
at a molecular and cellular levels, the effector functions of IgA and S-IgA, in vitro and 
in vivo through the use of hybridoma technology and appropriate animal models (SCID 
mouse) 3) to study the mechanisms of local regulation of IgA response. Two model 
peptides will be used to meet these objectives, i.e. a parasitic and a bacterial epitope. 
The first model peptide is taken from the parasite Schistosoma mansoni responsible for 
a disease affecting 200 millions people in the world and in which parasite eggs laid in 
mucosal tissues (small and large intestine, urinary tract and bladder) as well as in the 
liver and other tissue represent the main source of pathology. Recent work in our 
laboratory has established that both in human infection and in experimental models, 
IgA antibodies to the parasite glutathione S-transferase and its C-terminal domain play 
a major role in inhibiting worm fecundity and egg viability. The second model peptide 
is the 50-64 peptide of the B subunit of cholera toxin. This toxin is responsible for the 
diarrhoeal syndrome of cholera as well as for immunoprotection against the disease. 
The chosen epitope has been shown to elicit neutralizing anti-toxin antibodies and to 
induce protection. Oral administration of the peptide can induce S-IgA and local 
protection in the mouse. The final goal of these studies is to contribute through the use 
of these two well characterized models, to the development of new vaccine strategies 
exploiting the mucosal immune system. 
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Communication systems within living matter 
Development of BCG as a live vaccine vector to stimulate protective 
immunityagainst intracellular parasites 
Contract number: CT930238 (Basic Research Project) 
Start date: 01/08/93 Duration: 36 months 
EC contribution: 842,000 ECU 
Objectives: 
175 
-Development of a vector for secretion of heterologous proteins in BCG.- Evaluation 
of BCG as a live carrier for vaccination against intracellular parasites. - Study of 
Mycobacterium tuberculosis expression signals in BCG. 
Brief description: 
The proposed project aims at the development of a system to stimulate protective 
immunity against an intracellular parasite (Toxoplasma gondii) by using a non-
pathogenic intracellular live vector (BCG, Bacillus Calmette-Guerin). Two well 
characterized antigens of the parasite, GRA2 and ROP2, were selected since they 
follow two different pathways of processing and presentation to the immune system. 
The genes encoding these antigens will be expressed in BCG using the promoter and 
signal sequence of a gene from the 85A complex, encoding a protein which is secreted 
by M. tuberculosis. The recombinant BCG strains will be evaluated for their capacity 
to provoke protective immunity against toxoplasmosis in a mouse and a rat model. The 
humoral and cellular response towards both model antigens will be studied. Eventually, 
vaccination experiments with live recombinant BCG/toxo will be performed in sheep. 
The results obtained with this model system may also have some bearing on protection 
from infection with other important intracellular pathogens like Plasmodium falciparum. 
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Communication systems within living matter 
New vaccines based on optimal reconstruction of immunogenic structures 
targeted for systemic or oral delivery 
Contract number: CT930349 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 464,000 ECU 
Objectives: 
177 
- to solve instability of vectors carrying foreign antigens. - to solve suboptimal exposure 
of foreign antigens on living and nonliving vectors 
Brief description: 
Mucosal vaccines offer advantages over parenteral vaccines since they can be 
administered by nonmedically qualified personnel and avoid the need for expensive and 
potentially contaminated needles. Prime candidates for oral vaccines are living 
pathogens, for instance attenuated Salmonella strains which have been shown to induce 
potent local and sometimes systemic responses. Nonliving antigens, for instance cholera 
toxin and its B subunit (CT-B), are excellent candidates too, but there is a requirement 
for alternative carriers. Theoretically both living pathogens and nonliving antigens 
would form attractive general carriers to deliver foreign antigens or epitopes at the 
mucosal surfaces. Success however depends critically on the ability to solve the 
following problems: 1. instability of live recombinant vectors which carry foreign 
antigens or epitopes. 2. improper folding and suboptimal exposure of foreign antigens 
or epitopes on both living and nonliving carriers. The main object of this proposal is 
to solve these problems using two immunogens, FHA of B. pertussis and S 
glycoprotein of Transmissible Gastro-enteritis Virus (TGEV), and established 
carriersystems. As living carriersystems will be used attenuated Salmonella strains and 
TGEV (which has the added advantage that it can be targeted to either the gut or the 
respiratory tract). As nonliving carriersystems will be used Mal-E and Lam-B proteins 
of E. coli and FHA itself which has exciting potential as a nonliving mucosal 
immunogen. The relevant epitopes both in the native and nonnative context will be 
defined at the level of single amino acids, while the responses of the recombinant 
products will be monitored at a similar level. Thus combining the latest technologies 
versatile live and nonlive carriersystems will be compared and developed and will form 
a new generation of carrier-based oral vaccines. 
Keywords: 
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Communication systems within living matter 
Antigen presentation for induction of optimal T cell-mediated immune 
responses 
Contract number: CT930489 (Basic Research Project) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 1,270,000 ECU 
Objectives: 
179 
To characterise the T cell responses induced by viral glycoproteins expressed in 
vaccinia and bovine herpes virus vectors and to determine the influence on these 
responses of the site of antigen expression in infected cells, co-expression of cytokine 
genes and systemic versus mucosal routes of infection. 
Brief description: 
Recent advances in immunology have demonstrated that the cell types in which antigen 
is processed and the intracellular pathways of antigen processing are of fundamental 
importance in determining the type of T cell response that is induced. The relative 
importance of a particular T cell response varies for different pathogens and indeed 
inappropriate immune responses sometimes result in enhanced disease. This project 
aims to bring together complementary expertise in molecular virology, vector 
technology and immunology to investigate strategies for preferential induction of 
specific types of T cell responses in mice and cattle. The project will utilise, as model 
antigens, the F and G glycoproteins of respiratory syncytial virus (RSV) expressed in 
recombinant vaccinia and bovine herpes virus vectors. The project will investigate the 
influence of three parameters on T cell responses: 1. The use of recombinants 
constructed to give expression of the RSV proteins in different sites within infected 
cells. 2. The use of recombinants expressing IFN-gamma or IL-4, along with viral 
proteins, in order to bias the response towards TH1 or TH2 CD4 responses. 3. The 
effect of immunising systemically or locally, via the respiratory mucosa (ie. directing 
antigen to different antigen-presenting cell and T cell populations). Analyses of 
immune responses induced by various recombinant viruses will aim to identify the type 
of T cell response (CD4 and/or CD8) which has been stimulated, the cytokines 
produced by the reactive T cells and the levels and isotype composition of antibody 
produced. 
Keywords: 
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IN VITRO HUMAN IMMUNE 
RESPONSES 
2.3.2 Development in vitro of human immune responses, either humoral (conventional 
lgM-IgG, predominantly lgE or lgA) or cellular (T cytotoxic, cell mediated 
hyper-sensitivity, ... ) for fundamental and/or applied research. The project will 
include the development of models closely related to common situations such 
as, for instance, skin sensitization or oral route immunization, which could be 
used for the identification of immunogenic properties, the production of B or 
T activated cells against determined antigens, isotype selection of humoral 
responses, definition of vaccine strategy, in vitro immunotoxicological tests, 
screening of substances likely to cause autoimmune responses,... Priority shall 
be given to multidisciplinary proposals dealing with precise, well described 
objectives and leading to simple and reliable techniques. Proposals will have to 
clearly describe the ethical and safety problems linked to the use of cells of 
human origin and outline the solutions envisaged by the proposers. 
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Structure/function relationship of the T cell antigen receptor complex : study of 
molecular interactions and activation events induced upon antigen binding 
Contract number: CT920164 (Basic Research Project) 
Start date: 01/04/93 Duration: 36 months 
EC contribution: 902,000 ECU 
Objectives: 
- To find sequences involved in antigen/MHC recognition by TCR/CD3 and in 
interactions within the TCR/CD3 complex and with accessory molecules. - To study 
activation pathways, receptor internalization and apoptosis induced following 
stimulation of T cells via TCR/CD3 and accessory molecules. 
Brief description: 
The aim of this proposal is to determine in molecular detail how the TCR binds the 
peptide antigen/MHC complex and then transduce signals to the nucleus resulting in 
T cell activation or apoptosis. Mutants of the TCR and CD3 subunits will be generated 
using recombinant DNA techniques. Transfection experiments will allow the structural 
determinants of the TCRa/- heterodimer that contact antigen/MHC, and also those that 
are involved in subunit-subunit interactions, to be characterized. The signaling pathways 
employed by the TCR will be investigated in two ways. Firstly, identifying intracellular 
proteins which are phosphorylated on tyrosine. Secondly, nuclear communication with 
the cell surface will be investigated using a T cell specific enhancer as a model system. 
The activity of the TCR "B" enhancer is upregulated by changes in the levels of the Ets 
binding proteins following stimulation via the TCR. The mechanism of activation will 
be investigated by transfection of T cell lines with wild type and catalytically inactive 
protooncogene products and assay of the activity of the TCR"B" enhancer and of Ets. 
Such an approach will also be used to analyze the pathways involved in the induction 
of apoptosis following stimulation of the TCR. The role of accessory molecules in 
signaling via the TCR and also in the internalization and intracellular trafficking of the 
TCR will be analyzed by generating mutant T cell lines lacking one or more accessory 
molecules. These cell lines will also be used to investigate the role of accessory 
molecules in the induction of apoptosis. 
Keywords: 
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Immunoregulatory role of epitopes from infectious pathogens 
Contract number: CT920206 (Basic Research Project) 
Start date: 01/02/93 Duration: 36 months 
EC contribution: 425,000 ECU 
Objectives: 
Identification and production of T -cell epitopes from mycobacterial and plasmodial 
antigens. Define the role of such epitopes for induction of protective immunity or 
pathology. Define the cellular and genetic mechanisms regulating these responses. 
Brief description: 
New strategies for controlling infectious diseases by immunological means such as 
modern vaccines require detailed knowledge of the immune response to the infecting 
organisms. As infectious agents induce a large variety of such responses it is necessary 
to distinguish between those which give rise to protection against infection and those 
which may induce reactions which are harmful to the host, including potentially 
dangerous autoimmunity. In this project we aim at investigating these questions in the 
human system which requires application of new, in vitro methodologies. Four antigens 
from two types of organisms causing some of the most important infectious diseases 
worldwide (mycobacteria and the malaria parasite plasmodium falciparum) will serve 
as model substances to elucidate how the human immune response to infection is 
regulated at the molecular and cellular levels. To achieve these aims T -cell epitopes of 
the plasmodial or mycobacterial antigens have been identified. The potential of these 
epitopes to induce protection and/or autoimmunity will be established by defining their 
fine specificities and by investigating the functional role of the lymphocyte responses 
they set into motion under different conditions of antigen presentation. For this purpose, 
special emphasis will be given to the analysis of the different lymphokines released 
from in vitro activated CD4+ T -cells. The function of these cells to amplify antibody 
production and induce functionally dieferent immunoglobulin isotypes (including lgE) 
after activation with the different immunogens will be studied in specially developed 
T -/B-cell cooperation systems in vitro. This will be achieved using lymphocytes from 
donors with different levels of immunity to malaria or mycobacteria. In parallel the 
genetic regulation of the capacity of the lymphocytes from different donors to respond 
to the epitopes under study will be investigated with regard to restrictions imposed by 
the MHC-system or other genetic factors. The project is expected to render important 
new information about how the immune response to infection is regulated in humans. 
This will provide a basis for a rational design of vaccine immunogens. The in vitro 
strategies which will be used are of great potential for analyzing cellular immune 
responses in humans, in general. 
Keywords: 
T cell response, Immunology 
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In vitro immunization of human B lymphocytes 
Contract number: CT920269 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,060,000 ECU 
Objectives: 
The objectives of this project are to define and develop the methodologies for the in 
vitro immunization of human B lymphocytes in order to produce human monoclonal 
antibodies of desired specificity and affinity for antigen. 
Brief description: 
The project focuses on the understanding of how human B cells can be antigenically 
activated in vitro and is both precompetitive and multidisciplinary. The goal of the 
proposed project is to form this basis in the sense that it will provide the tools to 
manipulate human B cells for the purpose of generating specific, high affinity human 
antibodies. The final goal of the proposed project can clearly be divided into discrete 
subprojects with individual intermediary targets, as outlined below: 1. To define the 
antigen presentation needed to obtain an optimal T cell help. Here we have several 
novel approaches such as e.g. evaluation oflipopeptides, heterotopes (synthetic peptides 
containing both BandT cell epitopes) and use of the superantigen SEA; 2. To define 
the signals that regulate the somatic mutations in centroblasts, i.e. how are the antigen 
specifically activated B cells driven towards a centroblastic phenotype and how is the 
hypermutation initiated and controlled. This involves establishment of T cell clones 
(THl, TH2 and germinal center T cells); 3. To define the role of CD19/21!23, CDS/72, 
CD40, CD44, 4F2/CD43 in the in vitro immunization of human B cells; 4. To define 
the signals which regulate the switching of isotype from lgG to IgM in antispecifically 
activated B cells; 5. To define the parameters important for the cloning and expression 
of antibody genes isolated from single B cells. After designing the proper single cell 
propagation system, this point will be restricted to the use of chaperonins in pathway 
engineering to enhance the secretion of functionally active antibodies. 
Keywords: 
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In vitro cellular correlates in allograft recipients 
Contract number: CT920300 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,270,000 ECU 
Objectives: 
To study in vitro correlates of the cellular immune response against organ and bone 
marrow allografts. 
Brief description: 
In vitro cellular correlates in allograft recipients. The proposal is aimed at designing 
rapid and powerful in vitro tests to study immune cellular correlates in recipients of 
organ (OT) or bone marrow transplantation (BMT), topics which are central to the 
themes of the project. Seven laboratories with internationally recognized 
complementary skills in immunology and with transplantation clinics will participate. 
Experiments will be organized within 3 main themes. 1/ Pre-graft correlates to predict 
the strength of the alloresponse in OT and BMT: alloresponsive cell frequencies 
against various donor/host targets. Designing of rapid in vitro techniques to assess 
allodiversity with a special interest in correlation between gene polymorphisms (PCR), 
gene product expression (PCR/FACS), function (MLR) and clinical outcomes. 2/ 
Studies of in vitro correlates during rejection and tolerant states. Here, the emphasis 
will be on assessment of the production of a variety of cytokines and activation 
proteins on cells derived from the graft itself (PCR) to define patterns with clinical 
relevance. Semiquantitative analysis of TCR diversity (PCR for VB, JB and N length 
polymorphisms) will be also studied during rejection of different types of organs. In 
addition, functional assays specifically designed to study adhesion processes during 
bioreagent treatment (anti-LFAI, anti-CD4) are planned. 3/ Post BMT events will be 
analysed: characteristics of the peripheral reconstitution of Lymphocyte population by 
flow cytometry using a panel of VB moAb and TCR repertoire of dominant clones 
(PCR and sequence) will be correlated to clinical status. Culture and clones obtained 
from GVHD skin lesions will be used to understand the disease mechanisms: 
characterization of major and minor histocompatibility targets and their distribution, 
study of skin homing process of anti host cell and TH1/TH2 profile of clones extracted 
from the skin. 
Keywords: 
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In vitro immunisation and phage antibodies in the derivation of high 
affinity human antibodies against the protein products of cloned genes 
Contract number: CT920351 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 635,000 ECU 
Objectives: 
191 
To provide a system by which human antibodies can be easily derived against antigens 
which are used to immunise B cells of human in vitro 
Brief description: 
mAbs are becoming increasingly important in health care. The derivation of mabs using 
traditional methods has some defects: 1) human antibodies cannot be easily derived and 
humanisation is not a real substitute; 2) the process is expensive and time 
consuming.The expression of antibody binding domains on the surface of fd phage 
(phage antibodies - phab) goes some way to overcoming these problems. One procedure 
to select a phage antibody involves passing a library of such phabs over antigen bound 
to a solid support and eluting those which bind. However this too has its disadvanta-cc: 
1) The affinity of PhAbs derived from unimmunised animals (mouse or human) is low 
(KDI0-7M); although the use of immunised animals can increase KDI0-9 and higher, 
immunisation of human beings is impossible. 2) The selection procedure requires the 
purification of large amounts of the protein antigen and this can be laborious. The goal 
of this project is to develop the conditions for immunisation of human cells in vitro 
using different forms of antigens derived from cloned genes (expression as fusion 
proteins, on the surface of bacteria or presented on B cells or macrophages ). The 
conditions which will be investigated in the in vitro immunisation include the effects 
of source and fractionation of the human cells, interleukins, feeder cells and general 
culture conditions. Following immunisation, the response of the in vitro culture to the 
antigen will be monitered at the cellular level by cellular proliferation, phenotype and 
the production of immunoglobulin. This should provide a population of immunised 
human cells from which MRNA can be prepared and used to create libraries of phabs. 
The selection and sequencing of antigen binding V regions from these phab libraries 
will allow the study of the progress of the immunisation of human cells in vitro at the 
molecular level (increase in affinicy by somatic mutation). The selection procedure will 
involve panning phabs over antigen in solid phase, as well as the use of bacteria 
expressing the antigen of interest as the solid phase. The development of this use of 
bacteria as living columns will be carried out within the framework of this project. If 
successful it will eliminate the need to purify the large amounts of ancigen needed for 
selection by panning. 
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Communication systems within living matter 
In vitro study of the human immune response to the pollen allergens of 
Parietaria 
Contract number: CT920363 (Basic Research Project) 
Start date: 01/03/93 Duration: 36 months 
EC contribution: 635,000 ECU 
Objectives: 
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This proposal is aimed at studying in vitro the fine mechanisms regulating the immune 
response in allergy, using the major allergens of the pollen of Parietaria as a model. 
Brief description: 
The physicochemical structure of these proteins will be investigated by using 
recombinant DNA technologies; the structures that are ligands in the interactions of 
immune recognition will be delineated. Genomic events underlying immunoglobulin 
isotype switching and T cells control of IgE antibody synthesis will be analysed. B, T 
and antigen presenting (APC) cell collaboration and the role of allergen in IgE isotype 
modulation will be explored. These goals will be attained through cooperation among 
groups with distinct cultural backgrounds and expertise. Recent studies have provided 
insights into the fine mechanisms of IgE mediated allergy. Ricci (participant 2) and 
others have documented the regulating role ofT helper (Th) cells. The genomic events 
oflgE isotype switching have been investigated by several groups including Radbruch's 
(participant 3). The major allergens of the pollens of Parietaria, a Mediterranean weed, 
whose pollen is a major cause of respiratory allergy in Europe, appear suitable tools 
for structure function studies because of the low m w (12 kDa) and of the availability 
of a highly dominant B cell epitope, expressed in E. coli by recombinant eDNA 
(Ruffilli, participant 1). The possibility of utilizing recombinant DNA products 
developed during this study in the field of diagnosis of allergy appears real. 
Informations useful for the planning of strategies for immunotherapy may derive from 
several of the described approaches. 
Keywords: 
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IN VITRO IMMUNOTOXICOLOGY 
2.3.3 Development of in vitro test systems, compatible with prenormative 
requirements and suitable for the assessment of immunotoxicological or 
immunogenic potential of medicinal substances and, particularly, 
biotechnology -derived compounds. 
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Immunotoxicology of drugs and biotechnology-derived products : development 
of in vitro assays based on cellular and molecular immunobiology 
Contract number: CT920316 (Generic Research Project) 
Start date: 01!01!93 Duration: 36 months 
EC contribution: 4,697,000 ECU 
Objectives: 
To develop in vitro tests to evaluate the ability of therapeutic agents including 
recombinant cytokines, cytokine inhibitors and monoclonal antibodies to trigger specific 
or non-specific immune responses or to induce immunosuppression. 
Brief description: 
The programme proposes to utilise recent advances in molecular immunology and 
related disciplines to develop in vitro assays for the assessment of adverse immune 
reactions induced by drugs and medical compounds. In the first phase, it will be based 
on reference substances whose effects have been studied and elucidated in humans 
and/or experimental animals. At this stage, the programme will rely on the common use 
by all participants of selected in vitro models. Techniques to be used for assessing 
immunomodulatory effects will include cell activation and differentiation markers by 
F ACS analysis and evaluation of cytokine production by multiple approaches such as 
bioassays, immunoenzymatic assays (ELISA) and cytokine mRNA levels by northern 
blot or reverse polymerase chain reaction (PCR) analysis. The project will focus on five 
major areas : 1) in vitro tests to evaluate the immunotoxicity of biotechnology-derived 
compounds such as monoclonal antibodies or recombinant cytokines and growth factors 
2) the use of established animal models to develop in vitro predictive assays for 
drug-induced autoimmunity, followed by the assessment of the validity of these tests 
in the human situation 3) the development of test systems for predictive drug-specific 
human T cell responses in allergic drug reactions 4) development of in vitro 
immunotoxicity test systems to assess immunosuppression using existing animal data 
base for validation 5) in vitro preparation of drug metabolites followed by evaluation 
of their immunotoxic potential. If the proposed programme is successful in relating in 
vivo effects of reference substances to in vitro changes, the scientific basis of in vitro 
immunotoxicology will have been significantly improved. A second phase of the 
programme will then be to define the relevance of each assay system for 
pharmacological and toxicological screening and the feasability of each system for 
routine use will be evaluated. Selected in vitro tests could then be standardised as much 
as possible and be subject to interlaboratory comparison. Hopefully, this programme 
should thus lead to the definition and establishment of in vitro tests compatible with 
prenormative requirements. 
Keywords: 
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NEUROBIOLOGY 
2.3.4 Coordination of research activities focused on molecular, biochemical and 
pharmacological approaches for the study of nerve and glial cells, their 
interactions and their dysfunctions (e.g. BSE and related diseases). 
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Molecular neuropathogenesis of bovine spongiform encephalopathy and related 
neurodegenerative diseases 
Contract number: CT930248 (Basic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 210,000 ECU 
Objectives: 
1. To identify and characterise the infectious agents of scrapie, BSE and CJD. 2. To 
identify and characterise non-PrP molecules in infectious fractions. 3. To test the roles 
of normal and abnormal PrP in the replication of the agent. 4. To investigate 
mechanisms by which the infectious agent causes disease. 
Brief description: 
Bovine spongiform encephalopathy (BSE) is a new member of the group of related 
transmissible neurodegenerative diseases that includes scrapie and CJD. While these 
diseases can be transmitted between species experimentally, often with great difficulty, 
natural transmissions are thought to be prevented by the species barrier. The probable 
crossing of this barrier by scrapie to cause BSE in cattle has raised concern about the 
safety of products based on bovine organs, tissues or fluids for human use, which has 
had serious implications for European industry, particularly the bio-pharmaceutical 
companies. Control of the disease and quality of bovine products is greatly hindered 
by lack of a diagnostic test, which stems directly from lack of knowledge about the 
causative agent and the pathogenesis of the disease. This proposal is for a cooperative 
European programme bringing together research expertise of leading laboratories in 
Belgium, France, Germany, Italy, Netherlands and United Kingdom. It will address the 
basic question of the molecular nature of the agent by analysing highly purified 
fractions of infectivity. The involvement of the host-encoded protein PrP in the disease 
process and the structure of the agent will be studied through characterisation of (a) Pr P 
genes in species of domestic animals, (b) the effects of expression of altered PrP genes 
in transgenic mice, in terms of pathogenesis and accumulation of infectivity, (c) cells 
of the LRS which first replicate infectivity upon inoculation and (d) the effects of 
altered PrP expression on the replication of the agent in vitro in persistently infected 
SMB cells. This will form the core of a European Network on BSE and scrapie. 
Keywords: 
Bovine spongiform encephalopathy (BSE), Neurodegeneration, Prp 
202 Cellular and Organism Approaches 
Coordinator 
DR BOSTOCK CHRISTOFFER 
AFRC INSTITUTE FOR ANIMAL HEALTH 
COMPTON,LABORATORY 
GB - RGI6 ONN COMPTON, NR. NEWBURY 
Participants 
DIRINGER HEINO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . D 
EIKELENBOOM PIET ..................................... NL 
FRASER HUGH .......................................... GB 
LOCHT CAMILLE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . F 
PASTORET PAUL-PIERRE ................................... B 
POCCHIARI MAURIZIO ..................................... I 
Communication systems within living matter 203 
Homeogenes and adhesion molecules in the nervous system 
Contract number: CT930012 (Concerted Action) 
Start date: 01/08/93 Duration: 36 months 
EC contribution: 270,000 ECU 
Objectives: 
The objective is to analyse in several experimental systems the interplay between 
adhesion molecules and transcription factors of the homeoprotein family. 
Brief description: 
One of the most intriging question in developmental biology is the mechanisms by 
which biological shapes can be both inherited and influenced by the environment. In 
the case of the nervous system, we shall address this question by studying the interplay 
between developmental genes and surface proteins with morphoregulatory activity. 
Expression of several classes of homeogenes will be analysed in different species and 
correlated with anatomical borders, differentiation events and expression of diverse 
cell and substrate adhesion molecules (CAMs and SAM). The regulation by 
homeoproteins of the expression of genes coding for CAMs and SAMs will be further 
analysed. New targets for homeogenes will be investigated. The regulation of 
homeogenes transcription through cell interactions and by diffusible factors will 
analysed in vivo and in vitro. In addition to the possibility that new information will 
be gained on the mechanism at work during development and evolution, this action 
may have practical consequences in the field of teratology since some homeogenes 
could be the targets for hazardous compounds during development. We also anticipate 
a better understanding of learning modalities associated with structural changes in 
neuronal networks. Finally, we hope that the project will shed some light on 
mechanisms at work in distinct neurodegenerative diseases. 
Keywords: 
Homeogenes, Nervous system, Development, Morphogenesis, Neurodegeneration, 
Adhesion molecules 
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Communication systems within living matter 
Insect neuropeptides : structure determination, chemical synthesis and 
biological activities 
Contract number: CT930073 (Concerted Action) 
Start date: 01/08/93 Duration: 36 months 
EC contribution: 60,000 ECU 
Objectives: 
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Study the structure-function relationship of novel insect neuropeptides which may have 
agricultural and medical interest. Obtain by synthesis these peptides and analogues and 
determine their neuronal and myotropic effects Design peptide mimetics. Create an 
European network for insect peptide scientists. 
Brief description: 
This project will provide information on the structure-function relationship of novel 
neuropeptides, which we have previously isolated from the central nervous system 
(CNS) of the locust Locusta migratoria. Since in insects, many of the peptides present 
in the CNS control behavioural response, motility of muscles and development, some 
of the peptides which we have already characterized may have considerable agricultural 
interest. Also one of the peptides we intend to study, the 5-kDa peptide, is the insect 
counterpart of the vetebrate C-peptide of insulin. We have shown that the insect 
C-peptide affects the membrane potential and conductance of Locusta neurones, and is 
therefore of considerable scientific and medical interest. The data arising from our 
studies should enable us to determine which novel peptides are active in the insect 
CNS, the neurones that synthesise them, the location of their receptors and the 
structural and functionnal determinants of those peptides. At the same time, 
conformational studies of the active peptides and their analogues will be done by 
nuclear magnetic resonance (NMR) and will establish their tertiary stucture. This will 
help design peptide mimetics (non peptidic analogues) which are required for an 
agricultural or medical use of these peptides. We will address these questions with a 
multidisciplinary approach involving chemical, biophysical, electrophysiological, 
immunocytochemical and pharmacological techniques. The two laboratories, the 
Strasbourg (01) and Oxford (02) groups, involved in that project have already 
established informal collaborative links through the exchange of expertise and materials, 
visits to Oxford and Strasbourg, poster presentahon at scientific conferences and joint 
publications. Thus, the proposed collaboration will build upon solid foundations. In 
addition, our two groups (01,02) will organise an Europeen Insect Peptide Workshop 




206 Cellular and Organism Approaches 
Coordinator 
PROF BANG LUU 
LABORATOIRE DE CHIMIE ORGANIQUE DES 
SUBSTANCES NATURELLES 
5 BLAISE PASCAL 
F - 67084 STRASBOURG 
Participants 
BERMUDEZ ISABEL ...................................... GB 
Communication systems within living matter 207 
A molecular neurobiological approach to the study of the normal function and 
degenerative disorders of the basal ganglia 
Contract number: CT930074 (Concerted Action) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 90,000 ECU 
Objectives: 
The main objectives of our Concerted Action will be: (i) To focus on the 
neurotransmitter-receptor networks of neurons using monoamines (dopamine and 
noradrenaline) as the transmitter (all research groups involved). (ii) To 
undertake specific enzymological studies on the tyrosine hydroxylase system, 
the rate-limiting enzyme in the biosynthesis of dopamine/noradrenaline. 
Brief description: 
The studies will be based on our recent cloning of the four isoforms of human tyrosine 
hydroxylase (Paris) and structural and functional studies on these isoforms (Bergen, 
Paris). Our planned research will include studies on the structure, relation between 
structure and function, and the catalytic mechanism of the recombinant human isozymes 
expressed in E. coli (Bergen, Bilbao, Paris)). Site-directed mutagenesis will represent 
an essential aspect of these studies (Paris, Bergen). (iii) To study specific aspects of 
the cellular biosynthesis, storage and release of the biogenic amines (Bergen, Paris, 
Lund). In dopaminergic/noradrenergic neurons the transmitter is stored at very high 
concentrations in complexes involving proteins, calcium and ATP. Our research 
programme aims at a better understanding of the biogenesis of the secretory granules, 
including their maturation, after budding from the trans-Golgi network, and reutilization 
following exocytosis. The aim is also to improve our knowledge about the molecular 
mechanisms involved in their fusion with the plasma membrane ( exocytosis) and 
retrieval from that membrane (endocytosis). (iv) To obtain a better understanding of 
the pathogenesis and treatment of degenerative disorders of the basal ganglia, in 
particular parkinsonism. Efforts will be made to develop transplantable hybrid cell lines, 
expressing the key phenotypic properties of dopaminergic neurons, which can survive, 
make phenotypic plasticity, synthesize/release dopamine, and ameliorate motor 
dysfunction (Paris, Lund, Bergen). Genetic engineering is required to generate cell lines 
with such a phenotype (v) A main objective of the programme is also to design new, 
synthetic derivatives of tetrahydrobiopterin with improved cofactor properties in the 
tyrosine hydroxylase reaction (Konstanz, Bergen, Bilbao, Paris). The research thus 
includes projects of basic molecular neurobiology as well as projects related to the 
treatment of degenerative disorders of the CNS. The approach will be a combination 
of generating hybrid transplantable cells expressing a dopaminergic phenotype, with the 
goal to replace degenerated dopaminergic neurons, as well as a pharmacological 
modulation of the biosynthesis, storage and release of the neurotransmitter. To attain 
these goals an interdiciplinary collaboration is essential. The methods employed will 
be those pertaining to molecular biology, biochemistry, biophysics and cell biology. 
Keywords: 
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Detection and characterization of genes involved in smell recognition 
Contract number: CT930097 (Concerted Action) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 60,000 ECU 
Objectives: 
To understand the basis of smell perception by studying: a) molecular components 
involved in signal reception and transduction b) coding processes of the olfactory 
information c) modulation of this information by other sensorial inputs at the 
integration level 
Brief description: 
We use the model system Drosophila to contribute to the understanding of the process 
of smell perception. Because of its relatively simple olfactory system consisting of only 
1200 receptor neurons genetic methods have proven particularly useful in detecting 
olfactory genes that are not accessible through sequence similarity to other genes. We, 
therefore, employ genetic and molecular techniques to identify specific components of 
the system whose functional contribution to the odorant perception process can be 
measured in vivo either by physiological or behavioural tests. Our experimental 
approach can be devided in two parts: First, we dissect the organization of the olfactory 
system by introducing at random into the genome transposons that report on genes 
activated in cells or cell populations of the olfactory organ. The transposon insertion 
thus leads us into close proximity of genes that are specifically activated and are likely 
to act in the olfactory perception cascade. Transposon insertions might have hit and 
inactivated the olfactory gene and thereby reveal a mutant phenotype. If this is, 
however, not the case, a new genetically induced "jump out" in a high proportion gives 
rise to deletion of neighbouring genomic DNA. The phenotype of mutations induced 
either by transposon insertion or remobilization caused deletions is analysed in the 
second part of our approach. Here, we apply methods to measure the behavioural or 
electrophysiological response of the mutant animals. Behavioural paradigms are used 
to test the response to different odorants. Direct electrophysiological measurements are 
performed at the main olfactory organ of the adults, the third antenna! segment, in 
response to different airborne chemicals. In this way one can uncover mutations 
affecting olfactory perception or transduction in primary olfactory neurons. Applying 
different odorants we can distinguish mutations that have an effect on specific receptors 
from those that influence the general transduction pathways. 
Keywords: 
Smell perception, Signal transduction 
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Role of neuronal receptors in signal transduction and development 
Contract number: CT930169 (Concerted Action) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 150,000 ECU 
Objectives: 
Molecular cloning of G- protein linked receptors. - Methods for determining the ligand 
for molecularly cloned receptors. - Mapping of neurons. -physiological role of receptors 
in signal transduction systems. - Role of G- linked receptors in development. 
Brief description: 
We propose a concerted action in order to form a network of related laboratories to 
participate in the exchange of materials, workers and ideas. This pan-European network 
involving five laboratories from four countries will specialise in the application of 
molecular neurobiology to ligand:receptor systems. The network is multi-disciplinary, 
ranging from molecular biology, gene cloning to neurophysiology and developmental 
biology. All the participating laboratories are well-funded by national sources and by 
international collaboration. For example, the GB and NL laboratories have an EC 
twinning grant. The specific areas in which training will be given are as follows: 1 
Molecular cloning of G-protein linked receptors. 2 Methods for determining the ligand 
for molecularly cloned receptors and ion channels. 3 Mapping of neurons in simple 
nervous systems. 4 Determining the physiological role of receptors and other 
components of signal transduction systems. 5 Understanding the role of G-linked 
receptors in development. All the laboratories involved in this proposal are conversant 
with the state-of-the-art techniques. A major aim of our programme will be to facilitate 
exchanges between our laboratories, all of which share common goals. It appears that 
this area, which is vitally important for both the pharmaceutical and agricultural 
industries, is not well-supported in other countries of the EC. We believe that by 
providing support for exchanges between laboratories then we will be able to compete 
with the USA and Japan. 
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Serotonin receptors : molecular characteristics and therapeutic potentialities of 
their selective ligands 
Contract number: CT930179 (Concerted Action) 
Start date: 01!08/93 Duration: 36 months 
EC contribution: 100,000 ECU 
Objectives: 
To focus on the 5-HTIB/5HTID receptor family in order to explore in detail the 
molecules, pharmacological and functional properties of its 5 distinct components 
5-HTIBa, 5-HTIBB, 5-HTIDa, 5-HTIDB, 5-HTIE. 
Brief description: 
Serotonin (5-hydroxytryptamine, 5-HT) is a major neurotransmitter in the central 
nervous system which participates in the control of several functions such as food 
consumption, sleep, nociception, sexual behaviour etc, and alterations in central5-HT 
neurotransmission have been demonstrated in some diseases, notably dementia 
(Alzheimer disease), depression and generalized anxiety. These numerous actions of 
5-HT are mediated through its interaction with multiple receptors which were first 
characterized by pharmacological methods and then cloned and sequenced thanks to 
molecular biology techniques. The precise knowledge of the pharmacological, 
biochemical and molecular properties of a given receptor type is especially helpful for 
the synthesis of selective ligands with potential therapeutic interest. The present project 
will focus on receptors of the 5-HTIB /5-HTID family which have been cloned 
recently, but the functional roles of which are still poorly known. The therapeutic 
potential of selective 5-HTIB /5-HTID receptor ligands is important as one can recall 
for instance that the most efficient anti-migraine drug to date is sumatriptan, i.e. a non 
selective agonist at these receptors. The collaboration between the eight participants to 
this programme will allow a multidisciplinary approach with studies in molecular 
biology (M. Voigt, R. Hen), immunocytochemistry (M. Hamon, J. Lanoir, N.N. 
Osborne), chemistry (J. Chauveau, B. Guardiola), biochemistry (M. Voigt, M. 
Hamon,.J.:Lanoir, M. Gothert,N.Osbome) and animal behaviour (J.Lanoir,B. Guardiola). 
The cloned 5-HTIB /.5-HTID receptor subtypes will be overexpressed in appropriate 
cell types for studies of their pharmacological properties (binding studies) and coupled 
transduction mechanism. Site-directed mutagenesis will be used for identifying the 
receptor domains involved in ligand binding and effector coupling. Modelisation will 
help for designing new drugs which will then be tested on transfected cells, brain 
tissues and whole animals (behavioural studies). In addition, fusion proteins including 
large domains of the 5-HTIB I 5-HTlD receptor subtypes will be made for raising 
specific antibodies to be used for the visualization of the receptors at the optic and 
electron microscope levels. Finally, drugs acting at 5-HTIB /5-HTID receptors will be 
tested in appropriate in vitro and in vivo models, including transgenic mice (R- Hen). 
Keywords: 
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Modulation of intracellular transport by small GTP ases in cultured cells and 
during mouse development 
Contract number: CT930205 (Concerted Action) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 120,000 ECU 
Objectives: 
The aim of this proposal is to study the in vivo functional properties of five different 
small GTPases of the RAB family in established cell lines, in primary cultures of 
foetal hippocampal neurons and in the developing mouse. 
Brief description: 
The proposed project is aimed at studying several members of the rab sub- family of 
small GTPases. These proteins are implicated in the regulation of specific steps of 
intracellular membrane transport. Our four groups will focus on rab1, rab4, rab5, rab6 
and rab17. We will focus on three main points: 1. The elucidation of the basic 
mechanism of function of rab GTPases. This involves the identification and functional 
characterization of interacting components using biochemical methods. 2. The 
modulation of membrane traffic by various rab proteins. Using rab proteins as specific 
transport regulators we plan to either positively or negatively influence the cellular 
parameters of secretion and endocytosis in established cell lines and in primary 
cultures of foetal rat hippocampal neurons. 3. The impact of alterations in intracellular 
transport on mouse development. Functional studies will be performed in transgenic 
mice expressing functional wild type and dominant non-functional mutant rab proteins. 
The phenotypic effects during embryonic development and in the adult animals will 
be investigated. The understanding of the mechanisms controlling intracellular 
transport is not only relevant for the basic knowledge on how cellular organization is 
controlled but has also functional implications for biotechnological tasks. The 
availability of molecules which are playing an important role in the regulation of 
intracellular transport will hopefully allow the development of animal models which 
are amenable to the experimental studies of various human diseases and to the 
improvement of the biology of farm animals. 
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Neuronal development and regeneration 
Contract number: CT930260 (Concerted Action) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 180,000 ECU 
Objectives: 
To elucidate the processes involved in neural development, neural degeneration and 
regeneration in the central nervous system. 
Brief description: 
During neurodevelopment controlled interactions between neurons and glial cells are 
of paramount importance. Establishment of neural networks requires growth factors 
which may be secreted from both glial and neuronal cells and which stimulate growth 
and differentiation of other cells. Furthermore, adhesion molecules present on the cell 
surface or secreted into the extracellular matrix assist in the regulation of cell migration 
and neurite outgrowth. During adult life, degenerative processes may disrupt neural 
networks. However, even aged brain has a capacity for regeneration to a certain extent. 
The molecular mechanisms involved in neurodevelopment may be reactivated in 
regenerative processes. The purpose of this project is to elucidate the influence of 
growth factors, cell adhesion molecules and proteoglycans on interactions between 
neurons and glial cells during development, aging and regeneration. Furthermore, signal 
pathways between neuronal stimulation and neuronal response are to be studied. In 
brain, nerve growth factor (NGF) and basic fibroblast growth factor (bFGF) are of 
importance not only for growth and differentiation but also for sustained survival of 
neural cells. The interaction between these growth factors and the excitotoxic 
neurotransmittor glutamate which is believed to be involved in neuronal cell death 
during aging will be investigated in in vitro cell culture systems. Growth of neuronal 
processes may not only be stimulated by growth factors. Cell adhesion molecules and 
proteoglycans are likewise involved in dendritic and axonal growth. The mechanism 
responsible for the dendrite promoting effect of proteoglycans and glycosaminoglycans 
will be studied at the molecular level. Furthermore, the importance of the neural cell 
adhesion molecules, NCAM, Ll and N-cadherin, for interactions between neurons and 
glia will be investigated. NCAM is a highly complex molecule due to alternative 
splicing and differential glycosylation. Regulation of NCAM function via alternative 
exon usage and the effect on posttranslational processing will be studied. Finally, the 
second messenger systems involved in NCAM function will be elucidated. The project 
will establish a strong european network of scientists working on different important 
aspects of neurobiology. During the project in vitro systems for evaluation of 
neurotoxicity will be developed. Furthermore, the project will contribute to the 
understanding of neurodevelopment and neurodegeneration, hopefully providing a basis 
for further research into pathological processes in brain. 
Keywords: 
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Adhesion molecules in mammalian neuraldevelopment and regeneration 
Contract number: CT930326 (Concerted Action) 
Start date: 01/08/93 Duration: 36 months 
EC contribution: 150,000 ECU 
Objectives: 
The shared objectives of our laboratories are to characterize the structure and the 
function of cell adhesion molecules (CAMs), and to pinpoint their involvement in the 
ontogeny and regenerative processes of the nervous system. This should suggest 
therapeutic approaches to influence, restore or replace components of injured neurons. 
Brief description: 
The functional properties of the nervous system depend critically on the intricate 
network of neuronal connections that is generated during development. The patterning 
of these connections emerges from precise and coordinated adhesive interactions 
between developing neurons and their environment. Similar mechanisms are also at 
work during regeneration. This project intends to provide information on the structure 
and metabolism of adhesion molecules, to describe intracellular pathways triggered by 
their activation and to delineate their function. The first aspect is analytical and 
concerns studies on in vitro systems aimed to define the structure/function relationship 
of the studied molecules. The second aspect deals with the description of events 
depending on their correct spatio-temporal expression. In our network, three groups 
are working on the structural and functional characterization of adhesion molecules. 
Two groups are focusing their efforts in the biological characterization of glial cells and 
two groups are involved in the identification of intracellular signals triggered by the 
activation of cell adhesion molecules. Three groups have also set up in vitro and in 
vivo models to study normal development and regeneration. Antibodies, cell 
permanently transfected with intact or deleted adhesion molecules, enzymes shown to 
specifically modify their structure, will be exchanged between the groups. They will 
be used in the model systems to investigate the participation of these molecules in 
morphogenetic events and in regenerative processes. The diversity of the competence 
of the groups and the complementarity of their approaches should allow them to 
undertake integrative studies on the role of adhesion molecules. 
Keywords: 
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Area 3 
Ecology and Population Biology 

3.1 Ecological implications of 
biotechnology 

3.1.1 Basic understanding of soil microbial ecology and of possible adverse 
effects by engineered microorganisms: 
genetic studies of plasmid ecology, maintenance and transfer, 
mainly concerning genes encoding resistance to heavy metals and 
ability to degrade organic pollutants (role of selection pressure in 
gene stability and transfer ability) 
mechanisms of microbial competition and phenomena which control 
the distribution of microbes and affect their diversity within 
populations (community population dynamics) 
environmental factors which control gene mobility and gene 
expression in target ecosystems. 
3.1.2 Studies of the rhizosphere of economically important European crops 
susceptible to benefit from the introduction of microorganisms with 
defined properties (engineered or not). In particular the molecular and 
chemical phenomena of the interactions between microbes and with the 
host plant will be studied with the aim of understanding at the 
molecular level the growth promoting and plant protection mechanisms. 
3.1.3 Studies of the possible ecological risks from the interactions of 
engineered microorganisms with biological components of the 
rhizosphere of economically important European crops. 
3.1.4 Genetically engineered fish, insects and nematodes: methods of 
biological containment; competition with indigenous related species and 
gene transfer. 

Ecological implications of biotechnology 
Quantifying the impact of GMOs in the environment: development of 
non-disruptive biomarkers to monitor stability, expression and mobility of 
recombinant genes in polluted ecosystems 
Contract number: CT920084 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,046,000 ECU 
Objectives: 
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- Developping luminiscent/immunological markers to examine GMO performance in 
the field. 
- Non-disruptive monitoring of gene expression and transfer in complex populations. 
- Assessment of antigenic reporters to visualise growth-phase of individual cells. 
- Constructing novel vectors and reporters for environmental applications. 
Brief description: 
Deliberate release of genetically modified microorganisms (GMOs) for agricultural and 
bioremediation purposes is currently hampered by the uncertainty about their ecological 
impact on native ecosystems. To overcome this problem, the somewhat vague concept 
of risk must refer to specific, quantifiable parameters so that concrete limits on what 
is permissible or not can be clearly defined. The major indicators of risks and benefits 
associated with GMO performance are (1) the degree of recombinant (r) gene 
expression, (2) rDNA stability, (3) the degree of rDNA lateral transfer and (4) the 
physiological status regarding its life cycle. Although new techniques to increase 
predictability of GMOs have become available over the last few years, there are still 
major methodological gaps for measuring these four indicators in the field. This project 
intends to provide the genetic and biochemical tools to examine non-disruptively GMO 
performance in situ by following the presence and activity of novel biomarkers 
specifically tailored for environmental applications. Four types of reporter systems 
(enzymatic, surface reporters, adaptation biomarkers and mRNA) will be developed 
along with hypersensitive analytical technology to measure their activity in terms of 
gene expression, lateral transfer, stability and growth phase. A special emphasis will 
be given to detection of fluorescence and light emmision through fiber optics 
technology and CCD cameras with image processing. These will be most efficient when 
combined with immuno magnetic separation of GMOs from complex communities by 
heterologous surface epitopes and immunofluorescent quantification. Alternatively, 
simpler phenotypes such as ice nucleation or complementation of engineered catabolic 
pathways will be used as indicators of recombinant gene scape. In any case, the 
biomarkers will be integrated into regulatory circuits of recombinant soil and 
rhizosphere pseudomonas targeted to degrade PCBs and halo/alkyl benzoates. 
Keywords: 
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RNA, Biomerediation 
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Acquisition of genes from indigenous bacteria by inoculant strains at long- term 
release sites 
Contract number: CT920370 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,066,000 ECU 
Objectives: 
To screen indigenous rhizobia! populations for natural genetic elements. 
To recover established introduced rhizobia and to screen for such elements. 
To estimate genetic interactions between introduced and indigenous strains. 
To refine risk assessments on the release of genetically modified bacteria. 
Brief description: 
We propose to recover strains of Rhizobium and Bradyrhizobium that have been 
released as inoculants in the past, and to screen them for evidence that they have 
acquired new genetic elements during their time in the field. The genetic elements that 
we shall look for are bacterial plasmids, prophages, and transposable elements, which 
are widespread in natural populations of bacteria and can serve as markers of gene 
transfer. We have access to field sites where marked strains were released in the past 
and have become established, and intend to tackle the question of genetic import by 
undertaking five tasks, which are: (A) isolating natural genetic elements and developing 
detection methods for them; (B) determining the distribution of these genetic elements 
in indigenous populations; (C) screening established introductions for the acquisition 
of genetic elements; (D) developing and releasing strains designed as potential 
recipients; (E) analyzing any genetic acquisitions that are discovered. In order to fulfil 
these tasks, we shall be using and refining novel screening methods based on the 
polymerase chain reaction, and significant scientific outputs from the work will be a 
large set of sequence data and primers for native genetic elements in rhizobia, new 
protocols for screening, and information on the genetic structure of indigenous 
populations. As the primary achievement of this project, we should have quantitative 
data on the acquisition of genetic material by bacterial inoculants in the field, as well 
as information on the types of material that are involved in transfer. This will be 
essential information for assessing the potential risks involved in environmental releases 
of bacteria, including GMO's. Our findings will assist the implementation of 
science-based risk assessment within the EC, and thereby increase the potential for 
benefit, and decrease the likelihood of harm, resulting from the application of genetic 
technology to meet agricultural and environmental needs. 
Keywords: 
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Ecological implications of biotechnology 
Ecological and molecular study of gene-mobilizing capacity of soils and 
related ecosystems 
Contract number: CT920491 (Basic Research Project) 
Start date: 01!01/93 Duration: 36 months 
EC contribution: 1,423,000 ECU 
Objectives: 
. To assess risk of gene spread in soil caused by natural mobilizing elements . 
. To characterize the elements involved . 
. To identify ecological factors affecting gene mobilisation in soils . 
. To follow the fate of genes in/from GMM's released into soils. 
Brief description: 
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The aims of this proposal are to gain insight into the gene transfer potential of 
bacterial communities,both Gramnegative and Grampositive ones, in soil and related 
ecosystems, and to determine its effect on introduced genes carried by genetically 
modified bacteria. Focus will be on different parts of the soil ecosystem, i.e. 
rhizosphere and related soil, rhizoplane/ phylloplane, polluted soil and soil in relation 
to the input of manure. A baseline description of the bacterial and plasmid populations 
present will be given in terms of the occurrence of genetic elements involved in gene 
mobility( defined as "Gene Transfer Potential ")in relation to the microbial diversity and 
numbers. The description will be made using classical microbiological techniques, 
endogenous and exogenous isolations of plasmids and modern molecular techniques. 
Each system will be characterized as indicated by its peculiarities, i.e. the rhizosphere, 
rhizoplane and phylloplane will be studied in relation to plant development, and 
manured soils will be compared to unmodified soils. New plasmids or transposons 
obtained will be characterized. They will be used as probes to study their prevalence 
in the natural microbial communities. A specific mobilizable (tra- mob+) 
broad-host-range plasmid will be used to study gene spread from introduced organisms 
into the native microbial community in soil. Special emphasis will be placed on the 
effect of abiotic factors on gene mobilization. Combination of the results of the 
transfer potential and the mobilization studies will provide a better insight into the 
hazards associated with GMM's accidentally or deliberately released into the soil 
environments. 
Keywords: 
Gene mobilization, Released gmm's, Soil, Rhizosphere, Wheat, Sugarbeet, Plasmid, 
Risk assessment 
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Ecological implications of biotechnology 
Molecular and chemical basis of the interaction between plant-protecting 
pseudomonads and their crop plants 
Contract number: CT930196 (Generic Research Project) 
Start date: 01/10/93 Duration: 36 months 
EC contribution: 835,000 ECU 
Objectives: 
- Isolation of bacterial root colonization genes 
- Optimization of 2,4-diacetyl-phloroglucinol production 
- Molecular analysis of attachment 
233 
- Combination of this information in order to improve biocontrol of tomato and 
sugarbeet 
Brief description: 
An attractive alternative for chemical disease control in crop plants is the use of 
naturally occurring plant-associated bacteria which can limit the growth of plant 
pathogens. This type of disease control is termed BC (Biological Control, as distinct 
from chemical control). This proposal is directed to the BC of soil-borne plant 
pathogens by PGP (Plant-Growth Promoting) strains of rhizobacteria which promote 
plant growth by limiting or controlling the populations of pathogenic micro-organisms. 
A prerequisite for effective BC is aggressive root colonization to enable the bacteria 
to be targeted to and become established in the rhizosphere. The failures of BC by PGP 
organisms in some field experiments are largely due to poor colonization of the 
introduced strain. The genetic and functional traits required for colonization are poorly 
understood, especially the roles of plant exudates and attachment in the colonization 
process. Therefore this project will strongly focus on the functions of root and seed 
exudate, of attachment, and of yet unknown colonization genes in biological control. 
In addition we will focus on the genes involved in the synthesis of a recently identified 
biocontrol agent from Pseudomonas (2,4-diacetylphloroglucinol; Phl), which is directly 
involved in BC and has the advantage that (some of) these genes are located on a small 
(6 kbp) DNA fragment. 
Keywords: 
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IMPACT - Interactions between Microbial inoculants and resident Populations 
in the rhizosphere of Agronomically important Crops in Typical soils 
Contract number: CT930053 (Generic Research Project) 
Start date: 01/09/93 Duration: 36 months 
EC contribution: 2,328,655 ECU 
Objectives: 
To study the "molecular ecology" of rhizosphere/soil microbial communities following 
introduction of microbial inoculants. 
To develop molecular identification techniques, data storage and retrieval (based on 
PCR) systems. 
To construct genetic tools for the monitoring, biological containment and detection of 
gene transfer in rhizosphere inoculants. 
Brief description: 
Existing GMOs and WT strains will be selected from participating laboratories, and 
will include Rhizobium, Pseudomonas and Azospirillum strains. The microbial 
population dynamics of soil/rhizospheres of the following important European crop 
plants will be addressed: wheat, maize, rice, legumes, sugarbeet and tomato. 
Standardisation of methods and where possible plant cultivars used will be of utmost 
importance to allow us to compare and contrast the information gathered in the project. 
The IMP ACT project will examine a number of different parameters. The effect of 
inoculation on overall soil fertility as measured by total biomass and various 
biochemical parameters will be measured. The potential benefits (in terms of 
plant-health and yield) that can be achieved with these strains in comparison with 
wild-type inoculants will also be assessed. The interaction such inoculants have on 
selected components of the rhizosphere/soil flora such as beneficial/pathogenic bacteria 
and mycorrhizal/pathogenic fungi will be evaluated. Potential additional ecological 
effects, related to transfer and expression of rDNA in the indigenous flora will be 
investigated. An important strand of the project is the development and standardisation 
of novel molecular identification methods; a databank with appropriate access software 
will be developed. It is anticipated that the IMPACT project will provide key 
information to National and European institutions on the benefits obtainable and the 
ecological impact associated with the introduction of GMOs into agricultural systems 
of economic importance. This project will develop new technologies and new 
environmentally-friendly inoculants with limited persistence which will be of 
commercial benefit to European agribusiness. 
Keywords: 
Microbial inoculants, Rhizosphere, Ecological impact, Genetically engineered 
microorganisms, Biocontrol, Molecular strain identification, Database, Genetic tools, 
Gene transfer 
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3.2 Conservation of genetic resources 

3.2.1 
RAPID MOLECULAR GENETIC 
SCREENING METHODS 
Development of rapid molecular genetic screening methods for the 
assessment and evaluation of genetic diversity and potentials in 
systematic groups, crop and farm animal germplasm collections or wild 
populations of plants and animals. 
This project should lead to the development of efficient routine 
procedures to obtain genetic data on large numbers of samples in order 
to estimate genetic distances or to identify specimens bearing genetic 
traits associated with economically interesting properties. The genetic 
information to be obtained will supplement and progressively substitute 
phenotypical data on gene pools in order to rationalise conservation 
(identification of duplicates in germplasm collections and analysis of 
degree and structure of genetic diversity in natural populations) and 
open new opportunities for breeding and industry by disclosure of 
genetic potentials in biological resources. 
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Development of universal techniques for the rapid screening of genetic variation 
Contract number: CT920476 (Generic Research Project) 
Start date: 01!03/93 Duration: 36 months 
EC contribution: 1,065,000 ECU 
Objectives: 
Design of PCR primers for chosen intron and mtDNA amplifications. Assessment of 
primer universality and development of efficient screening. Isolation of novel 
microsatellite markers. Genetic structure of chosen populations and species, as revealed 
by these. 
Brief description: 
The aim of this proposal is to develop new and efficient techniques for the screening 
of genetic variation in a wide range of animals including mammals, reptiles, fish and 
insects. It will use PCR assays to analyse DNA sequences from parts of the genome 
that show sufficient variability, including introns, spacer regions and microsatellites. 
We will attempt to make them as universal as possible. Such techniques will work on 
very small amounts of animal material, and will be developed for use on dried and 
alcohol preserved samples. This will revolutionize the assessment of genetic variation 
in wild populations, since material from all over Europe could be readily collected and 
transported economically. It also means that rare and endangered species can be 
examined without loss, and it would facilitate the use of the vast museum collections 
of Europe. It will be possible to assess the genetic variation between populations in 
many species and will be of use to agriculturalists and conservationists, who need this 
knowledge in order to make decisions on what we may exploit and what we should 
preserve. The project combines the different talents of five proven European 
laboratories, who will benefit greatly from the interchange of techniques, sequences and 
personnel. The group has already worked on whales, sheep, mice, birds, fish, flies, 
grasshoppers and beetles, and its expertise covers mitochondrial DNA, ribosomal DNA, 
nuclear DNA, population genetics, statistics and systematics. Each laboratory will be 
responsible for work on a subset of sequences in different organisms, which will then 
be exchanged and tested for their universality. The best ones will be used for wider 
population surveys. 
Keywords: 
Genetic resources, Biodiversity, Genetic variation, DNA sequences, PCR, Introns, 
Mitochondrial, D loop, Ribosomal spacers, Microsatellites, Mammals, Fish, Reptiles, 
Insect, Taxonomy, Systematics 
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Rapid molecular screening of genetic diversity in cultivated and wild Hordeum 
SPP 
Contract number: CT920486 (Generic Research Project) 
Start date: 01/03/93 Duration: 36 months 
EC contribution: 855,000 ECU 
Objectives: 
To evaluate four different molecular techniques for screening genetic diversity in 
cultivated and wild species of Hordeum. To provide guidelines and recommendations 
concerning methodology and germplasm selection for scientific, plant breeding, and 
genebanking purposes. 
Brief description: 
The proposed project has as its main objectives to evaluate four different molecular 
techniques (RFLP, RAPD, VNTR, & PCR/sequencing) on a common set of germplasm 
with respect to both speed and scale, and to make a direct comparison between the 
information obtained by each of the techniques for practical, commercial and financial 
reasons. The common germplasm will be selected in close cooperation with the 
developing Barley Core Collection. Hence a much better estimate of the genetic 
diversity within the selected Hordeum germplasm will be obtained and links with 
classical descriptions will be secured, such that guidelines and recommendations can 
be made when considering approaches to specific problems. The final comparisons 
between all four molecular methodologies and the classical descriptions should take us 
considerably closer to making the BCC the world's best characterized germplasm 
collection, and hence towards making the BCC of utmost importance for plant breeding. 
Keywords: 
Hordeum, Genetic diversity, Molecular techniques, Barley core collection, RAPD, 
RFLP, VNTR, PCR, Sequencing 
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Development of rapid novel molecular and cellular tools for the assessment and 
evaluation of genetic diversity in plants 
Contract number: CT930295 (Generic Research Project) 
Start date: 01/08/93 Duration: 30 months 
EC contribution: 1,788,500 ECU 
Objectives: 
To develop standardised techniques for screening genetic variation in plants. To speed 
up techniques using micro-methods, rapid assays and automation. To isolate universal 
probes for variable regions and for stress tolerance. To test the tools in screening 
agronomically important species and against existing classifications of diversity. 
Brief description: 
The objective of this proposal is the development of tools for rapid screening of genetic 
variation in germplasm collections and natural and cultivated populations of rare, 
endangered, ecologically or economically important plants. The work programme is 
organised into five tasks. The first task is to develop standardised techniques which 
give highly reproducible results independent of plant species, plant material or 
laboratory. The species tested include Gramineae, Solanacea, Ericacea, sugar beet and 
trees. "Genetic Screening Packages" will be exchanged amongst participants of 
extracted DNA, selected primers\probes, samples of freeze-dried or living material ( eg 
seeds), the experimental conditions and protocols used and the photographed results, 
for RAPDs, RFLPs and VNTRs. The second task is to adapt the tools for large 
population sampling by developing micro-methods, using non-radioactive labelling 
techniques and exploiting automation. A third task will exploit the release of variation 
which occurs when plant cells\tissues are cultured in vitro to generate probes for stress 
tolerance and for "hot spots" of genetic change. The tools will be evaluated by testing 
their effectiveness in detecting variation in wild and cultivated populations (task 4), and 
against existing classifications of diversity using the well catalogued living and 
herbarium collections of cultivated and wild Rhododendron as a test case (task 5). 
Keywords: 
Plant, Genetic variation, RAPD, RFLP, VNTR, PCR, Sequencing, Stress tolerance 
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Development and adaptation of rapid molecular screening technics for assessing 
genetic diversity in forest trees 
Contract number: CT930373 (Generic Research Project) 
Start date: 01/09/93 Duration: 30 months 
EC contribution: 1,080,600 ECU 
Objectives: 
Molecular genetic screening methods will be put into practice to serve as an effective 
tool for defining future research needs and applications in forest biodiversity. The 
improved methods will broaden the scientific base for EC regulation concerning 
declaration and conservation of genetic resources and trade with reproductive material. 
Brief description: 
Forest ecosystems are valuable natural resources providing manifold economic, 
environmental and social functions. As threats to their genetic diversity endanger their 
stability and adaptability there is an urgent need in the EC countries for quick, large 
scale and cost efficient methods in order to study genetic diversity. This will enlarge 
the knowledge about genetic resources, their importance for the function of 
ecosystems,their utilization for breeding and their erosion. Classical biochemical 
methods used to analyze genetic parameters have turned out to be insufficient. Thus the 
proposal in question focuses on the development and adaptation of rapid molecular 
screening techniques for assessing genetic diversity in forest tree species. According 
to their ecological and economic importance the project concentrates on certain species 
of leading function in European forest ecosystems which require different methodical 
approaches. The molecular genetic screening methods will be developed concerning 
technics of identification (RFLP, RAPD, TGGE, sequencing, non-radioactive 
hybridization) and also concerning special probe providing techniques. Their adaptation 
to forest trees will have to surmount specific limitations in the fields of DNA-isolation, 
identification and characterization of DNA polymorphisms, quantification of genetic 
diversity and image and data processing. Intensive interactions between reference and 
user labs will most effectively improve techniques and generate models to apply them 
in practice. The improved methods will broaden the scientific basis for EC regulations 
concerning declaration and conservation of genetic resources and trade with 
reproductive material. 
Screening techniques will be developed in cooperation with and in complementarity to 
the activities of the other participants in the generic project coordinated by A.Karp 
(proposals PL920295,PL920476, PL920486), a specific contribution of this project will 
be the consideration of needs in the forestry sector. 
Keywords: 
Forest trees, Genetic diversity, Molecular screening, RFLP, RAPD, TGGE, Sequencing, 
Polymorphism 
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3.2.2 Development of reference systems for plant taxonomy with specific 
emphasis on the integration of novel (molecular genetic and 
biochemical) and classical descriptors. 
3.2.3 Assessment and development of different conservation means 
(cryogenic storage of semen, oocytes, embryos, stem cells and cell 
lines; preservation of genetic information as isolated chromosomes, 
genomic DNA and eDNA libraries, isolated genes, etc.) as a basis for an 
integrative animal germplasm conservation strategy. 
3.2.4 Novel approaches for the exploration of so far hidden microbial 
communities. This includes the isolation, cultivation and taxonomic 
characterisation of so far non-cultured microbial strains. 
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A unified datastructure for floristic databases in Europe 
Contract number: CT930328 (Concerted Action) 
Start date: 01/08/93 Duration: 30 months 
EC contribution: 125,000 ECU 
Objectives: 
The development of project-independent structures to be used in the design of floristic 
database systems in Europe, with special consideration given to the integration of 
phytochemical and cytological data. Production of a relational data model (data 
structure and entity/relation model) for floristic database design. 
Brief description: 
Floristic information is nomenclatural information linked with data gathered during the 
collection of herbarium specimens, such as collection site, date, abundance etc. 
Nomenclatural data provide access to all information available for the specific taxon. 
Floristic information links this with geographical, ecological and, potentially, economic 
data. Thus, an ably designed floristic database has a variety of applications and 
potential uses apart from pure Flora writing: access to genetic resources by 
circumscribing the area where a certain plant is likely to be found, definition of areas 
with high endemism to identify conservation priorities, as well as information on 
potential collection sites. Local uses, often recorded by collectors, are valuable 
indicators of a possible economic potential of a plant (e.g. pharmaceutical potential). 
Geographic areas which are underrepresented in collections can be defined for priority 
research. The inclusion of novel descriptions (such as from biochemical and cytological 
information) in the basic data structure will enhance collection of such data from new 
research. The results of the project will not only consist of a written document, but of 
a CASE database which can serve directly as starting point for follow-up research and 
system development. The use of CASE (Computer Aided Software Engineering) 
techniques throughout the project represents a novel approach in the development of 
taxonomic database systems. The concerted action project can be considered as the 
first phase in a project leading to program prototypes and a model database system for 
European floristic data. 
Keywords: 
Floristic databases, Plant, Botany, Case-tools 
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European Solanaceae Information Network (ESIN) 
Contract number: CT930397 (Concerted Action) 
Start date: 01/10/93 Duration: 36 months 
EC contribution: 180,000 ECU 
Objectives: 
To collate biotechnological, molecular, taxonomic and other information about species 
of Solanaceae (potato family), and to create a data base not only providing a taxonomic 
reference system but also aiding efficient biotechnological utilisation of the Solanaceae. 
Brief description: 
This Concerted Action is intended to: a) Gather biotechnological and other information 
about species of Solanaceae. b) Build a taxonomically based reference system for the 
Solanaceae. This will be a taxonomic checklist of species names tied to minimal 
passport data (e.g. authors, publication details, etc.) for selected taxa of Solanaceae 
(potato family). This will serve as the core taxonomic backbone or framework for the 
whole system. c) Use this taxonomic checklist to reference other, non-taxonomic 
information, notably molecular constituents, biotechnology potential, pharmaceutical 
uses, etc. Each data set will be included in a distinct but related database module. d) 
Accumulate and evaluate new molecular data in a systematic context. Established 
taxonomic opinions will be tested with these new data, to produce new paradigms of 
Solanaceae systematics and evolution. e) Develop collaboration between European 
Solanaceae scientists, primarily for amassing molecular data on a standard but diverse 
set of taxa, but also for exchange of information, materials, techniques and personnel. 
f) Plan research action for future shared cost projects in the following areas: · Further 
biotechnology of all Solanaceae crop species and related wild germplasm, to enhance 
breeding techniques and germplasm utilisation. · Complete the taxonomic checklist for 
almost 2,500 species in 100 genera of Solanaceae and build up the database for all 
most important information types. g) This ESIN Concerted Action should serve as a 
testable prototype model for the proposed international network (ISIN), a unified, 
factual database to contain plant diversity information for all the world's Solanaceae, 
but the immediate value of the European Solanaceae Information Network will be the 
availability of a taxonomically referenced database of molecular and other information. 
Keywords: 
Solanaceae, Crop plants, Database, Taxonomy, Systematics, Evolution, Names 
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Germplasm cryobanking : a practical approach using the rabbit species as a 
model 
Contract number: CT930184 (Concerted Action) 
Start date: 01!09/93 Duration: 36 months 
EC contribution: 77,200 ECU 
Objectives: 
Cryo-preservation of animal germ plasm is an attractive complement to the 
indispensable maintenance of genetic diversity through living animals. 
Techniques are now available to freeze store both sperm and embryos of several 
domestic species. However their efficiencies and cost of utilisation under routine 
conditions are at the moment not defined. Research is needed to effectively employ 
these techniques in a multidisciplinary program aimed at the preservation of the 
numerous subpopulations of animals that exist within a given species. 
Brief description: 
The proposal is aimed towards the effective utilization of gamete and embryo 
cryobanking for the preservation and exploration of genetic diversity in a domestic 
species. Rabbit has been chosen as an experimental model because it allows access to 
different and numerous subpopulation categories with less constraints than with other 
major species of similar economic value. Three research groups already engaged in 
ex -situ conservation of rabbit germ plasm are willing to participate in this concerted 
action which will examine on an experimental basis both technical, genetic, economical 
and legal aspects of germplasm cryobanking. Particular attention will be given to the 
standardisation of storage conditions, to the sampling of genetic material for each rabbit 
population concerned and to the availability of genetic information through a data base 
network. 
Keywords: 
Cryobanking, Rabbit, Genetic diversity, Sperm, Embryo 
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Development of genetic resource bank systems and guidelines 
Contract number: CT930521 (Concerted Action) 
Start date: 01!09/93 Duration: 24 months 
EC contribution: 260,000 ECU 
Objectives: 
To formulate goals and objectives of a genome banking programme. Evaluate 
effectiveness of current preservation technologies for gametes, embryos and somatic 
cells. Identify future research priorities in preservation technology. Implement and test 
a small scale model genetic resource bank. 
Brief description: 
The aim of the proposed programme is to develop systems and guidelines for the 
establishment of pan-European resource banks for the conservation of genetic material 
and biodiversity. Within the programme a number of roundtable meetings will be held 
to identify the issues involved in such a venture, formulate possible solutions and 
recommendations, then test them in small collaborative projects. For this a balanced 
group of centres and individuals has been identified who together share a common 
interest in the conservation of genetic resources, and who will each bring special skills, 
knowledge of facilities to the consortium. Consortium members therefore include 
laboratory-based scientists with interests in cryobiology, reproductive biotechnology and 
computer science, as well as centres which can supply resources, i.e. semen, oocytes 
and embryos, from fish and mammals. It is envisaged that a model genetic resource 
bank will be set up on a modest scale within this programme. The experience gained 
by testing the effectiveness of this model will be made available through publication 
for implementation on a larger scale. 
Keywords: 
Genome bank, Genetic diversity, Biodiversity, Bioresources, Cryopreservation, 
Cryobiology, Mammals, Fish, Oocytes, Embryo 
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Concerted action in Biotechnology : exploration of microbial diversity (EMD) 
Contract number: CT930119 (Concerted Action) 
Start date: 01!09/93 Duration: 24 months 
EC contribution: 440,000 ECU 
Objectives: 
- organize an extensive consortium of experts into a research network 
- exchange environmental samples, microbial strains and researchers 
- training in classical and molecular techniques in the various expert groups 
- develop a scientific strategy to assess global microbial diversity 
Brief description: 
Microbial diversity is defined as the measure of the range of significantly different 
microorganisms in a natural assembly or habitat. The term microorganism will be used 
in a broad sense, i.e. not only prokaryotic bacteria will be included but also lower 
eukaryotes such as microalgae, funghi and protozoa. To turn natural microbial diversity 
into the resources useful to biotechnology several steps are necessary and several 
scientific hurdles have to be overcome. The major hurdle in this process is the 
cultivation of single microorganisms from their natural habitat. We know that for many 
environments (habitats) only a very small fraction, often less than 1%, of the total 
number of microbial cells can at present be cultured. We do not know how 
representative the isolated microorganisms are of the natural assembly. A solution to 
this classical dilemma of microbiology is the analysis of nucleic acids directly obtained 
from the natural microbial assembly with molecular methods, e.g. sequencing and 
probing, and a comparison with data obtained from isolated microorganisms of the 
same site and relevant data bases. These comparisons allow an assessment of natural 
microbial diversity and of the diversity of our culture collections. Using such methods 
we may finally learn how many and which kind of microorganisms we have missed 
during the cultivation process. The major steps for such a comparison and the 
conservation and assessment of genetic diversity are: i) isolation and cultivation of 
novel microorganisms, ii) molecular taxonomy of microorganisms, iii) conservation of 
new isolates, and iv) direct analysis of microbial communities. 
Keywords: 
Microbial diversity, Microbial identification, Molecular taxonomy, Microbial 
communities, Microbial ecology, Genetic resources 
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Area 4 
HORIZONTAL ACTIVITIES COMMON 
TO ALL AREAS 

4.1 Assessment of the ethical and socio-
economic effects and technological 
risks from biotechnology 
This topic is addressed with different modalities, involving the implementation of 
accompanying measures of the programme. 
A separate list of activities can be obtained upon request. 

4.2 Information infrastructure 
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Integrated procedures for recording and validating results of 3D structural 
studies of biological macromolecules 
Contract number: CT920524 (Basic Research Project) 
Start date: 01/01/93 Duration: 36 months 
EC contribution: 1,197,968 ECU 
Objectives: 
The aim is to produce a software package integrating a number of existing as well as 
new procedures and protocols for recording, communicating and validating results of 
3D structural studies on peptides, proteins, nucleic acids and other molecules that act 
as ligands and co-factors. 
Brief description: 
This is a proposal for a coordinated European effort to cope with the problem of 
efficient recording and exchanging of 3D structural data and validating their quality. 
It complements recent US efforts to improve the biomolecular data handling capacity 
of the Brookhaven Databank, with which the present project will entertain close ties. 
There are 3 major tasks. (1 )In collaboration with several organizations world-wide 
(Brookhaven,IUCr, ESF network-CBM, CODATA/IUPAC), to define standards for the 
contents and file formats for results from 3D structure studies by techniques such as 
x-ray diffraction, neutron scattering and nuclear magnetic resonance and to design and 
implement automatic user-friendly protocols to read and write datafiles based on the 
dictionary standards. (2) To design and test criteria for assessing the quality and 
precision of 3D structural models.These will rely on statistical analyses of known 
structures as well as on scoring agreement with experimental measures (electron 
density, structure factors, NMR derived distance constraints and coupling constants). 
By producing such criteria we hope to effectively address the important issue of quality 
control for the rapidly growing body of structural data being generated world-wide. (3) 
To integrate the tools for handling the 3D Data Dictionary and the validating protocols 
in a flexible software environment using an x-Window based, object oriented package 
for GUI (Graphic User Interface) development. This should permit wide dissemination 
of the results of this project and promote active participation of other members of the 
scientific community. 
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Carbank - A complex carbohydrate structural database 
Contract number: CT930001 (Basic Research Project) 
Start date: 01/11/93 Duration: 30 months 
EC contribution: 256,000 ECU 
Objectives: 
The objective of the proposed research project is to contribute to the further 
development of the Complex Carbohydrate Structural Database (CCSD) and its 
accompanying database management program CarbBank. The database contains 
published oligosaccharide structures larger than disaccharides. 
Brief description: 
The project is an international effort to supply scientists working in the carbohydrate 
field with a structural database, containing published oligosaccharide structures, mostly 
of biologically relevant compounds. Besides the three European partners, scientific 
groups in the USA and Japan are included in the collaboration. The latest release 
CCSD6 of the database contains 22300 oligosaccharide structures. A contract with 
Chemical Abstract Services provided the partners of the CarbBank project with already 
published oligosaccharide structures. Currently, the project is funded under the 
BRIDGE program (BIOT-CT90-0184). In addition to the bibliographic information the 
database should contain related spectroscopic data, i.e. NMR. The Dutch group is 
working on a NMR database containing chemical shift data of oligosaccharides. 
Furthermore, an interface between CarbBank and a force field program (GEGOP) is 
planned by the Danish partners to allow users to generate a 3D-structure of the 
molecule of interest. The fact that biological relevant oligosaccharides often originate 
from glycoproteins makes it desirable to have a link between CarbBank and protein 
Sequence Databases. Contacts to the protein sequence databases MIPS and PIR are 
existing and will be intensified. The connection to other databases will be increased in 
the future. Furthermore, K. Bock (Copenhagen) is a member of the CODATA Task 
group on Biological Macromolecules which insures coordination to other database 
efforts in the field. The CCSD database is distributed on a CD-ROM by the NCBI 
(National Center for Biotechnology Information) and on the NCBI file server. Similar 
distribution is scheduled in collaboration with MIPS. 
Keywords: 
Database, Carbohydrate structures, Spectroscopy, Oligo saccharides 
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Continuation of the Services of the EMBL Data Library and Upgrade of the 
International Protein Sequence Databank 
Contract number: CT930003 (Basic Research Project) 
Start date: 01/09/93 Duration: 24 months 
EC contribution: 2,000,000 ECU 
Objectives: 
The provision of the EMBL Nucleotide Sequence, SWISS-PROT and other Databases. 
The development of a new model for protein sequence databases including data 
evaluation and analysis and the development of tools to handle sequence data and 
annotation using the object oriented paradigm. 
Brief description: 
MIPS will complete mechanisms to ensure consistency of the Protein Sequence 
Database and EMBL will provide and develop its information services, while 
collaborative work will result in mechanisms for exchange of information currently 
collected by the two groups. MIPS will enhance annotation by protein families and 
develop object-oriented database methods for data processing. The specification of a 
Sequence Database Definition Language will ensure syntactic and semantic consistency. 
The collaboration in data exchange with the SwissProt databank will improve quality, 
complementarity and completeness of the data collections. The EMBL group will 
provide the Nucleotide Sequence Database in collaboration with international partners. 
Also provided will be the SwissProt protein sequence database maintained in 
collaboration with the University of Geneva and a number of other databases of 
interest to molecular biologists maintained by collaborators of the Data Library. Both 
groups will continue to provide regular releases of the databases on optical and 
magnetic media, as well as network access to data between releases. Explicit 
collaborative goals include sharing data about citations of the biological literature, 
sharing sequence data, and the development of nomeclature and annotation standards. 
Keywords: 
Database, DNA, Biosequences, Sequence analysis, Nucleotide sequence, Software, 
Protein sequence data 
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CENTRO OCEANOGRAFICO DE VIGO 
CABO ESTAY-CANIDO 1552 
E - 36280 VIGO 
BREM GOTTFRIED 
LEHRSTUHL FUR MOLEKULARE TIERZUCHR 
INSTITU FUR TIERZUCHT UNO TIERHYGIEN 
LUDWIG-MAXIMILIANS-UNIVERSITAER 
VETERINAERSTR. 13 
D - W8000 MUNCHEN 22 
Tel. : 498921802170 
Fax : 4989344925 
BRIGHT S.W.J. 
JEALOTT'S HILL RESEARCH STATION 
ICI SEEDS 
WAREFIELD 
GB - RGI2 6EY BRACKNELL 
Tel. : 44344424701/4821 
Telex : 847556 ICIPPJG 
Fax : 44344434996 
BRON SIERD 
DEPARTMENT OF GENETICS 




NL - 9751 NN HAREN 
Tel. : 3150632105 
Fax : 3150632348 
E-mail: S.BRON@BIOL.RUG.NL 
BROWN NIGEL 
MRC EXPERIMENTAL EMBRYOLOGY AND 
TERATOLOGY UNIT 
ST. GEORGE'S HOSPITAL MEDICAL SCHOOL 
CRANMER TERRACE 
GB - SW170RE LONDON 
Tel. : 44816729944 
Fax : 44817679109 
E-mail: NBROWN@UX.SGHMS.LON AC.UK 
BROWN PETER 
UNIVERSITAT HAMBURG 




INSTITUT FUR ALLGEMEINE BOTANIK 
OHNHORSTSTR 18 
D - W2000 HAMBURG 
Tel. : 494082282366 
Fax : 494082282229 
BROWNLEE GEORGE 
SIR WILLIAM DUNN SCHOOL OF PATHOLOGY 
SOUTH PARKS ROAD 
GB - OX1 3RE OXFORD 
Tel. : 44865275559 
Fax : 44865275556 
E-mail: BROWNLEE@VAX.PATH.OX.AC.UK 
BRUNORI MAURIZIO 
DIPARTIMENTO DI SCIENZE BIOCHIMICHE 
"A. ROSSI FANELLI" 
PIAZZALE A. MORO 5 
I - 00185 ROMA 
Tel. : 3964450291 
Fax : 3964453933 
BRUSCHI CARLO 
INTERNATIONAL CENTRE FOR GENETIC 
ENGINEERING 
AND BIOTECHNOLOGY 
DEPARTMENT OF MICROBIOLOGY 
PADRICIANO 99 
AREA SCIENCE PARK 
I - 34012 TRIESTE 
Tel. : 39.40.375.7304 




PER LA BIOLOGIA MOLECOLARE DELLE 
PlANTE SEDE DI FlRENZE,DIPARTIMENTO DI 
VIA ROMANA 17 
I - 50125 FlRENZE 
Tel. : 3955229453 
Fax : 3955222565 
BULL ALAN THOMAS 
UNIVERSITY OF KENT ACANTERBURY 
BIOLOGICAL LABORATORY 
GB-CT27NJCANTERBURY 
Tel. : 44.227.764000EXT3443 
Fax : 44.227.463487 
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BURGKORNEL 




A- A 2444 SEIBERSDORF 
Tel. : 432254803600 
Telex : 014-353 FZS 
Fax : 432254802118 
BURKE JULIAN 
SUSSEX CENTRE FOR NEUROSCIENCE 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF SUSSEX 
GB - BNI 9QG BRIGHTON 
Tel. : 44273678308 
Fax : 44273678433 
BURNY ARSENE 
MOLECULAR BIOLOGY AND PHYSIOLOGY 
UNIT 
MICROBIOLOGY UNIT 
PASSAGE DES DEPORTES 2 
B- 5030 GEMBLOUX 
Tel. : 3281622152 
Telex : 59482 FSAGX 
Fax : 3281613888 
BURTONBOY GUY 
LABORA TOIRE DE VlROLOGIE 
FOND AMENT ALE 
MBLG/54.90 
A VENUE HIPPOCRATE 54 
B- 1200 BRUSSELS 
Tel. : 3227645492 
Fax : 3227645481 
BUURMAN WILLEM A. 
DEPT. OF SURGERY, RIJKSUNIVERSITEIT 
LIMBURG BIOMEDICAL CENTER 
P.O. BOX 616 
NL - 6200 MD MAASTRICHT 
Tel. : 3143881499 
Fax : 3143670964 
CABOCHE MICHEL 
LABORATOIRE DE BIOLOGIE CELLULAIRE 
INSTITUT NATIONAL DE RECHERCHE 
AGRONOMIQUE 
ROUTE DE SAINT-CYR 
F- 78026 VERSAILLES CEDEX 
Tel. : 33130833017 
Fax : 33130833111 
E-mail: CABOCHE@VERSAILLES.INRA.FR 
List of participants 
CACCIA SILVIO 
ISTITUTO DI RICERCHE FARMACOLOGICHE 
"MARIO NEGRI" 
LABORATORY OF DRUG METABOLISM 
VIA ERITREA 62 
I - 20157 MILANO 
Tel. : 392390141 
Telex: 331268 NEGRI I 
Fax : 3923546277 
CADENASEDUARDO 
DIVISION DE BIOQUIMICA 
PO BOX 99 
E- 03080 ALICANTE 
Tel. : 3465903523 
Fax : 3465903464 
CAMARA BILAL 
LAB. PHYSIOL. CELLULAIRE VEGETALE 
BIOCHIMIE ET REGULATIONS CELLULAIRES 
UNIVERSITE:BORDEAUX I, URA:SGB'CNRS.: 
A VENUE DES FACULTES 
F- 33405 TALENCE 
Tel. : 3356848783 
Fax : 33568487011 
CAMBILLAU CHRISTIAN 
FACULTE DE MEDECINE NORD MARSEILLE 
LABORATOIRE DE CRISTALLOGRAPHIE ET 
CRISTALLISATION DES MACROMOLECULES 
BIOLOGIQUES - URA 1296 
BVD PIERRE DRAMARD 
F- 13326 MARSEILLE 15 
Tel. : 3391698909 
Fax : 3391698913 
CAMERON GRAHAM 
THE EUROPEAN MOLECULAR 
BIOLOGY LABORATORY 
POSTFACH 10.2209 
D - 6900 HEIDELBERG 
Tel. : 496221387257 
Fax : 496221387519 
E-mail: CAMERON@EMBL-HEIDELBERG.DE 
CAPRON ANDRE 
INSTITUT PASTEUR DE LILLE 
CENTRE D'IMMUNOLOGIE ET DE BIOLOGIE 
P ARASITAIRE 
1 RUE DU PROFESSEUR CALMETTE 
F- 59019 LILLE 
Tel. : 3320877962 
Fax : 3320877888 
CARRA VEDO MIGUEL 
DIPUTACION GENERAL DE ARAGON 
DEPT. AGRIC., GANAD. Y MONTES 
281 
BANCO DE GERMOPLASMA DE HORTICOLAS 
MONTANANA 177 
APPARTADO 727 
E - 50080 ZARAGOZA 
Tel. : 34.765.76311 
Fax : 34.765.75501 
CARTRON JEAN-PIERRE 
INSTITUT NATIONAL DE LA SANTE ET DE LA 
RECHERCHE MEDICALE UNITE 76 
6 INTS RUE ALEXANDRE CABANEL 
F- 75739 PARIS 15 
Tel. : 33143067000 
Fax : 33147347431 
CASAL JOSE IGNACIO 
INMUNOLOGIA Y GENETICA APLICADA,SA 
HERMANOS GARCIA NOBLEJAS 41 
E - 28037 MADRID 
Tel. : 3412680501 
Fax : 3414087598 
CATELLO POLITO 
DIP ARTIMENTO DI GENETICA 
BIOLOGIA GENERALE E MOLECOLARE 
VIA MEZZOCANNONE 8 
I - 80134 NAPOLI 
Tel. : 39815526208 
Fax : 39815527950 
CATTIVELLI LUIGI 
ISTITUTO SPERIMENTALE PER LA CEREALI-
COLTURA 
VIA S.PROTASO 302 
I - 29017 FIORENZUOLA D' ARDA (PC) 
Tel. : 39523983758 
Fax : 39523983750 
CERDA OLMEDO ENRIQUE 
UNIVERSIDAD DE SEVILLA 
DEPARTAMENTO DE GENETICA 
APARTADO 1095 
E - 41080 SEVILLA 
Tel. : 3454624107 
Fax : 3454624107 
CEREGHINI SILVIA 
INSTITUT PASTEUR 
UNITE DE GENETIQUE DE LA 
DIFFERENCIATION 
25 RUE DU DR. ROUX 
F- 75724 PARIS 15 
Tel. : 33145688502 
282 
CESBRON MARIE-FRANCE 
CENTRE D'IMMUNOLOGIE ET DE BIOLOGIE 
PARASITAIRE,UNITE MIXTE INSERM U167 
CNRS624, INSTITUT PASTEUR 
1 RUE DU PROFESSEUR A. CALMETTE 
F- 59019 LILLE 
Tel. : 3320877783 
Fax : 3320877888 
CHAMBERT REGIS 
INSTITUT JACQUES MONOD 
LABORATOIRE GENETIQUE ET MEMBRANES 
2 PLACE JUSSIEU 
F- 75251 PARIS 05 
Tel. : 33144276946 
Fax : 33146332305 
CHANGEUX JEAN-PIERRE 
INSTITUT PASTEUR 
25 RUE DU DR ROUX 
F- 75724 PARIS 15 
Tel. : 33 1 45 68 88 05 
Fax : 33 1 45 68 88 36 
CHARDIN PIERRE 
CNRS 
INSTITUT DE PHARMACOLOGIE 
MOLECULAIRE 
ET CELLULAIRE - GROUPE BIOPHYSIQUE 
660 ROUTE DES LUCIOLES 
F- 06560 VALBONNE 
Tel. : 3393957772 
Fax : 3393957710 
CHARNAY PATRICK 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
ECOLE NORMALE SUPERIEURE 
INSERM U368 
46 RUE D'ULM 
F- 75230 PARIS CEDEX 05 
Tel. : 33144323607 
Fax : 33144323988 
CHARPIGNY GILLES 
INSTITUT NATIONAL DE LA RECHERCHE 
AGRONOMIQUE 
STATION DE PHYSIOLOGIE ANIMALE 
F- 78352 JOUY-EN-JOSAS CEDEX 
Tel. : 33134652345 
Fax : 33134652364 
E-mail: GCH@JOUY.INRA.FR. 
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CRATER KEITH 
JOHN INNES FOUNDATION 
JOHN INNES INSTITUTE 
COLNEYLANE 
GB - NR4 7UH NORWICH 
Tel. : 4460352571 
Telex : 975L22JIINOR G 
Fax : 4460356844 
CHAUVEAUJACQUES 
IMMUNOTECH 
130 AVENUE DE LATTRE DE TASSIGNY 
F- 13009 MARSEILLE 
Tel. : 3391758200 
Telex : IMMTECH 430 246 F 
Fax : 3391412794 
CRISWELL DAVID 
CAMBRIDGE ANTIBODY TECHNOLOGY 
LIMITED 
THE SCIENCE PARK 
GB - SG8 6EJ MELBOURN, CAMBRIDGESHIRE 
Tel. : 0763263233 
Fax : 0763263413 
CHOURROUT DANIEL 
LABORATORY OF FISH GENETICS 
INSTITUT NATIONAL DE LA RECHERCHE 
AGRO 
F- 78352 JOUY EN JOSAS 
Tel. : 33134652391 
Fax : 33134652390 
CHRISTOPHE DANIEL 
UNIVERSITE LIBRE BRUXELLES 
INSTITUT DE RECHERCHE 
INTERDISCIPLINAIRE 
EN BIOLOGIE HUMAINE ET NUCLEAIRE 
ROUTE DE LENNIK 808 
B- 1070 BRUXELLES 
Tel. : 3225554171 
Fax : 3225554655 
CLARKSON DAVID 
DEPT. OF AGRICULTURAL SCIENCES 
UNIVERSITY OF BRISTOL 
AFRC INSTITUTE OF ARABLE CROP 
RESEARCH 
GB - BSI8 9AF LONG ASHTON, BRISTOL 
Tel. : 44275392181 
Fax : 44275394007 
List of participants 
COEN ENRICO 
JOHN INNES INSTITUTE 
COLNEYLANE 
GB - NR4 7UH NORWICH 
Tel. : 4460352571 
Telex : 975122 JIINOR G 
Fax : 4460356844 
COHEN JAMES 
UNITED MEDICAL AND DENTAL SCHOOLS OF 
GUYS AND ST.THOMAS HOSPITALS 
ST.THOMAS'S CAMPUS 
GB - SE1 7EH LONDON BRIDGE 
Tel. : +44/1/928 9292 
Fax : +44/1/928 1468 
COHEN JONATHAN 
DEPARTMENT OF INFECTIOUS DISEASES 
AND BACTERIOLOGY 
ROYAL POSTGRADUATE MEDICAL SCHOOL 
DUCANE ROAD 150 
GB - W12 ONN LONDON 
Tel. : 44817403243 
Telex : 926128 HHRPMS 
Fax : 44817492281 
COLEMAN JOHN 
DEPARTMENT OF PHARMACOLOGY 
AND THERAPEUTICS 
P.O.BOX 147 
GB - L693BX LIVERPOOL 
Tel. : 44517945551 
Fax : 44517945540 
COLENBRANDER BEN 
UNIVERSITY OF UTRECHT 
FACULTY OF VETERINARY MEDICINE 
DEPT.OF HERD HEALTH REPRODUCTION 
NL - 3584 CL UTRECHT 
Tel. : 31.30.531248 
Fax : 31.30.521887 
COLLINS MATTHEW DAVID 
AGRICULTURAL AND FOOD RESEARCH 
COUNCIL 




GB - RG6 2EF READING 
Tel. : +44-734-357000 
Telex : 265871 ARSOOl 
Fax : +44-734-267917 
COMOGLIO PAOLO 
UNIVERSITY OF TORINO 
DEP. OF BIOMEDICAL SCIENCES 
AND ONCOLOGY 
CORSO MASSIMO D' AZEGLIO 52 
I - 10126 TORINO 
Tel. : 39116707739 
Fax : 39116509105 
CONTRERAS ROLAND 
LABORATORY OF MOLECULAR BIOLOGY 
K.L.LEDEGANCKSTRAA35 
B- 9000 GENT 
Tel. : 3291645136 
Fax : 3291645348 
E-mail: CONTRERA@MOLEBIOL.RUG.AC.BE 
CORNIC GABRIEL 
LABORATOIRE D'ECOLQG~j: VEGETALE 
UNIVERSITE PARIS SUD 
BAT. 362 
F- 91405 ORSAY 
Tel. : 33169416359 
Telex : FACORS 602 166 F 
Fax : 33169417238 
CORTESE RICCARDO 
ISTITUTO DI RICERCHE DI BIOLOGIA 
MOLECOLARE P. ANGELETTI SPA 
VIA PONTINA KM. 30,600 
I- 00040 POMEZIA (ROME) 
Tel. : 396910931 
Fax : 39691093634 
COSTA TOMMASO 
INSTITUTO SUPERIORE DI SANITA 
LABORATORIO D1 FARMACOLOGIA 
VIALE REGINA ELENA 299 
I - 00161 ROMA 
Tel. : 3964990 
Fax : 3964440053 
COSTANTINO PAOLO 
283 
CONSORZIO BIOLOGIA MOLECOLARE DELLE 
DIP.GENETICA E BIOLOGIA MOLECOLARE 
UNIVERSITA DI ROMA 'LA SAPIENZA" 
P.LE ALDO MORO 5 
I - 00185 ROMA 
Tel. : 3964455344 
Fax : 3964440812 
284 
COSTAS EDUARDO 
UNIVERSIDAD POLITECNICA DE MADRID 
RAMIRO DE MAEZTU SIN 
E - 28040 MADRID 
Tel. : +34-1-3366047 
Fax : +34-1-3366173 
COTECCHIA SUSANNA 
UNIVERSITE DE LAUSANNE 
INSTITUT DE PHARMACOLOGIE 
ET TOXICOLOGIE 
RUE DU BUGNON 27 
CH - 1005 LAUSANNE 
Tel. : 41213132700 
Fax : 41213132775 
COUPLAND G. 
INSTITUTE OF PLANT SCIENCE RESEARCH, 
CAMBRIDGE LABORATORY 
COLNEYLANE 
GB - NR4 7UH NORWICH 
Tel. : 4460352571 
Telex : 975122 
Fax : 4460356844 
COVE DAVID 
DEPARTMENT OF GENETICS 
UNIVERSITY OF LEEDS 
WOODHOUSE LANE 
GB - LS2 9JT LEEDS 
Tel. : 0044532333081 
Fax : 0044532441175 
COVE JONATHAN 
UNIVERSITY OF LEEDS 
DEPARTMENT OF MICROBIOLOGY 
GB - LS29JT LEEDS 
Tel. : 0044532335630 
Telex : 0044532556473 
Fax : 0044532335638 
CROUZET MARC 
UNIVERSITE DE BORDEAUX II 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
ET DE SEQUENCAGE 
146 RUE LEO SAIENAT 
F- 33076 BORDEAUX 
Tel. : 56.960714 
Fax : 56.518561 
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DALLMAN MARGARET 
THE UNIVERSITY OF OXFORD 
NUFFIELD DEPARTMENT OF SURGERY 
JOHN RADCLIFFE HOSPITAL 
HEADINGTON 
GB - OX3 9DU OXFORD 
Tel. : 44865221316 
Fax : 4486568876 
DALSGAARD KRISTIAN 
IMMUNOLOGY SECTION 
DEPARTMENT OF CHEMISTRY 
STATE VETERINARY INSTITUTE 
LINDHOLM 
DK- 4771 KALVEHAVE 
Tel. : 4555814523 
Telex: 40 306 VIRUS DK 
Fax : 4555811766 
DANCHIN ANTOINE 
INSTITUT PASTEUR 
UNITE REGULATION EXPRESSION GENETIQUE 
UNITE DE BIOCHIMIE MICROBIENNE 
25 RUE DU DOCTEUR ROUX 
F- 75724 PARIS 15 
Tel. : 33145688847 
Fax : 33145688938 
E-mail: REG AP ASTEUR.BITNET 
DANGLJEFF 
MAX-DELBRUCK-LABORATORIUM IN DER 
MAX-PLANCK-GESELLSCHAFT 
CARL-VON-LINNE-WEG 10 
D - 5000 KOLN 30 
Tel. : 492215062430 
Telex : 8 881 028 MPIZ D 
Fax : 492215062613 
DANSETTE PATRICK 
LABORATOIRE DE CHIMIE ET BIOCHIMIE 
PHARMACOLOGIQUES ET TOXICOLOGIQUES 
UNIVERSITE RENE DESCARTES 
45 RUE DES SAINTS-PERES 
F- 75270 PARIS 06 
Tel. : 33142862191 
Fax : 33142868387 
DARLISON MARK 
UNIVERSITAT HAMBURG 
INSTITUT FUR ZELLBIOCHEMIE UND 
KLINISCHE NEUROBIOLOGIE 
MARTINISTRASSE 52 
D - 20 HAMBURG 
Tel. : 494047174551 
Fax : 494047174541 
List of participants 
DAUNA Y MARIE CHRISTINE 
INSTITUT NATIONAL DE LA RECHERCHE 
AGRONOMIQUE 
CENTRE DE RECHERCHE D' A VIGNON 
DOMAINE SAINT PAUL 
F- 84143 MONTFAVET CEDEX 
Tel. : +33-90-316000 
Fax : +33-90-316298 
DAVIES HOWARD 
SCOTTISH CROP RESEARCH INSTITUTE 
GB - DD2 5DA INVERGOWRIE, DUNDEE 
Tel. : 44382562731 
Telex: 9312133325SC G 
Fax : 44382562426 
DE GEUS PIETER 
UNILEVER RESEARCH LABORATORIUM 
VLAARDINGEN 
OLIVIER VAN NOORTLAAN 120 
NL - 3133 AVLAARDINGEN 
Tel. : 31104605072 
Telex : 23261 
Fax : 31104605873 
DE GROOT HERBERT 
MEDIZINISCHE EINRICHTUNGEN DER 
UNIVERSITAET - GH - ESSEN 
HUFELANDSTRASSE 55 
D - 04300 ESSEN 
Tel. : 492017234100 
Fax : 492017235943 
DE LEENHEER LEEN 
RAFFINERIE TIRLEMONTOISE 
AANDORENSTRAA1 
B- 3300 TIENEN 
Tel. : 321680351 
Telex: RAFSEC B 22251 
Fax : 3216820317 
DE LOECKER WILLY 




B- 3000 LEUVEN 
Tel. : 32.16.21.5700 
Fax : 32.16.21.5995 
DE LORENZO VICTOR 
CENTRO DE INVESTIGACIONES BIOLOGICAS 
C/. VELAZQUEZ 144 
E- 28006 MADRID 
Tel. : 3415854243 
Fax : 3415627518 
DE SIMONE VINCENZO 
UNIVERSITY OF NAPLES 
CEINGE-DIP. D1 BIOCHIMICA E 
BIOTECNOLOGIE MEDICHE, 
II SCHOOL OF MEDICINE 
VIA P ANSINI 5 
I- 80131 NAPOLI 
Tel. : 39817463073 
Fax : 39817463074 
DE VIENNE DOMINIQUE 
STATION DE GENETIQUE VEGETALE 
UPS INRA/CNRS 
FERME DU MOULON 
F- 91190 GIF SUR YVETTE 
Tel. : 33169417608 
Fax : 33169412790 
DE VOS WILLEM M. 
NEDERLANDS INSTITUUT VOOR 
ZUIVELONDERZOEK 
P.O. BOX 
NL - 6710 BA EDE 
Tel. : 31838059558 
Fax : 31838050400 
DE VOS WILLEM M. 
DEPARTMENT OF MICROBIOLOGY 
HESSELINK VAN SUCHTELENWEG 4 
NL - 6703 CT WAGENINGEN 
Tel. : 31837083110 
Fax : 31837083829 
E-mail: WMDEVOSCRCL.WAU.NL 
DE VRIES SACCO 
285 
DEPT. MOLECULAR BIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
DREIJENLAAN 3 
NL - 6703 HA WAGENINGEN 
Tel. : 31837082036 
Fax : 31837083584 
E-mail: SACCO.DEVRIES@MAC.MB.WAU.NL 
DE W AELE PETER 
INNOGENETICS NV 
INDUSTRIEPARK 7 
B- 9052 ZWIJNAARDE 
Tel. : 3292410711 
Fax : 3292410799 
286 
DEAN CAROLINE 
PLANT SCIENCE RESEARCH LIMITED 
COLNEYLANE 
GB - NR4 7UJ NORWICH 
Tel. : 4460352571 
Telex : 975122 JIINOR G 
Fax : 44603505725 
DEBLAERE ROLF 
UNIVERSITEIT GENT 
LABORATORIUM VOOR GENETICA 
K.L.LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3291645197 
Telex : 11995 GENGEN B 
Fax : 3291645349 
E-mail: ROBLA(A)GENGENP.RUG.AC.BE 
DECKWER WOLF- DIETER 
GBF-GESELLSCHAFT FUER 
BIOTECHNOLOGISCHE 
FORSCHUNG MBH; BEREICH 
BIOVERFAHRENSTECHNIK 
MASCHERODER WEG 1 
D - W3300 BRAUNSCHWEIG 
Tel. : 495316181100 
Fax : 495316181111 
DEFAGO GENEVIEVE 
INSTITUTE OF PLANT SCIENCES 
GROUP PHYTOMEDICINE/PATHOLOGY 
UNIVERSITATSTRASSE 2 
CH - 8092 ZURICH 
Tel. : 4112563869 
Fax : 4112529613 
DEGRIP WILLEM 
KATHOLIEKE UNIVERSITEIT NIJMEGEN 
FACULTY OF MEDICAL SCIENCES 
DEPARTMENT OF BIOCHEMISTRY 
PO BOX 9101 
NL - 6500 HB NIJMEGEN 
Tel. : 3180614263 
Fax : 3180540525 
E-mail: U401003 AT HNYKUNII 
DEKKER BERNARDUS 
MOGEN INTERNATIONAL NV 
EINSTEINWEG 97 
NL - 2333 CB LEIDEN 
Tel. : 3171258282 
Fax : 3171221471 
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DEL PRETE GIANFRANCO 
ISTITUTO D1 CLINICA MEDICA 
UNIVERSITA' STUDI DI FIRENZE 
LABORATORY OF PATHOPHYSIOLOGY 
VIALE MORGAGNI 85 
I- 50134 FIRENZE 
Tel. : 39554379533 
Fax : 3955412867 
DEL VAL MARGARITA 
CENTRO NACIONAL DE MICROBIOLOGIA, 
VIROLOGIA E INMUNOLOGIA SANITARIAS 
CTRA. POZUELO, KM 2 
E - 28220 MAJADAHONDA (MADRID) 
Tel. : 3416380011 
Fax : 3416391859 
DELIUS HAJO 
DEUTSCHES KREBSFORSCHUNGSZENTRUM 
(GERMAN CANCER RESEARCH CENTRE) 
ANGEW ANDTE TUMORVIROLOGIE 
IM NEUENHEIMER FELD 506 
D - 69120 HEIDELBERG 
Tel. : 49.6221.424661 
Fax : 49.6221.424667 
DELSENY MICHEL 
LABORATOIRE DE PHYSIOLOGIE ET BIOLOGIE 
MOLECULAIRE VEGETALES- CNRS UNIT URA 
565 
UNIVERSITE DE PERPIGNAN 
52 A VENUE DE VILLENEUVE 
F- 66860 PERPIGNAN CEDEX 
Tel. : 3368668848 
Fax : 3368668499 
E-mail: GOT @ FRPERP 51BITNET 
DENARIE JEAN 




CHEMIN DE BORDE ROUGE ,27 
F- 31326 CASTANET TOLOSAN CEDEX 
Tel. : 3361285050 
Fax : 3361285061 
DENCKER LENNART 
UPPSALA UNIVERSITET 
PO BOX 594 
S - 751 24 UPPSALA 
Tel. : 4618174250 
Fax : 4618174253 
List of participants 
DEPICKER ANNA 
UNIVERSITEIT GENT 
LABORATORIUM VOOR GENETICA 
K.L.LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3292645174 
Telex : 11995 GENGEN B 
Fax : 3292645349 
E-mail: ANPIC(A)GENGENP.RUG.AC.BE 
DESCOTES JACQUES 
LABORATORY OF FUNDAMENTAL AND 
CUNICAL IMMUNOTOXICOLOGY 
INSERM U80 ALEXIS CARREL FACULTY OF 
RUE GUILLAUME PARADIN 
F- 69008 LYON 
Tel. : 78778664 
Fax : 78778612 
DESSY FRANZ 
UNITE DES SCIENCES VETERINAIRES 
PLACE CROIX DU SUD 3 
B- 1348 LOUV AIN-LA-NEUVE 
Tel. : 3210473701 
Fax : 3210474745 
E-mail: DESSY AT VETE.UCL.AC.BE 
DEUTSCHER JOSEF 
INSTITUT DE BIOLOGIE ET CHIMIE DES 
PROTEINES 
CNRS - UPR 412 
7 PASSAGE DU VERCORS 
F- 69007 LYON 
Tel. : 3372722677 
Fax : 3372722601 
DEVAUX PHIUPPE 
INSTITUT DE BIOLOGIE PHYSICO-CHIMIQUE 
LABORATOIRE DE BIOPHYSIQUE 
CELLULAIRE 
13 RUE PIERRE ET MARIE CURIE 
F- 75005 PARIS 
Tel. : 33143252609 
Fax : 33143298088 
DEVINE KEVIN 
TRINITY COLLEGE, 
DEPARTMENT OF GENETICS, 
UNCOLN PLACE GATE, 
IRL- DUBUN 2 
Tel. : 35317021872 
Fax : 35316798558 
E-mail: KDEVINE@V AXI.TCD.IE 
D1 LAURO ROBERTO 
STAZIONE ZOOLOGICA ANTON DOHRN 
VILLA COMUNALE 
I - 80121 NAPOU 
Tel. : 39815833278 
Fax : 39817641355 
DINGERMANN THEODOR 
INSTITUT FUER PHARMAZEUTISCHE 
BIOLOGIE DER JOHANN WOLFGANG 
GOETHE UNIVERSITAET 
GEORG-VOIGT-STRASSE 16 
D- W 6000 FRANKFURT/MAIN 
Tel. : 49697982384 
Fax : 49697988185 
DIRINGER HEINO 
ROBERT-KOCH INSTITUT ABL 
NORDUFER 20 
D - WlOOO BERLIN 65 
Tel. : 0304503286 
Fax : 0304503328 
DODSON ELEANOR JOY 
UNIVERSITY OF YORK 
DEPARTMENT OF CHEMISTRY 
GB - Y01 SDD YORK 
Tel. : 44904432565 
Fax : 44904410519 
DOLF GAUDENZ 
INSTITUTE OF ANIMAL BREEDING 
UNIVERSITY OF BERNE 
DIVISION OF MOLECULAR GENETICS 
BREMGARTENSTRASSE 109A 
CH - 3012 BERNE 
Tel. : 4131274320 
Fax : 4131247021 
DOMDEY HORST 
C/0 GENZENTRUM MUNCHEN 
PROGENTEC 
AM KLOPFERSPITZ 18A 
D - 82152 MARTINSRIED 
Tel. : 49.89.8578.3941 
Fax : 49.89.8578.3795 
DOTSIKA ELENI 
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LABORATORY OF PARASITE IMMUNOLOGY 
HELLENIC PASTEUR INSTITUTE 
VAS. SOFIAS AVE. 127 
GR - 115 21 ATHENS 
Tel. : 3016447959 
Telex : 301221188 IPH GR 
Fax : 3016423498 
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DOUGAN GORDON 
DEPARTMENT OF BIOCHEMISTRY 
IMPERIAL COLLEGE OF SCIENCE 
EXHIBITION ROAD 
GB - SW7 2AZ LONDON 
Tel. : 44-71-2258286 
Fax : 44-71-712258288 
DRAINAS CONSTANTIN 
SECTOR OF ORGANIC CHEMISTRY AND 
BIOCHEMISTRY 
DEPARTMENT OF CHEMISTRY 
P ANEPISTEMIOPOLIS, DOUROUTI 
GR - 45110 IOANNINA 
Tel. : 3065192210 
Telex : 322160 PNRS GR 
Fax : 3065174112 
DRIESSEN ARNOLD 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY OF GRONINGEN 
KERKLAAN 30 
NL - 9751 NN HAREN 
Tel. : 3150632164 
Fax : 3150632154 
DRUET PHILIPPE 
PATHOLOGIE RENALE ET VASCULAIRE 
INSERM U 28 
96 RUE DIDOT 
HOPITAL BROUSSAIS 
F- 75674 PARIS 14 
Tel. : 33143959583 
Fax : 33145459059 
DU JARDIN PATRICK 
GENETICSANDPLANTIMPROVEMENT 
UNIT. FACULTY OF AGRICULTURAL 
SCIENCES 
A V. MARECHAL JUIN, BAT. 48 
B- 5030 GEMBLOUX 
Tel. : 3281622456 
Telex : 59482 FSAGX 
Fax : 3281614544 
DUBOIS PHILIPPE 
UNITE DE PARASITOLOGIE EXPERIMENTAL£ 
INSTITUT PASTEUR 
25 RUE DU DOCTEUR ROUX 
F- 75724 PARIS 15 
Tel. : 45688627 
Telex : PASTEUR 250609 F 
Fax : 42732240 
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DUERING KLAUS 
UNIVERSITAET HAMBURG 
INSTITUT FUER ALLGEMEINE BOTANIK, 
AMP II 
OHNHORSTSTR. 18 
D - W2000 HAMBURG 52 
Tel. : 494082282360 
Fax : 494082282229 
DUJON BERNARD 
INSTITUT PASTEUR 
UNITE DE GENETIQUE MOLECULAIRE DES 
LEVU RES 
25 RUE DU DR. ROUX 
F- 75724 PARIS 15 
Tel. : 33.1.4568.8482 
Fax : 33.1.4061.3060 
DUPONT YVES 
COMMISSARIAT A L'ENERGIE ATOMIQUE 
CENG GRENOBLE 
LABORATOIRE DE BIOPHYSIQUE 
AVENUE DES MARTYRS 
BP 85X 
F- 38041 GRENOBLE 
Tel. : 3376884677 
Fax : 3376885487 
DUPUIS ALAIN 
COMMISSARIAT A L'ENERGIE ATOMIQUE 
CENG GRENOBLE 
DEPARTEMENT DE BIOLOGIE 
LABORATOIRE DE BIOCHIMIE 
BP85 X A V. DES MARTYRS 
F- 38041 GRENOBLE CEDEX 
Tel. : 3376883119 
Fax : 3376885185 
DURSTON ANTONY 




NL - 3584CT UTRECHT 
Tel. : 3130510211 
Fax : 3130516464 
DUNACH MIREIA 
UNIVERSIDAD AUTONOMA DE BARCELONA 
UNIDAD DE BIOFISICA - DEP. DE 
BIOQUIMICA I BIOLOGIA MOLECULAR 
E- 08193 BELLATERRA 
Tel. : 3435812105 
Fax : 3435812004 
E-mail: IKBFO@ EBCCUABI 
List of participants 
DYBDAHL TIIOMSEN PREBEN 
DEPARTMENT OF ANIMAL SCIENCE 
DIVISION OF ANIMAL GENETICS 
TilE ROYAL VETERINARY AND AGRI-
BULOWSVEJ 13 
DK - 1870 FREDERIKSBERG C 
Tel. : 4535283073 
Fax : 4535283042 
DUSTERHOFf ANDREAS 




D- 40724 HILDEN 
Tel. : 49.2103.892.0 
Fax : 49.2103.892.222 
EDWARDS KEITII 
IMPERIAL CHEMICAL INDUSTRIES PLC 
ICI SEEDS 
JEALOTT'S HILL RESEARCH STATION 
GB - RG12 6EY BRACKNELL BERKSHIRE 
Tel. : 44344414821 
Telex : 847556 ICIPPJG 
Fax : 44344414996 
EHRLICH STANISLA V DUSKO 
INSTITUT NATIONAL DE LA RECHERCHE 
AGRONOMIQUE 
GENETIQUE MICROBIENNE 
DOMAINE DE VILVERT 
F- 78352 JOUY EN JOSAS CEDEX 
Tel. : 33134652511 
Fax : 33134652521 





D - W7800 FREIBURG 
Tel. : 497615108541 




VANDER BOECHORSTSTRAAT 7 
NL- 1081 HV AMSTERDAM 
Tel. : 31205736666 
Fax : 31205736687 
ELLIS TIIOMAS HENRY NOEL 
AGRICULTURAL AND FOOD RESEARCH 
COUNCIL 
289 
INSTITUTE OF PLANT SCIENCE RESEARCH 
JOHN INNES INSTITUTE - DEPARTMENT OF G 
ENETICS 
COLNEY LANE 1 
GB - NR4 7UH NORWICH 
Tel. : 44 603 52571 
Fax : 44 603 56844 
EMBLEY TIIOMAS MARTIN 
BRITISH NATURAL HISTORY MUSEUM 
CROMWELL ROAD 
GB - SW7 5BD LONDON 
Tel. : 44.71.938.8760 
Fax : 44.71.938.8754 
ENGEL PAUL 
KREBS INSTITUTE - DEPARTMENT OF 
MOLECULAR BIOLOGY AND 
BIOTECHNOLOGY, 
UNIVERSITY OF SHEFFIELD. 
P. 0. BOX 594 
GB- SlO 2UH SHEFFIELD 
Tel. : 44742824242 
Fax : 44742728697 
ENJUANES LUIS 
CENTRO NACIONAL DE BIOTECNOLOGIA 
CONSEJO SUPERIOR DE INVESTIGACIONES 
CIENTIFICAS 
CAMPUS UNIVERSIDAD AUTONOMA 
CANTO BLANCO 
E - 28049 MADRID 
Tel. : 34-1-5854555 
Fax : 34-1-5854506 
E-mail: LENJUANES@EMDCNB51.BITNET 
ENTIAN KARL-DIETER 
UNIVERSITY OF FRANKFURT/MAIN 
INSTITUTE FOR MICROBIOLOGY 
MARIE-CURIE-STR. 9 
D- 60053 FRANKFURT/MAIN 
Tel. : 49.69.5800.9525 
Fax : 49.69.5800.9527 
EPPLEN JORG TIIOMAS 
RUHR-UNIVERSIT T BOCHUM 
MEDIZINISCHE FAKULT T 
INSTTTUT FUR GENETIK 
UNIVERSITATSSTRASSE 150 102148 
D - 4630 BOCHUM 
Tel. : 492347003839 




DEPARTMENT OF ANIMAL BREEDING 
AND GENETICS 
LUDWIGSTRASSE 21 
D - 6300 GIESSEN 
Tel. : 496417026129 
Fax : 496417026128 
ERRINGTON JEFFERY 
THE SIR WILLIAM DUNN SCHOOL OF 
PATHOLOGY 
SOUTH PARKS ROAD 
GB - OXL 3RE OXFORD 
Tel. : 44865275561 
Fax : 44865275556 
E-mail: ERRING@V AX.OX.AC.UK 
EVANS DAVID 
DEPARTMENT OF MICROBIOLOGY 
UNIVERSITY OF READING 
WHITEKNIGHTS 
PO BOX 228 
GB - RG6 2AJ READING 
Tel. : 0734318893 
Telex : 847813 
Fax : 0734750140 
E-mail: (DJE-X)@LEIC.AC. UK 
F AMULOK MICHAEL 
INSTITUT FUR BIOCHEMIE DER LMU 
MUNCHEN 
IM MAX-PLANCK INSTITUT FUR BIOCHEMIE 
GEBAUDE F3 
AM KLOPFERSPITZ 18A 
D - 8033 MARTINSRIED 
Tel. : 49.89.85782453(/4) 
Fax : 49.89.85782470 
E-mail: FAMULOK@GENMIC.BIOCHEM.MPG.DE 
FELDMANN HORST 
ISTITUT FUR PHYSIOLOGISCHE CHEMIE 
UNIVERSITAT MUNCHEN (LMU) 
SCHILLERSTRASSE 44 
D - 80336 MUNCHEN 
Tel. : 49.89.5996.451 
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PELLE HUBERT 
BOTANISCHES INSTITUT I 
WSTUS-LIEBIG-UNIVERSITAT 
SENCKENBERGSTRASSE 17-21 
D - W6300 GIESSEN 
Tel. : 496417028454 
Fax : 496417028464 
FERNANDEZ EMILIO 
DEPARTAMENTO DE BIOQUIMICA 
FACULTAD DE CIENCIAS 
UNIVERSIDAD DE CORDOBA 
A VDA. SAN ALBERTO MAGNO SIN 
E - 14071 CORDOBA 
Tel. : 3457218592 
Fax : 3457218606 
E-mail: BFIEMFER CC.UCO.ES 
FERRER ESTHER 
UNIVERSIDAD DE ALCALA DE HENARES 
APARTADO 20 
E - 28801 ALCALA DE HENARES 
FERRETTI LUCA 
ISTITUTO PER LA DIFESA ELA 
V ALORIZZAZIONE DEL GERMOPLASMA 
ANI MALE 
VIA CELORIA 10 
I- 20133 MILANO 
Tel. : 39226680350 
Fax : 39382528496 
FEY/MOSE LARSEN S./P. 
UNIVERSITY OF AARHUS 
INSTITUTE OF MEDICAL MICROBIOLOGY 
BARTHOLIN BUILDING 
DK - 8000 AARHUS 
Tel. : 45.86.139711 EXT3877 
Fax : 45.86.191277 
FIERS/HAEGEMAN W./G. 
UNIVERSITEIT GENT 
LABORATORIUM VOOR MOLEKULAIRE 
BIOLOGIE 
K.L. LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3292645166 
Fax : 3292645348 
FILIPOWICZ WITOLD 
FRIEDRICH MIESCHER-INSTITUT 
P.O. BOX 2543 
CH - 4002 BASEL 
Tel. : 41616974128 
Fax : 41616973976 
E-mail: FILIPOWICZ@FMI.CH 
List of participants 
FINDLAY JOHN B.C. 
UNIVERSITY OF LEEDS 
DEP. OF BIOCHEMISTRY AND 
MOLECULAR BIOLOGY 
GB - LS2 9JT LEEDS 
Tel. : 44532333140 
Fax : 44532333167 
FINLAY BLAND JAMES 
NATURAL ENVIRONMENT RESEARCH 
COUNCIL 
INSTITUTE OF FRESHWATER ECOLOGY 
~NDERMERELABORATORY 
THE FERRY HOUSE, FAR SAWREY 
GB - LA22 OLP AMBLESIDE 
Tel. : +44-9662-2468 
Fax : +44-9662-6914 
FISCHER BERND 




D - W5100 AACHEN 
Tel. : 02418089106 
Fax : 0241804413 
FLATMARK TORGEIR 
UNIVERSITY OF BERGEN 
DEPARTMENT OF BIOCHEMISTRY 
AARSTANDVEIEN 19 
N - 5007 BERGEN 
FLA YELL RICHARD 
JOHN INNES INSTITUTE 
COLNEYLANE 
GB - NR4 7UH NORWICH 
Tel. : 4460352571 
Telex : 975122 JIINOR G) 
Fax : 4460356844 
FLECHON JACQUES - E. 
INSTITUT NATIONAL DE LA RECHERCHE 
AGRONOMIQUE 
LABORATOIRE DE BIOLOGIE CELLULAIRE ET 
BIOTECHNOLOGIES INRA 
F- 78352 JOUY-EN-JOSAS CEDEX 
Tel. : 33134652537 




MITTLERER DALLENBERGWEG 64 
D - W8700 WUERZBURG 
Tel. : 4993173085 
Fax : 4993171446 
FORDE BRIAN 
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ROTHAMSTED EXPERIMENTAL STATION 
AFRC-INST. OF ARABLE CROPS RESEARCH 
GB - AL5 2JQ HARPENDEN, HERTS 
Tel. : 44582763133 
Telex : 825726REXPSTG 
Fax : 44582760981 
FORTERRE PATRICK 
INSTITUT DE GENETIQUE ET MICROBIOLOGIE 
BATIMENT 409 
UNIVERSITE PARIS SUD II 
F- 91405 ORSAY 05 
Tel. : 33169417489 
Fax : 33169417808 
FOUEILLASSAR XAVIER 
ASSOCIATION GENERALE DES PRODUCTEURS 
DE MAIS 
CENTRE TECHNIQUE 
F- 64121 MONTARDON 
Tel. : 3359724700 
Fax : 3359724720 
FOURY FRANCOISE 
UNIVERSITE CATHOLIQUE DE LOUV AIN 
UNITE DE BIOCHIMIE PHYSIOLOGIQUE 
PLACE CROIX DU SUD 2-20 
B- 1348 LOUVAIN-LA-NEUVE 
Tel. : 3210473614 
Fax : 3210473872 
E-mail: AGROFYSA BUCLLN11.BITNET 
FOYER CHRISTINE 
LABORATOIRE DU METABOLISME ET DE 
LA NUTRITION DES PLANTES,INRA 
ROUTE DE ST-CYR 
F- 78026 VERSAILLES CEDEX 
Tel. : 33130833098 
Fax : 33130833096 
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FRASER HUGH 
AFRC & MRC NEUROPATHOGENESIS UNIT 
INSTITUTE FOR ANIMAL HEALTH 
WEST MAINS ROAD 
GB - EH9 3JF EDINBURGH 
Tel. : 0316675204 
Fax : 0316683872 
FREUDL ROLAND 
INSTITUT FUER BIOTECHNOLOGIE I 
POSTFACH 1913 
D - W5170 JUELICH 
Tel. : 492461613472 
Telex: 833556KFAD 
Fax : 492461612710 
FRIES RUEDI 
SWISS FEDERAL INSTITUTE OF 
TECHNOLOGY 
INSTITUTE OF ANIMAL SCIENCES 
ETH ZENTRUM 
TAND2 
CH - CH8092 ZUERICH 
Tel. : 4112563258 
Fax : 4112622161 
E-mail: R.FRIES@RZV AX.ETH.CH 
FROMMER WOLF B. 




D - W1000 BERLIN 
Tel. : 493083000790 
Fax : 493083000736 
FRY JOHN C. 
UNIVERSITY OF WALES 
COLLEGE OF CARDIFF 
SCHOOL OF PURE AND APPLIED BIOLOGY 
PO BOX 915 
GB - CF1 3TL CARDIFF 
Tel. : 44222874000 
Fax : 44222874305 
FRY STEPHEN C. 
INSTITUTE OF CELL & MOLECULAR BIOLOGY 
DIVISION OF BIOLOGICAL SCIENCES 
DANIEL RUTHERFORD BUILDING 
KING'S BUILDINGS 
GB - EH9 3JH EDINBURGH 
Tel. : 44316505320 
Telex : 727442 
Fax : 44316505392 
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GADAL PIERRE 
PHYSIOLOGIE VEGETALE MOLECULAIRE 
INSTITUT DE RECHERCHES SUR LES PLANTES 
BAT 430 1ER ETAGE 
F- 91405 ORSA Y CEDEX 
Tel. : 33169417977 
Fax : 33169853715 
GAILLARDIN CLAUDE 
INSTITUT NATIONAL AGRONOMIQUE 
PARIS-GRIGNON 
GENETIQUE MOLECULAIRE ET CELLULAIRE 
F- 78850 THIVERV AL-GRIGNON 
Tel. : 33.1.3081.5452 
Fax : 33.1.3081.5457 
GALIBERT FRANCIS 
HEMATOLOGIE EXPERIMENTAL£ 
1 HOPITAL SAINT LOUIS 
AVENUE CLAUDE VELLEFAUX 
F- 75010 PARIS 
Tel. : 33142021605 
Fax : 33142060250 
GALINSKI ERWIN A. 
INSTITUT FUER MIKROBIOLOGIE 
& BIOTECHNOLOGIE 
MECKENHEIMER ALLEE 168 
D - W5300 BONN 
Tel. : 49228733799 
Fax : 49228737576 
GALIZZI ALESSANDRO 
UNIVERSITA' DEGLI STUDI D1 PAVIA 
DIP. DI GENETICA E MICROBIOLOGIA 
ABBIATEGRASSO 207 
I- 27100 PAVIA 
Tel. : 39382391548 
Fax : 39382528496 
GALLI CESARE 
LABORATORIO DI TECNOLOGIE DELLA 
RIPRODUZIONE C.I.Z. S.R.L. 
VIA PORCELLASCO 7 IF 
I - 26100 CREMONA 
Tel. : 39372437242 
Fax : 39372437242 
GALLOIS P. 
LABORATOIRE DE PHYSIOLOGIE VEGETALE 
UNIVERSITE DE PERPIGNAN 
A VENUE DE VILLENEUVE 
F- 66025 PERPIGNAN 
Tel. : 3368668848 
Fax : 3368668499 
List of participants 
GAMBARDELLA RAFFAELE 
DIPARTIMENTO DI BIOLOGIA VEGETALE 
UNIVERSITA DEGLI STUDI D1 NAPOLI 
VIA FORIA 223 
I - 80139 NAPOLI 
Tel. : 3981440681 
Fax : 3981450165 
GANCEDO CARLOS 
INS1ITUTO DE INVESTIGACION ES 
BIOMEDICAS, 
CONSEJO SUPERIOR I.C. 
C/ARTURO DUPERIER 4 
E - 28029 MADRID 
Tel. : 34.1.585.4620 
Fax : 34.1.585.4587 
GANDOLFI FUL VIO 
IS1ITUTO DI ANATOMIA DEGLI ANIMALI 
DOMESTIC! CON ISTOLOGIA ED 
EMBRIOLOGIA 
VIA G. CELORIA 10 
I - 20133 MILANO 
Tel. : 39270630920 
Fax : 3922367788 
GARAY AUBAN ESPERANZA 
UNIVERSIDAD DE VALENCIA 
FACULTAD C.C.BIOL6GICAS 
DEPARTAMENTO MICROBIOLOGIA 
DR. MOLlNER 50 
E- 46100 BURJASOT 
Tel. : 34.6.3864612 
Fax : 34.6.3864372 
GARCIA LOBO JUAN MARIA 
DEPARTAMENTO DE BIOLOGIA MOLECULAR 
FACULTAD DE MEDICINA 
CARDENAL HERRERA ORIA SIN 
E - 39011 SANTANDER 
Tel. : 3442201948 
Fax : 3442201903 
GARRETT ROGER 
INSTITUT FOR BIOLOGISK KEMI B 
COPENHAGEN UNIVERSITY 
SOELVGADE 83 
DK - 1307 K COPENHAGEN K 
Tel. : 4533156338 
Fax : 4533145058 
GATZ CHRISTIANE 
FREIE UNIVERSITAET BERLIN 
FACHBEREICH BIOLOGIE 
INSTITUT FUR ANGEW ANDTEGENETIK 
ALBRECHTTHAER WEG - 6 
D - W-1000 BERLIN 33 
Tel. : 49308385801 
Fax : 49308384345 
GEBHARDT CHRISTIANE 
MAX-PLANCK-GESELLSCHAFT 
INSTITUT FUR ZUCHTUNGSFORSCHUNG 
ERWIN BAUER INSTITUT 
CARL-VON-LINNE-WEG 10 
D - W5000 KOLN 30 
Tel. : 49.221.5062-280 
Telex : 8 881 028 MPIZ D 
Fax : 49.221.5062213 
GEIDERMANN HERMANN 
DEPARTMENT OF ANIMAL BREEDING 
GARBENSTRASSE 17 
D - 7000 STUTTGART 
Tel. : 0497114592470 
Fax : 0497114593290 
GENNARINI GIANFRANCO 
ISTITUTO DI FISIOLOGIA UMANA 
POLICLINICO-PIAZZALE 
GIULIO CESARE 1 
I - 70124 BARI 
Tel. : 39.80.278421 
Fax : 39.80.278416 
GEORGOUDIS ANDREAS 
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ARISTOTLE UNIVERSITY OF THESSALONIKI 
FACULTY OF AGRICULTURE 
DEPARTMENT OF ANIMAL PRODUCTION 
GR - 54006 THESSALONIKI 
Tel. : 3031992544 
Fax : 3031473275 
GERAERTS WIJNAND 
DEPARTMENT OF ZOOLOGY 
D BOELELAAN 1087 
NL - 1081 HV AMSTERDAM 
Tel. : 31205483516 




LABORATORIUM VOOR GENETICA 
K.L.LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3291645182 
Telex : 11995 GENGEN B 






D- W4600 DORTMUND 
Tel. : 4923112061 
Fax : 492311206389 
GHERARDI ERMANNO 
ICRF CELL INTERACTIONS LABORATORY 
CAMBRIDGE UNIVERSITY MEDICAL SCHOOL 
MRC CENTER HILLS ROAD 
GB - CAMBRIDGE CB2 2QH 
Tel. : 44223215308 
Fax : 44223215318 
E-mail: E. GHERARDI @UK.AC.ICRF 
GHERSI-EGEA JEAN-FRANCOIS 
CENTRE DU MEDICAMENT, CNRS URA 597 
30 RUE LIONNOIS 
F- 54000 NANCY 
Tel. : 3383322923 
Fax : 3383321322 
GHEZZI PIETRO 
ISTITUTO DI RICERCHE FARMACOLOGICHE 
"MARIO NEGRI" 
VIA ERITREA 62 
I - 20157 MILANO 
Tel. : 392390141 
Telex : 331268 NEGRI I 
Fax : 3923546277 
E-mail: GHEZZI@IMIMNVX.IRFMN.MNEGRI.IT 
GIA VINI ERMINIO 
UNIVERSITY OF MILAN 
DEPARTMENT OF BIOLOGY 
SECTION OF ZOOLOGY AND COMPARATIVE 
VIA CELORIA 26 
I - 20133 MILAN 
Tel. : 39226604436 
Fax : 3922361070 
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GICQUEL BRIGITTE 
INSTITUT PASTEUR 
MYCOBACTERIAL GENETICS UNIT 
25 RUE DU DR. ROUX 
F- 75724 PARIS CEDEX 15 
Tel. : 1.45.688828 
Fax : 1.45.688843 
E-mail: BGICQUEL@PASTEUR.FR 
GIL JOSE A. 
UNIVERSIDAD DE LEON 
DEPARTAMENTO DE ECOLOGIA, GENETICA Y 
MICROBIOLOGIA 
CAMPUS DE VEGAZANA, SIN 
E - 24071 LEON 
Tel. : 3487291503 
Telex : 89892 EDUCI E 
Fax : 3487291479 
E-mail: JAGIL AT ELEULE II 
GILLARD JEAN 
UNIVERSITE CATHOLIQUE DE LOUVAIN 
LABORATOIRE DE PHARMACIE 
GALENIQUE ET INDUSTRIELLE 
A VENUE E. MOUNIER 73.20 
FARG 
B- 1200 BRUXELLES 
Tel. : 3227647320 
Fax : 3227647363 
GILLES RIVEAU 
LABORATOIRE D'IMMUNOPHARMACOLOGIE 
INSTITUT PASTEUR DE LILLE 
1 RUE DU PROFESSEUR CALMETTE 
F- 59019 LILLE 
Tel. : 3320877890 
Fax : 3320877888 
GIRAUDAT J. 
INSTITUT DES SCIENCES VEGETALES 
CENTRE NATIONAL DE LA RECHERCHE 
SCIENTIFIQUE 
A VENUE DE LA TERRASSE 
F- 91198 GIF-SUR-YVETTE CEDEX 
Tel. : 33169823696 
Telex : 601137F 
Fax : 33169823695 
GIUDICE GIOVANNI 
DIPARTIMENTO DI BIOLOGIA CELLULARE 
E DELLO SVILUPPO "A.MONROY" 
VIA ARCHIRAFI 22 
I- 90123 PALERMO 
Tel. : 39916161892 
Fax : 39916165665 
List of participants 
GIULIANO GIOVANNI 
ENTE PER LE NUOVE TECNOLOGIE, 
AREA ENERGIA ED 
INNOV AZIONE-BIOTECHNOLOGIE 
P.O. BOX 2400 
I - 00100 AD ROMA 
Tel. : 39630483192 
Fax : 39630484808 
GLANDSDORFF/PIERARD N./A. 
RESEARCH INSTITUTE OF CERIA-COOVI 
AVENUE EMILE GRYZON 1 
B- 1070 BRUSSELS 
Tel. : 3225267270 
Fax : 3225267042 
GLEICHMANN ERNST 
MEDIZINISCHES INSTITUT FUER 
UDMELTHYGIENE AN DER HEINRICH-HEINE-
UNIVERSITAET DUESSELDORF 
AUF'M HENNEKAMP 50 
D- W4000 DUESSELDORF 
Tel. : 492113389393 
Telex : 8582164 MIUD 
Fax : 492113190910 
GLOSSL JOSEF 
ZENTRUM FOR ANGEW ANDTE GENETIK 
UNIVERSIT-T FOR BODENKULTUR 
GREGOR-MENDEL-STRASSE 33 
A- A 1180 WIEN 
Tel. : 431342500 
Fax : 4313105175 
E-mail: GLOESSL@MAIL.BOKU.AC.AT 
GOETHERT MANFRED 
INSTITUT FUER PHARMAKOLOGIE UND 
TOXIKO 
TOXIKOLOGIE DER RHEINISCHEN FRIEDRICH-
WILHELMS UNIVERSITAET BONN 
REUTERSTRASSE 2B 
D - W5300 BONN 
Tel. : 49228735410 




AUF DER MORGENSTELLE 28 
D - W7400 TUEBINGEN 
Tel. : 497071294636 
Fax : 497071295937 
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GOLDMAN MICHEL 
DEPARTMENT OF IMMUNOLOGY, HOPITAL 
ERASME, AND LABORATOIRE PLURIDISCIPLI-
NAIRE DE RECHERCHE EXPERIMENTALE 
ROUTE DE LENNIK 808 
B- 1070 BRUSSELS 
Tel. : 3225553862 
Fax : 3225554499 
GONI FELIX M. 
UNIVERSIDAD DEL PAIS VASCO 
FACULTAD DE CIENCIAS 
DEPARTAMENTO DE BIOQUIMICA Y 
BIOLOGIA MOLECULAR 
CAMPUS DE LEIOA 
E- 48080 BILBAO 
GORDON JOHN 
DEPARTMENT OF IMMUNOLOGY 
UNIVERSITY OF BIRMINGHAM 
UNIVERSITY OF BIRMINGHAM 
DEPARTMENT OF IMMUNOLOGY, 
EDGBASTON 
GB - B15 2TT BIRMINGHAM 
Tel. : 0214144065 
Fax : 0214143599 
GORIDIS CHRISTO 
MOLECULAR BIOLOGY OF CELL ADHESION 
LUMINY CASE 906 
F- 13288 MARSEILLE CEDEX 09 
Tel. : 33.91.269404 




NL - 9700 AB GRONINGEN 
GOUD BRUNO 
INSTITUT PASTEUR 
UNITE DE GENETIQUE SOMATIQUE 
25 RUE DU DR. ROUX 
F- 75724 PARIS 15 
Tel. : 33145688568 
Fax : 33145688639 
GOULMYELS 
DEPARTMENT OF IMMUNOHEMATOLOGY 
AND BLOOD BANK 
UNIVERSITY HOSPITAL LEIDEN 
P.O. BOX 9600 
NL - 2300 RC LEIDEN 
Tel. : 3171263826 
Telex : 39266 






D - 7000 STUTTGART 80 
Tel. : 497116855040 
Fax : 497116855096 
GRANDI GUIDO 
ENIRICERCHE S.P.A. 
VIA MARITANO 26 
I- 20097 SAN DONATO MILANESE 
Tel. : 3925201 
Fax : 3925204422 
GRANJON LAURENT 
MUSEUM NATIONAL D'HISTOIRE NATURELLE 
LABORATOIRE MAMMIFERES ET OISEAUX 
55 RUE BUFFON 
F- 75005 PARIS 
Tel. : 33.1.40.79.3069 
Fax : 33.1.40.79.3063 
GRANT WILLIAM 
DEPARTMENT OF MICROBIOLOGY 
MEDICAL SCIENCES BUILDING 
UNIVERSITY OF LEICES1ER 
PO BOX 138 
GB - LE1 9HN LEICES1ER 
Tel. : 44533522950 
Fax : 4453523013 
GRAU GEORGES 
DPT DE PATHOLOGIE- C.M.U. 
CENTRE MEDICAL UNIVERSITAIRE 
1, RUE MICHEL SERVET 
CH - 1211 GENEVE 4 
Tel. : 41227025733 
Fax : 41223473334 
GRAY JOHN 
DEPARTMENT OF PLANT SCIENCES 
UNIVERSITY OF CAMBRIDGE 
DOWNING STREET 
GB - CB2 3EA CAMBRIDGE 
Tel. : 44223333925 
Telex : 81240 CAMSPL G 
Fax : 44223333953 
E-mail: JCG2@UK.AC.CAM.PHX 
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GREENWOOD COLIN 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF EAST ANGLIA 
GB - NR4 7TJ NORWICH 
Tel. : 44603592196 
Telex : 975197 
Fax : 44603259492 
GRIFFITHS ROGER 
DIVISION OF BIOCHEMISTRY 
IRVINE BUILDING 
NORTH STREET 
GB - KY169AL ST ANDREWS 
Tel. : 4433476161 
Fax : 4433478721 
GRIMONT PATRICK 
INSTITUT PAS1EUR 
UNI1E DES EN1EROBAC1ERIES 
28 RUE DU DOC1EUR ROUX 
F- 75724 PARIS 15 
Tel. : 33.1.45.688340 
Fax : 33.1.45.688837 
GRIVELL LESLIE ALAN 
UNIVERSITY OF AMS1ERDAM (UV A) 
SECTION FOR MOLECULAR BIOLOGY 
KRUISLAAN 318 
NL - 1098SM AMS1ERDAM 
Tel. : 31.20.525.7924 
Fax : 31.20.668.5086 
GROBETLUC 
SERVICE DE GENETIQUE 
FACUL1E DE MEDECINE VE1ERINAIRE 
UNIVERSI1E DE LIEGE 
BOULEY ARD DE COLONS1ER 20 
BATIMENR B43 
B- 4000 LIEGE 
Tel. : 3241564151 
Fax : 3241564122 
GROGAN VINCENT 
IRISH SUGAR PLC 
SUGAR DIVISION 
IRL - 41 CARLOW 
Tel. : 35350331487 
Fax : 35350343087 
GRONEMEYER HEINRICH 
U184/INSERM- LGME/CNRS 
INSTITUT DE CIDMIE BIOLOGIQUE UPR A6520 
11 RUE HUMANN 
F- 67085 STRASBOURG 
Tel. : 3388371255 
Fax : 3388370148 
List of participants 
GROSVELD FRANK 
FACULTY MEDICINE 
DEPT. CELL BIOLOGY - GENETICS 
ERASMUS UNIV. ROTTERDAM 
PO BOX 1738 
NL - 3000 DR ROTTERDAM 
Tel. : 31.10.408.7593 
Fax : 31.10.436.0225 
GUARDIOLA BEATRICE 
INSTITUT DE RECHERCHES 
INTERNATIONALES SERVIER 
6 PLACE DES PLEIADES 
F- 92415 COURBEVOIE 
Tel. : 33146416809 
Fax : 33146416011 
GUERCHE PHILIPPE 
LABORATOIRE DE BIOLOGIE CELLULAIRE 
INSTITUT NATIONAL DE LA RECHERCHE 
AGRONOMIQUE 
ROUTE DE SAINT-CYR 
F- 78026 VERSAILLES CEDEX 
Tel. : 33130833073 
Fax : 33130833099 
GUERN JEAN 
INSTITUT DES SCIENCES VEGETALES 
AVENUE DE LA TERRASSE 
F- 91198 GIF SUR YVETTE CEDEX 
Tel. : 33169823868 
Telex : 601137F 
Fax : 33169823768 
HAEHNEL WOLFGANG 
ALBERT LUDWIGS UNIVERSITAT FREIBURG 
INSTITUT FUR BIOLOGIE II 
LEHRSTUHL FUR BIOCHEMIE DER PFLANZEN 
SCHANZLESTR. 1 
D - 79104 FREIBURG 
Tel. : 497612032690 
Fax : 497612032701 
E-mail: HAEHNEL .AT. 
IBM.RUF. UNI-FREIBURG.DE 
HAFFRA Y PIERRICK 
SYNDICAT DES SELECTIONNEURS A VICOLES 
ET AQUACOLES FRANCAIS 
78 RUE DE V ARENNE 
F- 75007 PARIS 
Tel. : 3399285378 
Fax : 3399285310 
297 
HALFORD NIGEL GEORGE 
DEPARTMENT OF AGRICULTURAL SCIENCES 
UNIVERSITY OF BRISTOL 
LONG ASHTON RESARCH STATION 
GB - BS18 9AF BRISTOL 
Tel. : 44275392181 
Fax : 44275394281 
E-mail: HALFORDN@.UK.AC.AFRC.LARS 
HALL MICHAEL 
DEPARTMENT OF BIOLOGICAL SCIENCES 
THE UNIVERSITY COLLEGE OF WALES 
ABERYSTWYTH 
GB - SY233DA ABERYSTWYTH 
Tel. : 44970622313 
Telex : 35181 ABYUCW G 
Fax : 44970622350 
E-mail: MZH@AC.UK.ABER 
HAMON MICHEL 
NEUROBIOLOGIE CELLULAIRE ET 
FONCTIONNELLE (INSERM ULBB) 
91 BOULEVARD DE L'HOPITAL 
F- 75634 PARIS 13 
Tel. : 33140779708 
Fax : 33140779790 
HANSEN KIM 
NOVO NORDISK NS 
MICROBIAL PHYSIOLOGY 
NOVOALLE 
DK- 2880 BAGSVAERD 
Tel. : 4544448888 
Fax : 4544983622 
HARBERD NICHOLAS 
PLANT SCIENCE RESEARCH LIMITED 
COLNEYLANE 
GB - NR4 7UJ NORWICH 
Tel. : 4460352571 
Telex : 975122 JIINOR G 
Fax : 44603502270 
HARITOS A THANASSIOS 
UNIVERSITY OF ATHENS 
DEPARTMENT OF BIOLOGY 
ZOOLOGICAL LABORATORY 
P ANEPISTIMIOPOLIS 
GR -157 84 ATHENS 
Tel. : 3017284610 
Fax : 3017284604 
298 
HARWOOD COLIN 
DEPARTMENT OF MICROBIOLOGY 
THE MEDICAL SCHOOL 
FRAMLINGTON PLACE 
GB - NE2 4HH NEWCASTLE UPON TYNE 
Tel. : 44912227708 
Fax : 44912227736 
E-mail: COLIN.HARWOOD@NEWCASTLE.AC.UK 
HASSIOTOU EFTHIMIA 
UNIVERSITY OF THESSALONIKI 
RESEARCH COMMITTEE 
DEPARTMENT OF GENETICS AND PLANT 
BREEDING 
GR - 54006 THESSALONIKI 
Tel. : 3031992547 
Fax : 3031200392 
HATZOPOULOSPOLYDEFKIS 
AGRICULTURAL UNIVERSITY OF ATHENS 
DEPART. OF AGRICULTURAL 
BIOLOGY /BIOTECH. 
LABORATORY OF MOLECULAR BIOLOGY 
IERA ODOS 75 
GR - 118 55 ATHENS 
Tel. : 3013469000 
Fax : 3013460885 
HEGEMANNJOHANNES 
JUSTUS-LIEBIG-UNIVERSITAT GIESSEN 
INSTITUT FUR MIKROBIOLOGIE UND 
MOLEKULARBIOLOGIE 
FRANKFURTER STRASSE 107 
D - 35392 GIESSEN 
Tel. : 49.641.24634 
Fax : 49.641.702.7390 
HELDT HANS WALTER 
INSTITUT FUER BIOCHEMIE DER PFLANZE 
DER UNIVERSITAET GOETTINGEN 
UNTERE KARSPUELE 2 
D - W3400 GOETTINGEN 
Tel. : 49551395741 
Telex : 096703 UNIGOE D 




INSTITUT DE CHIMIE BIOLOGIQUE 
11 RUE HUMANN 
F- 67085 STRASBOURG CEDEX 
Tel. : 3388371255 
Telex : 890780 F 
Fax : 3388370148 
HENRI DURAND 
CAYLA 
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A VENUE DE LARRIEU 
F- 31094 TOULOUSE 
Tel. : 3361442440 
Telex : 530162 F 
Fax : 3361402067 
HENSEN EVERT J. 
INSTITUTE OF INF. DIS. AND IMMUNOLOGY 
DEPT. OF IMMUNOLOGY 
PAC. OF VETERINARY MEDICINE 
YALELAAN 1 
NL - 3584 CL UTRECHT 
Tel. : 3130532471 
Fax : 3130540784 
HERBERT CHRISTOPHER 
CENTRE NATIONAL DE RECHERCHE 
SCIENTIFIQUE (CNRS) 
CENTRE DE GENETIQUE MOLECULAIRE 
A VENUE DE LA TERRASSE 
F- 91198 GIF-SUR-YVETTE 
Tel. : 33.1.6982.3191 
Fax : 33.1.6907.5539 
HERNALSTEENS JEAN-PIERRE 
LABORATORIUM GENETISCHE VIROLOGIE 
PAARDENSTRAAT 65 
B- 1640 SINT-GENESIUS-RODE 
Tel. : 3223582194 
Fax : 3223590399 
HERRERO ENRIQUE 
UNIVERSIDAD DE LLEIDA 
DEPT. CIENCIES MEDIQUES BASIQUES 
FACULTY OF MEDICINE 
AVGDA ROVIRA ROURE 44 
E - 25006 LLEIDA 
Tel. : 34.73.702.409 
Fax : 34.73.702.426 
HERRMANN ANDREAS 
HUMBOLDT-UNIVERSITAT ZU BERLIN 
FACHBEREICH BIOLOGIE 
INSTITUT FUR BIOPHYSIK 
INV ALIDENSTRASSE 42 
D - 01040 BERLIN 
Tel. : 493028972696 
Fax : 493028972641 
List of participants 
HEWITT GODFREY 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF EAST ANGLIA 
GB - NR4 7fJ NORWICH 
Tel. : 44603592182 
Fax : 44603259492 
E-mail: B340@UK.AC.EAST-ANGLIA 
HIGGINS CHRISTOPHER 
JOHN RADCLIFFE HOSPITAL 
ICRF LABORATORIES 
INSTITUTE OF MOLECULAR MEDICINE 
GB - OX3 9DU OXFORD 
Tel. : 44865222459 
Fax : 44865222431 
E-mail: C-HIGGINS@UK.AC.ICRF 
HILGER/PORTERELLE F./D. 
FACULTY OF AGRONOMY (FSAGX) 
MICROBIOLOGY 
A VENUE MARECHAL JUIN 6 
B- 5030 GEMBLOUX 
Tel. : 081.622.353 
Tel. : 081.622.354 
Fax : 081.611.555 
HILLEN WOLFGANG 
LEHRSTUHL FUER MIKROBIOLOGIE 
INSTITUT FUER MIKROBIOLOGIE UND 
BIOCHEMIE 
STAUDT STR 5 
D - W8520 ERLANGEN 
Tel. : 499131858081 
Fax : 499131858082 
HIREL BERTRAND 
LABORATOIRE DU METABOLISME ET DE LA 
NUTRITION DES PLANTES, INRA 
ROUTE DE ST-CYR 
F- 78026 VERSAILLES CEDEX 
Tel. : 33130833088 
Fax : 33130833096 
HIRSCH PENNY 
AFRC INSTITUTE OF ARABLE CROPS 
RESEARCH 
ROTHAMSTED EXPERIMENTAL STATION 
GB - AL5 2JQ HARPENDEN 
Tel. : 44582763133 
Telex : 825726 REXPST G 
Fax : 44582760981 
HIRSCH PETER 
CHRISTIAN-ALBRECHfS UNIVERSITAT KIEL 
OLSHAUSENSTRASSE 40-60 
D - W2300 KIEL 
HOBBS SHAUN L.A. 
CAB INTERNATIONAL MYCOLOGICAL 
INSTITUTE 
FERRY LANE, KEW 
GB - TW9 3AF RICHMOND, SURREY 
Tel. : 44.81.940 4086 
Fax : 44.81.332 1171 
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HOCHEREAU-DE REVIERS MARIE-THERESE 
PHYSIOLOGY OF REPRODUCTION OF 
DOMESTIC 
MAMMALS 
URA INRNCNRS 1291 
F- 37380 NOUZILL Y 
Tel. : 3347427794 
Telex : 750 954 F 
Fax : 3347427743 
HODGES JOHN KEITH 
GERMAN PRIMATE CENTRE 
KELLNERWEG 4 
D - W3400 GOETTINGEN 
Tel. : 495513851140 
Fax : 495513851228 
HOFLACK BERNARD 




D - 69117 HEIDELBERG 
Tel. : 496221387285 
Telex : 46I6L3(EMBL D) 
Fax : 496221387306 
HOFNUNG MAURICE 
GICA GENETIQUE 
PROGRAMMA TION MOLECULAIRE ET 
TOXICOLOGIQUE 
RUE DU DR ROUX 25 
MR - 75724 PARIS 15 
Tel. : 33.1.45688830 
Telex : 250 609 
Fax : 33.1.45688834 
HOFSTRA HARMEN 
NEDERLANDSE ORGANISATIE VOOR 
TOEGEPAST NATUURWETENSCHAPPELIJK 
ONDERZOEK 
DW ARSVERBAND BIOTECHNOLOGIE TNO 
UTRECHfSEWEG 48 
NL - 3700 AC ZEIST 
Tel. : +31 3404 44144 
Fax : +31 3404 54186 
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HOLLAND IAN BARRY 
UNIVERSITE PARIS SUD II 
INSTITUT DE GENETIQUE ET MICROBIOLOGIE 
BATIMENT 409 
F- 91405 ORSAY 05 
Tel. : 33169417706 
Fax : 33169417808 
HOLLENBERG CORNELIS P. 
HEINRICH-HEINE-UNIVERISTAT DUSSELDORF 
INSTITUT FUR MIKROBIOLOGIE 
UNIVERSITATSSTR. 1 
GEB. 26.12 
D - 40225 DUSSELDORF 
Tel. : 49.211.311.4720 
Fax : 49.211.311.5370 
HOLM LARS ERIK 
NATIONAL INSTITUTE OF ANIMAL SCIENCE 
DEPARTMENT OF ANIMAL PHYSIOLOGY 
AND BIOCHEMISTRY 
P.O. BOX 39 
DK - 8830 TJELE 
Tel. : 4589991900 
Fax : 4589991919 
HOLST OLLE 
DEPT. OF BIOTECHNOLOGY 
CHEMICAL CENTER 
LUND UNIVERSITY 
PO BOX 124 
S - 221 00 LUND 
Tel. : 4646109844 
Telex : 335 33 LUNIVER S 
Fax : 4646104713 
HOLSTERS MARCELLE 
UNIVERSITEIT GENT 
LABORATORIUM VOOR GENETICA 
K.L.LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3291645181 
Telex : 11995 GENGENB 
Fax : 3291645349 
E-mail: MAHOL(A)GENGENP.RUG.AC.BE 
HOLT WILLIAM 
INSTITUTE OF ZOOLOGY 
ZOOLOGICAL SOCIETY OF LONDON 
REGENT'S PARK 
GB - NW1 4RY LONDON 
Tel. : 44717223333 
Fax : 44715862870 
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HOOYKAASPAUL 
CLUSIUS LABORATORY 
DEPT. PLANT MOLECULAR BIOLOGY 
LEIDEN UNIVERSITY 
WASSENAARSEWEG 64 
NL - 2333 AL LEIDEN 
Tel. : 3171274933 




D - 44780 BOCHUM-QUERENBURG 
Tel. : 492347004235 
Telex: 17-234356 
Fax : 492347094105 
HOWARD JONATHAN 




GB- CB2 4AT CAMBRIBGE 
Tel. : 44223832312 





D - W5000 COLOGNE 
Tel. : 492215062191 
Fax : 492215062113 
HUMPHRIES PETER 
UNIVERSITY OF DUBLIN 
TRINITY COLLEGE 
LINCOLN PLACE GATE 
IRL - 2 DUBLIN 
Tel. : 35317021253 
Telex : 93782TCDEL 
Fax : 35316798558 
E-mail: RKSINGH@V AXI.TCD.IE 
HUYLEBROECK DANNY 
K. U. LEUVEN 
LABORATORY OF MOLECULAR BIOLOGY 
HERESTRAAT 49 
B- 3000 LEUVEN 
Tel. : 3216345916 
Fax : 3216345933 
List of participants 
HOFLE MANFRED 
GESELLSCHAFf FUR BIOTECHNOLOGISCHE 
FOR SCHUNG MBH 
ABTEILUNG FUR MIKROBIOLOGIE 
MASCHERODER WEG 1 
D - W3300 BRAUNSCHWEIG 
Tel. : +49 531 6181415 
Fax : +49 531 6181411 
IJZERMAN AD 
LEIDEN UNIVERSITY 
CENTER FOR BIO-PHARMACEUTICAL 
SCIENCES 
DIVISION OF MEDICINAL CHEMISTRY 
PO BOX 9502 
NL - 2300RA LEIDEN 
Tel. : 3171274651 
Fax : 3171274277 
INGRAM DAVID 
ROYAL BOTANIC GARDEN EDINBURGH 
INVERLEITH ROW 
GB - EH3 5LR EDINBURGH 
Tel. : 0315527171 
Fax : 0315520382 
INZE DIRK 
UNIVERSITEIT GENT 
LABORATORIUM VOOR GENETICA 
K.L.LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3291645192 
Telex : 11995 GENGEN B 
Fax : 3291645349 
E-mail: DIINZ(A)GENGENP.RUG.AC.BE 
ISAAC PETER 
NICKERSON BIOCEM LTD 
CAMBRIDGE SCIENCE PARK 
MILTON ROAD 
GB - CB4 4GZ CAMBRIDGE 
Tel. : 44223423933 
Fax : 44223420925 
E-mail: TELECOM GOLD (DIALCOM) 75:DBI0246 
IVANYI JURAJ 
MEDICAL RESEARCH COUNCIL(MRC) 
TUBERCULOSIS AND RELATED 
INFECTIONS UNIT,ROYAL POSTGRADUATE 
HAMMERSMITH HOSPITAL 
DU CANE ROAD 
GB - W120HS LONDON 
Tel. : 44817403161 
Fax : 44817438536 
JACQ CLAUDE 
ECOLE NORMALE SUPERIEURE 
GENETIQUE MOLECULAIRE 
46 RUE D'ULM 
F- 75230 PARIS CEDEX 05 
Tel. : 33144323546 
Fax : 33144323941 
JACQUET MICHEL 
UNIVERSITE DE PARIS-SUD 
301 
INSTITUT DE GENETIQUE ET MICROBIOLOGIE 
INFORMATION GENETIQUE ET 
DEVELOPPEMENT 
BATIMENT 400 
F- 91405 ORSAY 
Tel. : 33.1.6941.7963 
Fax : 33.1.6941.7296 
JAHOOR AHMED 
TECHNISCHE UNIVERSITAT MUNCHEN 
LICHTENBERGSTRASSE 4 
D - W8046 GARCHING 
Tel. : 49 89 3209 3300 
Fax : 49 89 3209 3210 
JAKUPOVIC JASMIN 
ANAL YTICON GESELLSCHAFf FUR 
CHEMISCHE 
ANALYTIK UND CONSULTING MBH 
D - W1000 BERLIN 65 
Tel. : 49.30.4694107 
Fax : 49.30.4632012 
JAMES KEITH 
DEPARTMENT OF SURGERY 
MEDICAL SCHOOL 
TEVIOT PLACE 
GB - EH8 9AG EDINBURGH 
Tel. : 44316503557 
Fax : 44316676190 
JAMES RICHARD 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF EAST ANGLIA 
GB - NR4 7TJ NORWICH 
Tel. : 44603592197 
Telex : 975334 






IM NEUENHEIMER FELD 242 
POSTFACH 101949 
D - 69009 HEIDELBERG 
Tel. : 49.6221.424971 
Fax : 49.6221.424962 
JESSEN KRISTJAN R. 
UNIVERSITY COLLEGE LONDON 
DEPARTMENT OF BIOLOGY 
GOWER STREET 
GB - WClE 6BT LONDON 
Tel. : 44.1.387.7050-2686 
Fax : 44.1.380-7026 
JIMENEZ ANTONIO 
CENTRO DE BIOLOGIA MOLECULAR 
UNIVERSIDAD AUTONOMA 
CANTO BLANCO 
E - 28049 MADRID 
Tel. : 3413978442 
Fax : 3413974799 
E-mail: AJIMENEZ@EMDUAM51 
JOERGENSEN STEEN T. 
NOVO NORDISK 
BACTERIAL GENE TECHNOLOGY 
INDUSTRIAL BIOTECHNOLOGY 
NOVOALLE 
DK - 2880 BAGSV AERD 
Tel. : 4544448888 
Fax : 4544983622 
JOHN PHILIP 
DEPARTMENT OF AGRICULTURAL BOTANY 
PLANT SCIENCE LABORATORIES 
WHITEKNIGHTS 
PO BOX 221 
GB - RG6 2AS READING 
Tel. : 44734318098 
Telex : 847813 RULIB G 
Fax : 44734750630 
JOLIOT PIERRE 
INSTITUT DE BIOLOGIE PHYSICO-CHIMIQUE 
SERVICE DE PHOTOSYNTHESE 
13 RUE PIERRE ET MARIE CURIE 
F- 75005 PARIS 
Tel. : 33143252609 
Fax : 33140468331 
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JONES BRIAN 
GIST-BROCADES B.V. 
P.O. BOX 1 
NL - 2600 MA DELFT 
Tel. : 015799111 
Fax : 015793482 
JUNG GUENTHER 
UNIVERSITY OF TUEBINGEN 
INSTITUT FUER ORGANISCHE CHEMIE 
AUF DER MORGENSTELLE 18 
D- W7400 TUEBINGEN 
Tel. : 497071296925 
Telex: 49177071914 UTIOC 
Fax : 497071296925 
JURGENS GERD 
INSTITUT FOR GENETIK UND 
MIKROBIOLOGIE DER LMU MUNCHEN 
MARIA-WARD-STRASSE 1A 
D - W8000 MUNCHEN 
Tel. : 498917919868 
Fax : 49891785633 
KALTSIKES PANTOUSES 
DEPARTMENT OF PlANT BREEDING AND 
BIOMETRY 
AGRICULTURAL UNIVERSITY OF ATHENS 
IERA ODOS 75 
GR - 10001 ATHENS 
Tel. : 3013471504 
Fax : 3013460885 
E-mail: 118 55 
KANE MICHAEL 
DEPARTMENT OF PHYSIOLOGY 
UNIVERSITY COLLEGE, GALWAY 
UNIVERSITY ROAD 
IRL- 31 GALWAY 
Tel. : 3539124411 
Telex : 50023 UCG EI 
Fax : 3539125700 
KANELLIS ANGELOS 
FOUNDATION FOR RESEARCH AND 
TECHNOLOGY 
INSTITUTE OF MOLECULAR 
BIOLOGY/BIOTECHNOLOGY 
PO BOX 1527 
GR - 711 10 HERAKLION - CRETE 
Tel. : 3081210091 
Telex : 262896IMBBGR 
Fax : 3081230469 
List of participants 
KAPTEIN ROBERT 
BIJVOET CENTER FOR BIOMOLECULAR 
RESEARCH 
PADUALAAN 8 
NL - 3584 CH UTRECHT 
Tel. : 3130533787 
Fax : 3130540980 
KARAGOGEOS DOMNA 
FOUNDATION FOR RESEARCH AND 
TECHNOLOGY-HELLAS 
INSTITUTE OF MOLECULAR BIOLOGY AND 
BIOTECHNOLOGY 
MAMMALIAN MOLECULAR BIOLOGY GRP. 
MATZAPETAKI 21 
GR - 71110 HERAKLION-CRETE 
Tel. : 30.81.210091 
Fax : 30.81.230469 
KARP ANGELA 
DEPARTMENT OF AGRICULTURAL SCIENCES 
UNIVERSITY OF BRISTOL 
LONG ASHTON RESEARCH STATION 
GB - BS18 9AF LONG ASHTON, BRISTOL. 
Tel. : 44275392181 
Fax : 44275394281 
KARSSEN C. 
DEPARTMENT OF PLANT PHYSIOLOGY 
AGRICULTURAL UNIVERSITY WAGENINGEN 
ARBORETUMLAAN 4 
NL - 6703 BD WAGENINGEN 
Tel. : 33837083645 
Fax : 33837084761 
KATINAKIS PANAGIOTIS 
AGRICULTURAL UNIVERSITY OF ATHENS 
DEPT OF AGRICULTURAL BIOLOGY AND 
BIOTECHNOLOGY 
IERA ODOS 75 
GR- 118 55 ATHENS 
Tel. : 13462832 
Fax : 13460885 
E-mail: AUAIF & GRATH DEM 
KAVANAGH TONY 
TRINITY COLLEGE 
UNIVERSITY OF DUBLIN 
DEPARTMENT OF GENETICS 
COLLEGE GREEN 
LINCOLN PLACE GATE 
IRL - DUBLIN 2 
Tel. : 3531772941 EXT.1908 
Telex : 93782 TCD EI 
Fax : 3531798558 
E-mail: KA V ANAGH@V AXl.TCD.IE 
KEIGHTLEY RICHARD 
BECKMAN INSTRUMENTS (UK) LIMITED 
PROGRESS ROAD 
SANDS INDUSTRIAL ESTATE 
GB - HP12 4JL HIGH WYCOMBE 
Tel. : 0494441181 
Fax : 0494463843 
KEIL GUENTHER 
FEDERAL RESEARCH CENTRE FOR VIRUS 
DISEASES OF ANIMALS 
PAUL-EHRLICH-STR. 28 
D - W7400 TUEBINGEN 
Tel. : 497071603323 
Telex : 17707131 
Fax : 497071603201 
KEPES FRANCOIS 
COMMISSARIAT A L'ENERGIE ATOMIQUE 
DSV DBCM 
303 
SERVICE DE BIOCHIMIE ET DE GENETIQUE 
F- 91191 GIF SUR YVETTE CEDEX 
Tel. : 33169083460 
Fax : 33169084712 
KINGHORN JAMES 
DIVISION OF ENVIRONMENTAL AND 
EVOLUTIONARY BIOLOGY 
SCHOOL OF BIOLOGICAL AND MEDICAL 
SCIENCES 
SIR HAROLD MITCHELL BUILDING 
GB - KYI6 9TH ST. ANDREWS, FIFE 
Tel. : 4433476161 
Fax : 4433475398 
KIRSTEN OLRIK 
MIUOBIOLOGISK LABORATORIUM APS 
LABORATORY OF ENVRONMENTAL BIOLOGY 
DK - 3050 HUMLEBAEK 
KISS JOZSEF ZOLTAN 
UNIVERSITE DE GENEVE 
DEPARTMENT OF MORPHOLOGY 
PLACE DE L'UNIVERSITE 3 
CH - 1211 GENEVE 4 
Tel. : 41.227057464 
Fax : 41.22202922 
KJELLEBERG STAFFAN 
UNIV. GOTEBORG 
DEPARTMENT OF GENERAL AND MARINE 
MICROBIOLOGY 
CARL SKOTTSBERGS GATA 22 
S - 413 19 GOTEBORG 
Tel. : 4631418700 
Fax : 4631826790 
304 
KLEINIG HANS 
INSTITUT FUER BIOLOGIE II 
ZELLBIOLOGIE 
SCHAENZLESTRASSE 1 
D - W7800 FREIBURG 
Tel. : 497612032679 
Fax : 497612032675 
KLENK HANS-DIETER 
INSTITUT FUR VIROLOGIE 
ROBERT-KOCH-STR. 17 
D - W 3550 MARBURG 
Tel. : 496421284300 
Fax : 496421286540 
E-mail: KLENK AT DMRHRZI11 
KNEBEL-MOERSDORF DAGMAR 
UNIVERSITY OF COLOGNE 
INSTITUTE OF GENETICS 
WEYERTAL 121 
D - W5000 COLOGNE 
Tel. : 492214703414 
Fax : 492214705163 
KOCHOYAN MICHEL 
ECOLEPOLYTECHNIQUE 
GROUPE DE BIOPHYSIQUE 
ROUTE DE SACLA Y 
F- 91128 PALAISEAU CEDEX 
Tel. : 16.1.69333298 
Fax : 16.1.69333004 
E-mail: POLY.POL YTECHNIQUE.FR 
KOES RONALD 
VRIJE UNIVERSITEIT AMSTERDAM 
DEPARTMENT OF GENETICS 
DE BOELELAAN 1087 
NL - 1081 HV AMSTERDAM 
Tel. : 31205484478 





D - 5000 KOELN 30 
Tel. : 492215062350 
Telex : 8 881 028 MPIZ D 
Fax : 492215062413 





D - W5000 KOLN 
Tel. : 492215062230 
Telex: 8 881 028 MPIZ D 






D - W5300 BONN 2 
KONINGS WIL 
UNIVERSITY OF GRONINGEN 
DEPARTMENT OF MICROBIOLOGY 
BIOLOGICAL CENTER 
KERKLAAN 30 
NL - 9751 NN HAREN 
Tel. : 3150632152 
Fax : 3150632154 
KOOLA. 
PLANT BIOTECHNOLOGY DEPARTMENT 
ZAADUNIE 
WESTEINDE 62 
NL - 1600 AA ENKHUIZEN 
Tel. : 31228011411 
Fax : 31228012818 
KOORNNEEF MAARTEN 
WAGENINGEN AGRICULTURAL UNIVERSITY 
DEPARTMENT OF GENETICS 
DREIJENLAAN 2 
NL- 6703 HA WAGENINGEN 
Tel. : 31837082150 
Fax : 31837083146 
E-mail: MAARTEN KOORNNEEF@CELGEN@ 
EL.WAU 
KOSSMANN JENS 
INSTITUT FUR GENBIOLOGISCHE FORSCHUNG 
BERLIN GMBH 
IHNESTRASSE 63 
D- W1000 BERLIN 
Tel. : 493083000792 
Fax : 493083000736 
List of participants 
KOSZINOWSKI ULRICH 
INSTITUT FOR MEDIZINISCHE VIROLOGIE 
IM NEUENHEIMER FELD 324 
D - 69120 HEIDELBERG 
Tel. : 06221.563000 
Tel. : 06221.563104 
KOURILSKY PHILIPPE 
BIOLOGIE MOLECULAIRE DU GENE 
25 DR. ROUX 
F- 75724 PARIS 15 
Tel. : 145688545 
Telex : 250609 F 
Fax : 145688548 
KRAAIJENHOF RUUD 
VRIJE UNIVERSITEIT 
DEPARTMENT OF MOLECULAR AND 
CELLULAR 
BIOLOGY 
DE BOELELAAN 1087 
NL - 1081 HV AMSTERDAM 
Tel. : 31205484778 
Fax : 31206429202 
E-mail: KLAAS@BIO.VU.NL 
KRAMBOVITIS ELIAS 
INSTITUTE OF MOLECULAR BIOLOGY AND 
BIOTECHNOLOGY 
P.O. BOX 1527 
GR - 71110 HERAKLION 
Tel. : 3081210363 
Telex : 262897 BlOT GR 
Fax : 3081231308 
KRAMER WILFRIED 
GEORG-AUGUST-UNVIERSITAT GOTTINGEN 
INSTITUT FOR MOLEKULARE GENETIK 
GRISEBACHSTR. 8 
D - 37077 GOTTINGEN 
Tel. : 49.551.399653 
Fax : 49.551.3933805 
KREIS MARTIN 
UNIVERSITE PARIS XI 
BIOLOGIE DU DEVELOPPEMENT DES 
PLANTES 
INSTITUT DE RECHERCHES SUR LES PLANTES 
BATIMENT 430,RDC 
F- 91405 ORSAY CEDEX 
Tel. : 33169417239 
Fax : 33169853715 
KREMER ANTOINE 
LABORATOIRE DE GENETIQUE 
PIERROTON 
P.O.BOX 45 
F- 33610 CESTAS 
Tel. : 3356680303 
Fax : 3356680223 
E-mail: ANTOINE PIERROTON.INRA.FR. 
KREUZALER FRITZ 
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D - W5100 AACHEN 
Tel. : 241806633 
Telex : 832704THACD 
Fax : 241806678 
KRISTJANSSON JAKOB 
TECHNOLOCICAL INSTITUTE OF ICELAND 
DEPARTMENT OF BIOTECHNOLOGY 
KELDNAHOLT 
IS - 112 REYKJAVIK 
Tel. : 3541687000 
Telex : 3020 ISTECH 
Fax : 3541687409 
KROGSGAARD-LARSEN POVL 
DEPARTMENT OF ORGANIC CHEMISTRY 
ROYAL DANISH SCHOOL OF PHARMACY 
UNIVERSITETSP ARKEN 2 
DK - 2100 COPENHAGEN 
Tel. : 194535370850 
Fax : 194535375744 
KROLALAIN 
STRUCTURE DES MACROMOLECULES 
BIOLOGIQUES 
ET MECANISMES DE RECONNAISSANCE 
15 RUE DESCARTES 
F- 67084 STRASBOURG CEDEX 
Tel. : 88417050 
Telex : F 880492 
Fax : 88610680 
KRUGER NICHOLAS 
DEPARTMENT OF PLANT SCIENCES 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
GB - OX1 3RB OXFORD 
Tel. : 44865275000 
Telex : 83147 PLANTOX 




TOLAKKERLAAN 3 3 
NL - 3704 JA ZEIST 
Tel. : 31340570139 
Fax : 31340567642 
KRUMLAUF ROBERT 
NATIONAL INSTITUTE FOR MEDICAL 
RESEARCH 
LAB OF EUKARYOTIC MOLECULAR GENETICS 
THE RIDGEWAY 
MILL HILL 
GB - NW71AA LONDON 
Tel. : 44819593666 
Fax : 44819064477 
KUBICEK CHRISTIAN P. 
INSTITUT FUR BIOCHEMISCHE TECHNOLOGIE 
UND MIKROBIOLOGIE 
TECHNISCHE UNIVERSIT-T WIEN 
GETREIDEMARKT 9 
1725 
A- A1060 WIEN 
Tel. : 43222588014708 
Fax : 432225874835 
KUNST FREDERIK 
INSTITUT PASTEUR 
UNITE DE BIOCHIMIE MICROBIENNE 
25 RUE DU DOCTEUR ROUX 
F- 75724 PARIS 15 
Tel. : 33145688869 
Fax : 33145688938 
E-mail: F. KUNST AT PASTEUR.FR. 
KUNTZ MARCEL 
INSTITUT DE BIOLOGIE MOLECULAIRE 
DES PLANTES DU CNRS 
UPR A0406 
12 RUE DU GENERAL ZIMMER 
F- 67084 STRASBOURG 
Tel. : 3388417200 





D- W4600 DORTMUND 
Tel. : 4923112061 
Fax : 492311206389 
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KORNER MARIE 
LABORATOIRE D'IMMUNOLOGIE CELLULAIRE 
ET TISSULAIRE 
CNRS URA 625 
83 BLVD DE L'HOPITAL 
F- 75651 PARIS 13 
Tel. : 33145703824 
Fax : 33145703825 
LABORDA FERNANDO 
DEPARTAMENTO DE MICROBIOLOGIA Y 
P ARASITOLOGIA. UNIVERSIDAD DE ALCALA 
DEHENARES. 
CARRETERA MADRID-BARCELONA KM.33.6 
ALCALA DE HENARES 
E- 28871 MADRID 
Tel. : 3418854621 




CENTRUM FOR STRUKTURBIOKEMI 
BLICKAGANGEN 6 
S- 14157 HUDDINGE 
Tel. : 086089222 
Fax : 086089290 
E-mail: RLA@BARRA. CSB.KI.SE 
LALOUE MICHEL 
LABORATOIRE DE BIOLOGIE CELLULAIRE 
INSTITUT NATIONAL DE LA RECHERCHE 
AGRONOMIQUE 
ROUTE DE SAINT-CYR 
F- 78026 VERSAILLES CEDEX 
Tel. : 33130833046 
Fax : 33130832099 
LANDT OLFERT 
TIB MOLBIOL BERLIN GMBH IG. 
OSTPREUBENDAMM, 111 
D - 1000 BERLIN 45 
Tel. : 49.030.712.3315 





D - W7800 FREIBURG 
Tel. : 497615108533 
Fax : 497615108221 
List of participants 
LANOIR JEANNE 
LABORATOIRE DE NEUROBIOLOGIE URS 1B 
DU CNRS 
31 CHEMIN JOSEPH AIGUIER 
F- 13402 MARSEILLE 09 
Tel. : 3391164178 
Telex : CNRSMAR 430 225 F 
Fax : 3391226333 
LATINNE DOMINIQUE 
DEPARTEMENT DE BIOLOGIE MOLECULAIRE 
CLINIQUE 
CLINIQUES UNIVERSITAIRES SAINT-LUC 
CLOS CHAPELLE AUX CHAMPS 30/46 
B- 1200 BRUSSELS 
Tel. : 3227643145 
Fax : 3227643959 
LATTES ALDO 
UNIVERSITA DEGLI STUDI DI GENOVA 
VIA BALBI 5 
I- 16126 GENOVA 
Tel. : 39.10.20991 
LAUQUINGUY 
INSTITUT DE BIOCHIMIE CELLULAIRE/CNRS 
PHYSIOLOGIE MOLECULAIRE & CELLULAIRE 
1 RUE C. ST. SAeNS 
F- 33077 BORDEAUX 
Tel. : 33.56.99.90.37 
Fax : 33.56.99.90.59 
LE RUDULIER DANIEL 
LABORATOIRE DE BIOLOGIE VEGETALE ET 
MICROBIOLOGIE-URA CNRS 1114 
PARC VALROSE FACULTE DES SCIENCES 
F- 06108 NICE 2 
Tel. : 3393529933 
Telex: UNINICE 970 231 F 
Fax : 3393529948 
LECLERC CLAUDE 
BIOLOGIE DES REGULATIONS IMMUNITAIRES 
INSTITUT PASTEUR 
25 RUE DU DR ROUX 
F- 75015 PARIS 15 
Tel. : 3345688618 
Telex : 250609 
Fax : 3345688639 
LEEMANS J. 
PLANT GENETIC SYSTEMS N.V. 
J. PLATTEAUSTRAAT 22 
B- 9000 GENT 
Tel. : 3291358498 
Fax : 3291240694 
LEESE HENRY 
DEPARTMENT OF BIOLOGY 
UNIVERSITY OF YORK 
GB - YOl 5DD YORK 
Tel. : 44904432821 
Telex : YORKUL 57933 
Fax : 44904432917 
E-mail: HJL I@YORK.AC.UK 
LEHLE LUDWIG 




D - W8400 REGENSBURG 
Tel. : 499419433043 
307 
Fax : 499419433052 
LEIGH ROGER 
ROTHAMSTED EXPERIMENTAL STATION 
AFRC-INST. OF ARABLE CROPS RESEARCH 
GB - AL5 2JQ HARPENDEN 
Tel. : 44582763133 
Telex : 825726 REXPST G 
Fax : 44582760981 
LEISER ROBERT-MATTHIAS 
DIAGEN INSTITUT FUR MOLEKULARBIOLO-
GISCHE DIAGNOSTIK GMBH 
MAX VOLMER STR. 4 
D- W4010 HILDEN 
Tel. : 4921038920 
Fax : 492301892222 
LENSTRA JOHANNES 
INSTITUTE OF INFECTIOUS DISEASES AND 
IMMUNOLOGY, FACULTY OF VETERINARY 
MEDICINE, STATE UNIVERSITY OF 
PO BOX 80165 
NL - 3508 TD UTRECHT 
Tel. : 3130534992 




CONSEJO SUPERIOR DE 
INVESTIGACIONES CIENTIFICAS 
A VENIDA DOCTOR ARCE 37 
E - 28002 MADRID 
Tel. : 3415854114 
Fax : 3415854154 
LESCURE BERNARD 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
DES RELATIONS 
PLANTES-MICROORGANISMES 
CHEMIN DE BORDE-ROUGE 
BP 27 
F- 31326 CASTANET TOLOSAN CEDEX 
Tel. : 3361285049 
Fax : 3361285061 
E-mail: LESCURE@TOULOUSE.INRA.FR 
LESTER RICHARD NEVILLE 
UNIVERSITY OF BIRMINGHAM 
SCHOOL OF BIOLOGICAL SCIENCES 
GB - B15 2TT BIRMINGHAM 
Tel. : 44.21.4145564/5571 
Fax : 44.21.4145925 
LEVEZIEL HUBERT 
DEPARTEMENT DE GENETIQUE ANIMALE 
LABORATOIRE DE GENETIQUE BIOCHIMIQUE 
INRA, CRJ 
F- 78352 JOUY-EN-JOSAS 78352 
Tel. : 33134652580 






S- S10691 STOCKHOLM 
Tel. : 468154003 
Fax : 468152187 
E-mail: MHL@EROS.MISU.SU.SE 
LEY STEVEN C 




GB - NW7 IAA LONDON 
Tel. : 44819593666 
Fax : 44819064477 
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LINDSEY K. 
LEICESTER BIOCENTRE 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
GB - LEI 7RH LEICESTER 
Tel. : 44533522263 
Telex : 342318 LEIBIO G 
Fax : 44533551219 
LOCHT CAMILLE 
LABORATOIRE DE MICROBIOLOGIE 
GENETIQUE ET MOLECULAIRE 
INSERM OF9109 
1 RUE DU PROFESSEUR CALMETTE 
F- 59019 LILLE 
Tel. : 3320877728 
Fax : 3320877906 
LOHSE MARTIN 
JULIUS MAXIMILIANS UNIVERSITAT 
INSTITUT FUR PHARMAKOLOGIE UND 
TOXIKOLOGIE 
VIRSBACHIR 8 
D - 97078 wURZBURG 
Tel. : 49.931.2015400 
Fax : 49.931.2013539 
LOOFT CHRISTIAN 
INSTITUT FOR TIERZUCHT UND 
TIERHALTUNG 
DER CHRISTIAN ALBRECHTS UNIVERSIT- T 
ZU KIEL 
OLSHAUSENSTRABE40 
D- 2300 KIEL 
Tel. : 494318802586 
Fax : 494318802588 
LOPEZ RIVAS ABELARDO 
INSTITUTO LOPEZ NEYRA DE 
P ARASITOLOGIA 
VENTANILLA 11 
E - 18001 GRANADA 
Tel. : 3458203802 
Fax : 3458203323 
LOPEZ-FERBER MIGUEL 




F- 30380 SAINT-CHRISTOL-LEZ-ALES 
Tel. : 3366783700 
Fax : 3366524699 
List of participants 
LOTZ WOLFGANG 
UNIVERSITAT ERLANGEN-NURNBERG 
INST. MIKROBIOL. BIOCHEM. 
LEHRSTUHL MIKROBIOLOGIE 
STAUDTSTR. 5 
D - W8520 ERLANGEN 
Tel. : 499131858086 
Fax : 499131858103 
LOUREIRO-DIAS MARIA 
INSTITUTO GULBENKIAN DE CIENCIA 
P - 2780 OEIRAS 
LUGTENBERG BEN 
LEIDEN UNIVERSITY 
INSTITUTE OF MOLECULAR PLANT SCIENCES 
BOTANICAL LABORATORY 
NONNENSTEEG 3 
NL- 2311 YJ LEIDEN 
Tel. : 3171275063 
Telex : 39427 BURUL NL 
Fax : 3171275088 
LUGTENBERGEGBERTUS 
INSTITUTE OF MOLECULAR PLANT SCIENCES 
CLUSIUS LABORATORY 
WASSENAARSEWEG 64 
P.O. BOX 9505 
NL - 2300 RA LEIDEN 
Tel. : 3171275063 
Fax : 3171275088 
LUGTENBURG JOHAN 
UNIVERSITY OF LEIDEN 
GORLAEUS LABORATORIES 
PO BOX 9502 
NL - 2300 RA LEIDEN 
Tel. : 3171274405 
Fax : 3171274537 
E-mail: ONZLUGTEN@RULGL.LEIDENUNIV.NL 
LUMARET ROSEL YNE 
CENTRE D'ECOLOGIE FONCRIONNELLE ET 
EVOLUTIVE 
5051 1919 ROUTE DE MENDE 
F- 34033 MONTPELLIER 
Tel. : 3367613201 
Fax : 3367412138 
LYNCH JAMES 
SCHOOL OF BIOLOGICAL SCIENCES 
UNIVERSITY OF SURREY 
GUILD FORD 
GB - GU2 5XH SURREY 
Tel. : 44483509721 
Fax : 44483576978 
MACHE REGIS 
309 
LABORATOIRE DE BIOLOGIE MOLECULAIRE 
VEGETALE 
UNIVERSITE JOSEPH FOURIER 
BP 53X 
F- 38041 GRENOBLE CEDEX 
Tel. : 3376514667 
Telex : USMG 980134F 
Fax : 3376514336 
E-mail: RMACHE@FRGREN81 BITNET 
MACINO GIUSEPPE 
DIPARTIMENTO BIOPATOLOGIA UMANA 
SEZIONE BIOLOGIA CELLULARE 
VIALE REGINA ELENA 324 
I - 00161 ROMA 
Tel. : 3964457731 
Fax : 3964462891 
MAKI-TANILA ASKO 
DEPARTMENT OF ANIMAL BREEDING 
AGRICULTURAL RESEARCH CENTRE 
SF- 31600 JOKIOINEN . 
Tel. : 358161881 
Telex : 6741 MTTK SF 






CONSIGLIO NAZIONALE RICERCHE, CNR 
VIA SANTENA 19 
I - 10126 TORINO 
Tel. : 39116961734 
Fax : 39116966155 
MALLET JACQUES 
CENTRE NATIONAL DE LA RECHERCHE 
SCIENTIFIQUE 
UPR23 LABORATOIRE DE NEUROBIOLOGIE 
CELLULAIRE ET MOLECULAIRE 
1 A VENUE DE LA TERRASSE 
DR ILE-DE-FRANCE: SECTEUR SUD 
F- 91198 GIF-SUR-YVETTE 
Tel. : 33.1.69823646 
Fax : 33.1.69823580 
310 
MARCKER KJELD A. 
LABORATORY OF GENE EXPRESSION 
DEPARTMENT OF MOLECULAR BIOLOGY 
UNIVERSITY OF AARHUS 
GUSTAV WIEDS VEJ 10 
DK - DK8000 AARHUS C 
Tel. : 4586202000 
Fax : 4586201222 
MARGARITIS L. 
DEPT. OF BIOLOGY I DIY. OF BIOCHEMISTRY 
CELL_MOLECULAR BIOLOGY & GENETICS 
UNIVERSITY OF ATHENS 
GR - 15701 P ANEPISTIMIOUPOLI 
MARKL HERBERT 
TECHNICAL UNIVERSITY HAMBURG 
HARBURG 
BIOPROCESS- AND BIOCHEMICAL 
DENICKESTRASSE 15 
D - W2100 HAMBURG 90 
Tel. : 494077183017 
Fax : 494077182909 
MARMIROLI NELSON 
INSTITUTE OF GENETICS AND DEPARTMENT 
OF EVOLUTIONARY BIOLOGY - UNIVERSITY 
OF PARMA 
VIALE DELLE SCIENZE 
I- 43100 PARMA 
Tel. : 39521580606 
Fax : 39521580665 
MAROTEAUX LUC 
U184/INSERM - LGME/CNRS 
INSTITUT DE CHIMIE BIOLOGIQUE 
11 RUE HUMANN 
F- 67085 STRASBOURG 
Tel. : 88371255 
Fax : 88370148 
MARQUEZ ANTONIO J. 
UNIVERSIDAD DE SEVILLA 
DEPARTAMENTO DE BIOQUIMICA VEGETAL 
Y BIOLOGIA MOLECULAR 
APARTADO 553 
E - 41080 SEVILLA 
Tel. : 3454626853 
Fax : 3454624952 
E-mail: CABEZA C CICA.ES 
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MARTIN CARLOS 
MICROBIOLOGIA 
FACULTAD DE MEDICINA 
DOMINGO MIRAL SIN 
E - 50009 ZARAGOZA 
Tel. : 3476357916 
Fax : 3476357015 
MARTIN CATHERINE 
JOHN INNES FOUNDATION 
JOHN INNES INSTITUTE 
COLNEYLANE 
GB - NR4 7UH NORWICH 
Tel. : 4460352571 
Telex : 975122(JIINOR G) 
Fax : 4460356844 
MARTIN ROBERT P. 




15 RUE R. DESCARTES 
F- 67084 STRASBOURG 
Tel. : 33.88.41.70.40 
Fax : 33.88.61.06.80 
MARTINEZ SALVADOR 
UNIVERSIDAD DE MURCIA 
FACULTAD DE MEDICINA 
DEPARTMENT OF MORPHOLOGICAL 
SCIENCES 
CAMPUS MURCIA 
E - 30100 MURCIA 
Tel. : 34.96.833000 
Fax : 34.68.835418 
MARTINEZ ZAPATER J.M. 
DEPARTAMENTO DE PROTECCION VEGETAL 
CENTRO DE INVESTIGACION Y TECNOLOGIA 
INSTITUTO NACIONAL DE INVESTIGACION 
CARRETERA DE LA CORUNA, KM. 7.5 
E - 28040 MADRID 
Tel. : 3413476890 
Fax : 3413573107 
MASSIP ALBAN 
UNITE DES SCIENCES VETERINAIRES 
PLACE CROIX DU SUD 3 
B- 1348 LOUV AIN-LA-NEUVE 
Tel. : 3210473756 
Fax : 3210474745 
E-mail: MASSIP@VETE.UCL.AC.BE 
List of participants 
MASTERSON R. 





D - 5000 KOELN 30 
Tel. : 492215062245 
Telex : 8 881 028 MPIZ D 
Fax : 492215062213 
MATHIESON PETER 
UNIVERSITY OF CAMBRIDGE 
DEPARTMENT OF MEDICINE 
ADDENBROOKE'S HOSPITAL 
HILLS ROAD 
GB - CB2 2QQ CAMBRIDGE 
Tel. : 233336741 
Fax : 223411052 
MATRANGA VALERIA 
CONSIGLIO NAZIONALE DELLE RICERCHE 
ISTITIJTO DI BIOLOGIA DELLO SVILUPPO 
VIA ARCHIRAFI 20 
I- 90123 PALERMO 
Tel. : 39-91-6161892 
Telex: 910403 IBSPA 
MATSAS REBECCA 
HELLENIC PASTEUR INSTITUTE 
V ASSILISSIS SOFIAS A VENUE 127 
GR- 11521 ATHENS 
Tel. : 3016431303 
Telex: 221188 IPH 
Fax : 3016423498 
MA VILIO FULVIO 
ISTITUTO SCIENTIFICO H.S. RAFFAELE 
DIPARTIMENTO DI RICERCA BIOLOGICA E 
TECNOLOGICA 
VIA OLGETTINI 60 
I - 20132 MILANO 
Tel. : 39226432357 
Fax : 39226432640 
MAYOR FEDERICO 
UNIVERSIDAD AUTONOMA MADRID 
CENTER OF MOLECULAR BIOLOGY 
DEPARTMENT OF MOLECULAR BIOLOGY 
CARRETERA DE COLMENAR KM. 15 
E - 28049 MADRID 
Tel. : 3413974865 
Fax : 3413974799 
E-mail: FMA YOR CBM2.UAM.ES 
MCCAFFREY MARY 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY COLLEGE CORK 
LEE MALTINGS, PROSPECf ROW 
IRL- 41 CORK 
Tel. : 353212768714933 
Fax : 35321274034 
MELANDRI BRUNO ANDREA 
UNIVERSITA DI BOLOGNA 
DIPARTIMENTO DI BIOLOGIA 
EVOLUZIONISTICA SPERIMENTALE 
VIA BELMELORO 8 
I - 40126 BOLOGNA 
Tel. : 3951351293 
Fax : 3951242576 
MELERO JOSE A. 
311 
INSTITIJTO DE SALUD "CARLOS III" 
CENTRO NATIONAL DE MICROBIOLOGIA, 
VIROLOGIA E IMMUNOLOGIA SANITARIAS 
CTRA. MAJADAHONDA-POZUELO, KM 2,200 
E - 28220 MAJADAHONDA.- MADRID 
Tel. : 3416380011 
Fax : 3416391859 
MELIEF CORNELIS 
DEPARTMENT OF IMMUNOHEMATOLOGY 
AND BLOOD BANK 
P.O. BOX 9600 
NL - 2300 RC LEIDEN 
Tel. : 3171263800 
Telex : 39622 
Fax : 3171216751 
MELLADO RAFAEL P 
CENTRO NACIONAL DE BIOTECHNOLOGIA 
CANTOBLANCO- NUCLEIC ACID UNIT 
CANTO BLANCO 
E - 28049 MADRID 
Tel. : 3413974171 
Telex : 27810 EDUCI E 
Fax : 3413974799 
E-mail: R.P.MELLADO.CNB.UAM.ES 
MELOEN ROBBERT HANS 
CENTRAAL DIERGENEESKUNDIG INST. T 
DIENST LANDBOUWKUNDIG ONDERZOEK 
POSTBUS 65 
NL - 8200 AB LELYSTAD 
Tel. : 31-320073911 
Fax : 31-320073473 
312 
MENEZANDRE 
DEPARTEMENT D'INGENIERIE ET D'ETUDES 
DES PROTEINES 
BATIMENT 152 
CENTRE D'ETUDES DE SACLA Y 
F- 91190 GIF SUR YVETTE CEDEX 
Tel. : 33169083803 
Fax : 33169089071 
E-mail: GILQUIN@GOLIATH.SACLA Y.CEA.FR 
MEREDITH CLIVE 
BIBRA TOXICOLOGY INTERNATIONAL 
WOODMANSTERNE ROAD 
GB- SM5 4DS CARSHALTON, SURREY 
Tel. : 44816434411 
Fax : 44816617029 
MERGEA Y MAXIMILIEN 
VLAAMSE INSTELLING VOOR 
TECHNOLOGISCH 
LABORATORIUM VOOR GENETICA EN 
BIOTECHNOLOGIE 
BOERETANG 200 
B- 2400 MOL 
Tel. : 3214333111 
Fax : 3214320372 
MERMILLOD PASCAL 
PHYSIOLOGY OF REPRODUCTION OF 
DOMESTIC MAMMALS 
URA INRNCNRS 1291 
F- 37380 NOUZILLY 
Tel. : 3347427798 
Telex : 750 954 F 
Fax : 3347427743 
E-mail: PASCAL.MERMILLOD@TOURS.INRA.FR 
MEWES HANS-WERNER 
MAX PLANCK INSTITUT FUER BIOCHEMIE 
AM KLOPFERSPITZ 18 
D - 8033 MARTINSRIED 
Tel. : 498985782656 
Fax : 498985782655 
MEYER P. 
MAX-DELBRUEK-LABORATORIUM IN DER 
MPG 
CARL-VON-LINNE-WEG 10 
D - 5000 KOELN 30 
Tel. : 492215062490 
Fax : 492215062319 
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MICHAELIS GEORG 
BOTANISCHES INSTITUT ABTEILUNG 
BOTANISCHE CYTOLOGIE 
HEINRICH HEINE UNIVERSITAT DUSSELFORF 
UNIVERSITAETSSTRASSE 1 
D- W4000 DUESSELDORF I 
Tel. : 492113114801 
Fax : 492113113085 
MICHEL FRANCOIS 
CENTRE GENETIQUE MOLECULAIRE C.N.R.S. 
A VENUE DE LA TERRASSE 
F- 91198 GIF-SUR-YVETTE CEDEX 
Tel. : 16.1.69823215 
Fax : 16.1.69075322 
E-mail: MICHEL@FRCGM51 
MILLER ANTHONY 
ROTHAMSTED EXPERIMENTAL STATION 
WEST COMMON 
GB - AL5 2JQ HARPENDEN 
Tel. : 44582763133 
Telex : 825726 REXPST G 
Fax : 44582760981 
MILLER JAMES 
AFRC INSTITUTE OF ANIMAL PHYSIOLOGY 
AND GENETICS RESEARCH, CAMBRIDGE 
RESEARCH STATION 
BABRAHAM 
GB - CB2 4AT CAMBRIDGE 
Tel. : 44223832312 
Fax : 44223837304 
E-mail: MILLER@UK.AC.AFRC.IAPC 
MILLER KLARA 
BIBRA TOXICOLOGY INTERNATIONAL 
WOODMANSTERNE ROAD 
GB- SM5 4DS CARSHALTON, SURREY 
Tel. : 44816434411 
Fax : 44-223-837952 
MINGO-CASTEL ANGEL 
POTATO BIOTECH LAB. UPNA 
CAMPUS ARROSADIA 
E- 31006 PAMPLONA 
Tel. : 3348151517 
Fax : 3348151161 
MOLIN SOEREN 
THE TECHNICAL UNIVERSITY OF DENMARK 
DEPARTMENT OF MICROBIOLOGY 
BUILDING 221 
DK - 2800 L YNGBY 
Tel. : 4545933422 
Fax : 4545932809 
List of participants 
MOLLERERNA 
DEPARTMENT OF CLINICAL IMMUNOLOGY 
KAROLINSKA INSTITUTE 
HUDDINGE HOSPITAL 
S - S14186 HUDDINGE 
Tel. : 4687465718 
Fax : 4687466869 
MONIZ PEREIRA JOSE 
MICROBIOBOGIA MOLECUlAR 
FACULDADE DE FARMACIA DA 
UNIVERSIDADE LISBOA 
AV.DASFORCASARMADAS 
P- 1600 LISBOA 1699 
Tel. : 35117933064 
Fax : 35117934212 
MORATA GINES 
CENTRO DE BIOLOGIA MOLECULAR 
UNIVERSIDAD AUTONOMA DE MADRID 
E - 28049 CANTOBLANCO MADRID 
Tel. : 34.1.3978498 
Fax : 34.1.3974799 
MOREIN BROR 
SWEDISH AGRICULTURE UNIVERSITY 
DEPARTMENT OF VIROLOGY BOX 585 
BIOMEDICAL CENTRE 
S - S 751 23 UPPSALA 
Tel. : 4618174570 
Telex : 76132 BIOMED S 
Fax : 4618504603 
MORGAN ANDREW 
DEPT. OF PATHOLOGY & MICROBIOLOGY 
SCHOOL OF MEDICAL SCIENCES 
UNIVERSITY OF BRISTOL 
UNIVERSITY WALK 
GB- BS8 lTD BRISTOL 
Tel. : 44272303451 
Telex : 445938 BSUNIV G 
Fax : 44272303451 
MORNON JEAN PAUL 
UNIVERSITE PIERRE ET DMRIE CURIE 
MINERALOGIE CRISTALLOGRAPHIE 
4 PLACE JUSSIEU TOUR 16 
F- 75252 PARIS 05 
Tel. : 33144274587 
Fax : 33144273785 
E-mail: MORNONALMCP.JUSSIEU.FR 
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MORRISON W IV AN 
AFRC INSTITUTE FOR ANIMAL HEALTH 
GB - RG16 ONN COMPTON, NEAR NEWBURY 
Tel. : 635578411 
Telex : 93 12110326 
Fax : 635578844 
MOTTO MARIO 
ISTITUTO SPERIMENTALE PER LA CEREALI-
COLTURA 
VIA STEZZANO 24 
I - 24100 BERGAMO 
Tel. : 3935313132 
Fax : 3935316054 
MUELLER-STARCK GERHARD 
EIDGENOESSISCHE 
FORSCHUNGSANSTALT FUER WALD, SCHNEE 
UND LANDSCHAFT 
ZUERCHERSTRASSE 111 
CH- 8903 BIRMENSDORF-ZH 
Tel. : 004117392111 
Fax : 004117392215 
MULLER CLAUDE P. 
DEPARTMENT OF IMMUNOLOGY 
LABORATOIRE NATIONAL DE SANTE 
RUE DU LABORATOIRE 
BOlTE POSTALE 1102 
L- 1011 LUXEMBOURG 
Tel. : 352493218 
Fax : 352404238 
MULLIGAN B. 
DEPARTMENT OF BOTANY 
UNIVERSITY OF NOTTINGHAM 
GB - NG7 2RD NOTTINGHAM 
Tel. : 44602484848 EXT. 346 
Fax : 44602420825 
MUMMERY CHRISTINE 




NL - 3584 CT UTRECHT 
Tel. : 3130510211 
Fax : 3130516464 
MURPHY GEORGE 
PLANT SCIENCE RESEARCH LIMITED 
COLNEY LANE 
GB - NR4 7UJ NORWICH 
Tel. : 4460352571 
Telex: 975122 JIINOR G 
Fax : 44603502270 
314 
NAU HEINZ 
FREE UNIVERSITY BERLIN 
INSTITUTE OF TOXICOLOGY 
GARYSTRA-E 5 
D - W1000 BERLIN 
Tel. : 0049308385053 
Fax : 0049308316139 
NETTER PIERRE 
CNRSIUNIVERSITE PARIS 6 
CENTRE DE GENETIQUE MOLECULAIRE 
A VENUE DE LA TERRASSE 
F- 91190 GIF!YVETTE 
Tel. : 33.1.6982.3203 
Fax : 33.1.6907.5539 
NICKLIN MARTIN 
ROYAL HALLAMSHIRE HOSPITAL 
DEPARTMENT OF MEDICINE AND 
PHARMACOLOGY 
SECTION OF MOLECULAR MEDICINE 
GB- S10 2JF SHEFFIELD 
Tel. : 44742766222 
Fax : 44742721104 
NIELSEN SOREN VEDEL SAABY 
THE BIOTECHNOLOGY GROUP 
RESEARCH CENTRE FOR PLANT PROTECTION 
DANISH INSTITUTE FOR PLANT SCIENCE 
LOTTENBORGVEJ 2 
DK - 2000 L YNGBY 
Tel. : 4545872361 
Fax : 4545872210 
NIMIS PIER LUIGI 
UNIVERSITA DEGLI STUDI DI TRIESTE 
PIAZZALE EUROPA 1 
I - 34127 TRIESTE 
Tel. : +39-40-301034 
Fax : +39-40-5603176 
NITSCHKE WOLFGANG 
ALBERT LUDWIGS UNIVERSITAT 
BIOLOGISCHES INSTITUT II 
BIOCHEMIE DER PFLANZEN 
SCHAENZLESTRASSE 1 
D - 79104 FREIBURG 
Tel. : 497612032699 
Fax : 497612032701 
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NOMBELA CESAR 
DEPARTMENT OF MICROBIOLOGY, FACULTY 
OF PHARMACY 
UNIVERSIDAD COMPLUTENSE 
UNlOAD DE SECUENCIACION 
AUTOMATIZADA DE D.N.A. 
CIUDAD UNIVERSITARIA 
E - 28035 MADRID 
Tel. : 34.1.394.1744 
Fax : 34.1.394.1745 
NOTARIANNI ELENA 
INSTITUTE OF ANIMAL PHYSIOLOGY AND 
GENETICS RESEARCH 
BABRAHAM 
GB - CB2 4AT CAMBRIDGE 
Tel. : 223832312 
Fax : 223836481 
NOVAIS J.M. 
INSTITUTO SUPERIOR TECNICO 
DEPTO. DE ENGENHARIA QUIMICA 
AV. ROVISCO PAIS 
P - 1096 LISBOA 
NUTI MARCO PAOLO 
UNIVERSITY OF PADOVA 
DIP. BIOTECHNOLOGIE AGRARIE 
VIA GRADENIGO 6 
I- 35131 PADOVA 
Tel. : 0498071442 
Fax : 0498070517 
O'GARA FERGAL 
UNIVERSITY COLLEGE CORK 
DEPARTMENT OF MICROBIOLOGY 
IRL- 31 CORK 
Tel. : 35321272097 
Telex : 76050 UNIC EI 
Fax : 35321275934 
E-mail: STDM 8008@IRUCCV AX.UCC.IE 
OKKELS FINN 
MARIBO SEED BIOTECHNOLOGY 
DANISCONS 
LANGEBROGADE 1 
DK - 1001 COPENHAGEN 
Tel. : 4531954100 
Telex: 31430 DANSUK DK 
Fax : 4531953022 




P.O. BOX 17 
GB - 1001 COPENHAGEN K 
Tel. : 45319541002210 
Telex: 31430 DANSUK DK 
Fax : 4531953022 
OLIVARES PASCUAL JOSE 
ESTACION EXPERIMENTAL DEL ZAIDIN 
DEPARTAMENTO DE MICROBIOLOGIA 
PROFESOR ALBAREDA 1 
E - 18008 GRANADA 
Tel. : 3458121011 
Fax : 3458129600 
OLIVER STEPHEN 
UNIVERSITY OF MANCHESTER 
INSTITUTE OF SCIENCE AND TECHNOLOGY 
MANCHESTER BIOTECHNOLOGY CENTRE 
P. 0. BOX 88 
SACKVILLE STREET 
GB - MANCHESTER M60 1QD 
Tel. : 44.61.200.4222 
Fax : 44.61.236.0409 
OLIVIERI ANGELO MARIO 
DIPARTIMENTO Dl PRODUZIONE VEGETALE 
E TECNOLOGIE AGRARIE 
FAGAGNA 208 
I - 33100 UDINE 
Tel. : 39432558605 
Fax : 39432558603 
OLSAKER INGRID 
DEPARTMENT OF ANIMAL GENETICS 
NORWEGIAN COLLEGE OF VETERINARY 
MEDICINE 
PO BOX DEP 8146 
N- 0033 OSLO 
Tel. : 4722964779 
Fax : 4722964786 
E-mail: INGRIDO@BIOMED.UIO.NO 
OSBORNE NEVILLE 
NUFFIELD LABORATORY OF 
OPHTHALMOLOGY 
UNIVERSITY OF OXFORD 
WALTON STREET 
GB - OX2 6A W OXFORD 
Tel. : 44865248996 
Fax : 44865794508 
OTTOLENGHI SERGIO 
DIPARTIMENTO DI GENETICA EDI 
BIOLOGIA DEI MICROORGANISMI 
VIA CELORIA 26 
I - 20133 MILANO 
Tel. : 39226605225 
Fax : 3922664551 
OWEN MICHAEL 
LYMPHOCYTE MOLECULAR BIOLOGY 
LABORATORY 
IMPERIAL CANCER RESEARCH FUND 
LINCOLN'S INN FIELDS 44 
PO BOX 123 
GB - WC2A 3PX LONDON 
Tel. : 44712693069 
Fax : 44712693479 
PAGES MONTSERRAT 
DEP. GENETICA MOLECULAR 
315 
CENTRO DE INVESTIGACION Y DESARROLLO 
CONSEJO SUPERIOR DE INVESTIGACIONES 
JORDI GIRONA 18-26 
E - 08034 BARCELONA 
Tel. : 3432040600 
Fax : 3432045904 
PALACIOS FERNANDO 
CONSEJO SUPERIOR DE INVESTIGACIONES CI 
ENTIFICAS 
MUSEO NACIONAL DE CIENCIAS NATURALES 
JOSE GUTIERREZ ABASCAL 2 
E - 28006 MADRID 
Tel. : 34.1.411.1328 
Fax : 34.1.564.5078 
PALME KLAUS 
MAX PLANCK-INSTITUT FOR 
ZUCHTUNGSFORSCHUNG 
CARL-VON-LINNE-WEG 10 
D - W5000 KOLN 30 
Tel. : 492215062280 
Telex : 8 881 028 MPIZ D 
Fax : 492215062213 
PALMGREN MICHAEL 
DEPARTMENT OF PLANT BIOLOGY 
ROYAL VETERINARY AND AGRICULTURAL 
UNIVERSITY 
THORVALDSENSVEJ40 
DK - 1871 FREDERIKSBERG C 
Tel. : 4535282828 
Fax : 4535283310 
316 
PANOPOULOS NICKOLAS 
INSTITUTE OF MOLECULAR BIOLOGY AND 
BIOTECHNOLOGY 
FOUNDATION FOR RESEARCH 
POBOX 1527 
GR- 71110 HERAKLION-CRETE 
Tel. : 3081210091 
Telex : 262896IMBBGR 
Fax : 3081230469 
PANZER! LUCIA 
UNIVERSITA DI MILANO 
DIP ARTIMENTO DI GENETICA E DI 
BIOLOGIA DEI MICRORGANISMI 
26, VIA CELORIA 
I - 20133 MILANO 
Tel. : 39.2.26605218 
Fax : 39.2.2664551 
PAPADOPOULOS GEORGE K. 
LABORATORY OE BIOLOGICAL CHEMISTRY -
MEDICAL SCHOOL 
UNIVERSITY OF IOANNINA 
P.O. BOX 1186 1186 
GR - 451 10 IOANNINA 
Tel. : 3065133442 
Telex : 322160 PNPS GR 
Fax : 3065128388 
PARKER MALCOLM 
MOLECULAR ENDOCRINOLOGY LAB. 
IMPERIAL CANCER RESEARCH FUND 
LINCOLN'S INN FIELDS 44 
PO BOX 123 
GB - WC2A3PX LONDON 
Tel. : 44712693280 
Telex : 265107 ICRF G 
Fax : 44714050190 
PARMEGGIANIANDREA 
ECOLE POL YTECHNIQUE 
LABORATOIRE DE BIOCHIMIE 
CNRS 61840 
F- 91128 PALAISEAU 
Tel. : 33169334180 
Telex : ECOLEX 601596 
Fax : 33169333301 
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PASTORET PAUL-PIERRE 
UNIVERSITE DE LIEGE 
VIROLOGIE-IMMUNOLOGIE 
FACULTE DE MEDECINE VETERINAIRE 
BATIMENT B6 
SARTTILMAN 
B- B 4000 LIEGE 
Tel. : 3241563469 
Fax : 3241563580 
PASZKOWSKI J. 




CH - 8092 ZUERICH 
Tel. : 4112564438 
Fax : 4112529613 
PAULSEN HANS 
INSTITUT FUER ORGANISCHE CHEMIE 
DER UNIVERSITAET HAMBURG 
MARTIN-LUTHER-KING-PLATZ 6 
D - 2000 HAMBURG 
Tel. : 494041232820 
Telex: 214732 UNIHHD 
Fax : 494041233834 
PAZ-ARES JAVIER 
LAB. DE GENETICA MOLECULAR DE 
PLANTAS CENTRO DE INVESTIGACIONES 
BIOLOGICAS 
VELAZQUEZ 144 
E- 28006 MADRID 
Tel. : 3415854214 
Fax : 3415627518 
PEBERDY JOHN 
MICROBIAL BIOCHEMISTRY AND 
GENETICS LABORATORY 
UNIVERSITY OF NOTTINGHAM 
UNIVERSITY PARK 
GB - NG7 2RD NOTTINGHAM 
Tel. : 0602 513231 
Telex : 37346 UNINOT G 
Fax : 0602 513251 
PELICCI PIER GIUSEPPE 
UNIVERSITA DI PERUGIA 
ISTITUTO CLINICA MEDICA I 
POLICLINICO MONTELUCE 
VIA BRUNAMONTI 51 
I- 06100 PERUGIA 
Tel. : 755783255 
Fax : 755783444 
List of participants 
PELLEGRINI GRAZIELLA 
CELLIFE BIOTECNOLOGIE PER LA VITA SRL 
VIALE BENEDETTO XV 10 
I - 16132 GENOVA 
Tel. : 003910355504 
Fax : 003910352999 
PENTTILA MERJA 
VTT BIOTECHNICAL LABORATORY 
PO BOX 202 
SF- 02151 ESPOO 
Tel. : 35804561 
Telex : 122972 VITHA SF 
Fax : 35804552028 
PEREIRA A 
MOLECULAR BIOLOGY DEPARTMENT 
ONDERZOEKINSTITUUT 
KEIJENBERGSEWEG 6 
NL - 6700 AA WAGENINGEN 
Tel. : 31837091911 
Fax : 31837014435 
PEREZ LORENCES ESTER 
DEPARTAMENTO BIOLOGIA VEGETAL 
FACULTAD DE BIOLOGICAS 
DOCTOR MOLlNER 50 
E - 46100 BURJASSOT (VALENCIA) 
Tel. : 3463864634 
Fax : 3463864372 
PEREZ MARTINEZ GASPAR 
INSTITUTO DE AGROQUIMICA Y 
TECNOLOGIA DE ALIMENTOS 
JAIME ROIG 11 
E - 46010 VALENCIA 
Tel. : 3463690800 
Fax : 3463930001 
PEREZ-SUAREZ GONZALO 
UNIVERSIDAD DE ALCALA DE HENARES 
DEPT. BIOLOGIA ANIMAL 
N-11, KM 33.5 
E - 28801 ALCALA DE HENARES 
Tel. : 34.1.885.4967 
Fax : 34.1.885.4953 
PERUCH UGO 
AGRONOMICA S.R.I. CONSORTILE 
PIAZZA LUIGI CARLO FARINI 4 
I- 48100 RAVENNA 
Tel. : 3954435078 
Telex : 551278 AGFERI 
Fax : 39544510082 
PETIT GLATRON MARIE FRANCOISE 
INSTITUT JACQUES MONOD 
317 
LABORATOIRE GENETIQUE ET MEMBRANES 
2 PLACE JUSSIEU 
F- 75251 PARIS 05 
Tel. : 33144276946 
Fax : 33146332305 
PETRE JEAN 
SMITHKLINE BEECHAM BIOLOGICALS 
RUE DE L'INSTITUT 89 
B- B1330 RIXENSART 
Tel. : 3226568444 
Fax : 3226568113 
PENAL VA MIGUEL ANGEL 
LABORATORIO DE GENETICA 
MOLECULAR DE ASPERGILLUS 
CENTRO DE INVESTIGACIONES BIOLOGICAS 
VELAZQUEZ 144 
E - 28006 MADRID 
Tel. : 3415611800 EXT4358 
Fax : 3415627518 
PFLEIDERER WOLFGANG 
UNIVERSITAT KONSTANZ 
FAKULTAT FUR CHEMIE 
D - W7750 KONSTANZ 
PHILIBERT DANIEL 
ROUSSEL UCLAF 
CENTRE DE RECHERCHES 
107 ROUTE DE NOISY 
F- 93230 ROMAINVILLE 
Tel. : 330148914891 
Fax : 33148915949 
PHILIPPSEN PETER 




CH - 4056 BASEL 
Tel. : 41612672140 
Fax : 41612672118 
PHITOS DIMITRIOS 
UNIVERSITY OF PATRAS 
BOTANICAL INSTITUTE 
P ANEPISTIMIOPOULIS 
GR- 26010 PATRAS 
Tel. : 30/61991813 
318 
PICARD JACQUES 
LABORATORY OF DEVELOPMENTAL 
GENETICS 
PLACE CROIX DU SUD 5 
B- 1348 LOUV AIN-LA-NEUVE 
Tel. : 3210473506 
Fax : 3210473109 
PICHLER WERNER 
INSTITUTE OF CLINICAL IMMUNOLOGY 
INSELSPIT AL 
FREIBURGSTRASSE 
CH - 3010 BERN 
Tel. : 4131642285 
Fax : 4131255735 
PLANTA RUDI J. 
VRIJE UNIVERSITEIT, AMSTERDAM 
FACULTEIT SCHEIKUNDE 
LAB. BIOCHEMIE EN MOL.BIOL. 
D BOELELAAN 1083 
NL - 1081 HV AMSTERDAM 
Tel. : 31205485648 
Fax : 31206461479 
PLUCKTHUN ANDREAS 
UNIVERSITY OF ZURICH 
BIOCHEMICAL INSTITUTE 
WINTERTHURER STREET 190 
CH - 8057 ZURICH 
Tel. : 41.1.2575570 
Fax : 41.1.257.57.12 
POCCHIARI MAURIZIO 
LABORATORIO DI VIROLOGIA 
INSTITUTO SUPERIORE DI SANITA 
VIALE REGINA ELENA 299 
I - 00161 ROMA 
Tel. : 3964457888 
Fax : 3964453369 
POHL FRITZ M. 
UNIVERSITAT KONSTANZ 
FAKUTAT FUR BIOLOGIE 
POSTFACH 5600-906 
JAKOB-BURCKHART -STR. 25 
D- 78434 KONSTANZ 
Tel. : 49.7531.882134 
Fax : 49.7531.882134 
POHLTHOMAS 
GATC GMBH 
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GESELLSCHAFT FUR ANAL YSETECHNIK 
UND CONSULTING MBH 
FRITZ-ARNOLD-STR. 23 
D- 78467 KONSTANZ 
Tel. : 49.7531.57209 
Fax : 49.7531.57313 
POPOT JEAN-LUC 
INSTITUT DE BIOLOGIE PHYSICO-CHIMIQUE 
SERVICE DE PHOTOSYNTHESE 
13 RUE PIERRE ET MARIE CURIE 
F- 75005 PARIS 
Tel. : 33143252609 




UNIVERSIT · T TUBINGEN 
AUF DER MORGENSTELLE 28 
D - W7400 TUBINGEN 
Tel. : 497071292080 
Fax : 497071293094 
POSSEE ROBERT 
INSTITUTE OF VIROLOGY AND 
ENVIRONMENTAL MICROBIOLOGY 
MANSFIELD ROAD 
GB - OX1 3SR OXFORD 
Tel. : 44865512361 
Telex : 83147VIROX-G 
Fax : 4486559962 
POUWELS PETER 
MEDICAL BIOLOGICAL LABORATORY 
P.O.BOX45 
NL - 2280 AA RIJSWIJK 
Tel. : 3115842842 
Telex : 38034 PMTNO NL 
Fax : 3115843989 
POZZI GIANNI 
DIPARTIMENTO DI BIOLOGIA MOLECOLARE 
SEZIONE DI MICROBIOLOGIA 
VIA LATERINA 8 
I - 53100 SIENA 
Tel. : 39577280903 
Fax : 3957742011 
List of participants 
PRATSALOME 
CENTRO DE INVESTIGACION Y 
DESARROLLO, C.S.I.C. 
JORGE GIRONA 18-26 
E - 08034 BARCELONA 
Tel. : 3432046851 
Fax : 3432045904 
PRIEUR DANIEL 
CNRS UPR 4601 
STATION BIOLOGIQUE 
PLACE G. TEISSIER 
F- 29680 ROSCOFF 
Tel. : 3398292340 
Fax : 3398292324 
PROCHIANTZ ALAIN 
ECOLE NORMALE SUPERIEUR 
660 46, RUE D'ULM 
F- 75230 PARIS 
Tel. : 33-1-44323712 
Fax : 33-1-44323988 
PROME JEAN-CLAUDE 
LABORATOIRE DE PHARMACOLOGIE ET 
TOXICOLOGIE FONDAMENTALES 
205 ROUTE DE NARBONNE 
F- 31077 TOULOUSE 
Tel. : 3361335845 
Fax : 3361335886 
PUHLER ALFRED 
UNIVERSITXT BIELEFELD 
FAKULTAT FOR BIOLOGIE 
LEHRSTUHL FOR GENETIK 
POSTFACH 100131 
D - W33501 BIELEFELD 
Tel. : 495211065607 
Fax : 495211065626 
PUIGDOMENECH PEDRO 
CENTRO DE INVESTIGACION Y DESARROLLO 
CONSEJO SUPERIOR DE INVESTIGACIONNES 
CIENTIFICAS 
JORDI GIRONA 18 
E - 08034 BARCELONA 
Tel. : 3432040600 
Fax : 3432045904 
PURNELLE BENEDICTE 
UNIVERSITE CATHOLIQUE DE LOUVAIN 
UNITE DE BIOCHIMIE PHYSIOLOGIQUE 
PLACE CROIX DU SUD 2/20 
B- 1348 LOUV AIN-LA-NEUVE 
Tel. : 32.10.473618 
Fax : 32.10.473872 
QUAX WILHELMUS J. 
GIST-BROCADES BV 
POSTBUS 1 
NL - 2600 MA DELFT 
Tel. : 015799111 
Telex : 38103 GBI NL 
Fax : 015793482 
RADBRUCH ANDREAS 
INSTITUT FUER GENETIK 
DER UNIVERSITAET ZU KOELN 
WEYERTAL 121 
D - W5000 KOELN 
Tel. : 492214703409 
Fax : 492214705185 
RAMON VIDAL DANIEL 
319 
INSTITUTO DE AGROQUIMICA Y TECNOLOGIA 
DE LOS ALIMENTOS 
JAIME ROIG 11 
E- 46010 VALENCIA 
Tel. : 3463690800 
Telex: 64197 AYTVE 
Fax : 3463930001 
E-mail: HONGOS8IATA.CSIC.ES 
RAMOS JUAN L. 
ESTACION EXPERIMENTAL DEL ZAIDIN 
PROFESOR ALBAREDA 1 
E - 18008 GRANADA 
Tel. : 3458121011 
Fax : 3458129600 
RANA KRISHEN 
UNIVERSITY OF STIRLING 
INSTITUTE OF AQUACULTURE 
GB - STIRLING FK9 4LA 
Tel. : 44.786.473171 
Fax : 44.786.472133 
RANDO ANDREA 
DIP ARTIMENTO DI SCIENZE DELLE 
PRODUZIONI ANIMALI 
NAZARIO SAURO 85 
I - 85100 POTENZA 
Tel. : 39971474289 
Fax : 39971470719 
RAPOPORT TOM 
MAX-DELBRUCK-CENTER FOR MOLECULAR 
MEDICINE 
ROBERT-ROESSLE-STRASSE 10 
D - 01115 BERLIN-BUCH 
Tel. : 3729462310 




IMMUNOLOGICHE DI SIENA 
VIA FIORENTINA 1 
I - 53100 SIENA 
Tel. : 39577293414 
Telex : 571329 
Fax : 39577293564 
RAY DAVID E. 
MRC TOXICOLOGY UNIT 
LANCASTER ROAD 
GB - LEICESTER LE1 9HN 
Tel. : 44-533-525585 
Fax : 44-533-525616 
REGAN CIARAN 
DEPARTMENT OF PHARMACOLOGY AND 
THERAPEUTICS 
UNIVERSITY COLLEGE DUBLIN 
BELFIELD 
IRL - 4 DUBLIN 
Tel. : 35317061619 
Telex : 32693 EI 
Fax : 35312692749 
REID GORDON 
NORTH OF ENGLAND ZOOLOGICAL SOCIETY 
- ZOOLOGICAL GARDENS 
UPTON 
GB - CHESTER CH2 1LH 
Tel. : 44.244.438.0280 





D - 5000 KOELN 30 
Tel. : 492215062220 
Fax : 492215062213 
RENARD JEAN PAUL 
LABORATOIRE DE BIOLOGIE CELLULAIRE ET 
MOLECULAIRE 
INRA - DO MAINE DE VIL VERT 
F- 78352 JOUY-EN-JOSAS CEDEX 
Tel. : 33134652594 
Fax : 33134652273 
RESKI RALF 
INSTITUT FUER ALLGEMEINE BOTANIK 
OHNHORSTSTRASSE 18 
D - W2000 HAMBURG SL 
Tel. : 494082282295 
Fax : 494082282254 
Catalogue of contracts 
REVILLARD JEAN-PIERRE 
LABORA TOIRE D'IMMUNOLOGIE INSERM 
U.80 
PLACE D' ARSONV AL 
F- 69437 LYON 03 
Tel. : 3378548021 
Fax : 3372330044 
RICCI MARIO 
LABORATORY OF ALLERGOLOGY AND 
CLINICAL 
IMMUNOLOGY, ISTITUTO DI CLINICA MEDICA 
III 
VIALE MORGAGNI 85 
I- 50134 FIRENZE 
Tel. : 3955411155 
Fax : 3955412867 
RICH PETER 
THE GLYNN RESEARCH FOUNDATION LTD 
GLYNN 
GB - PL30 4AU BODMIN 
Tel. : 4420882482 
Fax : 4420882575 
RIESNER DETLEV 
HEINRICH-HEINE UNIV. DUESSELDORF 
INSTITUT FUER PHYSIKALISCHE 
BIOLOGIE 
UNIVERSITAETSSTRASSE 1 
D- W4000 DUESSELDORF 
Tel. : 492113114840 
Fax : 492113115167 
RIGAUD JEAN-LOUIS 
COMMISSARIAT A L'ENERGIE ATOMIQUE 
DEP ARTEMENT BIOLOGIE CELLULAIRE 
ET MOLECULAIRE - SECTION BIOENERGIE 
CEN SACLAY 
BAT. 532 
F- 91191 GIF-SUR-YVETTE CEDEX 
Tel. : 33169082430 
Fax : 33169088717 
RITTER ENRIQUE 
CENTRO DE INVESTIGACION Y MEJORA 
AGRARIA IKT-CIMA-GRANJA MODELO 
APARTADO 46 
E- 01080 VITORIA 
Tel. : 3445281300 
Fax : 3445281422 
List of participants 
ROBILLARD GEORGE 
UNIVERSITY OF GRONINGEN 
GRONINGEN BIOMOLECULAR SCIENCES AND 
BIOTECHNOLOGY (GBB) 
DEPARTMENT OF CHEMISTRY 
NIJENBORGH 4 
NL - 9747 AG GRONINGEN 
Tel. : 3150634321 
Fax : 3150634165 
RODRIGUES-POUSADA CLAUDINA 
INSTITUTO GULBENKIAN DE CleNCIA 
LABORATORIO DE GENETICA MOLECULAR 
RUA DA QUINTA GRANDE 6 
APARTADO 14 
P- 2780 OEIRAS 
Tel. : 351.1.443.5600 
Fax : 351.1.443.1631 
RODRIGUEZ-FARRE EDUARDO 
CONSEJO SUPERIOR DE INVESTIGACIONES 
CIENTIFICAS 
DEPARTMENT OF PHARMACOLOGY & 
TOXICO-
C/ JORDI GIRONA 18-26 
E - 08034 BARCELONA 
Tel. : 3432040600 
Telex : 97977 
Fax : 3432045904 
RODRIGUEZ-NAVARRO ALONSO 
LABORATORIO DE MICROBIOLOGIA 
ESCUELA TECNICA SUPERIOR 
DE INGENIEROS AGRONOMOS 
E - 28040 MADRID 
Tel. : 3415444807 
Fax : 3415434879 
ROGERS MARK 
NATIONAL AGRICULTURAL AND 
VETERINARY 
BIOTECHNOLOGY CENTRE 
UNIVERSITY COLLEGE DUBLIN 
BELFIELD 
IRL - 4 DUBLIN 
Tel. : 35317062083 
Telex : 32693E1 
Fax : 353-317061153 
ROGNE SISSEL 
DEPARTMENT OF ANIMAL SCIENCE 
AGRICULTURAL UNIVERSITY OF NORWAY 
P.O. BOX 25 
N - 1432 AAS-NLH 
Tel. : 479948022 
Fax : 479947960 
321 
ROHMER MICHEL 
LABORATOIRE DE SYNTHESE ORGANIQUE ET 
DE CHIMIE MICROBIENNE 
ECOLE NATIONALE SUPERIEUR£ DE CHIMIE C 
3 RUE ALFRED WERNER 
F- 68093 MULHOUSE CEDEX 
Tel. : 3389427020 
Fax : 3389599859 
ROMAGNANI SERGIO 
CATTEDRA DI ALLERGOLOGIA & 
IMMUNOLO-GIA CLINICA 
ISTITUTO DI CLINICA 
MEDICA III 
VIALE MORGAGNI 85 
I - 50134 FIRENZE 
Tel. : 3955413663 
Fax : 3955412867 
ROMEO PAUL-HENRI 
HOPITAL HENRI MONDOR 
INSERM 
UNITE 91 
F- 94010 CRETEIL 
Tel. : 33149812896 
Fax : 33149812895 
ROSA FREDERIC 
U 368 INSERM 
DEPARTMENT OF BIOLOGY 
ECOLE NORMALE SUPERIEUR£ 
46 RUE D'ULM 
F- 75230 PARIS 05 
Tel. : 3344323607 
Fax : 334432394 
ROSSI MOSE 
DIPARTIMENTO DI CHIMICA ORGANICA E 
BIOLOGICA, UNIVERSITA' DEGLI STUDI DI 
NAPOLI "FEDERICO II" 
VIA MEZZOCANNONE 16 
I - 80134 NAPOLI 
Tel. : 39815521310 
Fax : 39815521217 
ROSSlER JEAN 
INSTITUT ALFRED FESSARD 
CENTRE NATIONAL DE LA 
RECHERCHE SCIENTIFIQUE 
F- 91198 GIF-SUR-YVETTE CEDEX 
Tel. : 33169823436 




BIOCHIMIE ET PHYSIOLOGIE VEGETALES 
INRA 
PLACE-P. VIALA 
F- 34060 MONTPELLIER 1 
Tel. : 3367612707 
Fax : 3367525737 
ROTTMANN OSWALD 
LEHRSTUHL FUR TIERZUCHT 
DER TU MUNCHEN 
D - 8050 FREISING-WEIHENSTEPHAN 
Tel. : 08161713228 
Fax : 08161713107 
ROUGON GENEVIEVE 
UNIVERSITE D'AIX-MARSEILLE II- CNRS 
FACULTE DES SCIENCES DE LUMINY 
BIOLOGIE DE LA DIFFERENCIATION 
CELLULAIRE 
LUMINY CASE 901 
F- 13288 MARSEILLE CEDEX 09 
Tel. : 33.91.269246 
Fax : 33.91.269386 
ROY POLLY 
LABORATORY OF MOLECULAR BIOPHYSICS 
DEPARTMENT OF BIOCHEMISTRY 
UNIVERSITY OF OXFORD 
SOUTH PARKS ROAD 
GB - OXL 3QU OXFORD 
Tel. : 44-865-512361 
Fax : 44-865-59962 
RUFFILLI ANNA 
ISTITUTO INTERNAZIONALE DI GENETICA E 
BIOFISICA 
VIA MARCONI 10 
I - 80125 NAPOLI 
Tel. : 0039817257299 
Fax : 0039815936123 
RUIZ-ARGUESO TOMAS 
ESCUELA TECNICA SUPERIOR DE 
INGENIEROS AGRONOMOS 
LABORATORIO DE MICROBIOLOGIA 
CIUDAD UNIVERSITARIA 
E - 28040 MADRID 
Tel. : 3415444807 
Fax : 3415434879 
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RUSSELL PETER 
DEPARTMENT OF PATHOLOGY 
AND INFECTIOUS DISEASE 
ROYAL VETERINARY COLLEGE 
ROYAL COLLEGE STREET 
GB - LONDON NW1 OTU 
Tel. : 44.71.387.2898 
Fax : 44.71.388.2342 
RUSSO VINCENZO E.A. 
MAX-PLANCK-INSTITUTE 
FUR MOLEKULARE GENETIK 
IHNESTR 73 
D - W1000 BERLIN 
Tel. : 49308307264 











D- 6900 HEIDELBERG 
Tel. : 496221486460 
Telex : 461 505 
Fax : 496221486459 
SALA FRANCESCO 
DIPARTIMENTO DI GENETICA E 
MICROBIOLOGIA- UNIVERSITA DI PAVIA 
VIA ABBIATEGRASSO 207 
I- 27100 PAVIA 
Tel. : 39382391569 





D - W5000 KOLN 
Tel. : 492215062420 
Fax : 402215062413 
List of participants 
SALAS JOSE A. 
UNIVERSIDAD DE OVIEDO 
DEPARTAMENTO DE BIOLOGIA FUNCTIONAL 
AREA DE MICROBIOLOGIA 
JULIAN CLA VERlA SIN 
E - 33006 OVIEDO 
Tel. : 3485103530 
Fax : 3485103354 
E-mail: JASF DWARFI.QUIMICA.UNIOVI.ES 
SALINAS JULIO 
DEPARTAMENTO DE PROTECCION VEGETAL 
CENTRO DE INVESTIGACION Y TECNOLOGIA 
INSTITUTO NACIONAL DE INVESTIGACION 
CARRETERA DE LA CORUNA, KM. 7.5 
E - 28040 MADRID 
Tel. : 3413476890 
Fax : 3413573107 
SAMARUT JACQUES 
ONCOGENESE VIRALE ET DIFFERENCIATION 
CELLULAIRE 
ECOLE NORMALE SUPERIEURE DE LYON 
46 ALLEE D'ITALIE 
F- 69364 LYON 07 
Tel. : 3372728135 
Fax : 3372728080 
SAMPA YO MARIA ANTONIA 
INSTITUTO NACIONAL DE INVESTIG. DAS 
PES CAS 
DEPARTMENT OF OCEANOGRAPHY 
A VENIDA BRASILIA 
P - 1400 LISBOA 
Tel. : +351 1 3016361/368 
Telex : 15857 INIP P 
Fax : +351 1 3015948 
SANCHEZSERRANOJOSEJUAN 
CENTRO DE INVESTIGACIONES BIOLOGICAS 
VELAZQUEZ 144 
E- 28006 MADRID 
Tel. : 3415611800 
Fax : 3415627518 
SANDER CHRIS 
PROTEIN DESIGN GROUP 
EUROPEAN MOLECULAR BIOLOGY 
LABORATORY 
MEYERHOFSTRASSE 
D - W6900 HEIDELBERG 
Tel. : 496221387361 
Fax : 496221387306 
E-mail: SANDER@EMBL-HEIDELBERG.DE 
SANDERS DALE 
DEPARTMENT OF BIOLOGY 
UNIVERSITY OF YORK 
HESLINGTON 
GB - Y01 5DD YORK 
Tel. : 44904432825 
Telex : 57933 YORKUL 




FAKULTAET FUER BIOLOGIE 
P.O. BOX 5560 
D- W7750 KONSTANZ 
Tel. : 497531883668 
Fax : 497531883042 
SANSONETTI PHILIPPE 
UNITE DE PATHOGENIE MICROBIENNE 
MOLECULAIRE 
INSERM U199 
28 RUE DU DOCTEUR ROUX 
F- 75724 PARIS 15 
Tel. : 33145688342 
Fax : 33145688953 
SANTISTEBAN PILAR 
INSTITUTO DE INVESTIGACIONES 
BIOMEDICAS - C.S.I.C. 
ARTURO DUPERIER 4 
E - 28029 MADRID 
Tel. : 3415854082 




CONSORZIO INTERUNIVERSITARIO PER LE 
BIOTECNOLOGIE 
PADRICIANO 99 
I - 34012 TRIESTE 
Tel. : 3940398992 
Fax : 3940398979 
SANTOS HELENA 
CENTRO DE TECNOLOGIA QUIMICA E 
BIOLGGICA 
RUA DA QUINTA GRANDE 6 
APARTADO 127 
P- 2780 OEIRAS 
Tel. : 35114426246 
Fax : 35114428766 
324 
SARTHOU JEAN-LOUIS 
INSTITUT PASTEUR DE DAKAR 
UNITE D'IMMUNOLOGIE I EPIDEMIOLOGIE 
B.P 220 
SN- DAKAR 
Tel. : 221235181 
Telex: 221 61241 PASTEUR 
Fax : 221238772 
SARVAS MATTI 
NATIONAL PUBLIC HEALTH INSTITUTE 
MANNERHEIMINTIE 166 
SF- 00300 HELSINKI 
Tel. : 35804744241 
Fax : 35804744238 
E-mail: MSARVAS@NPHI.FI 
SCANDURRA ROBERTO 
DIPARTIMENTO SCIENZE BIOCHIMICHE 
"A.ROSSI-FANELLI" 
UNIVERSITA"'LA SAPIENZA" 
P.LE A.MORO 5 
I - 00185 ROMA 
Tel. : 39649910947 
Fax : 3964440062 
SCARCEZ THIERRY 
INNOGENETICS 
INDUSTRIEP ARK ZWIJNAARDE 7 
BOX4 
B- 9052 GENT 
Tel. : 32.91.410711 
Fax : 32.91.410799 
SCAZZOCCHIO CLAUDIO 
INSTITUT DE GENETIQUE ET MICROBIOLOGIE 
UPS BATIMENT 409 
CENTRE D'ORSA Y 
15 GEORGES CLEMENCEAU 
F- 91405 ORSA Y CEDEX 
Tel. : 33169416356 
Fax : 33169417808 
SCHACHNER MELITTA 
SWISS FEDERAL INSTITUTE OF TECHNOLOGY 
DEPARTMENT OF NEUROBIOLOGY 
HUNGGERBERG 
CH - 8093 ZURICH 
Tel. : 41.1.3773396 
Fax : 41.1.3710235 
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SCHAFER GUNTER 
INSTITUTE OF BIOCHEMISTRY 
MEDICAL UNIVERSITY OF LUBECK 
RATZEBURGER ALLEE 160 
D - W2400 LUBECK 
Tel. : 494515004060 
Fax : 494515004068 
SCHARTL MANFRED 




D - W8700 WORZBURG 
Tel. : 499318884148 
Fax : 499318884150 
SCHEFFER RUDOLF 
ZAADUNIE B.V. 
P.O. BOX 26 
NL - 1600AA ENKUIZEN 
Tel. : 31228066235 
Telex : 57053 SG NL 





D - W5000 KOELN 
Tel. : 02215062200 
Fax : 02215062213 
SCHLEIFER KARL-HEINZ 
TECHNISCHE UNIVERSITAT MUNCHEN 




D - W8046 GARCHING BEl MUNCHEN 
SCHLEUNING WOLF-DIETER 
SCHERING AG 
INST. OF CELLULAR AND MOLECULAR 
BIOLOGY 
MULLERSTR. 170-178 
D - WlOOO BERLIN 65 
Tel. : 49304681390 
Fax : 493046916707 
List of participants 
SCHLOSSHAUER BURKHARD 
NATURWISSENSCHAFfLICHES UND 
MEDIZINISCHES INSTITUT AN DER 
UNIVERSITAT TUBINGEN 
GUSTAV-WERNER-STRASSE 3 
D - W7410 REUTLINGEN 
Tel. : 49712131980 
Fax : 497121319816 
SCHOELER HANS 
EUROPEAN MOLECULAR BIOLOGY 
LABORATORY 
MEYERHOFSTRASSE 1 
POSTFACH 10 2209 
D - W6900 HEIDELBERG 
Tel. : 496221387550 
Telex : 461613 EMBL D) 




LEHRSTUHL ALLGEMEINE GENETIK 
AUF DER MORGENSTELLE 28 
D - W7400 TUEBINGEN 
Tel. : 497071292076 




INSTITUT FOR FORSTGENETIK 
BUNDESFORSCHUNGSANSTALT FOR 
FORST-UND HOLZWIRTSCHAFT 
SIEKER LANDSTRASSE 2 
D - 2070 GROSSHANSDORF 
Tel. : 49410261079 
Fax : 49410262981 
SCHONHEIT PETER 
INSTITUTE FOR PFLANZENPHYSIOLOGIE 
UND MIKROBIOLOGIE 
FREIE UNIVERSITAT BERLIN 
KONIGIN-LUISE-STRASSE 12-16A 
D - W 1000 BERLIN 3 
Tel. : 0308383116 
Fax : 0308383118 
325 
SCHOTS ARJEN 
WAGENINGEN AGRICULTURAL UNIVERSITY 
DEPARTMENT OF NEMATOLOGY 
LABORATORY FOR MONOCLONAL 
P.O. BOX 9060 
NL - 6700 GW WAGENINGEN 
Tel. : 31837076214 
Fax : 31837010113 
E-mail: ARJEN.SCHOTS@IPO.AGRO.NL 
SCHOUSBOE ARNE 
DEPARTMENT OF BIOLOGY 
ROYAL DANISH SCHOOL OF PHARMACY 
UNIVERSITETSP ARKEN 2 
DK - DK2100 KOBENHA VN 
Tel. : 4535370850 
Fax : 4535375744 
SCHREMPF HILDGUND 
UNIVERSITY OSNABROCK 
FB BIOLOGIE CHEMIE 
BARBARASTR. 11 
D - W4500 OSNABRUCK 
Tel. : 05419692895 
Fax : 05419692804 
SCHROEDER RENEE 
INSTITUT FOR MIKROBIOLOGIE UND 
GENETIK 
UNIVERSITAT WIEN 
DR. BOHR-GASSE 9 
A-1030 WIEN 
Tel. : 43.1.79515 4609 






D - W8580 BAYREUTH 
Tel. : 49921552570 




PO BOX 101251 
D - W 8580 BAYREUTH 
Tel. : 921552708 







ABTEILUNG MOLEKULARBIOLOGIE DER 
ZELLE 
IM NEUENHEIMER FELD 280 
D - W6900 HEIDELBERG 
Tel. : 00496221423411 
Telex : 461 562 DKFZ D 





D - W5000 COLOGNE 
Tel. : 492215062140 
Fax : 492215062113 
SCHWEIZER MICHAEL 
AFRC INSTITUTE OF FOOD RESEARCH 
GENETICS AND MICROBIOLOGY DEPT. 
NORWICH RESEARCH PARK COLNEY 
GB - NORWICH NR4 7UA 
Tel. : 44.603.56122 
Fax : 44.603.58414 
SCHWENGER BARBARA 
INSTITUT FUER TIERZUCHT UND 
VERERBUNGSFORSCHUNG. 
BUENTEWEG 17P 
D - 3000 HANNOVER 
Tel. : 495119538875 




DEPARTMENT OF MOLECULAR BIOLOGY 
RESEARCH INSTITUTE FOR BIOLOGY OF 
FARM ANIMALS 
W.-STAHL-ALLEE 2 
D- 2551 DUMMERSTORF 
Tel. : 49382087209 
Telex : 3LL04FZDZ 
Fax : 49382087209 
SEBERG OLE 
KOBENHA VNS UNIVERSITET 
BOTANICAL LABORATORY 
GOTHERSGADE 140 
DK - 1123 KOBENHA VN K 
Tel. : 45.33114690 
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SEIFART KLAUS 




D - W3550 MARBURG 
Tel. : 496421285013 
Fax : 496421285390 
SEIFERT WILFRIED 
MAX-PLANCK-INSTITUT FUR BIOPHYSIKAL 
CHEMIE 
AM FASSBERG, POSTFACH 2841 
D - 3400 GOTTINGEN 
Tel. : 49551201678 
Fax : 49551201222 




AUF DER MORGENSTELLE 1 
D - 7400 TUBINGEN 
Tel. : 497071296159 
Fax : 497071293287 
SENTENAC ANDRE 
COMMISSARIAT A L'ENERGIE ATOMIQUE 
-DSVDBCM-
SERVICE DE BIOCHIMIE ET DE GENETIQUE 
MOLECULAIRE 
CENTRE D'ETUDES DE SACLA Y 
F- 91191 GIF SUR YVETTE CEDEX 
Tel. : 33169082236 
Fax : 33169084712 
SENTENAC HERVE 
BIOCHIMIE ET PHYSIOLOGIE VEGETALES 
INRA-ENSA 
F- 34060 MONTPELLIER 1 
Tel. : 3367612605 
Fax : 3367525737 
SEPULVEDA FRANCISCO 
AFRC INSTITUTE OF ANIMAL PHYSIOLOGY 
AND GENETICS RESEARCH 
BABRAHAM HALL 
GB- CB2 4AT CAMBRIDGE 
Tel. : 44223832312 
Fax : 44223837912 
E-mail: SEPULVEDA@UK.AC.AFRC.IAPC 
List of participants 
SERRANO RAMON 
UNIVERSIDAD POLITECNICA DE VALENCIA 
LABORATORIO DE BIOLOGIA MOLECULAR 
DEPARTAMENTO DE BIOTECNOLOGIA 
UNIVERSIDAD POLITECNICA 
CAMINO DE VERA 14 
E - 46022 VALENCIA 
Tel. : 3463877425 
Fax : 3463877429 
SHARP RICHARD JAMES 
PUBLIC HEALTH LABORATORY SERVICE 
CENTRE FOR APPLIED MICROBIOLOGY 
AND RESEARCH 
GB- SP4 OJG SALISBURY 
Tel. : 44980610391 
Telex : 47683 PHCAMR G) 
Fax : 44980611320 
SIMOES DA COSTA MILTON 
CENTRO DE BIOLOGIA CELULAR 
DEPARTAMENTO DE ZOOLOGIA 
UNIVERSDADE DE COIMBRA 
LARGO MARQUES DE POMBAL 
P - 3049 COIMBRA CEDEX 
Tel. : 3513934729 
Fax : 3513935812 




D - W7800 FREIBURG 
Tel. : 497615108433 
Fax : 497615108431 
SIMON REINHARD 
GENTECHNISCHES LABOR DES 
TUV SUDWEST, FACHBEREICH 
ENERGIETECHNIK UND UMWELTSCHUTZ 
ROBERT-BUNSEN-STR. 1 
D - W7800 FREIBURG 
Tel. : 49761506061 
Fax : 497615143622 
SJOEHOLM CARSTEN 




DK - 2880 BAGSV AERD 
SKIDMORE CHRISTOPHER 
DEPARTMENT OF BIOCHEMISTRY 
AND PHYSIOLOGY 
SCHOOL OF ANIMAL AND MICROBIAL 
AMS BUILDING 228 
WHITE KNIGHTS 
GB - RG6 2AJ READING : 
Tel. : 44734318012 
Telex : 847813 
Fax : 44734310180 
E-mail: SASSKIDM@CMS.AM.RDG.AC.UK 
SLONIMSKI PIOTR 
CENTRE NATIONAL DE LA RECHERCHE 
SCIENTIFIQUE 
CENTRE DE GENETIQUE MOLECULAIRE 
(GENOMES ET FONCTIONS) 
A VENUE DE LA TERRASSE 
F- 91198 GIF-SUR-YVETTE 
E-mail: SLONIMSKI FRGMSI.BITNET 
SMALLA KORNELIA 
327 
BIOLOGISCHE BUNDESANSTALT FUR LAND-
UND FORSTWIRTSCHAFT, INSTITUT FUR 
MESSEWEG 11-12 
D - W3300 BRAUNSCHWEIG 
Tel. : 495312990000 
Fax : 495312993000 
SMEEKENS JOSEPH 
UNIVERSITY OF UTRECHT 
DEPARTMENT OF MOLECULAR CELL 
BIOLOGY 
PADUALAAN 8 
NL - 3584 CH UTRECHT 
Tel. : 3130533184 
Fax : 3130513655 
E-mail: WBTMCBW@ACCUCX.CC.RUU.NL 
SMITH HARRY 
UNIVERSITY OF LEICESTER 
UNIVERSITY ROAD 
GB - LEI 7RH LEICESTER 
Tel. : 0533523381 
Fax : 0533522791 
SMITH JAMES 




GB - NW 7IAA LONDON 
Tel. : 44819523666 
Fax : 44819064477 
328 
SOLOMON ELLEN 
IMPERIAL CANCER RESEARCH FUND 
SOMATIC CELL GENETICS 
LINCOLN'S INN FIELDS 44 
PO BOX 123 
GB - WC2A 3PX LONDON 
Tel. : 44712693426 
Fax : 44718316786 
E-mail: E-SOLOMON OUK.AC.ICRF 
SONNEWALD UWE 
INSTITUT FUR PFLANZENGENETIK UND 
KULTURPFLANZENFORSCHUNG 
CORRENSSTRASSE 3 
D- 04325 GATERSLEBEN 
Tel. : 455925214 
Fax : 45592280 
SOR FREDERIC 
INSTITUT CURIE 
SECTION DE BIOLOGIE 
BaTIMENT 110 
F- 91405 ORSA Y 
Tel. : 33.1.6986.3060 
Fax : 33.1.6986.9429 
SOUCIET JEAN-LUC 
UNIVERSITE LOUIS PASTEUR & CENTRE 
NATIONAL DE 
LA RECHERCHE SCIENTIFIQUE 
URA-GEM 1481 
15 RUE RENE DESCARTES 
F- 67000 STRASBOURG 
Tel. : 33.88.41.70.39 
Fax : 33.88.61.06.80 
SOULILLOU JEAN-PAUL 
INSTITUT DE TRANSPLANTATION ET DE 
RECHERCHE EN TRANSPLANTATION (ITERT) 
9 INSERM U211 - INSTITUT DE BIOLOGIE 
QUAI MONCOUSU 
F- 44035 NANTES 01 
Tel. : 3340084747 
Fax : 3340356697 
SPEZIA FRANCOIS 
ROUSSEL UCLAF GROUP 
RESEARCH CENTER 
102 ROUTE DE NOISY 
F- 93230 ROMAINVILLE 
Tel. : 33148914253 
Telex : 235 477 F 
Fax : 33148914860 
SREENAN JOSEPH 
TEAGASC 
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AGRICULTURE AND FOOD DEVELOPMENT 
AUTHORITY 
BELCLARE 
IRL- 31 TUAM, CO. GALWAY 
Tel. : 3539355455 





NL - 2333 LEIDEN 
Tel. : 31.71.274.947 




S - 15185 SOEDERTAEUE 
Tel. : 46855326000 
Telex : 19237 
Fax : 46855328823 
STETTER KARL OTTO 
INSTITUT FUR BIOCHEMIE, GENETIK UND 
MIKROBIOLOGIE 
LEHRSTUHL FUR MIKROBIOLOGIE 
UNIVERSITAT REGENSBURG 31 
UNIVERSITATSSTRASSE 
D - W8400 REGENSBURG 
Tel. : 00499419433160 
Telex : 65658 UNIRE D 
Fax : 00499419432403 
STIEKEMA WILLEM 
CENTRE FOR PLANT BREEDING AND 
REPRODUCTION RESEARCH 
C.P.R.O. - D.L.O. 
DROEVENDAALSESTEEG16 
NL - 6700 AA WAGENINGEN 
Tel. : 31837077130 
Fax : 31837016513 
STIRLING COLIN 
DEPARTMENT OF BIOCHEMISTRY AND 
MOLECULAR BIOLOGY 
THE VICTORIA UNIVERSITY OF 
OXFORD ROAD 
GB - M13 9PT MANCHESTER 
Tel. : 44612755104 
Fax : 44612755082 
List of participants 
STITT MARK 
BOTANISCHES INSTITUT DER UNIVERSIT-T 
HEIDELBERG 
IM NEUENHEIMER FELD 360 
D - W6900 HEIDELBERG 
Tel. : 496221563284 
Fax : 496221565859 
STOUGAARD JENS 
DEPARTMENT OF MOLECULAR BIOLOGY 
LABORATORY OF GENE EXPRESSION 
UNIVERSITY OF AARHUS 
GUSTAV WIEDSVEJ 10 
DK - 8000 AARHUS C 
Tel. : 4586202000 
Fax : 4586201222 
SUNDQUIST BO 
NATIONAL VETERINARY INSTITUTE 
DIVISION OF VACCINE RESEARCH 
BOX 7073 
S - S75007 UPPSALA 
Tel. : 4618674000 
Telex : 7623 SV A VETS 
Fax : 4618674376 
TABLER MARTIN 
FOUNDATION FOR RESEARCH AND 
TECHNOLOGY 
INSTITUTE OF MOLECULAR BIOLOGY 
PO BOX 1527 





D - W8000 MUNCHEN 
Tel. : 49895902529 
Fax : 49895902450 
TEIXEIRA MIGUEL 
CENTRO DE TECNOLOGIA QUIMICA E 
BIOLOGICA 
RUA DA QUINTA GRANDE 6 
APT. 127 
P - 2780 OEIRAS 
Tel. : 35114426146 




CONSORZIO PER LA BIOLOGIA MOLECOLARE 
DELLE PlANTE 
SEZ. DI PADOVA, DIP.DI BIOLOGIA 
TRIESTE 75 
I- 35121 PADOVA 
Tel. : 39498286285 
Fax : 39498286261 
E-mail: TERZI @ HP800.BIO.UNIPD.IT 
THOMAS BRIAN 




GB - BN16 BN17 WEST SUSSEX 
Tel. : 0903716123 




AM BOTANISCHEN GARTEN 1-9 
D - W2300 KIEL 
Tel. : 494318804334 





D - W5000 KOLN 
Tel. : 492215062440 
Telex : 8 881 028 MPIZ D 
Fax : 492215062413 
THOMSON ANDREW 
SCHOOL OF CHEMICAL SCIENCES 
UNIVERSITY OF EAST ANGLIA 
GB - NR4 7TJ NORWICH 
Tel. : 44603592023 
Telex : 975197 
Fax : 44603259396 
THORNTON JANET 
BIOMOLECUL. STRUCTURE & MODELLING 
UNIT 
BIOCHEMISTRY & MOLECULAR BIOLOGY 
DEPT. 
UNIVERSITY COLLEGE LONDON 
GOWER STREET 
GB - WC1E 6BT LONDON 
Tel. : 44713807048 
Fax : 44713807193 
E-mail: THORNTON@UK.AC.UCL.BIOC.BSM 
330 
TIMMIS KENNETII N. 
GESELLSCHAFf FUR BIOTECHNOLOGISCHE 
FORSCHUNG 
DEPARTMENT OF MICROBIOLOGY 
MASCHERODER WEG 1 
D - W3300 BRAUNSCHWEIG 
Tel. : 495316181400 
Telex : 952667 GEBIOD 
Fax : 495316181411 
TINDALL BRIAN 
DSM-DEUTSCHE SAMMLUNG VON 
MIKROORGANISMEN UND ZELLKULTUREN 
GMBH 
MASCHERODER WEG LB 
D - W3300 BRAUNSCHWEIG 
Tel. : 053161870 
Fax : 0531618718 
E-mail: 10075:DB10225 
TIRABY GERARD 
LABORATOIRE DE MICROBIOLOGIE 
UNIVERSITE PAUL SABATIER 
118 ROUTE DE NARBONNE 
F- 31062 TOULOUSE 
Tel. : 61556735 
Fax : 61335886 
TODD GORDON 
BRITISH SUGAR TECHNICAL CENTRE 
NORWICH RESEARCH PARK 
COLNEY 
GB - NR4 7UB NORWICH 
Tel. : 44603250000 
Telex : 32149 
Fax : 4460355874 
TONELLI CHIARA 
UNIVERSITA DEGLI STUDI DI MILANO 
DIPARTIMENTO DI GENETICA E DI BIOLOGIA 
DEI MICRORGANISMI 
VIA CELORIA 26 
I - 20133 MILANO 
Tel. : 39226605210 
Fax : 3922664551 
E-mail: TONELLI AT MIUCCA.CSI.UNIMI.IT 
TORO GARCIA NICOLAS 
ESTACION EXPERIMENTAL DEL ZAIDIN 
DEPARTAMENTO DE MICROBIOLOGIA 
PROFESOR ALBAREDA 1 
E - 18008 GRANADA 
Tel. : 3458121011 
Fax : 3458129600 
Catalogue of contracts 
TORRES MARTINEZ SANTIAGO 
DEPARTAMENTO DE GENETICA 
Y MICROBIOLOGIA 
FACULTAD DE BIOLOGIA 
E - 30071 MURCIA 
Tel. : 3468833000 
Fax : 3468835418 
TOVEY MICHAEL 
LABORATOIRE ONCOLOGIE VIRALE (UPR274) 
CENTRE NATIONAL RECHERCHE 
SCIENTIFIQUE 
7 GUY MOCQUET 
F- 94801 VILLEJUIF 
Tel. : 33147264658 
Fax : 33147267602 
TREES ALEXANDER 
LIVERPOOL SCHOOL OF TROPICAL MEDICINE 
POMBROKE PLACE 
GB - L3 SQA LIVERPOOL 
Tel. : 44517089393 
Fax : 44517088733 
TROYE BLOMBERG MARITA 
DEPARTMENT OF IMMUNOLOGY 
STOCKHOLM UNIVERSITY 
S- 10691 STOCKHOLM 
Tel. : 468164164 
Fax : 468157356 
TSAFTARIS ATIIANASIOS 
UNIVERSITY OF TIIESSALONIKI 
DEPARTMENT OF GENETICS AND PLANT 
BREEDING 
GR - 54006 TRESSALONIKI 
Tel. : 3031992547 
Fax : 3031200392 
TSAGRI EFTIIIMIA 
BIOTECHNOLOGY -FOUNDATION FOR 
RESEARCH AND TECHNOLOGY 
INSTITUTE OF MOLECULAR BIOLOGY /BIOTEC. 
PO BOX 1527 
GR - 711 10 HERAKLION CRETE 
TSCHAPE HELMUT 
ROBERT KOCH INSTITUTE BEREICH 
WERNIGERODE 
LABORATORY OF MOLECULAR 
EPIDEMIOLOGY 
BURGSTRASSE 37 37 
D - W3700 WERNIGERODE 
Tel. : 49303790 
Fax : 4930379207 
List of participants 
UHLEN MATHIAS 
DEPARTMENT OF BIOCHEMISTRY AND 
BIOTECHNOLOGY 
ROYAL INSTITUTE OF TECHNOLOGY 
TEKNIKRINGEN 30-34 
S - 100 44 STOCKHOLM 
Tel. : 4687908792 
Fax : 468245452 
UNWIN NIGEL 
MEDICAL RESEARCH COUNCIL 
LABORATORY OF MOLECULAR BIOLOGY 
HILLS ROAD 
GB - CB2 2QH CAMBRIDGE 
Tel. : 44223402410 
Fax : 44223213556 
URBAIN JAQUES 
LABORATOIRE DE PHISICOLOGIE ANIMALE, 
ULB 
DEPARTEMENT DE BIOLOGIE MOLECULAIRE 
RUE DES CHEVAUX 67 
B- 1640 RHODE-ST-GENESE 
Tel. : 3226509852 
Fax : 3226509840 
URRESTARAZU ANTONIO 
UNIVERSITE LIBRE DE BRUXELLES 
PHYSIOLOGIE CELLULAIRE ET GENETIQUE 
DES LEVURES 
CAMPUS DE LA PLAINE 
BLD. DU TRIOMPHE - CP244 
B- 1050 BRUXELLES 
Tel. : 02.6505.416 
Fax : 02.6505.421 
VALDES BENITO 
UNIVERSIDAD DE SEVILLA 
DEPARTAMENTO DE BIOLOGIA VEGETALE Y 
EC OLOGIA 
APARTADO 1095 
E - 41080 SEVILLA 
Tel. : +34 5 4626308 
VALLE GIORGIO 
UNIVERSITY OF P ADO VA 
DEPARTMENT OF BIOLOGY 
CELLULAR BIOLOGY 
VIA TRIESTE 75 
I- 35121 PADOVA 
Tel. : 39.498286270 
Fax : 39.4982866261 
331 
VAN DE WEGHE ALEX 
FACULTY OF VETERINARY MEDICINE 
DEPARTMENT OF ANIMAL GENETICS AND. 
BREEDING 
HEIDESTRAAT 19 
B- 9820 MERELBEKE 
Tel. : 3291521941 
Fax : 3291525304 
VAN DEN ELZEN P.J.M. 
LABORATORY OF MOLECULAR BIOLOGY 
MOGEN INTERNATIONAL NV 
EINSTEINWEG 97 
NL - 2333 CB LEIDEN 
Tel. : 3171258282 
Fax : 3171221471 
VAN DEN HONDEL CEES 
MEDICAL BIOLOGICAL LABORATORY 
P.O. BOX 45 
NL - 2280 AA RIJSWIJK 
Tel. : 3115842842 
Telex : 38034 PMTNO NL 
Fax : 3115843989 
E-mail: V ANDENHONDEL@MBL.TNO.NL 




NL - 3740 AG BAARN 
Tel. : 31.2154.81238 
Fax : 31.2154.16142 
VAN DER WEERDEN GERARD M. 
KATHOLIEKE UNIVERSITEIT NIJMEGEN 
TOERNOOIVELD 
NL - 6525 ED NIJMEGEN 
Tel. : 31.8065.2883 
Tel. : 31.8065.2751/2761 
Telex : 48228 WINA NL 
Fax : 624001@HNYKUN11 
VAN ELSAS JAN DIRK 
SOIL BIOTECHNOLOGY GROUP IB-DLO 
IPO-DLO 
PO BOX 9060 
NL - 6700 GW WAGENINGEN 
Tel. : 31.8370.76210 
Fax : 31.8370.10113 
332 
VAN HEERIKHUIZEN HARM 
VRIJE UNIVERSITEIT, AMSTERDAM 
FACULTEIT SCHEIKUNDE 
LAB. BIOCHEMIE EN MOL. BIOLOGIE 
D BOELELAAN 1083 
NL - 1081 HV AMSTERDAM 
Tel. : 31205485659 
Fax : 31206461479 
E-mail: VHEERIK@CHEM.VU.NL 
VAN LOVEREN HENK 
NATIONAL INSTITUTE FOR PUBLIC HEALTH 
AND ENVIRONMENTAL PROTECTION 
ANTONIE VAN LEEUWENHOEKLAAN 9 
NL - 3720 BA BILTHOVEN 
Tel. : 3130742476 
Fax : 3130285283 
VAN MEER GERRIT 
UNIVERSITY OF UTRECHT 
DEPT. CELL BIOLOGY 
MEDICAL SCHOOL 
AZU H02.314 
NL - 3584 CX UTRECHT 
Tel. : 3130506480 
Fax : 3130541797 
VAN MONTAGU M. 
LABORATORIUM VOOR GENETICA 
RIJKSUNIVERSITEIT GENT 
K.L. LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3291645170 
Telex : 11995GENGENB 
Fax : 3291645349 
E-mail: JECOP@GENGENP.RUG.AC.BE 
VAN OIRSCHOT JAN T. 
DLO-CENTRAL VETERINARY INSTITUTE 
P.O. BOX 65 
NL- 8200 AB LELYSTAD 
Tel. : 0320073308 
Telex : 40227 CDI NL 
Fax : 0320073473 
VAN ROOIJEN NICO 
DEPARTMENT OF CELLBIOLOGY 
MEDICAL FACULTY 
VRIJE UNIVERSITEIT 
VAN DER BOECHORSTSTRAAT 7 
NL - 1081 BT AMSTERDAM 
Tel. : 31205482717 
Fax : 31206462228 
Catalogue of contracts 
VAN WIJNENDAELE FRANS 
INNOGENETICS N.V. 
INDUSTRIEPARK ZWIJNAARDE 7/4 
B- 9052 GENT 
Tel. : 32-9-2410711 
Fax : 32-9-2410799 
V ANDERLEYDEN JOS 
F.A. JANSSENS LABORATORIUM VOOR 
GENETICA 
FACULTEIT LANDBOUWWETENSCHAPPEN 
WILLEM DE CROYLAAN 42 
B- 3001 HEVERLEE 
Tel. : 3216220921 
Telex: 25941 ELEKUL B 
Fax : 3216220761 
E-mail: KIAAA31 A BLEKUL21 
V ARVIO SIRKKA-LIISA 
DEPARTMENT OF GENETICS 
UNIVERSITY OF HELSINKI 
ARKADIANKATU 7 
SF- 00100 HELSINKI 
Tel. : 35801917360 
Fax : 35801917376 
E-mail: SIRKKA-LIISA. V ARVIOATHELSINKI.FI 
VAZQUEZ ANA M. 
DEPARTAMENTO DE GENETICA 
FACULTAD DE BIOLOGIA 
UNIVERSIDAD COMPLUTENSE 
CIUDAD UNIVERSITARIA SIN 
E - 28040 MADRID 
Tel. : 3413941633 
Fax : 3413941638 
VEENHUIS MARTEN 
LABORATORY FOR ELECTRON MICROSCOPY 
KERKLAAN30 
NL - 7750 NN HAREN 
Tel. : 3150632176 
Fax : 3150635205 
VENDRAMIN GIOVANNI GIUSEPPE 
ISTITUTO MIGLIORAMENTO GENETICO 
PlANTE FORESTALl 
SAN BONA VENTURA 13 
I - 50145 FIRENZE 
Tel. : 3955311069 
Fax : 3955319413 
List of participants 
VENIS MICHAEL 
HORTICULTURE RESEARCH INTERNATIONAL 
EAST MALLING 
GB - ME19 6BJ WEST MALLING 
Tel. : 44732843833 
Fax : 44732849067 
VENTOSA ANTONIO 
DEPARTAMENTO DE MICROBIOLOGIA Y 
P ARASITOLOGIA 
FACULTAD DE FARMACIA 
PROFESOR GARCIA GONZALEZ SIN 
E- 41012 SEVILLA 
Tel. : 3454556765 
Fax : 3454628162 
VERSTRAETE WILLY 
UNIVERSITY OF GHENT 
LABORATORY OF MICROBIAL ECOLOGY 
COUPURE L 653 
B- 9000 GENT 
Tel. : 3291645976 
Fax : 3291646248 
E-mail: LME @FLAND.RUG.AC.BE 
VICENTE MIGUEL 
CENTRO DE INVESTIGACIONES BIOLOGICAS 
CSIC 
VELAZQUEZ 144 
E - 28006 MADRID 
Tel. : 3415611800 
Fax : 3415627518 
VICENTE ANTON JOSE SALVADOR 
UNIDAD DE FISIOLOGIA, DEPARTAMENTO 
CIENCIA ANIMAL 
UNIVERSIDAD POLITECNICA. 
CAMINO DE VERA 14 
E - 46071 VALENCIA 22012 
Tel. : 3463877433 
Fax : 3463877439 
VINCENT JEAN-DIDIER 
INSTITUT ALFRED FESSARD CNRS 
1, A VENUE DE LA TERRASSE 
F- 91198 GIF-SUR-YVETTE 
Tel. : 33.1.69823434 
Fax : 33.1.69070538 
VISSER JAAP 
DEPT. OF GENETICS, SECTION OF 
MOLECULAR GENETICS 
333 
WAGENINGEN AGRICULTURAL UNIVERSITY 
DREIJENLAAN 2 
NL - 6703 HA WAGENINGEN 
Tel. : 31837082865 
Fax : 31837084011 
VISSER RICHARD 
WAGENINGEN AGRICULTURAL UNIVERSITY 
DEPARTMENT OF PLANT BREEDING 
PO BOX 386 
NL - 6700 AJ WAGENINGEN 
Tel. : 31837082836 
Fax : 31837083457 
VLIEGENTHART JOHANNES 
BIJVOET CENTER FOR BIOMOLECULAR 
RESEARCH 
P.O.BOX 80.075 
NL - 3584 CH UTRECHT 
Tel. : 3130532184 
Fax : 3130540980 
VOIGT MARK 
NATIONAL AGRICULTURAL & VETERINARY 
BIOTECHNOLOGY CENTRE, 
UNIVERSITY COLLEGE DUBLIN 
BELFIELD 
IRL - 4 DUBLIN 
Tel. : 35317062214 
Telex : 32693 El 
Fax : 35312692016 
VOLCKAERT GUIDO 
UNIVERSITY OF LEUVEN 
LABORATORY OF GENE TECHNOLOGY 
WILLEM DE CROYLAAN 42 
B- 3001 LEUVEN 
Tel. : 016.286611 
Fax : 016.220761 




F- 75231 PARIS CEDEX 05 
Tel. : 33.1.40.51.6632 
Fax : 33.1.40.51.6674 
334 
VONBOTHMERROLAND 
SWEDISH UNIVERSITY OF AGRICULTURAL 
SCIENCES 
S- 75007 UPPSALA 
Tel. : 46.186.71022 
Telex : 76942 AGRUNIS 
Fax : 46.183.01553 
VON WETTSTEIN DITER 
CARLSBERG LABORATORY 
DEPARTMENT OF PHYSIOLOGY 
GAMLE CARLSBERG VEG 10 
DK - 2500 COPENHAGEN V ALBY 
Tel. : 45.31.22.10.22 
Fax : 45.33.27.47.66 
VOS PIETER 
KEYGENE N.V. 
P.O. BOX 216 
NL - 6700 AE WAGENINGEN 
Tel. : 31837024141 
Fax : 31837024939 
VOSMANBEN 
CENTRE FOR PLANT BREEDING AND 
REPRODUCTION RESEARCH - DLO 
P.O. BOX 16 
NL - 6700 AA WAGENINGEN 
Tel. : 31837076980 
Fax : 31837015983 
VREUGDENHIL DICK 
DEPARTMENT OF PLANT PHYSIOLOGY 
WAGENINGEN AGRICULTURAL UNIVERSITY 
ARBORETUMLAAN 4 
NL - 6703 BD WAGENINGEN 
Tel. : 31837084229 
Fax : 31837084740 
WALDMANN HERMAN 
LABORATORIES BLOCK 
ADDENBROOKE'S HOSPITAL, LEVEL 3, 
HILLS ROAD 
GB - CB2 2QQ CAMBRIDGE 
Tel. : 44223336904 
Fax : 44223336901 
WALKER JOHN 
MRC LABORATORY OF MOLECULAR 
BIOLOGY 
HILLS ROAD 
GB - CB22QH CAMBRIDGE 
Tel. : 44223402239 
Fax : 44223412178 
Catalogue of contracts 
WALSH FRANKS. 
UNITED MEDICAL AND DENTAL SCHOOLS OF 
G UYS AND ST.THOMAS HOSPITALS 
ST.THOMAS'S CAMPUS 
GB - SE1 7EH LONDON BRIDGE 
Tel. : +44/1/928 9292 
Fax : +44/1/928 1468 
WALSH FRANKS. 
DEPT. OF EXPERIMENTAL PATHOLOGY 
UMDS GUY'S HOSPITAL 
LONDON BRIDGE 
GB - SEI 9RT LONDON 
Tel. : 0719554574 
Fax : 0714038883 
WALTER FIERS 
LABORATORY OF MOLECULAR BIOLOGY 
K.L. LEDEGANCKSTRAAT 35 
B- 9000 GENT 
Tel. : 3291645131 
Fax : 3291645348 
WAMBUTT ROLF 
ABON GMBH (FORMERLY FZB BIOTECHNIK 
GMBH) 
GLIENICKER WEG 185 
D - 12489 BERLIN 
Tel. : 67.05.72.38 
Tel. : 55.01.224 
Fax : 67057228/5501219 
WANG TREVOR L. 
JOHN INNES INSTITUTE 
JOHN INNES CENTRE 
COLNEY LANE 
GB - NR4 7UH NORWICH 
Tel. : 4460352571 
Fax : 4460356844 
E-mail: W ANG@UK.AC.AFRC.JII 
WASSEF MARION 
INSERM UNITE 106 NEUROMORPHOLOGIE 
DEPARTEMENT, EVOLUTION 
47 BOULEY ARD DE L'HOPITAL 
F- 75651 PARIS CEDEX 13 
Tel. : 33.1.45826100 
Fax : 33.1.45709990 
WATSON PAUL 
ROYAL VETERINARY COLLEGE 
ROYAL COLLEGE STREET 
GB - NWI OTU LONDON 
Tel. : 44.71.387.2898 
Fax : 44713882342 
E-mail: UJAAPFW@UK.AC.UCL 
List of participants 
WAlTS ANTHONY 
UNVERSITY OF OXFORD 
DEPART. OF BIOCHEMISTRY 
SOUTII PARKS ROAD 
GB - OX1 3QU OXFORD 
Tel. : 44865275268 
Fax : 44865275234 
E-mail: WATTS@V AX.OX.UK.AC 
WAUGH ROBERT 
SCOTTISH AGRICULTURAL RESEARCH 
INSTITUTES 
SCOTTISH CROP RESEARCH INSTITUTE 
INVER GOWRIE 
GB - DD2 5DA DUNDEE 
Tel. : 44.382.562731 
Fax : 44.382.562426 
WAYNE ROBERT 
CONSERVATION GENETICS 
INSTITUTE OF ZOOLOGY 
ZOOLOGICAL SOCIETY OF LONDON 
REGENT'S PARK 
GB - NW1 4RY LONDON 
Tel. : 44715863011 
Fax : 44715862870 
E-mail: R.WAYNE@UCL.AC.UK 
WEENING JAN JURJEN 
VAKGROEPPATHOLOGIE 
UNIVERSITY OF AMSTERDAM 
ACADEMIC MEDICAL CENTER 
MEIBERGDREEF 15 
NL - 1105 AZ AMSTERDAM ZUID-OOST 
Tel. : 31205664100 
Fax : 31206960389 
WEIMA SJERP 
HUBRECHT LABORATORY NETHERLANDS 
INSTITUTE FOR DEVELOPMENTAL 
BIOLOGY OF THE ROYAL NETHERLANDS 
UPPSALALAAN 8 
NL - 3584CT UTRECHT 
Tel. : 3130510211 
Fax : 3130516464 
WEISS MARY 
INSTITUT PASTEUR 
DEP ARTEMENT DE BIOLOGIE 
MOLECULLAIRE 
UNITE DE GENETIQUE DE LA 
DIFFERENCIATION 
25 RUE DU DOCTEUR ROUX 
F- 75724 PARIS 15 
Tel. : 33145688500 





D- 5000 KOLN 
Tel. : 492215062310 
Telex : 8 881 028 MPIZ D 
Fax : 492215062313 
WEISZ ALESSANDRO 
ISTITUTO DI PATOLOGIA GENERALE 
EONCOLOGIA 
PIAZZETIA S. ANDREA DELLE DAME 2 
I - 80138 NAPOLI 
Tel. : 39815665703 
Fax : 39815665695 
WELLS JEREMY 
UNIVERSITY OF CAMBRIDGE 
DEPARTMENT OF PATHOLOGY 
TENNIS COURT ROAD 
GB- CB21QP CAMBRIDGE 
Tel. : 44223333734 
Fax : 44223333346 
WESTHOF ERIC 
INSTITUT DE BIOLOGIE MOLECULAIRE ET 
CELLULAIRE 
CNRS UPR SMBMR 
15 RUE R. DESCARTES 
F- 67084 STRASBOURG CEDEX 
Tel. : 3388417046 
Fax : 3388610680 
E-mail: WESTHOF@IBMC.U-STRASBG.FR 
WESTHOFF PETER 
INSTITUT FUR ENTWICKLUNGS- UNO 
MOLEKULARBIOLOGIE DER PFLANZEN 
UNIVERSITATSSTRASSE 1 
D - W4000 DUESSELDORF I 
Tel. : 492113112338 
Fax : 492113114871 
WILKINSON DAVID 
NATIONAL INSTITUTE FOR MEDICAL 
RESEARCH 
335 
LAB OF EUKARYOTIC MOLECULAR GENETICS 
THE RIDGEWAY 
MILL HILL 
GB - NW71AA LONDON 
Tel. : 44819593666 
Fax : 44819064477 
336 
WILLIAMS DAVID CLIVE 
UNIVERSITY OF DUBLIN 
TRINITY COLLEGE 
BIOCHEMISTRY DEPARTMENT 
IRL - 2 DUBLIN 
Tel. : 35317021802 
Telex : 93782TCDEI 
Fax : 3531772400 
WILLIAMS JOHN 
INSTITUTE OF ANIMAL PHYSIOLOGY AND 
GENETICS RESEARCH 
GB - EH259PS ROSLIN 
Tel. : 0314402726 
Fax : 0314400434 
E-mail: WILLIAMSJL@AFRC.IAPE.AC.UK 
WILLIAMS STAN 
UNIVERSITY OF LIVERPOOL 
DEPARTMENT OF GENETICS + 
MICROBIOLOGY + ENVIRONMENTAL + 
EVOLUTIONARY BIOLOGY 
GB - L69 3BX LIVERPOOL 
Tel. : +44 51 794 2000 
Telex : 627095 UNILPL G 
Fax : +44 51 7086502 
WILLMITZER LOTHAR 




D - W1000 BERLIN 33 
Tel. : 493083000760 
Fax : 493083000736 
WILMUTIAN 
INSTITUTE OF ANIMAL PHYSIOWGY AND 
GENETICS RESEARCH 
GB - EH259PS ROSLIN 
Tel. : 44314402026 
Fax : 44314400434 
E-mail: WILMUTI@AFRC.IAPE.AC.UK 
WILSON KEITH 
EUROPEAN MOLECULAR BIOWGY 
LABORATORY 
HAMBURG OUTSTATION 
C/0 DESY, NOTKESTRASSE 85 
D - W2000 HAMBURG 52 
Tel. : 4940899020 
Fax : 494089902149 
E-mail: KEITH EMBL-HAMBURG.DE 
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WITTINGHOFER FRED 
MAX PLANCK INSTITUT 
FOR MOLEKULARE PHYSIOLOGIE 
RHEINLANDDAMM 201 
D - 44139 DORTMUND 
Tel. : 49.231.1206280 
Fax : 49.231.1206230 
WODAK SHOSHANA 
UNITE DE CONFORMATION DE 
MACROMOLECULES BIOWGIQUES 
A VENUE PAUL HEGER 
CP160/16 
B- 1050 BRUXELLES 
Tel. : 3226485200 




INSTITUT FUR BIOWGIE IV 
(MIKROBIOLOGIE) 
WORRINGER WEG 
D - 52056 AACHEN 
Tel. : 49.241.806600 
Fax : 49.241.806602 
WOLF HERMAN FRIDMAN 
LABORATORY OF CELLULAR AND CLINICAL 
IMMUNOLOGY INSERM UNIT 255 
INSTITUT CURIE 
26 RUE D'ULM 
F- 75231 PARIS 05 
Tel. : 33142324220 
Fax : 33140510420 
WOLFE KENNETH 
UNIVERSITY OF DUBLIN 
TRINITY COLLEGE 
DEPARTMENT OF GENETICS 
LINCOLN PLACE GATE 
IRL - DUBLIN 2 
Tel. : 353.1.702.1064 
Fax : 353.1.679.8558 
WOLLMAN FRANCIS-ANDRE 
INSTITUT DE BIOLOGIE PHYSICO-CHIMIQUE 
SERVICE DE PHOTOSYNTHESE 
13 RUE PIERRE ET MARIE CURIE 
F- 75005 PARIS 
Tel. : 33143252609 
Fax : 33140468331 
List of participants 
WONNACOTT SUSAN 
UNIVERSITY OF BATH 
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